{
    "status": "OK",
    "results": {
        "docsMatched": 259,
        "docsExported": 259,
        "docs": [
            {
                "index": "1",
                "publicationKey": "CN_103724406_A",
                "lensId": "180-329-618-278-655",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 103724406 A",
                "publicationDate": "2014-04-16",
                "filingNumber": "CN 201310581981 A",
                "filingDate": "2013-11-20",
                "priorityFilingKeysActive": [
                    "CN 201310581981 A 20131120"
                ],
                "earliestPriorityDate": "2013-11-20",
                "title": "Mers-cov (middle East Respiratory Syndrome Coronavirus) Synthetic Peptide Vaccine With Neutralization Activity And Application Of Mers-cov Synthetic Peptide Vaccine",
                "applicants": [
                    "INST VIRAL DISEASE CONTROL & PREVENTION CHINESE CT DISEASE CONTROL & PREVENTION"
                ],
                "inventors": [
                    "TAN WENJIE",
                    "WEN BO",
                    "DENG YAO",
                    "YANG YANG",
                    "GENG HEYUAN",
                    "MENG XIN",
                    "WANG HUIJUAN"
                ],
                "owners": [],
                "url": "https://lens.org/180-329-618-278-655",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 4,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K39/215",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "HE Y.\u7b49: \"Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design\", \u300aJOURNAL OF VIROLOGY\u300b, vol. 80, no. 12, 30 June 2006 (2006-06-30), pages 5757 - 5767",
                    "WANG N.\u7b49: \"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4\", \u300aCELL RESEARCH\u300b, no. 23, 9 July 2013 (2013-07-09), pages 986 - 993"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "2",
                "publicationKey": "WO_2015_057966_A2",
                "lensId": "022-760-401-941-857",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2015/057966 A2",
                "publicationDate": "2015-04-23",
                "filingNumber": "US 2014/0060906 W",
                "filingDate": "2014-10-16",
                "priorityFilingKeysActive": [
                    "US 201361891677 P 20131016",
                    "US 201461993332 P 20140515"
                ],
                "earliestPriorityDate": "2013-10-16",
                "title": "Therapies, Vaccines, And Predictive Methods For Middle East Respiratory Syndrome Virus (mers Cov)",
                "applicants": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "inventors": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "owners": [],
                "url": "https://lens.org/022-760-401-941-857",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 239,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/70",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2317/34",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "G01N33/56983",
                    "G01N2333/165"
                ],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "3",
                "publicationKey": "WO_2015_057966_A3_20150618",
                "lensId": "102-393-490-848-432",
                "jurisdiction": "WO",
                "kindCode": "A3",
                "displayKey": "WO 2015/057966 A3",
                "publicationDate": "2015-06-18",
                "filingNumber": "US 2014/0060906 W",
                "filingDate": "2014-10-16",
                "priorityFilingKeysActive": [
                    "US 201361891677 P 20131016",
                    "US 201461993332 P 20140515"
                ],
                "earliestPriorityDate": "2013-10-16",
                "title": "Therapies, Vaccines, And Predictive Methods For Middle East Respiratory Syndrome Virus (mers Cov)",
                "applicants": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "inventors": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "owners": [],
                "url": "https://lens.org/102-393-490-848-432",
                "docType": "Search report",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 239,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/70",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2317/34",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "G01N33/56983",
                    "G01N2333/165"
                ],
                "ipcrClassifications": [
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "DE GROOT ET AL.: \"Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group\", JOURNAL OF VIROLOGY, vol. 87, no. 14, 15 May 2013 (2013-05-15), pages 7790 - 7792"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "083-152-458-546-878"
                ],
                "nplResolvedExternalIDs": [
                    "23678167",
                    "pmc3700179",
                    "10.1128/jvi.01244-13"
                ]
            },
            {
                "index": "4",
                "publicationKey": "WO_2015_161908_A1",
                "lensId": "024-553-140-872-320",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/161908 A1",
                "publicationDate": "2015-10-29",
                "filingNumber": "EP 2015000543 W",
                "filingDate": "2015-03-11",
                "priorityFilingKeysActive": [
                    "US 201461951106 P 20140311",
                    "US 201461951742 P 20140312"
                ],
                "earliestPriorityDate": "2014-03-11",
                "title": "Non-immunosuppressive Cyclophilin Inhibitors For The Treatment Of Coronavirus Infections",
                "applicants": [
                    "LUDWIG MAXIMILIANS UNIVERSIT\u00c4T M\u00dcNCHEN"
                ],
                "inventors": [
                    "NAOUMOV NIKOLAI",
                    "VON BRUNN ALBRECHT"
                ],
                "owners": [],
                "url": "https://lens.org/024-553-140-872-320",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 10,
                "cpcClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K38/12",
                    "A61K45/06",
                    "A61K2300/00"
                ],
                "ipcrClassifications": [
                    "A61K38/12",
                    "A61K31/7056",
                    "A61K38/13",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "JAVIER CARBAJO-LOZOYA ET AL: \"Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir\", VIRUS RESEARCH, vol. 184, 22 February 2014 (2014-02-22), pages 44 - 53, XP055206009, ISSN: 0168-1702, DOI: 10.1016/j.virusres.2014.02.010",
                    "TAN E L C ET AL: \"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs\", EMERGING INFECTIOUS DISEASES, EID, ATLANTA, GA, US, vol. 10, no. 4, 1 April 2004 (2004-04-01), pages 581 - 586, XP008102827, ISSN: 1080-6040, Retrieved from the Internet <URL:http://www.cdc.gov/ncidod/EID/vol10no4/03-0458.htm> [retrieved on 20150803]",
                    "MORGENSTERN B ET AL: \"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines\", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 326, no. 4, 28 January 2005 (2005-01-28), pages 905 - 908, XP004682899, ISSN: 0006-291X, DOI: 10.1016/J.BBRC.2004.11.128"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "074-960-744-959-701",
                    "064-999-125-102-982",
                    "129-401-973-660-415"
                ],
                "nplResolvedExternalIDs": [
                    "10.3201/eid1004.030458",
                    "24566223",
                    "pmc3323075",
                    "10.1016/j.virusres.2014.02.010",
                    "15607755",
                    "15200845",
                    "10.1016/j.bbrc.2004.11.128"
                ]
            },
            {
                "index": "5",
                "publicationKey": "US_9266844_B2",
                "lensId": "114-859-966-167-438",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9266844 B2",
                "publicationDate": "2016-02-23",
                "filingNumber": "US 201313919951 A",
                "filingDate": "2013-06-17",
                "priorityFilingKeysActive": [
                    "US 201261689952 P 20120615"
                ],
                "earliestPriorityDate": "2012-06-15",
                "title": "Suppression Of Sars Replication By Sars Helicase Inhibitors",
                "applicants": [
                    "UNIV MISSOURI"
                ],
                "inventors": [
                    "SARAFIANOS STEFAN G",
                    "ADEDEJI ADEYEMI O",
                    "SINGH KAMLENDRA"
                ],
                "owners": [
                    {
                        "name": "THE CURATORS OF THE UNIVERSITY OF MISSOURI",
                        "executionDate": "2013-08-22"
                    }
                ],
                "url": "https://lens.org/114-859-966-167-438",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 16,
                "cpcClassifications": [
                    "C07D249/12",
                    "A61K31/4196",
                    "C12Q1/18",
                    "G01N2333/165"
                ],
                "ipcrClassifications": [
                    "A61K31/4196",
                    "C07D249/12",
                    "C12Q1/18"
                ],
                "usClassifications": [],
                "nplCitationCount": 19,
                "nplCitations": [
                    "Talawar et al., Indian Journal of Heterocyclic Chemistry, vol. 5, Jan.-Mar. 1996, pp. 215-218.",
                    "CAS RN 675104-49-1, Indexed in STN Registry database, Entered STN Apr. 14, 2004. Accessed Jun. 15, 2015.",
                    "Ito et al. In Cancer Science 94(1), 3-8 (2003).",
                    "Adedeji et al., \"Identification of a Novel Inhibitor That Prevents SARS-CoV Replication by Interfering with the Unwinding Mechanism of the Viral Helicase,\" 12th Annual Symposium on Antiviral Drug Resistance, Nov. 2011.",
                    "Adedeji et al., \"Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral Helicase,\" Antimicrobial Agents and Chemotherapy 56(9):4718-4728, Sep. 2012.",
                    "Adedeji et al., \"Mechanism of nucleic acid unwinding by SARS-CoV Helicase,\" PLoS One 7(5):e36521, May 2012.",
                    "Adedeji et al., \"SARS-CoV Replication Inhibitor that Interferes with the Nucleic Acid Unwinding of the Viral Helicase,\" Antimicrob Agents Chemother 56:4718-28, 2012.",
                    "Adedeji et al., \"Structural and biochemical basis for the difference in the helicase activity of two different constructs of sars-cov helicase,\" Cell Mol Biol 58:114-121, 2012.",
                    "Alasdair et al., \"Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites,\" Oxford Journals 21:1906-1908, 2005.",
                    "Almazan et al., \"Construction of a severe acute respiratory syndrome coronavirus infections cDNA clone and a replicon to study coronavirus RNA synthesis,\" J Virol 80:10900-10906, 2006.",
                    "Durk et al., \"Inhibitors of foot and mouth disease virus targeting a novel pocket of the RNA-dependent RNA polymerase,\" PLoS One 5:e15049, 2010.",
                    "International Search Report and Written Opinion issued in PCT/US2013/0461999, dated Nov. 5, 2013.",
                    "Ivanov et al., \"Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase,\" J Virol 78:5619-5632, 2004.",
                    "Kleymann, \"New antiviral drugs that target herpesvirus helicase primase enzymes,\" Herpes 10(2):46-52, 2003.",
                    "Kwong et al., \"Viral and Cellular RNA Helicases as Antiviral Targets,\" Nature Reviews Drug Discovery 4:845-853, Oct. 2005.",
                    "Sarafianos et al., \"Mechanism of polyoxometalate-mediated inactivation of DNA polymerases: an analysis with HIV-1 reverse transcriptase indicates specificity for the DNA-binding cleft,\" Biochem J 319(Pt 2):619-626, 1996.",
                    "Sharma et al., \"DNA helicases as targets for anti-cancer drugs,\" Curr Med Chem Anticancer Agents 5(3):183-99, 2005.",
                    "Tanner et al., \"The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases,\" J Biol Chem 278:39578-39582, 2003.",
                    "Zhang et al., \"A simple statistical parameter for use in evaluation and validation of high throughput screening assays,\" J Biomol Screen 4:67-73, 1999."
                ],
                "nplResolvedCount": 15,
                "nplResolvedLensIDs": [
                    "003-518-463-670-939",
                    "028-450-139-890-891",
                    "069-366-695-251-949",
                    "031-350-975-474-711",
                    "004-001-811-739-459",
                    "044-313-524-523-851",
                    "059-862-174-165-412",
                    "064-753-583-450-482",
                    "004-336-171-565-212",
                    "013-102-099-846-742",
                    "052-044-410-776-241",
                    "040-448-762-727-406",
                    "145-098-152-895-779",
                    "035-017-401-933-161",
                    "132-910-657-022-562"
                ],
                "nplResolvedExternalIDs": [
                    "10.1074/jbc.c300328200",
                    "15701681",
                    "10838414",
                    "15992349",
                    "10.1038/nrd1853",
                    "16928748",
                    "10.1128/aac.00957-12",
                    "10.1042/bj3190619",
                    "10.1128/jvi.00385-06",
                    "10.1371/journal.pone.0015049",
                    "10.1177/108705719900400206",
                    "12708466",
                    "10.1128/jvi.78.11.5619-5632.2004",
                    "10.1371/journal.pone.0036521",
                    "22615777",
                    "21203539",
                    "15140959",
                    "pmc3421890",
                    "pmc415832",
                    "pmc1217812",
                    "14577954",
                    "22733076",
                    "23273200",
                    "pmc3006429",
                    "8912703",
                    "pmc1641757",
                    "12917423",
                    "16184083",
                    "10.1111/j.1349-7006.2003.tb01343.x",
                    "10.2174/1568011053765985",
                    "pmc3352918",
                    "10.1093/bioinformatics/bti315",
                    "12708475"
                ]
            },
            {
                "index": "6",
                "publicationKey": "US_2016_0082074_A1",
                "lensId": "025-205-095-624-576",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0082074 A1",
                "publicationDate": "2016-03-24",
                "filingNumber": "US 201514707356 A",
                "filingDate": "2015-05-08",
                "priorityFilingKeysActive": [
                    "US 201461951106 P 20140311",
                    "US 201461951742 P 20140312"
                ],
                "earliestPriorityDate": "2014-03-11",
                "title": "Compositions And Methods For Treating Coronavirus Infection",
                "applicants": [
                    "UNIV MUENCHEN L MAXIMILIANS"
                ],
                "inventors": [
                    "NAOUMOV NIKOLAI",
                    "VON BRUNN ALBRECHT"
                ],
                "owners": [
                    {
                        "name": "LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN",
                        "executionDate": "2016-05-30"
                    },
                    {
                        "name": "NOVARTIS AG",
                        "executionDate": "2015-03-09"
                    },
                    {
                        "name": "NOVARTIS PHARMA AG",
                        "executionDate": "2015-03-09"
                    }
                ],
                "url": "https://lens.org/025-205-095-624-576",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 10,
                "cpcClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K38/12",
                    "A61K45/06",
                    "A61K2300/00"
                ],
                "ipcrClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "7",
                "publicationKey": "CN_105543409_A",
                "lensId": "052-588-339-613-030",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 105543409 A",
                "publicationDate": "2016-05-04",
                "filingNumber": "CN 201510920098 A",
                "filingDate": "2015-12-11",
                "priorityFilingKeysActive": [
                    "CN 201510920098 A 20151211"
                ],
                "earliestPriorityDate": "2015-12-11",
                "title": "Double-target-gene Real-time Fluorescent Pcr Detection Method For Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "SHANGHAI ENTRY-EXIT INSPECTION AND QUARANTINE BUREAU OF THE PEOPLE'S REPUBLIC OF CHINA"
                ],
                "inventors": [
                    "TIAN ZHENGAN",
                    "LI SHENWEI",
                    "ZHANG XIAOHANG",
                    "ZHANG ZILONG",
                    "TAN WENJIE"
                ],
                "owners": [],
                "url": "https://lens.org/052-588-339-613-030",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 1,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [
                    "Y02A50/451"
                ],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12Q1/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "XIAOYAN LU\u7b49: \"Real-Time Reverse Transcription-PCR Assay Panel for Middle East Respiratory Syndrome Coronavirus\", \u300aJOURNAL OF CLINICAL MICROBIOLOGY\u300b",
                    "RITA DE SOUSA\u7b49: \"MERS coronavirus: Data gaps for laboratory preparedness\", \u300aJOURNAL OF CLINICAL VIROLOGY\u300b",
                    "BERIHUN DIRES\u7b49: \"Review on Middle East Respiratory\", \u300aOPEN ACCESS LIBRARY JOURNAL\u300b"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "8",
                "publicationKey": "US_9415087_B2",
                "lensId": "032-435-067-652-921",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9415087 B2",
                "publicationDate": "2016-08-16",
                "filingNumber": "US 201514707356 A",
                "filingDate": "2015-05-08",
                "priorityFilingKeysActive": [
                    "US 201461951106 P 20140311",
                    "US 201461951742 P 20140312"
                ],
                "earliestPriorityDate": "2014-03-11",
                "title": "Compositions And Methods For Treating Coronavirus Infection",
                "applicants": [
                    "LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN"
                ],
                "inventors": [
                    "NAOUMOV NIKOLAI",
                    "VON BRUNN ALBRECHT"
                ],
                "owners": [
                    {
                        "name": "LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN",
                        "executionDate": "2016-05-30"
                    },
                    {
                        "name": "NOVARTIS AG",
                        "executionDate": "2015-03-09"
                    },
                    {
                        "name": "NOVARTIS PHARMA AG",
                        "executionDate": "2015-03-09"
                    }
                ],
                "url": "https://lens.org/032-435-067-652-921",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 10,
                "cpcClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K38/12",
                    "A61K45/06",
                    "A61K2300/00"
                ],
                "ipcrClassifications": [
                    "A61K38/13",
                    "A61K31/7056",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 65,
                "nplCitations": [
                    "Carbajo-Lozoya et al. Virus Research. 184, 44-53. 2014.",
                    "Medical Xpress. MedicalXpress.com. \"Derivatives of a known drug inhibity the replication of a pathogenic coronavirus.\" Mar. 18, 2014.",
                    "Koren et al. JAMC. 168(10). 1289-1292. 2003.",
                    "Adedeji, et al., \"Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses\", Antimicrobial Agents and Chemotherapy, 58(8):4894, May 2014.",
                    "An, et al., \"Regulatory Polymorphisms in the Cyclophilin Gene, PPIA, Accelerate Progression to AIDS\", PLoS Pathog, 3(6):e88 Jun. 2007.",
                    "Arbour, et al., \"Neuroinvasion by Human Respiratory Coronaviruses\", Journal of Virology, 74(19):8913-8921, Oct. 2000.",
                    "Arevalo-Rodriguez, et al., \"Cyclophilin A and Ess1 interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase\", The EMBO Journal, 19(14):3739-3749, 2000.",
                    "Bartenschlager, et al., \"Efficient hepatitis C virus cell Culture system: What a difference the host cell makes\", PNAS, 102(28):9739-9740, Jul. 12, 2005.",
                    "Bigham, et al., \"Variants in Host Viral Replication Cycle Genes are Associated with Heterosexual HIV-1 Acquisition in Africa\", J. Acquir Immune Defic Syndr, 66(2):127-134, Jun. 2014.",
                    "Blight, et al., \"Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication\" Journal of Virology, 76(24):13001-13014, Dec. 2002.",
                    "Carbajo-Lozoya, et al., \"Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506\", Virus Research 165:112-117, Jan. 2012.",
                    "Carbajo-Lozoya, et al., \"Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosupressive cyclosporine A-derivatives including Alisporivir\", Virus Research, 184:44-53, Jan. 2014.",
                    "Cervantes-Barragan, et al., \"Dendritic Cell-Specific Antigen Delivery by Coronavirus Vaccine Vectors Induces Long-Lasting Protective Antiviral and Antitumor Immunity\", mBio, 1(4):e00171-10, Sep./Oct. 2010.",
                    "Collins, \"In Vitro Detection of Apoptosis in Monocytes/Macrophages Infected with Human Coronavirus\", Clinical and Diagnostic Laboratory Immunology, 9(6):1392-1395, Nov. 2002.",
                    "De Paulis, et al., \"Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine\", J. Allergy Clin. Immunol, 98(1):153-164, Jul. 1996.",
                    "Desforges, et al., \"HCoV-229E Infects and Activates Monocytes\", Adv. Exp. Med. Biol., 581:511-514. 2006.",
                    "De Wilde, et al., \"Cyclosporin A inhibits the replication of diverse coronaviruses\", Journal of General Virology, 92:2542-2548, Jun. 2011.",
                    "De Wilde, et al., \"Cyclosphilin Inhibitors Block Arterivirus Replication by Interfering with Viral RNA Synthesis\", J. Virol., 87(3):1454, Nov. 2012.",
                    "De Wilde, et al., \"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporine A or interferon-alpha treatment\", Journal of General Virology, 94:1749-1760, Mar. 2013.",
                    "De Wilde, et al., \"Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture\", Antimicrob. Agents Chemother. 58(8):4875, May 2014.",
                    "Dijkman, et al., \"Human Coronavirus NL63 and 229E Seroconversion in Children\", Journal of Clinical Microbiology, 46(7):2368-2373, Jul. 2008.",
                    "Dijkman, et al., \"The dominance of human coronavirus OC43 and NL63 infections in infants\", Journal of Clinical Virology, 53:135-139, Nov. 2011.",
                    "Dyall, et al., \"Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection\", Antimicrobial Agents and Chemotherapy, 58(8):4885, May 2014.",
                    "Feigelstock, et al., \"Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I\", Virology Journal, 7:10, Feb. 2010.",
                    "Friebe, et al., \"Kissing-Loop Interaction in the 3' End of the Hepatitis C Virus Genome Essential for RNA Replication\", Journal of Virology, 79(1):380-392, Jan. 2005.",
                    "Gallay, et al., \"Profile of alisporivir and its potential in the treatment of hepatitis C\", Drug Design, Development and Therapy, 7:105-115, 2013.",
                    "Gaunt, et al., \"Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method\", Journal of Clinical Microbiology, 48(8):2940, Jun. 2010.",
                    "Ge, et al., \"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor\", Nature, 503:535-538, Nov. 2013.",
                    "Gemmill, et al., \"Vanishingly Low Levels of Ess1 Prolyl-isomerase Activity Are Sufficient for Growth in Saccharomyces cerevisiae\", The Journal of Biological Chemistry, 280(16):15510-15517, Apr. 2005.",
                    "Hemida, et al., \"Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013\", Euro Surveill., 18(50):pii=20659, Dec. 2013.",
                    "Hopkins, et al., \"SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA Replication In Vitro\", Antimicrobial Agents and Chemotherapy, 54(2):660-672, Feb. 2010.",
                    "Huang, et al., \"Rapamycins-Mechanism of Action and Cellular Resistance\", Cancer Biology & Therapy, 2(3):222-232, May/Jun. 2003.",
                    "Huynh, et al., \"Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63\", Journal of Virology, 86(23):12816, Sep. 2012.",
                    "Koren, et al., \"Ribavirin in the treatment of SARS: A new trick for an old drug?\", Canadian Medical Association or its licensors, 168(10):1289-1292, May 2003.",
                    "Koutsoudakis, et al., \"The Level of CD81 Cell Surface Expression is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells\", Journal of Virology, 81(2):588-598, Jan. 2007.",
                    "Lafemina, \"Alternative Screening Approaches for Discovery of MERS Coronavirus Inhibitors\", Antimicrob. Agents Chemother. doi:10.1128/AAC.03406-14, American Society for Microbiology, Jun. 2014.",
                    "Lang, et al., \"Catalysis of protein folding by prolyl isomerase\", Letters to Nature, 329:268-270, Sep. 1987.",
                    "Legrue, et al., \"Does the Binding of Cyclosporine to Calmodulin Result in Immunosuppression\", Science, 234:68-71, Oct. 1986.",
                    "Lin, \"Curing a viral infection by targeting the host: The example of cyclophilin inhibitors\", Antiviral Research, 99:68-77, Jan. 2013.",
                    "Ludwig Maximilian University of Munich, \"Derivatives of a known drug inhibit the replication of a pathogenic coronavirus\", MedicalXpress, http://medicalxpress.com/news/2014-03-derivatives-drug-inhibit-replication-pathogenic.html , Mar. 18, 2014.",
                    "Lundin, et al., \"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus\", PLOS, 10(5):e1004166, May 2014.",
                    "Luo, et al., \"Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A\", Biochemical and Biophysical Research Communications, 321:557-565, Jun. 2004.",
                    "Malesevic, et al., \"Anti-inflammatory Effects of Extracellular Cyclosporins are Exclusively Mediated by CD147\", Journal of Medicinal Chemistry, 56:7302-7311, May 2013.",
                    "Membreno, et al., \"Cyclophilin Inhibitors for Hepatitis C Therapy\", Clin Liver Dis, 17:129-139, 2013.",
                    "Mesel-Lemoine, et al., \"A Human Coronavirus Responsible for the Common Cold Massively Kills Dendritic Cells but Not Monocytes\", Journal of Virology, 86(14):7577-7587, Jul. 2012.",
                    "Naoumov, \"Cyclophilin inhibition as potential therapy for liver disease\", Journal of Hepatology, 61:1166-1174, Nov. 2014.",
                    "Neuman, et al., \"Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3\", Journal of Virology, 82(11):5279-5294, Jun. 2008.",
                    "Nigro, et al., \"Cyclophilin A: a key player for human disease\", Cell Death and Disease, 4, e888, doi:10.1038/cddis.2013.410, Oct. 2013.",
                    "Perlman, et al., \"Coronaviruses post-SARS: update on replication and pathogenesis\", Nature Reviews Microbiology, 7:439-450, Jun. 2009.",
                    "Pfefferle, et al., \"Distant Relatives of Severe Acute Respiratory Syndrome Coronavirus and Close Relatives of Human Coronavirus 229E in Bats, Ghana\", Emerging Infectious Diseases, 15(9):1377-1384, Sep. 2009.",
                    "Pfefferle, et al., \"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors\", PLoS, 7(10):e1002331 Oct. 2011.",
                    "Prell, et al., \"Fine Tuning the Inhibition Profile of Cyclosporine A by Derivatization of the MeBmt Residue\", ChemBioChem, 14:63-65 2013.",
                    "Raj, et al., \"Dipeptidyl peptisdase 4 is a functional receptor for the emerging human coronavirus-EMC\", Letter, 495:251-256, Mar. 2013.",
                    "Reusken, et al., \"Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study\", LancetInfect Dis, 13:859-866 Oct. 2013.",
                    "Riva, et al., Hepatitis C virus and interferon type III (interferon lambda 3/interleukin 28B and interferon lambda 4): genetic basis of susceptibility to infection and response to antiviral treatment, Clinical Microbiology and Infection (Impact Factor: 5.77), doi: 10.1111/1469-0691.12797, Oct. 2014.",
                    "Sanglier, et al., \"Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110\", The Journal of Antibiotics, 52(5):466-473, May 1999.",
                    "Sastre, \"Differentiation between Human Coronaviruses NL63 and 229E Using a Novel Double-Antibody Sandwich Enzyme-Linked Immunosorbent Assay Based on Specific Monoclonal Antibodies\", Clin. Vaccine Immunol., 18(1):113, Nov. 2010.",
                    "Sims, et al., \"SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium\", ScienceDirect, 133:33-44, Apr. 2007.",
                    "Stadler, et al., \"SARS-Beginning to Understand a New Virus\", Nature Reviews Microbiology, 1:209-218, Dec. 2003.",
                    "Van Der Hoek, et al., \"Identification of a new human coronavirus\", Nature Medicine, published online, doi:10.1038.nm1024, Mar. 2004.",
                    "Van Hemert, et al., The inVitro RNA Synthesizing Activity of the Isolated ARterivirus Replication/Transcription Complex is Dependent on a Host Factor, The Journal of Biological Chemistry, 283(24):16525-16536, Jun. 2008.",
                    "Vijgen, et al., \"Complete Genomic Sequence of Human Cornoavirus OC43: Molecular Clock Analysis Suggests a Relatively Recent Zoonotic Coronavirus Transmission Event\", Journal of Virology, 79(3):1595-1604, Feb. 2005.",
                    "Von Hahn, et al., \"Hepatocytes that Express Variants of Cyclophilin A are Resistant to HCV Infection and Replication\", Gastroenterology, 143(2):439-447, Oct. 2011.",
                    "Woo, et al., \"Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia\", Journal of Virology, 79(2):884-895, Jan. 2005.",
                    "Zhou, et al., \"Cyclophilin A and viral infections\", Biochemical and Biophysical Research Communications, 424:647-650 Jun. 2012."
                ],
                "nplResolvedCount": 62,
                "nplResolvedLensIDs": [
                    "022-404-814-149-218",
                    "010-366-466-549-230",
                    "069-503-293-645-943",
                    "013-724-125-892-168",
                    "034-180-651-577-351",
                    "075-322-231-917-450",
                    "023-111-442-014-271",
                    "071-228-272-039-774",
                    "079-193-165-875-201",
                    "056-950-079-112-567",
                    "103-927-858-988-784",
                    "011-438-250-833-909",
                    "170-734-804-561-178",
                    "005-483-816-218-442",
                    "046-508-989-530-587",
                    "033-514-299-309-606",
                    "050-487-825-790-264",
                    "133-972-307-208-56X",
                    "084-383-272-528-908",
                    "064-999-125-102-982",
                    "011-379-100-989-88X",
                    "009-000-123-209-750",
                    "085-642-156-816-769",
                    "004-534-339-587-19X",
                    "094-971-760-491-845",
                    "034-987-129-287-957",
                    "069-221-292-019-080",
                    "142-004-422-588-420",
                    "138-840-356-153-97X",
                    "009-038-449-146-60X",
                    "114-615-248-574-417",
                    "039-053-666-913-127",
                    "088-764-625-204-541",
                    "017-353-572-975-921",
                    "064-672-615-629-942",
                    "038-278-863-521-49X",
                    "032-660-874-366-359",
                    "016-680-514-013-427",
                    "134-508-343-769-601",
                    "071-582-679-256-924",
                    "052-375-350-750-096",
                    "006-985-494-194-594",
                    "012-852-742-797-721",
                    "108-229-899-337-383",
                    "081-307-021-537-929",
                    "020-009-029-407-493",
                    "093-074-771-307-71X",
                    "033-737-476-374-790",
                    "084-893-855-384-248",
                    "073-038-408-550-957",
                    "055-961-145-484-279",
                    "088-862-562-214-599",
                    "019-231-459-111-141",
                    "020-132-199-967-470",
                    "006-981-427-811-70X",
                    "002-186-688-852-050",
                    "073-682-937-516-081",
                    "013-333-138-079-426",
                    "056-936-059-383-537",
                    "086-963-615-655-137",
                    "026-518-238-956-425",
                    "012-232-117-412-374"
                ],
                "nplResolvedExternalIDs": [
                    "10.1371/journal.ppat.1002331",
                    "10.3201/eid1509.090224",
                    "pmc3554155",
                    "pmc2831881",
                    "10.1038/nature12711",
                    "10.1128/mbio.00171-10",
                    "pmc4136071",
                    "24172901",
                    "10.1016/j.jhep.2014.07.008",
                    "pmc3352363",
                    "24874215",
                    "10.1128/jvi.00906-12",
                    "15596831",
                    "17451829",
                    "10.1128/aac.02994-14",
                    "pmc3920964",
                    "18495857",
                    "24841268",
                    "10.1099/vir.0.034983-0",
                    "23440335",
                    "24841269",
                    "10.1128/jvi.74.19.8913-8921.2000",
                    "pmc3203193",
                    "10.1073/pnas.0504296102",
                    "10.1016/j.virusres.2007.03.013",
                    "10.1038/329268a0",
                    "22580540",
                    "10.1128/aac.03036-14",
                    "10.1128/jvi.79.1.380-392.2005",
                    "10.2807/1560-7917.es2013.18.50.20659",
                    "10480570",
                    "pmc130109",
                    "24463784",
                    "24841273",
                    "pmc3497669",
                    "23486063",
                    "10.1074/jbc.m708136200",
                    "10.1128/jvi.79.3.1595-1604.2005",
                    "10.1128/jvi.76.24.13001-13014.2002",
                    "19933795",
                    "pmc2830095",
                    "pmc3578503",
                    "10.7164/antibiotics.52.466",
                    "10.1053/j.gastro.2012.04.053",
                    "15728580",
                    "22349148",
                    "10.1016/j.cld.2012.09.008",
                    "10.1128/jvi.01534-06",
                    "22046132",
                    "15613317",
                    "23177289",
                    "10982334",
                    "23964991",
                    "15035025",
                    "25273834",
                    "pmc3416289",
                    "12743076",
                    "24867994",
                    "10.1128/cvi.00355-10",
                    "18411274",
                    "pmc4038610",
                    "17079281",
                    "3749892",
                    "21084464",
                    "pmc313981",
                    "pmc4136000",
                    "pmc1797465",
                    "10.4161/cbt.2.3.360",
                    "10.1097/qai.0000000000000113",
                    "15358143",
                    "20844609",
                    "10.1016/j.virusres.2012.02.002",
                    "10.1038/nrmicro775",
                    "pmc136668",
                    "10.1128/cdli.9.6.1392-1395.2002",
                    "23933067",
                    "10.2147/dddt.s30946",
                    "pmc2395186",
                    "17590083",
                    "12414783",
                    "10.1128/jvi.00269-12",
                    "8765829",
                    "10.1128/aac.00660-09",
                    "pmc154189",
                    "10.1038/cddis.2013.410",
                    "10.1128/jvi.02631-07",
                    "pmc2384224",
                    "12438626",
                    "10.1128/jvi.02078-12",
                    "10.1038/nrmicro2147",
                    "20554810",
                    "pmc2916580",
                    "10.1016/s1473-3099(13)70164-6",
                    "10.1128/jcm.00533-08",
                    "10.1371/journal.ppat.0030088",
                    "24566223",
                    "pmc3019789",
                    "15998731",
                    "10.1016/j.virusres.2014.02.010",
                    "10.1016/j.bbrc.2012.07.024",
                    "10.1128/aac.03406-14",
                    "10.1128/jcm.00636-10",
                    "10.1093/emboj/19.14.3739",
                    "10.1021/jm4007577",
                    "10899127",
                    "10.1016/j.bbrc.2004.07.003",
                    "10.1016/j.jcv.2011.11.011",
                    "22993147",
                    "22814107",
                    "3306408",
                    "10.1002/cbic.201200621",
                    "23620378",
                    "10.1128/aac.03011-14",
                    "10.1126/science.3749892",
                    "19430490",
                    "12878853",
                    "10.1371/journal.ppat.1004166",
                    "pmc1894826",
                    "23578729",
                    "pmc538593",
                    "10.1074/jbc.m412172200",
                    "15650185",
                    "pmc2446899",
                    "pmc2812147",
                    "pmc4025588",
                    "24176846",
                    "pmc102086",
                    "10.1016/s0091-6749(96)70237-3",
                    "10.1111/1469-0691.12797",
                    "10.1007/978-0-387-33012-9_91",
                    "pmc544107",
                    "22188723",
                    "10.1128/jvi.79.2.884-895.2005",
                    "10.1038/nature12005",
                    "25048953",
                    "20170495",
                    "pmc4136041",
                    "22553325",
                    "10.1016/j.antiviral.2013.03.020",
                    "17037587",
                    "10.1099/vir.0.052910-0",
                    "pmc1175013",
                    "19788804",
                    "10.1186/1743-422x-7-44",
                    "23225707",
                    "pmc3749523",
                    "pmc4135998",
                    "pmc2819850",
                    "pmc4332838",
                    "pmc538730",
                    "24342517",
                    "21752960",
                    "18367524",
                    "23152531"
                ]
            },
            {
                "index": "9",
                "publicationKey": "US_2016_0235837_A1",
                "lensId": "185-808-559-387-025",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0235837 A1",
                "publicationDate": "2016-08-18",
                "filingNumber": "US 201415029169 A",
                "filingDate": "2014-10-16",
                "priorityFilingKeysActive": [
                    "US 201361891677 P 20131016",
                    "US 201461993332 P 20140515"
                ],
                "earliestPriorityDate": "2013-10-16",
                "title": "Therapies, Vaccines, And Predictive Methods For Middle East Respiratory Syndrome Virus (mers Cov)",
                "applicants": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "inventors": [
                    "BOGOCH SAMUEL",
                    "BOGOCH ELENORE S",
                    "BORSANYI ANNE-ELENORE BOGOCH",
                    "BOGOCH SAMUEL WINSTON"
                ],
                "owners": [],
                "url": "https://lens.org/185-808-559-387-025",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 239,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/70",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2317/34",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "G01N33/56983",
                    "G01N2333/165"
                ],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C07K14/005",
                    "C07K16/10",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "de Groot et al. \"Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group\u201d J. Virol. 2013; 87(14): 7790-7792"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "083-152-458-546-878"
                ],
                "nplResolvedExternalIDs": [
                    "23678167",
                    "pmc3700179",
                    "10.1128/jvi.01244-13"
                ]
            },
            {
                "index": "10",
                "publicationKey": "CN_106309961_A",
                "lensId": "068-522-843-479-95X",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 106309961 A",
                "publicationDate": "2017-01-11",
                "filingNumber": "CN 201510355543 A",
                "filingDate": "2015-06-19",
                "priorityFilingKeysActive": [
                    "CN 201510355543 A 20150619"
                ],
                "earliestPriorityDate": "2015-06-19",
                "title": "Traditional Chinese Medicine Extract For Preventing Middle East Respiratory Syndrome (mers)",
                "applicants": [
                    "YAN XIAOYUE"
                ],
                "inventors": [
                    "YAN XIAOYUE",
                    "LI QINGSHAN",
                    "XIA-ZHANG HONGLAI",
                    "WU DAWEI"
                ],
                "owners": [],
                "url": "https://lens.org/068-522-843-479-95X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K36/899",
                    "A61K33/06",
                    "A61K35/57",
                    "A61P11/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "11",
                "publicationKey": "WO_2017_196847_A1",
                "lensId": "072-933-474-452-559",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/196847 A1",
                "publicationDate": "2017-11-16",
                "filingNumber": "US 2017/0031758 W",
                "filingDate": "2017-05-09",
                "priorityFilingKeysActive": [
                    "US 201662334194 P 20160510"
                ],
                "earliestPriorityDate": "2016-05-10",
                "title": "Variable New Antigen Receptor (vnar) Antibodies And Antibody Conjugates Targeting Tumor And Viral Antigens",
                "applicants": [
                    "US HEALTH",
                    "UNIV MARYLAND"
                ],
                "inventors": [
                    "HO MITCHELL",
                    "FENG MINGQIAN",
                    "FLAJNIK MARTIN F"
                ],
                "owners": [],
                "url": "https://lens.org/072-933-474-452-559",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 97,
                "cpcClassifications": [
                    "C07K16/28",
                    "C07K16/10",
                    "C07K16/2896",
                    "C07K16/32",
                    "C07K2317/20",
                    "C07K2317/33",
                    "C07K2317/569",
                    "C07K2317/73",
                    "C07K2317/76",
                    "C07K2317/92"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "C07K16/28",
                    "C07K16/32"
                ],
                "usClassifications": [],
                "nplCitationCount": 105,
                "nplCitations": [
                    "YEN PHUNG ET AL: \"High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening\", MABS, vol. 4, no. 5, 1 September 2012 (2012-09-01), pages 592 - 599, XP055084048, ISSN: 1942-0862, DOI: 10.4161/mabs.20933",
                    "M. FENG ET AL: \"Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 110, no. 12, 19 March 2013 (2013-03-19), pages E1083 - E1091, XP055083878, ISSN: 0027-8424, DOI: 10.1073/pnas.1217868110",
                    "STEFAN ZIELONKA ET AL: \"Structural insights and biomedical potential of IgNAR scaffolds from sharks\", MABS, vol. 7, no. 1, 18 December 2014 (2014-12-18), US, pages 15 - 25, XP055235550, ISSN: 1942-0862, DOI: 10.4161/19420862.2015.989032",
                    "CAROLINE BARELLE ET AL: \"VNARs: An Ancient and Unique Repertoire of Molecules That Deliver Small, Soluble, Stable and High Affinity Binders of Proteins\", ANTIBODIES, vol. 4, no. 3, 1 September 2015 (2015-09-01), pages 240 - 258, XP055389558, DOI: 10.3390/antib4030240",
                    "WESOLOWSKI ET AL., MED MICROBIOL IMMUNOL, vol. 198, 2009, pages 157 - 174",
                    "RUMFELT ET AL., BMC IMMUNOL, vol. 5, 2004, pages 8",
                    "RUMFELT ET AL., J IMMUNOL, vol. 173, 2004, pages 1129 - 1139",
                    "FEIGE ET AL., PROC NATL ACAD SCI USA, vol. 111, 2014, pages 8155 - 8160",
                    "IRVING ET AL., J IMMUNOL METHODS, vol. 248, 2001, pages 31 - 45",
                    "STANFIELD ET AL., SCIENCE, vol. 305, 2004, pages 1770 - 1773",
                    "SIMMONS ET AL., J IMMUNOL METHODS, vol. 315, 2006, pages 171 - 184",
                    "FENNELL ET AL., J MOL BIOL, vol. 400, 2010, pages 155 - 170",
                    "BENJAMIN LEWIN: \"Genes V\", 1994, OXFORD UNIVERSITY PRESS, ISBN: 0-19-854287-9",
                    "KENDREW ET AL.: \"The Encyclopedia of Molecular Biology\", 1994, BLACKWELL SCIENCE LTD., ISBN: 0-632-02182-9",
                    "ROBERT A. MEYERS: \"Molecular Biology and Biotechnology: a Comprehensive Desk Reference\", 1995, VCH PUBLISHERS, INC., ISBN: 1-56081-569-8",
                    "KABAT ET AL.: \"Sequences of Proteins of Immunological Interest\", 1991, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                    "CHOTHIA; LESK, J MOL BIOL, vol. 196, 1987, pages 901 - 917",
                    "CHOTHIA ET AL., NATURE, vol. 342, 1989, pages 877",
                    "AL-LAZIKANI ET AL., JMB, vol. 273, 1997, pages 927 - 948",
                    "LEFRANC, NUCLEIC ACIDS RES, vol. 29, 2001, pages 207 - 9",
                    "KOVALENKO ET AL., J BIOL CHEM, vol. 288, no. 24, 2013, pages 17408 - 17419",
                    "FRANKEL ET AL., MOL. IMMUNOL., vol. 16, 1979, pages 101 - 106",
                    "\"Harrison's Principles of Internal Medicine, 14th edition\", article SLAPAK AND KUFE: \"Principles of Cancer Therapy, Chapter 86\"",
                    "\"Harrison's Principles of Internal Medicine\"",
                    "ABELOFF: \"Clinical Oncology, 2nd ed.\", 2000, CHURCHILL LIVINGSTONE, INC, article PERRY ET AL.: \"Chemotherapy (Ch. 17)\"",
                    "BALTZER, L., BERKERY, R.: \"Oncology Pocket Guide to Chemotherapy, 2nd ed.\", 1995, MOSBY-YEAR BOOK",
                    "FISCHER, D.S., KNOBF, M.F., DURIVAGE, H.J.: \"The Cancer Chemotherapy Handbook, 4th ed.\", 1993, MOSBY-YEAR BOOK",
                    "CONNOR ET AL., PHARM THER, vol. 28, 1985, pages 341 - 365",
                    "FILMUS; SELLECK, J CLIN INVEST, vol. 108, 2001, pages 497 - 501",
                    "HO; KIM, EUR J CANCER, vol. 47, no. 3, 2011, pages 333 - 338",
                    "ROUX ET AL., PROC NATL ACAD SCI USA, vol. 95, 1998, pages 11804 - 11809",
                    "HORTON ET AL., BIOTECHNIQUES, vol. 54, no. 3, 2013, pages 129 - 133",
                    "E.W. MARTIN: \"Remington's Pharmaceutical Sciences, 15th ed.\", 1975, MACK PUBLISHING CO.",
                    "GERRATANA, MED RES REV, vol. 32, no. 2, 2012, pages 254 - 293",
                    "SMITH; WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482",
                    "NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443",
                    "PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. U.S.A., vol. 85, 1988, pages 2444",
                    "HIGGINS; SHARP, GENE, vol. 73, 1988, pages 237",
                    "HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151",
                    "CORPET ET AL., NUCLEIC ACIDS RESEARCH, vol. 16, 1988, pages 10881",
                    "ALTSCHUL ET AL., NATURE GENET., vol. 6, 1994, pages 119",
                    "ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403",
                    "BARELLE ET AL., ADV EXP MED BIOL, vol. 655, 2009, pages 49 - 62",
                    "NUTTALL; WALSH, CURR OPIN PHARMACOL, vol. 8, 2008, pages 609 - 615",
                    "DIAZ ET AL., IMMUNOGENETICS, vol. 54, 2002, pages 501 - 512",
                    "MORDENTI ET AL., TOXICOL PATHOL, vol. 27, 1999, pages 536 - 544",
                    "LIU ET AL., MOL IMMUNOL, vol. 44, 2007, pages 1775 - 1783",
                    "STANFIELD ET AL., J MOL BIOL, vol. 367, 2007, pages 358 - 372",
                    "DOOLEY ET AL., MOL IMMUNOL, vol. 40, 2003, pages 25 - 33",
                    "DOOLEY; FLAJNIK, EUR J IMMUNOL, vol. 35, 2005, pages 936 - 945",
                    "DOOLEY ET AL., PROC NATL ACAD SCI USA, vol. 103, 2006, pages 1846 - 1851",
                    "SHAO ET AL., MOL IMMUNOL, vol. 44, 2007, pages 656 - 665",
                    "LIU ET AL., BMC BIOTECHNOL, vol. 7, 2007, pages 78",
                    "NUTTALL ET AL., MOL IMMUNOL, vol. 38, 2001, pages 313 - 326",
                    "NUTTALL ET AL., EUR J BIOCHEM, vol. 270, 2003, pages 3543 - 3554",
                    "NUTTALL ET AL., PROTEINS, vol. 55, 2004, pages 187 - 197",
                    "FAY; SCOTT, IMMUNOTHERAPY, vol. 3, no. 3, 2011, pages 381 - 394",
                    "BANDER, CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, vol. 10, no. 8, 2012, pages 3 - 7",
                    "QASBA ET AL., BIOTECHNOL PROG, vol. 24, 2008, pages 520 - 526",
                    "LEIMGRUBER ET AL., J AM CHEM SOC, vol. 87, 1965, pages 5793 - 5795",
                    "LEIMGRUBER ET AL., JAM CHEM SOC, vol. 87, 1965, pages 5791 - 5793",
                    "WOYKE ET AL., ANTIMICROB AGENTS AND CHEMOTHER, vol. 45, no. 12, 2001, pages 3580 - 3584",
                    "PETTIT ET AL., ANTIMICROB AGENTS CHEMOTHER, vol. 42, 1998, pages 2961 - 2965",
                    "HINMAN ET AL., CANCER RES, vol. 53, 1993, pages 3336 - 3342",
                    "LODE ET AL., CANCER RES, vol. 58, 1998, pages 2925 - 2928",
                    "QUINTIERI ET AL., CLIN CANCER RES, vol. 11, no. 4, 2005, pages 1608 - 1617",
                    "GRANDI ET AL., CANCER TREAT REV, vol. 17, 1990, pages 133",
                    "RIPAMONTI ET AL., BR J CANCER, vol. 65, 1992, pages 703 - 707",
                    "CHARI ET AL., CANCER RES, vol. 52, 1992, pages 127 - 131",
                    "CARTELLIERI ET AL., J BIOMED BIOTECHNOL, 2010, pages 956304",
                    "PARK ET AL., MOL THER, vol. 15, no. 4, 2007, pages 825 - 833",
                    "SIEGALL ET AL., J. BIOL. CHEM., vol. 264, 1989, pages 14256 - 14261",
                    "PAI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 3358 - 3362",
                    "KONDO ET AL., J. BIOL. CHEM., vol. 263, 1988, pages 9470 - 9475",
                    "PASTAN ET AL., BIOCHIM. BIOPHYS. ACTA, vol. 1333, 1997, pages C1 - C6",
                    "WELDON ET AL., BLOOD, vol. 113, no. 16, 2009, pages 3792 - 3800",
                    "ONDA ET AL., PROC NATL ACAD SCI USA, vol. 105, no. 32, 2008, pages 11311 - 11316",
                    "CONNOR ET AL., PHARM. THER., vol. 28, 1985, pages 341 - 365",
                    "PASZKO; SENGE, CURR MED CHEM, vol. 19, no. 31, 2012, pages 5239 - 5277",
                    "IMMORDINO ET AL., INT J NANOMEDICINE, vol. 1, no. 3, 2006, pages 297 - 315",
                    "\"Remington's Pharmaceutical Science, 19th ed.\", 1995, MACK PUBLISHING COMPANY",
                    "BANGA, A.J.: \"Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems\", 1995, TECHNOMIC PUBLISHING COMPANY, INC.",
                    "KREUTER, J.: \"Colloidal Drug Delivery Systems\", 1994, MARCEL DEKKER, INC., pages: 219 - 342",
                    "TICE; TABIBI: \"Treatise on Controlled Drug Delivery\", 1992, MARCEL DEKKER, INC, pages: 315 - 339",
                    "LANGER, ACCOUNTS CHEM. RES, vol. 26, 1993, pages 537 - 542",
                    "JOHNSTON ET AL., PHARM. RES., vol. 9, 1992, pages 425 - 434",
                    "PEC ET AL., J. PARENT. SCI. TECH., vol. 44, no. 2, 1990, pages 58 - 65",
                    "IJNTEMA ET AL., INT. J. PHARM., vol. 112, 1994, pages 215 - 224",
                    "M\u00dcLLER ET AL., MABS, vol. 4, 2012, pages 673 - 685",
                    "OHTANI ET AL., MAR BIOTECHNOL, vol. 15, 2013, pages 56 - 62",
                    "OHTANI ET AL., FISH SHELLFISH IMMUNOL, vol. 34, 2013, pages 724 - 728",
                    "ZIELONKA ET AL., J BIOTECHNOL, vol. 191, 2014, pages 236 - 245",
                    "KOPSIDAS ET AL., IMMUNOL LETT, vol. 107, 2006, pages 163 - 168",
                    "PHUNG ET AL., MABS, vol. 4, 2012, pages 592 - 599",
                    "GAO ET AL., NAT COMMUN, vol. 6, 2015, pages 6536",
                    "FENG ET AL., PROC NATL ACAD SCI USA, vol. 110, 2013, pages E1083 - E1091",
                    "FENG; HO, FEBS LETT, vol. 588, 2014, pages 377 - 382",
                    "LIU ET AL., PROC NATL ACAD SCI USA, vol. 109, 2012, pages 11782 - 11787",
                    "ALEWINE ET AL., MOL CANCER THER, vol. 13, 2014, pages 2653 - 2661",
                    "KOVALEVA ET AL., EXPERT OPIN BIOL THER, vol. 14, 2014, pages 1527 - 1539",
                    "CAMACHO-VILLEGAS ET AL., MABS, vol. 5, 2013, pages 80 - 85",
                    "MULLER ET AL., MABS, vol. 4, 2012, pages 673 - 685",
                    "WALSH ET AL., VIROLOGY, vol. 411, 2011, pages 132 - 141",
                    "GOODCHILD ET AL., MOL IMMUNOL, vol. 48, 2011, pages 2027 - 2037",
                    "NUTTALL ET AL., FEBS LETT, vol. 516, 2002, pages 80 - 6"
                ],
                "nplResolvedCount": 89,
                "nplResolvedLensIDs": [
                    "031-891-811-637-90X",
                    "125-887-305-963-629",
                    "126-670-872-645-263",
                    "060-391-827-069-40X",
                    "022-695-199-813-430",
                    "002-495-630-767-098",
                    "099-415-168-216-03X",
                    "138-792-006-137-992",
                    "123-559-100-031-929",
                    "027-670-963-287-976",
                    "032-749-455-659-553",
                    "048-389-769-784-036",
                    "065-684-269-783-203",
                    "049-955-273-394-333",
                    "004-694-440-872-537",
                    "109-664-639-230-056",
                    "048-853-055-063-524",
                    "016-155-290-797-107",
                    "083-672-921-972-481",
                    "004-056-961-843-815",
                    "140-686-709-284-617",
                    "052-724-213-786-191",
                    "049-134-753-209-354",
                    "054-257-655-602-057",
                    "093-576-263-928-739",
                    "081-177-071-539-997",
                    "005-813-390-127-218",
                    "044-695-786-434-628",
                    "114-264-767-617-683",
                    "123-452-046-644-23X",
                    "031-429-862-517-588",
                    "056-460-395-736-329",
                    "049-645-318-851-478",
                    "097-694-869-419-018",
                    "085-764-009-624-439",
                    "154-738-795-445-041",
                    "031-230-174-713-712",
                    "003-525-643-875-478",
                    "053-410-183-185-380",
                    "012-258-343-712-880",
                    "012-887-746-280-711",
                    "105-024-621-755-777",
                    "010-734-451-880-891",
                    "044-559-151-383-437",
                    "001-752-680-214-246",
                    "043-271-014-136-772",
                    "027-688-746-910-536",
                    "014-454-617-643-60X",
                    "015-796-443-867-043",
                    "101-914-796-586-505",
                    "109-354-311-139-255",
                    "117-416-919-237-41X",
                    "056-201-471-905-934",
                    "162-450-410-656-890",
                    "037-739-438-733-451",
                    "076-295-340-200-024",
                    "039-943-722-485-724",
                    "030-134-218-546-041",
                    "046-099-948-978-735",
                    "088-125-732-406-009",
                    "047-294-403-699-699",
                    "032-728-154-591-070",
                    "024-995-475-936-443",
                    "071-328-232-469-698",
                    "121-926-711-462-17X",
                    "100-041-294-232-313",
                    "101-693-241-437-665",
                    "023-693-113-014-951",
                    "128-112-305-146-026",
                    "016-617-627-772-41X",
                    "026-068-595-051-389",
                    "093-183-016-210-781",
                    "038-383-743-124-048",
                    "023-875-640-152-798",
                    "151-614-122-349-22X",
                    "003-280-353-877-595",
                    "119-624-955-614-365",
                    "050-268-426-304-10X",
                    "001-229-324-200-781",
                    "017-184-999-837-662",
                    "148-029-633-567-717",
                    "048-691-666-475-879",
                    "003-131-309-414-13X",
                    "071-273-910-767-454",
                    "011-012-284-651-080",
                    "032-720-983-972-675",
                    "014-423-782-126-065",
                    "038-994-369-651-86X",
                    "091-571-308-998-082"
                ],
                "nplResolvedExternalIDs": [
                    "9847182",
                    "17716160",
                    "10.1021/ar00034a004",
                    "10.1002/eji.200425760",
                    "pmc1977399",
                    "10.1016/0161-5890(79)90051-8",
                    "23599925",
                    "10.1177/019262339902700507",
                    "10.1093/nar/29.1.207",
                    "2272029",
                    "2231712",
                    "pmc2714450",
                    "11125093",
                    "12919318",
                    "16500706",
                    "pmc2435414",
                    "23471984",
                    "pmc2670794",
                    "10.1016/j.ejca.2010.10.024",
                    "23632026",
                    "11959108",
                    "10.1016/s0304-419x(97)00021-8",
                    "10.1128/aac.42.11.2961",
                    "10.1023/a:1015815624334",
                    "pmc4050542",
                    "10.1016/0022-2836(70)90057-4",
                    "21239030",
                    "21395380",
                    "10.1046/j.1432-1033.2003.03737.x",
                    "10.1002/prot.20005",
                    "10.1016/s0022-1759(00)00341-0",
                    "5420325",
                    "10.1016/s0014-5793(02)02506-1",
                    "10.1016/j.molimm.2006.07.299",
                    "10.1074/jbc.m112.435289",
                    "23257206",
                    "10528633",
                    "10.1007/s00430-009-0116-7",
                    "8162065",
                    "pmc4221527",
                    "17007931",
                    "10.1172/jci200113712",
                    "10.1073/pnas.1217868110",
                    "pmc3947105",
                    "pmc102442",
                    "10.1016/j.jbiotec.2014.04.023",
                    "pmc1413636",
                    "9751746",
                    "24140348",
                    "10.1128/aac.45.12.3580-3584.2001",
                    "pmc3682541",
                    "2720464",
                    "10.1073/pnas.1209292109",
                    "11223067",
                    "10.1021/bp0704034",
                    "pmc420240",
                    "15319492",
                    "22552958",
                    "10.1073/pnas.85.8.2444",
                    "10.1155/2010/956304",
                    "pmc3031711",
                    "10.1016/j.jim.2006.07.019",
                    "10.1073/pnas.88.11.5066-d",
                    "10.1038/sj.mt.6300104",
                    "10.2174/092986712803833362",
                    "2014255",
                    "10.1016/j.molimm.2006.01.010",
                    "10.4161/mabs.22242",
                    "10.1016/j.virol.2010.12.034",
                    "447371",
                    "10.1016/j.fsi.2012.11.041",
                    "10.1016/0163-7258(85)90058-0",
                    "pmc3502234",
                    "17717971",
                    "10.1038/342877a0",
                    "22753489",
                    "pmc105973",
                    "18426242",
                    "18678888",
                    "2849754",
                    "10.1111/1467-6486.00238",
                    "10.1126/science.1101148",
                    "23676205",
                    "19529959",
                    "10.1201/9781498710565",
                    "pmc165532",
                    "10.1182/blood-2008-08-173195",
                    "15240702",
                    "18988862",
                    "25239937",
                    "16962608",
                    "10.1006/jmbi.1997.1354",
                    "10.1093/bioinformatics/5.2.151",
                    "24830426",
                    "10.1002/med.20212",
                    "20047035",
                    "pmc280013",
                    "5845428",
                    "5845427",
                    "10.1016/0305-7372(90)90037-g",
                    "15688348",
                    "9395287",
                    "pmc2213646",
                    "3911220",
                    "22820551",
                    "10.3390/antib4030240",
                    "10.1021/ja00952a050",
                    "10.2144/000114017",
                    "10.1021/ja00952a051",
                    "pmc209407",
                    "10.1016/s0022-2836(05)80360-2",
                    "25523873",
                    "pmc146384",
                    "10592230",
                    "18021450",
                    "10.4049/jimmunol.173.2.1129",
                    "10.1016/j.jmb.2006.12.045",
                    "pmc3406843",
                    "10.1007/s10126-012-9456-1",
                    "10.1186/1472-6750-7-78",
                    "10.1073/pnas.1321502111",
                    "pmc2426795",
                    "pmc338945",
                    "10.1006/jmbi.1990.9999",
                    "pmc90872",
                    "10.4161/mabs.22593",
                    "pmc147225",
                    "10.1073/pnas.0508341103",
                    "17299405",
                    "15746066",
                    "10.1016/j.jmb.2010.04.061",
                    "10.1007/978-1-4419-1132-2_6",
                    "12389098",
                    "16446445",
                    "pmc3499300",
                    "10.1016/0022-2836(87)90412-8",
                    "2687698",
                    "1586598",
                    "10.1158/1535-7163.mct-14-0132",
                    "24862193",
                    "pmc2516223",
                    "pmc4127195",
                    "pmc51446",
                    "pmc148137",
                    "10.1038/bjc.1992.148",
                    "10.1007/s00251-002-0479-z",
                    "10.1093/nar/16.22.10881",
                    "10.1016/j.coph.2008.06.007",
                    "1727373",
                    "12909128",
                    "20450918",
                    "10.2217/17435889.1.3.297",
                    "11518720",
                    "25090369",
                    "10.1073/pnas.0804851105",
                    "11709343",
                    "10.1073/pnas.95.20.11804",
                    "10.1093/nar/27.1.209",
                    "23221782",
                    "20467460",
                    "8324745",
                    "10.1517/14712598.2014.937701",
                    "10.1073/pnas.88.8.3358",
                    "pmc3564889",
                    "9367782",
                    "10.4161/mabs.20933",
                    "21112773",
                    "10.2217/imt.11.5",
                    "10.1186/1472-6750-7-23",
                    "10.1158/1078-0432.ccr-04-1845",
                    "pmc21721",
                    "20544978",
                    "18619558",
                    "10.1016/j.febslet.2013.10.002",
                    "9797233",
                    "10.1186/1471-2172-5-8",
                    "17258766",
                    "21752470",
                    "pmc3607002",
                    "3243435",
                    "14997552",
                    "pmc2864912",
                    "17511866",
                    "17069896",
                    "15132758",
                    "10.1172/jci13712",
                    "10.1016/s0161-5890(01)00057-8",
                    "11566324",
                    "10.1016/0378-1119(88)90330-7",
                    "10.1016/0378-5173(94)90357-3",
                    "2357375",
                    "1614979",
                    "9679947",
                    "10.4161/19420862.2015.989032",
                    "22934774",
                    "10.1016/j.imlet.2006.09.004",
                    "10.1016/j.molimm.2011.06.437",
                    "10.1016/s0161-5890(03)00084-1",
                    "2503515",
                    "3132465",
                    "3681981",
                    "10.1097/00007611-195101000-00027",
                    "3162770",
                    "pmc29797",
                    "10.1038/ng0294-119"
                ]
            },
            {
                "index": "12",
                "publicationKey": "WO_2017_212422_A1",
                "lensId": "188-372-610-856-777",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/212422 A1",
                "publicationDate": "2017-12-14",
                "filingNumber": "IB 2017053367 W",
                "filingDate": "2017-06-07",
                "priorityFilingKeysActive": [
                    "US 201662347387 P 20160608"
                ],
                "earliestPriorityDate": "2016-06-08",
                "title": "Topical Compositions Comprising Carbomer For The Treatment And Prevention Of Viral Infections And Allergic Conditions",
                "applicants": [
                    "NOVARTIS CONSUMER HEALTH SA"
                ],
                "inventors": [
                    "CHURCH DENNIS JOSEPH",
                    "NICHOLS ANTHONY"
                ],
                "owners": [],
                "url": "https://lens.org/188-372-610-856-777",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/78",
                    "A61K9/0043",
                    "A61P31/16"
                ],
                "ipcrClassifications": [
                    "A61K31/78",
                    "A61K9/00",
                    "A61P11/02",
                    "A61P27/14",
                    "A61P31/16"
                ],
                "usClassifications": [],
                "nplCitationCount": 40,
                "nplCitations": [
                    "LUCZAK: \"Antiviral and anineoplastic effect of Carbopol\", 1 January 1979 (1979-01-01), pages 815 - 821, XP055396901, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pubmed/233349> [retrieved on 20170808]",
                    "CLERCQ ET AL: \"Antiviral activity of carbopol, a cross-linked polycarboxylate\", 1 January 1976 (1976-01-01), pages 151 - 158, XP055396905, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pubmed/187146> [retrieved on 20170808]",
                    "BLOEMERS H P J ET AL: \"Inhibition of RNA-dependent DNA polymerase of oncorna viruses by Carbopol 934\", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 52, no. 1, 15 March 1975 (1975-03-15), pages 141 - 144, XP025602906, ISSN: 0014-5793, [retrieved on 19750315], DOI: 10.1016/0014-5793(75)80657-0",
                    "K.H. MAIR ET AL: \"Carbopol improves the early cellular immune responses induced by the modified-life vaccine Ingelvac PRRS MLV\", VETERINARY MICROBIOLOGY, vol. 176, no. 3-4, 1 April 2015 (2015-04-01), NL, pages 352 - 357, XP055308822, ISSN: 0378-1135, DOI: 10.1016/j.vetmic.2015.02.001",
                    "\"Final report on the safety assessment of carbomers - 934, -910, -934P, -940, -941 and -962\", INT. J. TOXICOLOGY, vol. 1, 1982, pages 109 - 141",
                    "BARRETT B.: \"Medicinal properties of Echinacea: a critical review\", PHYTOMEDICINE, vol. 10, 2003, pages 66 - 86, XP004957204, DOI: doi:10.1078/094471103321648692",
                    "BERTINO JS.: \"Cost burden of viral respiratory infections: issues for formulary decision makers\", AM. J. MED., vol. 112, 2002, pages 42S - 49S",
                    "\"Carbopol. Water soluble resins.\", SERVICE BULL. GC-36, 1962",
                    "BLOEMERS HPJ; VAN DER HORST A.: \"Inhibition of RNA-dependent DNA polymerase of oncorna viruses by Carbapol 934\", FEBS LET., vol. 52, no. 1, 1975, pages 141 - 144, XP025602906, DOI: doi:10.1016/0014-5793(75)80657-0",
                    "CHOULIS N.: \"Timed-release tablets containing quinine sulfate\", J. PHORM. SCI., vol. 64, no. 6, 1976, pages 1033 - 1035, XP009014686, DOI: doi:10.1002/jps.2600640634",
                    "\"Final Report on the Safety Assessment of Carbomers-934, -910, -934P, -940, -941, and - 962\", JOURNAL OF THE AMERICAN COLLEGE OF TOXICOLOGY, vol. 1, 1982, pages 109 - 141",
                    "DE CLERCQ; LUCZAK M.: \"Antiviral activity of carpobol, a cross-linked polycarboxylate\", ARCH. VIROL, vol. 52, no. 1, 1976, pages 151 - 158, XP055396905",
                    "ELGINDY NA.: \"Molecular entrapment of cationic drugs by Carbopol 934\", CAN. J. PHARM. SCI., vol. 11, no. 1, 1976, pages 32 - 4",
                    "FENDRICK AM; MONTO AS; NIGHTENGALE B; SARNES M.: \"The economic burden of non-influenza-related viral respiratory tract infection in the United States\", ARCH. INTERN. MED., vol. 163, 2003, pages 487 - 494",
                    "GERN JE; MOSSER AG; SWENSON CA; RENNIE PJ; ENGLAND RJ; SHAFFER J; MIZOGUCHI H.: \"Inhibition of rhinovirus replication in vitro and in vivo by acid-buffered saline.\", J. INF. DIS, vol. 195, 2007, pages 1137 - 1143",
                    "GIRANDA VL; HEINZ BA; OLIVIERA MA.: \"Acid-induced structural changes in human rinovirus-14 and possible role in uncoating\", PROC. NAT'I ACAD. SCI. USA, vol. 89, 1992, pages 10213 - 10217",
                    "HAYDEN FG; GWALTNEY JM.: \"Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds infection\", J. INFECT. DIS, vol. 150, 1984, pages 174 - 180",
                    "HAYDEN FG; KAISER DL; ALBRECHT JK.: \"Intranasal recombinant alpha-2b interferon treatment of naturally occurring common colds.\", ANTIMICROB. AGENTS CHEMOTHER., vol. 32, 1988, pages 224 - 230",
                    "HAYDEN FG; ANDRIES K; JANSSEN PA.: \"Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection.\", ANTIMICROB. AGENTS CHEMOTHER, vol. 36, 1992, pages 727 - 732",
                    "HAYDEN FG; HIPSKIND GJ; WOERNER DH; EISEN GF; JANSSENS M; JANSSEN PA; ANDRIES K.: \"Intranasal pirodavir (R77975) treatment of rhinovirus colds.\", ANTIMICROB. AGENTS CHEMOTHER, vol. 39, 1995, pages 290 - 294, XP002474491",
                    "HAYDEN FG; HERRINGTON DT; COATS TL; KIM K; COOPER EC; VILLANO SA; LIU S; HUDSON S; PEVEAR DC; COLLETT M: \"Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of two double-blind, randomized, placebo-controlled trials.\", CLIN. INFECT. DIS., vol. 36, 2003, pages 1523 - 1532, XP002392816, DOI: doi:10.1086/375069",
                    "HAYDEN FG; TURNER RB; GWALTNEY JM; CHI-BURRIS K; GERSTEN M; HSYU P; PATICK AK; SMITH GJ; ZALMAN LS: \"Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray two-percent suspension for prevention and treatment of experimentally-induced rhinovirus colds in healthy volunteers.\", ANTIMICROB. AGENTS CHEMOTHER, vol. 47, 2003, pages 3907 - 3916",
                    "HULL D; RENNIE P; NORONHA A; POORE C; HARRINGTON N; FEARNLEY V; PASSALI D.: \"Effects of creating a non-specific, virus hostile environment in the nasopharanx on symptoms and duration of the common cold\", ACTA OTORHIN. ITAL., vol. 27, 2007, pages 73 - 77",
                    "JACOBS SE; LAMSON DM; ST. GEORGE K; WALSH TJ., CLIN. MICROBIOL. REV., vol. 26, no. 1, 2013, pages 135 - 162",
                    "JULLAPHANT T: \"Colloidal properties of montelukast sodium nasal spray. Paper presented at: 5th Thailand International Nanotechnology Conference (NanoThailand\", NANOTECHNOLOGY ASSOCIATION OF THAILAND., 2016",
                    "KENNEDY JL; TURNER RB; BRACIALE, T; HEYMANN, P; BORISH, L: \"Pathogenesis of rhinovirus infection\", CURRENT OPINION IN VIROLOGY, vol. 2, 2012, pages 287 - 293, XP055311472, DOI: doi:10.1016/j.coviro.2012.03.008",
                    "KUMAR BV.: \"Inhibition of reverse transcriptase and r-DNA polymerase by Carbapol 934\", MICROBIOS. LETT., vol. 2, no. 7, 1976, pages 219 - 223",
                    "LAZE L; BARENE I; NESTEROVA Z ET AL.: \"Formulation of product for topical delivery of heparin\", PAPER PRESENTED AT: INTERNATIONAL STUDENT CONFERENCE OF THE RIGAS STRADINA UNIVERSITY: HEALTH AND SOCIAL SCIENCES., 2017",
                    "NICHOL KL; D'HEILLY S; EHLINGER E.: \"Colds and influenza-like illnesses in university students: impact on health, academic and work performance, and health care use\", CLIN. INFECT. DIS., vol. 40, 2005, pages 1263 - 1270",
                    "PALMENBERG AC; SPIRO D; KUZMICKAS R; WANG S; DJIKENG A; RATHE JA; FRASER-LIGGETT CM; LIGGETT SB.: \"Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution.\", SCIENCE, vol. 324, 2009, pages 55 - 59, XP055118758, DOI: doi:10.1126/science.1165557",
                    "PALMENBERG AC; RATHE JA; LIGGETT SB.: \"Analysis of the complete genome sequences of human rhinovirus\", J. ALLERGY CLIN. IMMUNOL, vol. 125, 2010, pages 1190 - 1201",
                    "PATICK AK; BROTHERS MA; MALDONADO F; BINFORD S; MALDONADO O; FUHRMAN S; PETERSEN A; SMITH GJ; ZALMAN LS.: \"In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease\", ANTIMICROB. AGENTS CHEMOTHER, vol. 49, 2005, pages 2267 - 2275",
                    "PEVEAR DC; HAYDEN FG; DEMENCZUK TM; BARONE LR; MCKINLAY MA; COLLETT MS.: \"Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses\", ANTIMICROB. AGENTS CHEMOTHER, vol. 49, 2005, pages 4492 - 4499",
                    "RAJNIK M; TOLAN RW., RHINOVIRUS INFECTION, 2014, Retrieved from the Internet <URL:http://emedicine.medscape.com/ article/ 227820-overview#a0101>",
                    "RENNIE P; BOWTELL P; HULL D; CHARBONNEAU D; LAMBKIN-WILLIAMS R; OXFORD J.: \"Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection.\", RESPIR RES., vol. 8, no. 1, 2007, pages 38, XP021027435, DOI: doi:10.1186/1465-9921-8-38",
                    "ROELEN CAM; KOOPMANS PC; NOTENBOMER A; GROOTHOFF JW.: \"Job satisfaction and short sickness absence due to the common cold\", WORK, vol. 39, 2011, pages 305 - 313",
                    "SIMASEK M; BLANDINO DA.: \"Treatment of the common cold.\", AMER. FAM. PHYSICIAN, vol. 75, no. 4, 2007, pages 515 - 20",
                    "WINE TM; ALPER CM.: \"Cytokine responses in the common cold and otitis media.\", CURR ALLERGY ASTHMA REP., vol. 12, no. 6, 2012, pages 574 - 581, XP035135439, DOI: doi:10.1007/s11882-012-0306-z",
                    "WINDHOLZ M: \"The Merck Index, 9th ed.\", 1976, MERCK & CO",
                    "ZUCKERMAN AJ: \"Principles and Practice of Clinical Virology, 6th Edition,\", 2007, WILEY, pages: 496"
                ],
                "nplResolvedCount": 30,
                "nplResolvedLensIDs": [
                    "005-996-056-579-539",
                    "148-466-068-286-589",
                    "143-637-150-196-867",
                    "108-399-414-820-791",
                    "009-376-281-904-316",
                    "062-932-095-932-045",
                    "131-810-466-111-189",
                    "087-688-064-471-878",
                    "070-220-415-942-520",
                    "114-241-417-127-826",
                    "029-688-779-635-174",
                    "004-967-144-049-264",
                    "085-545-351-952-964",
                    "015-809-327-934-499",
                    "059-551-862-842-845",
                    "088-913-492-821-445",
                    "041-173-432-545-34X",
                    "132-658-871-904-61X",
                    "043-201-732-321-119",
                    "124-388-869-608-013",
                    "029-245-145-707-356",
                    "049-684-187-282-165",
                    "081-433-204-269-872",
                    "015-256-782-039-712",
                    "085-944-451-004-791",
                    "004-027-037-663-680",
                    "041-826-502-904-308",
                    "059-527-995-517-165",
                    "091-219-132-750-354",
                    "114-426-980-780-286"
                ],
                "nplResolvedExternalIDs": [
                    "pmc172139",
                    "pmc189373",
                    "10.1128/aac.49.6.2267-2275.2005",
                    "1332036",
                    "15917520",
                    "pmc296196",
                    "17608134",
                    "23054624",
                    "pmc1885256",
                    "pmc1280128",
                    "10.1093/infdis/150.2.174",
                    "10.1086/429237",
                    "10.1128/aac.47.12.3907-3916.2003",
                    "10.1007/bf01317874",
                    "15825028",
                    "21709366",
                    "47299",
                    "20471068",
                    "pmc2640010",
                    "10.1128/cmr.00077-12",
                    "1133722",
                    "10.1078/094471103321648692",
                    "12802751",
                    "10.1007/s11882-012-0306-z",
                    "7726484",
                    "12588210",
                    "12622467",
                    "10.1016/0016-0032(62)90965-1",
                    "pmc1140523",
                    "1503435",
                    "14638501",
                    "pmc2893015",
                    "10.1016/j.jaci.2010.04.010",
                    "10.1001/archinte.163.4.487",
                    "17357049",
                    "10.1016/j.coviro.2012.03.008",
                    "10.1073/pnas.89.21.10213",
                    "10.3233/wor-2011-1178",
                    "pmc50308",
                    "10.1128/aac.49.11.4492-4499.2005",
                    "23297263",
                    "11955459",
                    "187146",
                    "pmc3378761",
                    "10.1016/j.vetmic.2015.02.001",
                    "10.1128/aac.39.2.290",
                    "10.1126/science.1165557",
                    "10.1086/512858",
                    "10.1016/0014-5793(75)80657-0",
                    "6381610",
                    "17509128",
                    "10.1067/mda.2003.22",
                    "2834996",
                    "pmc3553670",
                    "10.3109/10915818209013151",
                    "25707990",
                    "10.1002/jps.2600640634",
                    "22542099",
                    "10.1186/1465-9921-8-38",
                    "pmc162529",
                    "16251287",
                    "10.1128/aac.36.4.727",
                    "10.1086/375069",
                    "17323712",
                    "pmc3923423",
                    "19213880",
                    "10.1128/aac.32.2.224"
                ]
            },
            {
                "index": "13",
                "publicationKey": "KR_101828794_B1",
                "lensId": "134-553-834-319-720",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101828794 B1",
                "publicationDate": "2018-02-13",
                "filingNumber": "KR 20160150961 A",
                "filingDate": "2016-11-14",
                "priorityFilingKeysActive": [
                    "KR 20160150961 A 20161114"
                ],
                "earliestPriorityDate": "2016-11-14",
                "title": "A Antibody Able To Neutralize Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "CELLTRION INC"
                ],
                "inventors": [
                    "LEE SOO YOUNG",
                    "YI KYE SOOK",
                    "KIM CHEOL MIN",
                    "YOON JOON SUN",
                    "RYU SOO HEE",
                    "LEE HWA JIN",
                    "SONG HANNA",
                    "BAE YEON JIN",
                    "LEE HYUN JOO",
                    "SHIM EUN YEONG"
                ],
                "owners": [],
                "url": "https://lens.org/134-553-834-319-720",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 3,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/00",
                    "A61K39/42"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "14",
                "publicationKey": "CN_104958755_B",
                "lensId": "053-052-825-170-061",
                "jurisdiction": "CN",
                "kindCode": "B",
                "displayKey": "CN 104958755 B",
                "publicationDate": "2018-05-04",
                "filingNumber": "CN 201510343520 A",
                "filingDate": "2015-06-19",
                "priorityFilingKeysActive": [
                    "CN 201510343520 A 20150619"
                ],
                "earliestPriorityDate": "2015-06-19",
                "title": "\u66ff\u8003\u62c9\u5b81\u5728\u5236\u5907\u6297\u4e2d\u4e1c\u547c\u5438\u7efc\u5408\u5f81\u51a0\u72b6\u75c5\u6bd2\u836f\u7269\u4e2d\u7684\u5e94\u7528",
                "applicants": [
                    "\u4e2d\u5c71\u5927\u5b66"
                ],
                "inventors": [
                    "\u6f58\u5a77",
                    "\u5468\u5357",
                    "\u5f20\u8f89"
                ],
                "owners": [],
                "url": "https://lens.org/053-052-825-170-061",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/14",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "15",
                "publicationKey": "EP_2961768_A4",
                "lensId": "083-643-980-020-12X",
                "jurisdiction": "EP",
                "kindCode": "A4",
                "displayKey": "EP 2961768 A4",
                "publicationDate": "2016-10-26",
                "filingNumber": "EP 14757347 A",
                "filingDate": "2014-02-28",
                "priorityFilingKeysActive": [
                    "US 201361771561 P 20130301",
                    "US 201461941076 P 20140218"
                ],
                "earliestPriorityDate": "2013-03-01",
                "title": "Immunogenic Composition For Mers Coronavirus Infection",
                "applicants": [
                    "NEW YORK BLOOD CT INC",
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU"
                ],
                "inventors": [
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU",
                    "JIANG SHIBO",
                    "DU LANYING"
                ],
                "owners": [],
                "url": "https://lens.org/083-643-980-020-12X",
                "docType": "Search report",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/55561",
                    "A61K2039/55566",
                    "A61K2039/575",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2319/21",
                    "C07K2319/30",
                    "C12N7/00",
                    "C12N2770/20021",
                    "C12N2770/20022",
                    "C12N2770/20034"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K39/215",
                    "C07K16/10",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 15,
                "nplCitations": [
                    "DU LANYING ET AL: \"A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines\", PL O S ONE, PUBLIC LIBRARY OF SCIENCE, US, vol. 8, no. 12, 1 December 2013 (2013-12-01), pages e81587 - 1, XP009182022, ISSN: 1932-6203",
                    "JIANG SHIBO ET AL: \"A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC\", JOURNAL OF INFECTION, ACADEMIC PRESS, LONDON, GB, vol. 66, no. 5, 22 December 2012 (2012-12-22), pages 464 - 466, XP028525281, ISSN: 0163-4453, DOI: 10.1016/J.JINF.2012.12.003",
                    "LANYING DU ET AL: \"The spike protein of SARS-CoV - a target for vaccine and therapeutic development\", NATURE REVIEWS. MICROBIOLOGY, vol. 7, no. 3, 1 March 2009 (2009-03-01), GB, pages 226 - 236, XP055302112, ISSN: 1740-1526, DOI: 10.1038/nrmicro2090",
                    "\"ACS Symposium Series\", vol. 1095, 1 January 2012, AMERICAN CHEMICAL SOCIETY/OXFORD UNIVERSITY PRESS, US, ISSN: 0097-6156, article ZHE YAN ET AL: \"Strategies for Designing Peptide Immunogens To Elicit [alpha]-Helical Conformation-Specific Antibodies Reactive with Native Proteins\", pages: 93 - 136, XP055302371, DOI: 10.1021/bk-2012-1095.ch006",
                    "L. DU ET AL: \"Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development\", JOURNAL OF VIROLOGY, vol. 87, no. 17, 1 September 2013 (2013-09-01), pages 9939 - 9942, XP055157122, ISSN: 0022-538X, DOI: 10.1128/JVI.01048-13",
                    "Y. CHEN ET AL: \"Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus\", JOURNAL OF VIROLOGY., vol. 87, no. 19, 31 July 2013 (2013-07-31), US, pages 10777 - 10783, XP055302118, ISSN: 0022-538X, DOI: 10.1128/JVI.01756-13",
                    "S. GIERER ET AL: \"The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies\", JOURNAL OF VIROLOGY, vol. 87, no. 10, 6 March 2013 (2013-03-06), pages 5502 - 5511, XP055162667, ISSN: 0022-538X, DOI: 10.1128/JVI.00128-13",
                    "S. VAN BOHEEMEN ET AL: \"Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans\", MBIO, vol. 3, no. 6, 20 November 2012 (2012-11-20), pages e00473 - 12, XP055128733, ISSN: 2150-7511, DOI: 10.1128/mBio.00473-12",
                    "NIANSHUANG WANG ET AL: \"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4\", CELL RESEARCH - XIBAO YANJIU, vol. 23, no. 8, 9 July 2013 (2013-07-09), GB, CN, pages 986 - 993, XP055302109, ISSN: 1001-0602, DOI: 10.1038/cr.2013.92",
                    "V. STALIN RAJ ET AL: \"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC\", NATURE, vol. 495, no. 7440, 13 March 2013 (2013-03-13), United Kingdom, pages 251 - 254, XP055302115, ISSN: 0028-0836, DOI: 10.1038/nature12005",
                    "GUANGWEN LU ET AL: \"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26\", NATURE, vol. 500, no. 7461, 7 July 2013 (2013-07-07), pages 227 - 231, XP055162686, ISSN: 0028-0836, DOI: 10.1038/nature12328",
                    "NAN ZHOU ET AL: \"The receptor binding domain of MERS-CoV: The dawn of vaccine and treatment development\", JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION., vol. 113, no. 3, 15 December 2013 (2013-12-15), HK, pages 143 - 147, XP055271033, ISSN: 0929-6646, DOI: 10.1016/j.jfma.2013.11.006",
                    "Y. HE ET AL: \"Identification of Immunodominant Sites on the Spike Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Implication for Developing SARS Diagnostics and Vaccines\", THE JOURNAL OF IMMUNOLOGY VOL.173 N.6, 7 September 2004 (2004-09-07), pages 4050 - 4057, XP055274774, Retrieved from the Internet <URL:http://www.jimmunol.org/content/173/6/4050.full.pdf+html> [retrieved on 20160524], DOI: 10.4049/jimmunol.173.6.4050",
                    "ALI M. ZAKI ET AL: \"Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia\", NEW ENGLAND JOURNAL OF MEDICINE VOL.367N. 19, 8 November 2012 (2012-11-08), pages 1814 - 1820, XP055274765, Retrieved from the Internet <URL:http://www.nejm.org/doi/pdf/10.1056/NEJMoa1211721> [retrieved on 20160524], DOI: 10.1056/NEJMoa1211721",
                    "See also references of WO 2014134439A1"
                ],
                "nplResolvedCount": 14,
                "nplResolvedLensIDs": [
                    "001-172-069-168-870",
                    "044-201-328-679-836",
                    "067-884-443-627-767",
                    "043-608-737-967-60X",
                    "025-246-608-570-632",
                    "023-939-052-489-028",
                    "020-009-029-407-493",
                    "003-376-346-248-551",
                    "145-146-407-738-040",
                    "014-707-760-101-558",
                    "123-665-708-230-239",
                    "034-012-759-664-649",
                    "023-671-383-084-282",
                    "099-697-433-610-66X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1038/cr.2013.92",
                    "23824801",
                    "23075143",
                    "19198616",
                    "23903833",
                    "pmc3807420",
                    "10.1038/nrmicro2090",
                    "pmc3731569",
                    "10.1128/jvi.01048-13",
                    "10.1128/mbio.00473-12",
                    "pmc3648152",
                    "10.1056/nejmoa1211721",
                    "pmc2750777",
                    "10.1128/jvi.00128-13",
                    "24342026",
                    "10.1038/nature12005",
                    "10.1016/j.jfma.2013.11.006",
                    "pmc3852489",
                    "10.1038/nature12328",
                    "10.1128/jvi.01756-13",
                    "23831647",
                    "10.4049/jimmunol.173.6.4050",
                    "15356154",
                    "23468491",
                    "10.1021/bk-2012-1095.ch006",
                    "10.1371/journal.pone.0081587",
                    "24324708",
                    "23835475",
                    "pmc3807362",
                    "10.1016/j.jinf.2012.12.003",
                    "23170002",
                    "23266463",
                    "pmc3754113",
                    "23486063"
                ]
            },
            {
                "index": "16",
                "publicationKey": "EP_2961768_A1",
                "lensId": "141-553-416-313-469",
                "jurisdiction": "EP",
                "kindCode": "A1",
                "displayKey": "EP 2961768 A1",
                "publicationDate": "2016-01-06",
                "filingNumber": "EP 14757347 A",
                "filingDate": "2014-02-28",
                "priorityFilingKeysActive": [
                    "US 201361771561 P 20130301",
                    "US 201461941076 P 20140218"
                ],
                "earliestPriorityDate": "2013-03-01",
                "title": "Immunogenic Composition For Mers Coronavirus Infection",
                "applicants": [
                    "NEW YORK BLOOD CT INC",
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU"
                ],
                "inventors": [
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU",
                    "JIANG SHIBO",
                    "DU LANYING"
                ],
                "owners": [],
                "url": "https://lens.org/141-553-416-313-469",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 24,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/55561",
                    "A61K2039/55566",
                    "A61K2039/575",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2319/21",
                    "C07K2319/30",
                    "C12N7/00",
                    "C12N2770/20021",
                    "C12N2770/20022",
                    "C12N2770/20034"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K39/215",
                    "C07K16/10",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "17",
                "publicationKey": "WO_2014_134439_A1",
                "lensId": "191-461-564-951-732",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2014/134439 A1",
                "publicationDate": "2014-09-04",
                "filingNumber": "US 2014/0019402 W",
                "filingDate": "2014-02-28",
                "priorityFilingKeysActive": [
                    "US 201361771561 P 20130301",
                    "US 201461941076 P 20140218"
                ],
                "earliestPriorityDate": "2013-03-01",
                "title": "Immunogenic Composition For Mers Coronavirus Infection",
                "applicants": [
                    "NEW YORK BLOOD CT INC",
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU"
                ],
                "inventors": [
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU",
                    "JIANG SHIBO",
                    "DU LANYING"
                ],
                "owners": [],
                "url": "https://lens.org/191-461-564-951-732",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 10,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 24,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/55561",
                    "A61K2039/55566",
                    "A61K2039/575",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2319/21",
                    "C07K2319/30",
                    "C12N7/00",
                    "C12N2770/20021",
                    "C12N2770/20022",
                    "C12N2770/20034"
                ],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "ZAKI ET AL.: \"Isolation of a novel coronavirus from a man with Pneumonia in Saudi Arabia\", THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 367, no. 19, 8 November 2012 (2012-11-08), pages 1814 - 1820, XP055274765",
                    "HE ET AL.: \"Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines\", THE JOURNAL OF IMMUNOLOGY, vol. 173, no. 6, 15 September 2004 (2004-09-15), pages 4050 - 4057, XP055274774",
                    "DU ET AL.: \"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines\", PLOS ONE, vol. 8, no. ISSUE, December 2013 (2013-12-01), pages 1 - 9, XP009182022",
                    "See also references of EP 2961768A4"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "003-376-346-248-551",
                    "123-665-708-230-239",
                    "023-671-383-084-282"
                ],
                "nplResolvedExternalIDs": [
                    "23075143",
                    "10.1056/nejmoa1211721",
                    "10.1371/journal.pone.0081587",
                    "24324708",
                    "pmc3852489",
                    "10.4049/jimmunol.173.6.4050",
                    "15356154"
                ]
            },
            {
                "index": "18",
                "publicationKey": "WO_2015_143335_A1",
                "lensId": "044-568-385-301-945",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/143335 A1",
                "publicationDate": "2015-09-24",
                "filingNumber": "US 2015/0021773 W",
                "filingDate": "2015-03-20",
                "priorityFilingKeysActive": [
                    "US 201461968279 P 20140320"
                ],
                "earliestPriorityDate": "2014-03-20",
                "title": "Methods And Compositions For Chimeric Coronavirus Spike Proteins",
                "applicants": [
                    "UNIV NORTH CAROLINA"
                ],
                "inventors": [
                    "BARIC RALPH",
                    "AGNIHOTHRAM SUDHAKAR",
                    "YOUNT BOYD"
                ],
                "owners": [],
                "url": "https://lens.org/044-568-385-301-945",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K2039/5256",
                    "A61K2039/5258",
                    "A61K2039/70",
                    "C07K16/10",
                    "C07K2317/34",
                    "C07K2317/76",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "C12N2770/36123",
                    "C12N2770/36143",
                    "C12N2770/36144"
                ],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K39/215",
                    "A61P31/12",
                    "C12N15/50"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "AGNIHOTHRAM S ET AL.: \"Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses\", J INFECT DIS., vol. 209, no. 7, 18 November 2013 (2013-11-18), pages 995 - 1006, XP055227760, [retrieved on 20140401]"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "089-209-533-057-090"
                ],
                "nplResolvedExternalIDs": [
                    "24253287",
                    "pmc3952667",
                    "10.1093/infdis/jit609"
                ]
            },
            {
                "index": "19",
                "publicationKey": "US_9884895_B2",
                "lensId": "131-058-428-999-313",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9884895 B2",
                "publicationDate": "2018-02-06",
                "filingNumber": "US 201515124992 A",
                "filingDate": "2015-03-20",
                "priorityFilingKeysActive": [
                    "US 201461968279 P 20140320"
                ],
                "earliestPriorityDate": "2014-03-20",
                "title": "Methods And Compositions For Chimeric Coronavirus Spike Proteins",
                "applicants": [
                    "UNIV NORTH CAROLINA CHAPEL HILL"
                ],
                "inventors": [
                    "BARIC RALPH",
                    "AGNIHOTHRAM SUDHAKAR",
                    "YOUNT BOYD"
                ],
                "owners": [
                    {
                        "name": "THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL",
                        "executionDate": "2016-10-05"
                    }
                ],
                "url": "https://lens.org/131-058-428-999-313",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 8,
                "cpcClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K2039/5256",
                    "A61K2039/5258",
                    "A61K2039/70",
                    "C07K16/10",
                    "C07K2317/34",
                    "C07K2317/76",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "C12N2770/36123",
                    "C12N2770/36143",
                    "C12N2770/36144"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K39/215",
                    "A61K39/395",
                    "A61K45/06",
                    "C07K14/005",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 292,
                "nplCitations": [
                    "Agnihothram et al. \u201cEvaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses\u201d The Journal of Infectious Diseases 209:995-1006 (2014).",
                    "International Search Report and the Written Opinion of the International Searching Authority corresponding to International Patent Application No. PCT/US2015/021773 (12 pages) (dated Jun. 10, 2015).",
                    "GenBank Accession No. ACJ60694.1, \u201cSpike glycoprotein [recombinant coronavirus]\u201d, NCBI, 2 pages, Jul. 26, 2016.",
                    "GenBank Accession No. AAP13441.1, \u201cS protein [SARS coronavirus Urbani]\u201d, NCBI, 2 pages, Jul. 25, 2016.",
                    "GenBank Accession No. ABG47069, \u201cSpike protein [Bat CoV 279/2005]\u201d, NCBI, 2 pages, Jul. 19, 2006.",
                    "GenBank Accession No. ABN10848.1, \u201cSpike glycoprotein [Bat coronavirus HKU4-2]\u201d, NCBI, 2 pages, Feb. 7, 2007.",
                    "GenBank Accession No. AFS88936.1, \u201cS protein [Human betacoronavirus 2c EMC/2012]\u201d, NCBI, 2 pages, Dec. 4, 2012.",
                    "GenBank Accession No. ABN10902.1, \u201cSpike glycoprotein [Bat coronavirus HKU5-5]\u201d, NCBI, 2 pages, Feb. 7, 2007.",
                    "GenBank Accession No. FJ211859, \u201cRecombinant coronavirus clone Bat SARS-CoV, complete sequence\u201d, NCBI, 11 pages, Jul. 26, 2016.",
                    "GenBank Accession No. FJ211860, \u201cRecombinant coronavirus clone Bat-SRBD spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Dec. 31, 2008.",
                    "GenBank Accession No. DQ022305, \u201cBat SARS coronavirus HKU3-1, complete genome\u201d, NCBI, 12 pages, Oct. 25, 2005.",
                    "GenBank Accession No. DQ084199, \u201cBat SARS coronavirus HKU3-2, complete genome\u201d, NCBI, 12 pages, Sep. 28, 2005.",
                    "GenBank Accession No. DQ084200, \u201cBat SARS coronavirus HKU3-3, complete genome\u201d, NCBI, 12 pages, Sep. 28, 2005.",
                    "GenBank Accession No. DQ412043, \u201cBat SARS coronavirus Rm1, complete genome\u201d, NCBI, 12 pages, Jul. 13, 2006.",
                    "GenBank Accession No. DQ648857, \u201cBat coronavirus (BtCoV/279/2005), complete genome\u201d, NCBI, 11 pages, Jul. 19, 2006.",
                    "GenBank Accession No. DQ412042, \u201cBat SARS coronavirus Rf1, complete genome\u201d, NCBI, 12 pages, Jul. 13, 2016.",
                    "GenBank Accession No. DQ648856, \u201cBat coronavirus (BtCoV/273/2005), complete genome\u201d, NCBI, 11 pages, Jul. 19, 2006.",
                    "GenBank Accession No. DQ071615, \u201cBat SARS coronavirus Rp3, complete genome\u201d, NCBI, 12 pages, Jan. 25, 2006.",
                    "GenBank Accession No. AY686863, \u201cSARS coronavirus A022, complete genome\u201d, NCBI, 12 pages, Jul. 21, 2006.",
                    "GenBank Accession No. AY278554, \u201cSARS coronavirus CUHK-W1, complete genome\u201d, NCBI, 14 pages, Jul. 31, 2003.",
                    "GenBank Accession No. AY278489, \u201cSARS coronavirus GD01, complete genome\u201d, NCBI, 13 pages, Sep. 1, 2009.",
                    "GenBank Accession No. AY515512, \u201cSARS coronavirus HC/SZ/61/03, complete genome\u201d, NCBI, 8 pages, Jan. 1, 2005.",
                    "Genbank accession No. AY304488, \u201cSARS coronavirus SZ16, complete genome\u201d, NCBI 8 pages, Nov. 5, 2003.",
                    "GenBank Accession No. AY278741, \u201cSARS coronavirus Urbani, complete genome\u201d, NCBI 14 pages, Jul. 25, 2016.",
                    "GenBank Accession No. AY572035, \u201cSARS coronavirus civet010, complete genome\u201d, NCBI, 12 pages, Dec. 1, 2005.",
                    "GenBank Accession No. DQ497008, \u201cSARS coronavirus strain MA-15, complete genome\u201d, NCBI, 13 pages, Mar. 20, 2007.",
                    "GenBank Accession No. KC881005, \u201cBat SARS-like coronavirus RsSHC014, complete genome\u201d, NCBI, 13 pages, Nov. 22, 2013.",
                    "GenBank Accession No. KC881006, Bat SARS-like coronavirus Rs3367, complete genome, NCBI, 13 pages, Nov. 22, 2013.",
                    "GenBank Accession No. KC881007, \u201cBat SARS-like coronavirus WIV1 spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Nov. 22, 2013.",
                    "GenBank Accession No. KF600652.1, \u201cMiddle East respiratory syndrome coronavirus isolate Riyadh\u20142\u20142012, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600651.1, \u201cMiddle East respiratory syndrome coronavirus isolate\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600647.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201417\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600645.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201415\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600644.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201416\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600634, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201421\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600632, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201419\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600630.1, \u201cMiddle East respiratory syndrome coronavirus isolate Buraidah\u20141\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600628.1, \u201cMiddle East respiratory syndrome coronavirus isolate Hafr-Al-Batin\u20141\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600627.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201412\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600620.1, \u201cMiddle East respiratory syndrome coronavirus isolate Bisha\u20141\u20142012, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600613.1, \u201cMiddle East respiratory syndrome coronavirus isolate Riyadh\u20143\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600612.1, \u201cMiddle East respiratory syndrome coronavirus isolate Riyadh\u20141\u20142012, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF186565.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20143\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF186567.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20141\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF186566.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20142\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF186564.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20144\u20142013, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF192507.1, \u201cMiddle East respiratory syndrome coronavirus, complete genome\u201d, NCBI, 13 pages, Jul. 24, 2014.",
                    "GenBank Accession No. NC\u2014019843, \u201cMiddle East respiratory syndrome coronavirus, complete genome\u201d, NCBI, 16 pages, Sep. 9, 2014.",
                    "GenBank Accession No. KC667074, \u201cHuman betacoronavirus 2c England-Qatar/2012, complete genome\u201d, NCBI, 13 pages, Apr. 30, 2013.",
                    "GenBank Accession No. KF600656.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201413d\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600655.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20147a\u20142013, partial genome\u201d, NCBI, 8 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600654.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149b\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600649.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149c\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600648.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149a\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600646.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201411b\u20142013, partial genome\u201d, NCBI, 4 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600643.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201414b\u20142013, partial genome\u201d, NCBI, 7 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600642.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201410b\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600640.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201413e\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600639.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149e\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600638.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20148b\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600637.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201413c\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600636.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201411c\u20142013, partial genome\u201d, NCBI, 7 pages, Jul. 24, 2014.",
                    "GenBank Accession No, KF600635.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20148d\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600631.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422e\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600626.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20148c\u20142013, partial genome\u201d, NCBI, 5 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600625.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422b\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600624.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201410c\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600623.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20147b\u20142013, partial genome\u201d, NCBI, 5 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600622.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20149d\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600621.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422f\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600619.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422d\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600618.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u20148a\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600616.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201413b\u20142013, partial genome\u201d, NCBI, 3 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600615.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201414a\u20142013, partial genome\u201d, NCBI, 4 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600614.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201410e\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600641.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201410d\u20142013, partial genome\u201d, NCBI, 1 page, Jul. 24, 2014.",
                    "GenBank Accession No. KF600633.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422c\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600629.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201411a\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KF600617.1, \u201cMiddle East respiratory syndrome coronavirus isolate Al-Hasa\u201422a\u20142013, partial genome\u201d, NCBI, 2 pages, Jul. 24, 2014.",
                    "GenBank Accession No. KC869678.2, \u201cCoronavirus Neoromicia/PML-PHE1/RSA/2011 RNA-dependent RNA polymerase (ORF1b) gene, partial cds\u201d, NCBI, 2 pages, Aug. 27, 2013.",
                    "GenBank Accession No. KF493885.1, \u201cBat Coronavirus Taper/CII\u2014KDS\u2014287/Bisha/Saudi Arabia/2012 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. KF493888.1, \u201cBat coronavirus Rhhar/CII\u2014KSA\u2014003/Bisha/Saudi Arabia/2013 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. KF493887.1, \u201cBat coronavirus Pikuh/CII\u2014KSA\u2014001/Riyadh/Saudi Arabia/2013 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. KF493886.1, \u201cBat coronavirus Rhhar/CII\u2014KSA\u2014002/Bisha/Saudi Arabia/2013 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. KF493884.1, \u201cBat coronavirus Rhhar/CII\u2014KSA\u2014004/Bisha/Saudi Arabia/2013 RNA-directed RNA polymerase gene, partial cds\u201d, NCBI, 1 page, Nov. 14, 2013.",
                    "GenBank Accession No. EF065506, \u201cBat coronavirus HKU4-2, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. NC\u2014009019, \u201cBat coronavirus HKU4-1, complete genome\u201d, NCBI, 13 pages, Mar. 28, 2016.",
                    "GenBank Accession No. EF065507, \u201cBat coronavirus HKU4-3, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. EF065508, \u201cBat coronavirus HKU4-4, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. NC\u2014008315, \u201cBat coronavirus (BtCoV/133/2005), complete genome\u201d, NCBI, 12 pages, May 22, 2007.",
                    "GenBank Accession No. EF065512, \u201cBat coronavirus HKU5-5, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. NC\u2014009020, \u201cBat coronavirus HKU5-1, complete genome\u201d, NCBI, 13 pages, Mar. 28, 2016.",
                    "GenBank Accession No. EF065510, \u201cBat coronavirus HKU5-2, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. EF065511, \u201cBat coronavirus HKU5-3, complete genome\u201d, NCBI, 12 pages, Feb. 7, 2007.",
                    "GenBank Accession No. KC776174.1, \u201cHuman betacoronavirus 2c Jordan-N3/2012, complete genome\u201d, NCBI, 13 pages, Mar. 25, 2013.",
                    "GenBank Accession No. JX869059.2, \u201cHuman betacoronavirus 2c EMC/2012, complete genome\u201d, NCBI, 13 pages, Dec. 4, 2012.",
                    "GenBank Accession No. KC522089.1, \u201cPipistrellus bat coronavirus HKU5 isolate 33R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522088.1, \u201cPipistrellus bat coronavirus HKU5 isolate 32R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522087.1, \u201cPipistrellus bat coronavirus HKU5 isolate 31R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522086.1, \u201cPipistrellus bat coronavirus HKU5 isolate 30R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522085.1, \u201cPipistrellus bat coronavirus HKU5 isolate 28R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522084.1, \u201cPipistrellus bat coronavirus HKU5 isolate 27R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522083.1, \u201cPipistrellus bat coronavirus HKU5 isolate 26R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522082.1, \u201cPipistrellus bat coronavirus HKU5 isolate 24R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522081.1, \u201cPipistrellus bat coronavirus HKU5 isolate 22R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522080.1, \u201cPipistrellus bat coronavirus HKU5 isolate 21R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522079.1, \u201cPipistrellus bat coronavirus HKU5 isolate 20R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522078.1, \u201cPipistrellus bat coronavirus HKU5 isolate 19R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522077.1, \u201cPipistrellus bat coronavirus HKU5 isolate 18R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522076.1, \u201cPipistrellus bat coronavirus HKU5 isolate 17R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522075.1, \u201cPipistrellus bat coronavirus HKU5 isolate 16R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522104.1, \u201cPipistrellus bat coronavirus HKU5 isolate 33S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522103.1, \u201cPipistrellus bat coronavirus HKU5 isolate 32S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522102.1, \u201cPipistrellus bat coronavirus HKU5 isolate 31S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522101.1, \u201cPipistrellus bat coronavirus HKU5 isolate 30S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522100.1, \u201cPipistrellus bat coronavirus HKU5 isolate 28S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522099.1, \u201cPipistrellus bat coronavirus HKU5 isolate 27S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522098.1, \u201cPipistrellus bat coronavirus HKU5 isolate 26S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522097.1, \u201cPipistrellus bat coronavirus HKU5 isolate 24S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522096.1, \u201cPipistrellus bat coronavirus HKU5 isolate 22S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522095.1, \u201cPipistrellus bat coronavirus HKU5 isolate 21S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522094.1, \u201cPipistrellus bat coronavirus HKU5 isolate 20S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522093.1, \u201cPipistrellus bat coronavirus HKU5 isolate 19S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522092.1, \u201cPipistrellus bat coronavirus HKU5 isolate 18S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522091.1, \u201cPipistrellus bat coronavirus HKU5 isolate 17S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522090.1, \u201cPipistrellus bat coronavirus HKU5 isolate 16S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522119.1, \u201cPipistrellus bat coronavirus HKU5 isolate 33N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522118.1, \u201cPipistrellus bat coronavirus HKU5 isolate 32N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522117.1, \u201cPipistrellus bat coronavirus HKU5 isolate 31N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522116.1, \u201cPipistrellus bat coronavirus HKU5 isolate 30N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522115.1, \u201cPipistrellus bat coronavirus HKU5 isolate 28N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522114.1, \u201cPipistrellus bat coronavirus HKU5 isolate 27N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522113.1, \u201cPipistrellus bat coronavirus HKU5 isolate 26N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522112.1, \u201cPipistrellus bat coronavirus HKU5 isolate 24N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522111.1, \u201cPipistrellus bat coronavirus HKU5 isolate 22N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522110.1, \u201cPipistrellus bat coronavirus HKU5 isolate 21N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522109.1, \u201cPipistrellus bat coronavirus HKU5 isolate 20N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522108.1, \u201cPipistrellus bat coronavirus HKU5 isolate 19N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522107.1, \u201cPipistrellus bat coronavirus HKU5 isolate 18N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522106.1, \u201cPipistrellus bat coronavirus HKU5 isolate 17N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522105.1, \u201cPipistrellus bat coronavirus HKU5 isolate 16N nucleocapsid protein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522048.1, \u201cTylonycteris bat coronavirus HKU4 isolate 15R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522047.1, \u201cTylonycteris bat coronavirus HKU4 isolate 14R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522046.1, \u201cTylonycteris bat coronavirus HKU4 isolate 12R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522045.1, \u201cTylonycteris bat coronavirus HKU4 isolate 11R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522044.1, \u201cTylonycteris bat coronavirus HKU4 isolate 10R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522043.1, \u201cTylonycteris bat coronavirus HKU4 isolate 9R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522042.1, \u201cTylonycteris bat coronavirus HKU4 isolate 8R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522041.1, \u201cTylonycteris bat coronavirus HKU4 isolate 7R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522040.1, \u201cTylonycteris bat coronavirus HKU4 isolate 6R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522039.1, \u201cTylonycteris bat coronavirus HKU4 isolate 5R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522038.1, \u201cTylonycteris bat coronavirus HKU4 isolate 4R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522037.1, \u201cTylonycteris bat coronavirus HKU4 isolate 3R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522036.1, \u201cTylonycteris bat coronavirus HKU4 isolate 2R RNA-dependent RNA polymerase gene, partial cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522061.1, \u201cTylonycteris bat coronavirus HKU4 isolate 15S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522060.1, \u201cTylonycteris bat coronavirus HKU4 isolate 14S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522059.1, \u201cTylonycteris bat coronavirus HKU4 isolate 12S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522058.1, \u201cTylonycteris bat coronavirus HKU4 isolate 11S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522057.1, \u201cTylonycteris bat coronavirus HKU4 isolate 10S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522056.1, \u201cTylonycteris bat coronavirus HKU4 isolate 9S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522055.1, \u201cTylonycteris bat coronavirus HKU4 isolate 8S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522054.1, \u201cTylonycteris bat coronavirus HKU4 isolate 7S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522053.1, \u201cTylonycteris bat coronavirus HKU4 isolate 6S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522052.1, \u201cTylonycteris bat coronavirus HKU4 isolate 5S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522051.1, \u201cTylonycteris bat coronavirus HKU4 isolate 4S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522050.1, \u201cTylonycteris bat coronavirus HKU4 isolate 3S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522049.1, \u201cTylonycteris bat coronavirus HKU4 isolate 2S spike glycoprotein gene, complete cds\u201d, NCBI, 3 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522074.1, \u201cTylonycteris bat coronavirus HKU4 isolate 15N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522073.1, \u201cTylonycteris bat coronavirus HKU4 isolate 14N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522072.1, \u201cTylonycteris bat coronavirus HKU4 isolate 12N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522071.1, \u201cTylonycteris bat coronavirus HKU4 isolate 11N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522070.1, \u201cTylonycteris bat coronavirus HKU4 isolate 10N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522069.1, \u201cTylonycteris bat coronavirus HKU4 isolate 9N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522068.1, \u201cTylonycteris bat coronavirus HKU4 isolate 8N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522067.1, \u201cTylonycteris bat coronavirus HKU4 isolate 7N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522066.1, \u201cTylonycteris bat coronavirus HKU4 isolate 6N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522065.1, \u201cTylonycteris bat coronavirus HKU4 isolate 5N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522064.1, \u201cTylonycteris bat coronavirus HKU4 isolate 4N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15 2013.",
                    "GenBank Accession No. KC522063.1, \u201cTylonycteris bat coronavirus HKU4 isolate 3N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. KC522062.1, \u201cTylonycteris bat coronavirus HKU4 isolate 2N nucleocapsid protein gene, complete cds\u201d, NCBI, 2 pages, Jul. 15, 2013.",
                    "GenBank Accession No. NC\u2014007025, \u201cFeline coronavirus, complete genome\u201d, NCBI, 13 pages, Dec. 1, 2009.",
                    "GenBank Accession No. NC\u2014002306, \u201cFeline infectious peritonitis virus, complete genome\u201d, NCBI, 12 pages, Dec. 13, 2013.",
                    "GenBank Accession No. DQ811789.2, \u201cTGEV virulent Purdue, complete genome\u201d, NCBI, 12 pages, Apr. 29, 2011.",
                    "GenBank Accession No. DQ811786.2, \u201cTGEV Miller M60, complete genome\u201d, NCBI, 12 pages, Apr. 29, 2011.",
                    "GenBank Accession No. DQ811788.1, \u201cTGEV Purdue P115, complete genome\u201d, NCBI, 11 pages, Jul. 14, 2016.",
                    "GenBank Accession No. DQ811785.1, \u201cTGEV Miller M6, complete genome\u201d, NCBI, 11 pages, Jul. 14, 2016.",
                    "GenBank Accession No. X52157.1, \u201cCoronavirus TGEV mRNA for nucleoprotein, 5\u2032 region\u201d, NCBI, 1 pages, Jul. 26, 2016.",
                    "GenBank Accession No. AJ011482.1, \u201cPorcine transmissible gastroenteritis virus minigenome\u201d, NCBI, 5 pages, Nov. 14, 2006.",
                    "GenBank Accession No. KC962433.1, \u201cTransmissible gastroenteritis virus isolate TGEV-HX, complete genome\u201d, NCBI, 11 pages, Apr. 1, 2015.",
                    "GenBank Accession No. AJ271965.2, \u201cTransmissible gastroenteritis virus complete genome, genomic RNA\u201d, NCBI, 13 pages, Apr. 15, 2005.",
                    "GenBank Accession No. JQ693060.1, \u201cTransmissible gastroenteritis virus isolate KT3 nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Mar. 22, 2013.",
                    "GenBank Accession No. KC609371.1, \u201cTransmissible gastroenteritis virus isolate ZH spike protein mRNA, complete cds\u201d, NCBI, 3 pages, May 21, 2013.",
                    "GenBank Accession No. JQ693059.1, \u201cTransmissible gastroenteritis virus isolate KT2 nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693058.1, \u201cTransmissible gastroenteritis virus isolate DAE nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693057.1, \u201cTransmissible gastroenteritis virus isolate 133 nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693052.1, \u201cTransmissible gastroenteritis virus isolate KT3 spike glycoprotein (S) gene, complete cds\u201d, NCBI, 3 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693051.1, \u201cTransmissible gastroenteritis virus isolate KT2 spike glycoprotein (S) gene, complete cds\u201d, NCBI, 3 pages, Mar. 22, 2013.",
                    "GenBank Accession No. JQ693050.1, \u201cTransmissible gastroenteritis virus isolate DAE spike glycoprotein (S) gene, complete cds\u201d, NCBI, 3 pages, Mar. 22, 2013.",
                    "GenBank Accession No. NC\u2014001961.1, \u201cPorcine respiratory and reproductive syndrome virus, complete genome\u201d, NCBI, 11 pages, Nov. 2, 2012.",
                    "GenBank Accession No. DQ811787, \u201cPRCV ISU-1, complete genome\u201d, NCBI, 11 pages, Jul. 14, 2016.",
                    "GenBank Accession No. NC\u2014010437, \u201cBat coronavirus 1A, complete genome\u201d, NCBI, 12 pages, Mar. 28, 2016.",
                    "GenBank Accession No. NC\u2014010436, \u201cBat coronavirus 1B, complete genome\u201d, NCBI, 13 pages, Apr. 23, 2008.",
                    "GenBank Accession No. NC\u2014010438, \u201cBat coronavirus HKU8, complete genome\u201d, NCBI, 13 pages, Mar. 28, 2016.",
                    "GenBank Accession No. DQ648858, \u201cBat coronavirus (BtCoV/512/2005) ORF1, spike protein, putative ORF3, envelope protein, matrix protein, and nucleocapsid protein genes, complete cds\u201d, NCBI, 11 pages, Jul. 19, 2006.",
                    "GenBank Accession No. NC\u2014003436, \u201cPorcine epidemic diarrhea virus, complete genome\u201d, NCBI, 12 pages, Feb. 10, 2015.",
                    "GenBank Accession No. DQ355224.1, \u201cPorcine epidemic diarrhea virus strain CH/S nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Feb. 1, 2006.",
                    "GenBank Accession No. DQ355223.1, \u201cPorcine epidemic diarrhea virus strain S nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Feb. 1, 2006.",
                    "GenBank Accession No. DQ355221.1, \u201cPorcine epidemic diarrhea virus strain CV777 nucleocapsid protein (N) gene, complete cds\u201d, NCBI, 2 pages, Feb. 1, 2006.",
                    "GenBank Accession No. JN601062.1, \u201cPorcine epidemic diarrhea virus strain CH/GXNN/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601061.1, \u201cPorcine epidemic diarrhea virus strain CH/SDRZ-2/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601060.1, \u201cPorcine epidemic diarrhea virus strain CH/SDRZ-1/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601059.1, \u201cPorcine epidemic diarrhea virus strain CH/HLJHG/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601058.1, \u201cPorcine epidemic diarrhea virus strain CH/GDQY-3/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601057.1, \u201cPorcine epidemic diarrhea virus strain CH/GDQY-1/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601056.1, \u201cPorcine epidemic diarrhea virus strain CH/GDQY-1/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601055.1, \u201cPorcine epidemic diarrhea virus strain CH/FJND/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601054.1, \u201cPorcine epidemic diarrhea virus strain CH/BJYQ-2/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601053.1, \u201cPorcine epidemic diarrhea virus strain CH/BJYQ-1/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN601052.1, \u201cPorcine epidemic diarrhea virus strain CH/HNZZ/2011 N protein (N) gene, complete cds\u201d, NCBI, 2 pages, Jun. 3, 2013.",
                    "GenBank Accession No. JN400902.1, \u201cPorcine epidemic diarrhea virus strain CH/HBQX/10 membrane glycoprotein (M) gene, complete cds\u201d, NCBI, 3 pages, Apr. 3, 2013.",
                    "GenBank Accession No. JN547395.1, \u201cPorcine epidemic diarrhea virus strain CH/HBQX/10 non-structural protein gene, complete cds\u201d, NCBI, 2 pages, Apr. 3, 2013.",
                    "GenBank Accession No. FJ687473.1, \u201cPorcine epidemic diarrhea virus isolate CPF1074 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687472.1, \u201cPorcine epidemic diarrhea virus isolate PFF1051 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687471.1, \u201cPorcine epidemic diarrhea virus isolate CPF531 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687470.1, \u201cPorcine epidemic diarrhea virus isolate PFF514 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687469.1, \u201cPorcine epidemic diarrhea virus isolate PFF513 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687468.1, \u201cPorcine epidemic diarrhea virus isolate PFF381 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687467.1, \u201cPorcine epidemic diarrhea virus isolate CPF299 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687466.1, \u201cPorcine epidemic diarrhea virus isolate PFF285 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687465.1, \u201cPorcine epidemic diarrhea virus isolate CPF259 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687464.1, \u201cPorcine epidemic diarrhea virus isolate BIF256 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687463.1, \u201cPorcine epidemic diarrhea virus isolate CPF193 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687462.1, \u201cPorcine epidemic diarrhea virus isolate PFF188 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687461.1, \u201cPorcine epidemic diarrhea virus isolate VF131 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687460.1, \u201cPorcine epidemic diarrhea virus isolate BIF118 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687459.1, \u201cPorcine epidemic diarrhea virus isolate MF78 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687458.1, \u201cPorcine epidemic diarrhea virus isolate V25010 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687457.1, \u201cPorcine epidemic diarrhea virus isolate M2366 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687456.1, \u201cPorcine epidemic diarrhea virus isolate M2227 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687455.1, \u201cPorcine epidemic diarrhea virus isolate M1763 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687454.1, \u201cPorcine epidemic diarrhea virus isolate e1697 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687453, \u201cPorcine epidemic diarrhea virus isolate e1642 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687452.1, \u201cPorcine epidemic diarrhea virus isolate M1595 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687451.1, \u201cPorcine epidemic diarrhea virus isolate BI1108 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687450.1, \u201cPorcine epidemic diarrhea virus isolate BI981 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. FJ687449.1, \u201cPorcine epidemic diarrhea virus isolate BI976 membrane protein (M) gene, complete cds\u201d, NCBI, 2 pages, Apr. 6, 2011.",
                    "GenBank Accession No. AF500215.1, \u201cPorcine epidemic diarrhea virus spike protein (Spk1) gene, complete cds\u201d, NCBI, 3 pages, Aug. 23, 2005.",
                    "GenBank Accession No. KF476061.1, \u201cPorcine epidemic diarrhea virus isolate CHHEB ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476060.1, \u201cPorcine epidemic diarrhea virus isolate CHZHZ-04 putative ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476059.1, \u201cPorcine epidemic diarrhea virus isolate CHJCH ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476058.1, \u201cPorcine epidemic diarrhea virus isolate CHXIP-03 putative ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476057.1, \u201cPorcine epidemic diarrhea virus isolate CHLSHAN ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476056.1, \u201cPorcine epidemic diarrhea virus isolate CHFH putative ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476055.1, \u201cPorcine epidemic diarrhea virus isolate CHLH ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476054.1, \u201cPorcine epidemic diarrhea virus isolate CHFCH-01 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476053.1, \u201cPorcine epidemic diarrhea virus isolate CHLY-09 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476052.1, \u201cPorcine epidemic diarrhea virus isolate CHXIP-01 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476051.1, \u201cPorcine epidemic diarrhea virus isolate CHKF-01 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476050.1, \u201cPorcine epidemic diarrhea virus isolate CHQX-02 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476049.1, \u201cPorcine epidemic diarrhea virus isolate CHXY-02 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF476048.1, \u201cPorcine epidemic diarrhea virus isolate CHYF-01 ORF3 protein (ORF3) gene, complete cds\u201d, NCBI, 2 pages, May 5, 2014.",
                    "GenBank Accession No. KF177258.1, \u201cPorcine epidemic diarrhea virus isolate YJ7C spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Sep. 18, 2013.",
                    "GenBank Accession No. KF177257.1, \u201cPorcine epidemic diarrhea virus isolate YJ3F spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Sep. 18, 2013.",
                    "GenBank Accession No. KF177256.1, \u201cPorcine epidemic diarrhea virus isolate JY7C spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Sep. 18, 2013.",
                    "GenBank Accession No. KF177255.1, \u201cPorcine epidemic diarrhea virus isolate JY6C spike protein (S) gene, complete cds\u201d, NCBI, 3 pages, Sep. 18, 2013.",
                    "GenBank Accession No. NC\u2014002645, \u201cHuman coronavirus 229E, complete genome\u201d, NCBI, 12 pages, Apr. 28, 20710.",
                    "GenBank Accession No. NC\u2014005831, \u201cHuman coronavirus NL63, complete genome\u201d, NCBI, 11 pages, Mar. 29, 2016.",
                    "GenBank Accession No. EF203066, \u201cBat coronavirus HKU2 strain HKU2/HK/298/2006, complete genome\u201d, NCBI, 12 pages, Oct. 9, 2007.",
                    "GenBank Accession No. EF203067.1, \u201cBat coronavirus HKU2 strain HKU2/HK/33/2006, complete genome\u201d, NCBI, 12 pages, Oct. 9, 2007.",
                    "GenBank Accession No. EF203065, \u201cBat coronavirus HKU2 strain HKU2/HK/46/2006, complete genome\u201d, NCBI, 12 pages, Oct. 9, 2007.",
                    "GenBank Accession No. EF203064, \u201cBat coronavirus HKU2 strain HKU2/GD/430/2006, complete genome\u201d, NCBI, 12 pages, Oct. 9, 2007.",
                    "GenBank Accession No. DQ339101, \u201cHuman coronavirus HKU1 strain N5P8 genotype A/B recombinant, complete genome\u201d, NCBI, 12 pages, Jun. 30, 2006.",
                    "GenBank Accession No. NC\u2014001846, \u201cMouse hepatitis virus strain MHV-A59 C12 mutant, complete genome\u201d, NCBI, 12 pages, Mar. 29, 2016.",
                    "GenBank Accession No. NC\u2014007732, \u201cPorcine hemagglutinating encephalomyelitis virus, complete genome\u201d, NCBI, 13 pages, Dec. 1, 2009.",
                    "GenBank Accession No. NC\u2014005147, \u201cHuman coronavirus OC43, complete genome\u201d, NCBI, 13 pages, Dec. 13, 2013.",
                    "GenBank Accession No. NC\u2014003045, \u201cBovine coronavirus, complete genome\u201d, NCBI, 16 pages, Feb. 10, 2015.",
                    "GenBank Accession No. EF065514, \u201cBat coronavirus HKU9-2, complete genome\u201d, NCBI, 11 pages, Feb. 7, 2007.",
                    "GenBank Accession No. NC\u2014009021, \u201cBat coronavirus HKU9-1, complete genome\u201d, NCBI, 12 pages, Dec. 8, 2008.",
                    "GenBank Accession No. EF065515, \u201cBat coronavirus HKU9-3, complete genome\u201d, NCBI, 11 pages, Feb. 7, 2007.",
                    "GenBank Accession No. EF065516, \u201cBat coronavirus HKU9-4, complete genome\u201d, NCBI, 11 pages, Feb. 7, 2007.",
                    "GenBank Accession No. DQ001339, \u201cAvian infectious bronchitis virus isolate IBV-p65, complete genome\u201d, NCBI, 11 pages, Oct. 17, 2005.",
                    "Akerstr\u00f6m et al. \u201cProtein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies\u201d, J Immunol 1985; 135:2589-2592.",
                    "Chen et al. \u201cBoosting with recombinant vacccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines\u201d, Vaccine, 18(19):2015-2022, Apr. 3, 2000 (Abstract Only).",
                    "Gonzalo et al. \u201cEnhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants\u201d, Vaccine, 17(7-8):887-892, Feb. 26, 1999 (Abstract Only).",
                    "Hanke et al. \u201cEnhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime\u201d, Vaccine, 16(5):439-445, Mar. 1998 (Abstract Only).",
                    "Huse et al. \u201cGeneration of a large combinatorial library of the immunoglobulin repertoire in phage lambda\u201d, Science, Dec. 8, 1989, vol. 246, Issue 4935, pp. 1275-1281 (Abstract Only).",
                    "Kohler and Milstein, \u201cContinuous cultures of fused cells secreting antibody of predefined specificity\u201d, Nature, vol. 256:494-497, Aug. 7, 1975.",
                    "Kronvall et al. \u201cA Surface Component in Group A, C, and G Streptococci with Non-Immune Reactivity for Immunoglobulin G\u201d, J. Immunol. 111:1401-1406 (1973).",
                    "Maddox et al. \u201cElevated Serum Levels in Human Pregnancy of a Molecule Immunochemically Similar to Eosinophil Granule Major Basic Protein\u201d, J. Exp. Med. 158:1211-1226 (Oct. 1983).",
                    "Pancholi et al. \u201cDNA Prime-Canarypox Boost with Polycistronic Hepatitis C Virus (HCV) Genes Generates Potent Immune Responses to HCV Structural and Nonstructural Proteins\u201d, J. Infect. Dis. 182:18-27, 2000.",
                    "Walker et al. \u201cInteraction of human IgG chimeric antibodies with the human FcRI and FcRII receptors: requirements for antibody-mediated host cell-target cell interaction\u201d, Molec. Immunol. Apr. 1989; 26(4):403-411 (Abstract Only).",
                    "International Preliminary Report on Patentability Corresponding to International Application No. PCT/US2015/021773; dated Sep. 29, 2016; 8 pages."
                ],
                "nplResolvedCount": 11,
                "nplResolvedLensIDs": [
                    "031-691-266-250-26X",
                    "106-695-963-997-796",
                    "111-704-019-488-289",
                    "091-415-113-195-947",
                    "006-138-564-118-46X",
                    "033-797-614-829-293",
                    "112-863-452-534-981",
                    "151-516-877-883-106",
                    "089-209-533-057-090",
                    "079-069-238-514-186",
                    "106-753-778-592-300"
                ],
                "nplResolvedExternalIDs": [
                    "10067695",
                    "10882577",
                    "1172191",
                    "4031496",
                    "10706963",
                    "10.1016/0161-5890(89)90129-6",
                    "10.1084/jem.158.4.1211",
                    "4744924",
                    "10.1093/infdis/jit609",
                    "10.1086/315646",
                    "24253287",
                    "10.1016/s0264-410x(99)00528-9",
                    "6619734",
                    "2716734",
                    "pmc3952667",
                    "10.1126/science.2531466",
                    "10.1016/s0264-410x(98)00274-6",
                    "10.1038/256495a0",
                    "9491498",
                    "10.1016/s0264-410x(97)00226-0",
                    "2531466"
                ]
            },
            {
                "index": "20",
                "publicationKey": "US_9889194_B2",
                "lensId": "181-547-830-575-026",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9889194 B2",
                "publicationDate": "2018-02-13",
                "filingNumber": "US 201414375083 A",
                "filingDate": "2014-02-28",
                "priorityFilingKeysActive": [
                    "US 201361771561 P 20130301",
                    "US 201461941076 P 20140218"
                ],
                "earliestPriorityDate": "2013-03-01",
                "title": "Immunogenic Composition For Mers Coronavirus Infection",
                "applicants": [
                    "NEW YORK BLOOD CENTER INC",
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU"
                ],
                "inventors": [
                    "JIANG SHIBO",
                    "DU LANYING",
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU"
                ],
                "owners": [
                    {
                        "name": "NEW YORK BLOOD CENTER INC",
                        "executionDate": "2016-01-18"
                    }
                ],
                "url": "https://lens.org/181-547-830-575-026",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 24,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/55561",
                    "A61K2039/55566",
                    "A61K2039/575",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2319/21",
                    "C07K2319/30",
                    "C12N7/00",
                    "C12N2770/20021",
                    "C12N2770/20022",
                    "C12N2770/20034"
                ],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K39/385",
                    "C07K14/005",
                    "C07K16/10",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 19,
                "nplCitations": [
                    "Qiu et al. Microbiology and immunology, 2012, vol. 56, pp. 554-561.",
                    "Chen et al. Journal of Virology, 2013, vol. 87, No. 19, pp. 10777-10783.",
                    "Edmund et al. Arch. Immunol. Ther. Exp. 2009, vol. 57, pp. 311-323.",
                    "Du et al., \u201cA truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines\u201d, Plos One, vol. 8, No. 12, Article No. e81587, pp. 1-9, Dec. 2013.",
                    "He et al., \u201cIdentification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines\u201d, The Journal of Immunology, vol. 173, No. 6, pp. 4050-4057, Sep. 15, 2004.",
                    "Zaki et al., \u201cIsolation of a novel coronavirus from a man with pneumonia in Saudi Arabia\u201d, The new England Journal of Medicine, vol. 367, No. 19, pp. 1814-1820, Nov. 8, 2012.",
                    "Perlman S. \u201cThe Middle East Respiratory Syndrome\u2014How worried should we be?\u201d mBio 4:e00531-13, 2013.",
                    "Perlman et al. \u201cHuman coronavirus EMC is not the same as Severe Acute Respiratory Syndrome coronavirus,\u201d mBio 4:e00002-13, 2013.",
                    "Van Boheemen et al. \u201cGenomic characterization of a newly discovered coronavirus associated with Acute Respiratory Distress Syndrome in humans,\u201d mBio 3:e00473-12, 2012.",
                    "Jiang et al., A predicated receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC. Journal of Infection, Letters to the Editor, vol. 66, No. 5, pp. 464-466 (2012).",
                    "Du et al., The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development. Nature Reviews, Microbiology, vol. 7, No. 3, pp. 226-236 (2009).",
                    "Yan et al., Strategies for designing peptide immunogens to elicit [alpha]-helical conformation-specific antibodies reactive with native proteins. ACS Symposium Series, vol. 1095, pp. 93-136 (2012).",
                    "Du et al., Identification of a receptor-binding domain in the S protein of the novel human coronavirus middle east respiratory syndrome coronavirus as an essential target for vaccine development. Journal of Virology, vol. 87, No. 17, pp. 9939-9942 (2013).",
                    "Gierer et al., The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. Journal of Virology, vol. 87, No. 10, pp. 5502-5511 (2013).",
                    "Wang et al., Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Research, 23:986-993 (2013).",
                    "Raj et al., Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus\u2014EMC. Nature, vol. 495, pp. 251-256 (2013).",
                    "Lu et al., Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature, vol. 500, pp. 227-232 (2013).",
                    "Zhou et al., The receptor binding domain of MERS-CoV: the dawn of vaccine and treatment development. Journal of the Formosan Medical Association, 113:143-147 (2013).",
                    "Supplementary European Search Report dated Sep. 26, 2016 for European Patent Application No. EP 14757347.1 filed on Feb. 28, 2014."
                ],
                "nplResolvedCount": 18,
                "nplResolvedLensIDs": [
                    "032-266-887-602-220",
                    "001-172-069-168-870",
                    "044-201-328-679-836",
                    "067-884-443-627-767",
                    "043-608-737-967-60X",
                    "025-246-608-570-632",
                    "023-939-052-489-028",
                    "020-009-029-407-493",
                    "003-376-346-248-551",
                    "145-146-407-738-040",
                    "056-369-069-472-252",
                    "045-897-557-709-319",
                    "014-707-760-101-558",
                    "086-142-242-181-443",
                    "123-665-708-230-239",
                    "034-012-759-664-649",
                    "023-671-383-084-282",
                    "099-697-433-610-66X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1038/cr.2013.92",
                    "23824801",
                    "23075143",
                    "19198616",
                    "23903833",
                    "pmc3807420",
                    "22530918",
                    "10.1038/nrmicro2090",
                    "pmc3731569",
                    "10.1128/jvi.01048-13",
                    "10.1128/mbio.00473-12",
                    "19688186",
                    "pmc3648152",
                    "10.1056/nejmoa1211721",
                    "10.1128/mbio.00002-13",
                    "10.1111/j.1348-0421.2012.00467.x",
                    "pmc2750777",
                    "10.1128/jvi.00128-13",
                    "24342026",
                    "10.1038/nature12005",
                    "10.1128/mbio.00531-13",
                    "10.1016/j.jfma.2013.11.006",
                    "pmc3852489",
                    "10.1038/nature12328",
                    "10.1128/jvi.01756-13",
                    "23831647",
                    "10.4049/jimmunol.173.6.4050",
                    "15356154",
                    "23468491",
                    "23322635",
                    "10.1021/bk-2012-1095.ch006",
                    "10.1371/journal.pone.0081587",
                    "24324708",
                    "23963179",
                    "10.1007/s00005-009-0040-y",
                    "23835475",
                    "pmc3807362",
                    "10.1016/j.jinf.2012.12.003",
                    "23170002",
                    "23266463",
                    "pmc3754113",
                    "23486063"
                ]
            },
            {
                "index": "21",
                "publicationKey": "US_9919034_B2",
                "lensId": "167-192-947-618-782",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9919034 B2",
                "publicationDate": "2018-03-20",
                "filingNumber": "US 201514736170 A",
                "filingDate": "2015-06-10",
                "priorityFilingKeysActive": [
                    "US 201514736170 A 20150610",
                    "US 201514667282 A 20150324",
                    "US 201414316893 A 20140627",
                    "US 201414247723 A 20140408",
                    "US 201562147209 P 20150414",
                    "US 201562102671 P 20150113",
                    "US 201462063551 P 20141014",
                    "US 201462040885 P 20140822"
                ],
                "earliestPriorityDate": "2014-04-08",
                "title": "Methods Of Treating And Prophylactically Protecting Mammalian Patients Infected By Viruses Classified In Baltimore Group V",
                "applicants": [
                    "TAMIR BIOTECHNOLOGY INC"
                ],
                "inventors": [
                    "HODGE III THOMAS W"
                ],
                "owners": [
                    {
                        "name": "TAMIR BIOTECHNOLOGY INC",
                        "executionDate": "2015-06-08"
                    }
                ],
                "url": "https://lens.org/167-192-947-618-782",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K38/465",
                    "A01N63/00",
                    "C12N9/22",
                    "C12Y301/27",
                    "C12Y301/27005"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A01N63/00",
                    "A61K38/46",
                    "C07H21/04",
                    "C07K7/00",
                    "C12N9/22"
                ],
                "usClassifications": [],
                "nplCitationCount": 73,
                "nplCitations": [
                    "Tamir Reports Positive Effect Against SARS Virus (Jul. 21, 2010).",
                    "Tamir's Compounds Show Remarkable Results Against Dengue Virus (Jul. 19, 2010).",
                    "Investor Village\u2014Form 10-Q for Tamir Biotechnology, Inc. (Aug. 15, 2011).",
                    "Baltimore, Bacteriological Reviews, vol. 35, No. 3, p. 235-241 (Sep. 1971).",
                    "Wikipedia: Baltimore classification (Mar. 6, 2013).",
                    "Ilinskaya et al, Molecular Biology, vol. 48, No. 5, pp. 615-623 (2014).",
                    "Qiao et al, Cell Research 22:1199-1202 (2012).",
                    "Lin et al, Biochemical and Biophysical Research Communications, vol. 204, No. 1, pp. 156-162 (Oct. 14, 1994).",
                    "Moreau et al, Antiviral Research 59, pp. 181-191 (2003).",
                    "Domachowske et al, Nucleic Acids Research, vol. 26, No. 14, pp. 3358-3363 (1998).",
                    "GlobeNewswire, Jul. 21, 2010, Tamir Reports Positive Effect Against SARS Virus.",
                    "GlobeNewswire, Jul. 19, 2010, Tamirs Compounds Show Remarkable Results Against Dengue Virus.",
                    "InvestorVillage.com, May 15, 2011, ACEL / Message Board/ Thread View.",
                    "Baltimore, Expression of Animal Virus Genomes, Bacteriological Reviews, Sep. 1971, vol. 35, No. 3, pp. 235-241.",
                    "Wikipedia, Baltimore classification, Mar. 6, 2013.",
                    "Ilinskaya, Ribonucleases as Antiviral Agents, Molecular Biology, 2014, vol. 48, No. 5, pp. 615-623.",
                    "Qiao, Onconase downregulates microRNA expression through targeting microRNA precursors, Cell Research, 2012, 22:1199-1202.",
                    "Lin et al., Biochemical and Biophysical Research Communications 201 (1), 156-162 (1994).",
                    "Ardelt et al, Onconase and Amphinase, the Antitumor Ribonucleases from Rana pipiens Oocytes Curr Pharm Biotechnol. Jun. 2008; 9(3): 215-225.",
                    "Saxena et al, Effect of Onconase on Double-stranded RNA in Vitr Anticancer Research 29: 1067-1072 (2009).",
                    "UniProtKB\u2014Amphinase-2 entry (2007).",
                    "PCT/US1999/030799, International Search Report and Written Opinion dated May 30, 2000, 7 pages.",
                    "PCT/US2000/023426, International Search Report dated Nov. 27, 2000, 3 pages.",
                    "PCT/US2004/014844, International Search Report and Written Opinion, dated May 10, 2006, 8 pages.",
                    "PCT/US2004/014844, International Preliminary Report on Patentability, dated Feb. 15, 2007, 5 pages.",
                    "PCT/US2015/022670, International Search Report and Written Opinion, dated Nov. 18, 2015, 29 pages.",
                    "PCT/US2015/022670, International Preliminary Report on Patentability, dated Oct. 4, 2016, 21 pages.",
                    "PCT/US2015/045272, International Search Report and Written Opinion, dated Dec. 1, 2015, 9 pages.",
                    "PCT/US2015/045272, International Preliminary Report on Patentability, dated Feb. 21, 2017, 6 pages.",
                    "PCT/US2016/037174, International Search Report and Written Opinion, dated Oct. 12, 2016, 14 pages.",
                    "Adinolfi, B.S., et al., \u201cFull antitumor action of recombinant seminal ribonuclease depends on the removal of its N-terminal methionine.\u201d Biochem Biophys Res Commun. (1995); 213(2): 525-532.",
                    "Ardelt, W., et al., \u201cAmino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases.\u201d J Biol Chem. (1991); 266(1): 245-251.",
                    "Boix, E., et al., \u201cRole of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.\u201d J Mol Biol. (1996); 257(5): 992-1007.",
                    "Branden et al., Introduction to Protein Structure, Garland Publishing Inc., New York, p. 247, 1991, 24 pages.",
                    "Bucher, M.H., et al., \u201cDifferential effects of short affinity tags on the crystallization of Pyrococcus furiosus maltodextrin-binding protein.\u201d Acta Crystallogr D Biol Crystallogr. (2002);58(Pt 3): 392-397. Epub Feb. 21, 2002.",
                    "Chao, Q., et al., \u201cExpression and partial characterization of Dolichos biflorus seed lectin in Escherichia coli.\u201d Arch Biochem Biophys. (1994); 313(2): 346-350.",
                    "Chaudhuri, T.K., et al., \u201cEffect of the extra n-terminal methionine residue on the stability and folding of recombinant a-lactalbumin expressed in Escherichia coli.\u201d J Mol Biol. (1999); 285(3): 1179-1194.",
                    "Chen, C-Y., et al., \u201cCloning, sequencing and expression of a cDNA encoding bovine pancreatic deoxyribonuclease I in Escherichia coli: purification and characterization of the recombinant enzyme.\u201d Gene (1998); 206(2): 181-184.",
                    "Durmazlar, K., et al., \u201cCantharidin treatment for recalcitrant facial flat warts: a preliminary study.\u201d J. Dermatol. Treatment (2009); 20(2): 114-119.",
                    "Dyer and Rosenberg, \u201cThe RNase a superfamily: generation of diversity and innate host defense.\u201d Mol Divers. (2006); 10(4): 585-597.",
                    "Fonda, I., et al., \u201cAttachment of histidine tags to recombinant tumor necrosis factor-alpha drastically changes its properties.\u201d ScientificWorldJournal (2002); 2: 1312-1325.",
                    "Geurrero, S.A., et al., \u201cHis-tagged tryparedoxin peroxidase of Trypanosoma cruzi as a tool for drug screening.\u201d Appl Microbiol Biotechnol. (2000); 53(4): 410-414.",
                    "Goda, S., et al., \u201cEffect of extra N-terminal residues on the stability and folding of human lysozyme expressed in Pichia pastoris.\u201d Protein Engineering (2000); 13(4): 299-307.",
                    "Gupta, P.K., et al., \u201cRole of N-Terminal Amino Acids in the Potency of Anthrax Lethal Factor.\u201d PLoS ONE (2008); 3(9): e3130.",
                    "Hariri, S., et al., \u201cHuman Papillomavirus.\u201d Centers for Disease Control VPD Surveillance Manual, 5th edition, Chapter 5, pp. 1 -11 (2011).",
                    "Hirel, P.H., et al., \u201cExtent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid.\u201d PNAS USA (1989); 86(21): 8247-8251.",
                    "Ho, S.N., et al., \u201cSite-directed mutagenesis by overlap extension using the polymerase chain reaction.\u201d Gene (1989); 77(1): 51-59.",
                    "Huang, H-C., et al., \u201cThe Rana catesbeiana rcr Gene Encoding a Cytotoxic Ribonuclease. Tissue Distribution, Cloning, Purification, Cytotoxicity, and Active Residues for RNase Activity.\u201d J. Biol. Chem. (1998); 273(11): 6395-6401.",
                    "Ishikiwa, N., et al., \u201cRemarkable destabilization of recombinant alpha-lactalbumin by an extraneous N-terminal methionyl residue.\u201d Protein Eng. (1998); 11(5): 333-335.",
                    "Kamiya, Y., et al., \u201cAmino acid sequence of a lectin from Japanese frog (Rana japonica) eggs.\u201d J Biochem. (1990); 108(1): 139-143.",
                    "Lehninger, A.L. (1975) Biochemistry, Second Edition, p. 962, 5 pages.",
                    "Liao, Y.D., et al., \u201cRemoval of N-terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase.\u201d Protein Sci. (2004); 13(7): 1802-1810.",
                    "Moore, J.A., et al., \u201cEquivalent Potency and Pharmacokinetics of Recombinant Human Growth Hormones with or without an N-Terminal Methionine.\u201d Endocrinology (1988); 122(6): 2920-2926.",
                    "Mosimann, S.C., et al., \u201cComparative molecular modeling and crystallization of P-30 protein: A novel antitumor protein of Rana pipiens oocytes and early embryos.\u201d Proteins (1992); 14(3): 392-400.",
                    "Notomista, E., et al., \u201cEffective expression and purification of recombinant onconase, an antitumor protein.\u201d FEBS Letters (1999); 463(3): 211-215.",
                    "Park, K.S., et al., \u201cBiologic and biochemic properties of recombinant platelet factor 4 demonstrate identity with the native protein.\u201d Blood (1990); 75: 1290-1295.",
                    "Porta, C., et al., \u201cRanpirnase and its potential for the treatment of unresectable malignant mesothelioma.\u201d Biologics (2008); 2(4): 601-609.",
                    "Saxena, S.K., et al., \u201cInhibition of HIV-1 production and selective degradation of viral RNA by an amphibian ribonuclease.\u201d J Biol Chem. (1996); 271(34): 20783-20788.",
                    "Saxena, S.K., et al., \u201cOnconase\u00ae and its Therapeutic Potential.\u201d Lab Medicine (2003); 34(5): 380-387.",
                    "Seffernick, J.L., et al., \u201cMelamine Deaminase and Atrazine Chlorohydrolase: 98 Percent Identical but Functionally Different.\u201d Journal of Bacteriology (2001); 183(8): 2405-2410.",
                    "Studier, F.W., et al., \u201cUse of T7 RNA polymerase to direct expression of cloned genes.\u201d Methods Enzymol. (1990); 185: 60-89.",
                    "Suhasini and Sirdeshmukh, \u201cTransfer RNA cleavages by onconase reveal unusual cleavage sites.\u201d J Biol Chem. (2006); 281(18): 12201-12209. Epub Feb. 23, 2006.",
                    "Supplementary European Search Report in European application No. EP 04751988.9, dated May 30, 2007 and dated Jun. 6, 2007, 6 pages.",
                    "Suzuki, M., et al., \u201cEngineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction.\u201d Nat Biotechnol. (1999); 17(3): 265-270.",
                    "Takano, K., et al., \u201cEffect of foreign N-terminal residues on the conformational stability of human lysozyme.\u201d The FEBS Journal (1999); 266(2): 675-682.",
                    "Trimble and Frazer, \u201cDevelopment of therapeutic HPV vaccines.\u201d Lancet Oncol. (2009); 10(10): 975-980.",
                    "Turcotte and Raines, \u201cDesign and Characterization of an HIV-Specific Ribonuclease Zymogen.\u201d AIDS Res Hum Retroviruses (2008); 24(11): 1357-1363.",
                    "Witkowski, A., et al., \u201cConversion of a \u03b2-Ketoacyl Synthase to a Malonyl Decarboxylase by Replacement of the Active-Site Cysteine with Glutamine.\u201d Biochemistry, (1999); 38(36): 11643-11650.",
                    "Wu and Filutowicz, \u201cHexahistidine (His6)-tag dependent protein dimerization: a cautionary tale.\u201d Acta Biochim Pol. (1999); 46(3): 591-599.",
                    "Wu, Y., et al., \u201cA cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.\u201d The Journal of Biological Chemistry (1993); 268(14): 10686-10693.",
                    "PCT/US2016/037174, International Preliminary Report on Patentability, dated Dec. 19, 2017, 9 pages.",
                    "PCT/US2017/043984, International Search Report and Written Opinion, dated Oct. 10, 2017, 15 pages.",
                    "Langston, \u201cHerpes Simplex Virus in the Eye\u201d, Digital Journal of Ophthalmology, Oct. 15, 2002, 3 pages."
                ],
                "nplResolvedCount": 45,
                "nplResolvedLensIDs": [
                    "183-199-955-821-58X",
                    "081-975-240-328-194",
                    "028-781-143-330-295",
                    "014-962-893-502-724",
                    "058-565-045-538-561",
                    "074-019-691-989-836",
                    "049-790-593-893-868",
                    "029-908-654-731-041",
                    "050-615-121-045-702",
                    "045-046-217-858-486",
                    "065-407-674-006-488",
                    "157-939-838-575-373",
                    "089-876-823-876-974",
                    "040-463-542-748-18X",
                    "033-673-240-985-077",
                    "012-664-898-846-608",
                    "068-350-979-903-088",
                    "081-606-351-847-620",
                    "019-318-201-447-272",
                    "128-620-645-455-459",
                    "179-052-482-657-722",
                    "069-538-319-620-681",
                    "067-045-038-523-385",
                    "129-892-405-589-373",
                    "000-429-842-178-350",
                    "009-620-258-695-693",
                    "027-493-429-522-118",
                    "063-918-616-263-074",
                    "034-784-012-662-936",
                    "020-130-144-194-934",
                    "023-973-012-067-612",
                    "039-290-617-350-793",
                    "051-335-014-275-668",
                    "056-331-009-417-186",
                    "044-705-117-387-162",
                    "053-960-716-570-131",
                    "056-171-629-693-587",
                    "079-736-607-266-605",
                    "054-547-223-876-922",
                    "012-361-686-036-568",
                    "046-926-645-516-900",
                    "034-122-884-140-729",
                    "002-018-167-726-726",
                    "023-481-904-534-57X",
                    "050-180-531-862-30X"
                ],
                "nplResolvedExternalIDs": [
                    "18769623",
                    "10.1134/s0026893314040050",
                    "pmc298257",
                    "10.1073/pnas.86.21.8247",
                    "19414347",
                    "10.1016/0076-6879(90)85008-c",
                    "pmc2888699",
                    "10.1128/mmbr.35.3.235-241.1971",
                    "10.1038/cr.2012.67",
                    "10803896",
                    "10.1093/nar/26.14.3358",
                    "10.1016/s0378-1119(97)00582-9",
                    "10.1089/aid.2008.0146",
                    "9497370",
                    "1985896",
                    "10.1371/journal.pone.0003130",
                    "4329869",
                    "10.1074/jbc.271.34.20783",
                    "10.1038/7010",
                    "10.18388/abp.1999_4131",
                    "10.1100/tsw.2002.215",
                    "10.1046/j.1432-1327.1999.00918.x",
                    "pmc95154",
                    "10.2147/btt.s2383",
                    "10.1016/s0014-5793(99)01623-3",
                    "10.1006/bbrc.1995.2163",
                    "11856823",
                    "8486718",
                    "15215523",
                    "10.1006/abbi.1994.1397",
                    "pmc378387",
                    "10.1128/jb.183.8.2405-2410.2001",
                    "10.2174/138920108784567245",
                    "10.1074/jbc.m504488200",
                    "2178704",
                    "7646508",
                    "10.1110/ps.04679104",
                    "19025416",
                    "10.1006/bbrc.1994.2439",
                    "10.1093/protein/11.5.333",
                    "10.1006/jmbi.1996.0218",
                    "10.1080/09546630802287546",
                    "10.1309/3td2-6gxn-65ge-c1bg",
                    "10.1002/prot.340140308",
                    "1438177",
                    "pmc147714",
                    "10561612",
                    "pmc3090037",
                    "8702832",
                    "10.1182/blood.v75.6.1290.1290",
                    "2199796",
                    "pmc2518864",
                    "pmc2586917",
                    "10810162",
                    "10.1210/endo-122-6-2920",
                    "16497678",
                    "2744487",
                    "10.1016/0378-1119(89)90358-2",
                    "8080282",
                    "10096294",
                    "8632481",
                    "9649619",
                    "10.1007/s002530051634",
                    "10.1093/oxfordjournals.jbchem.a123153",
                    "pmc2727885",
                    "10.1007/s11030-006-9028-2",
                    "22525336",
                    "16969722",
                    "19796749",
                    "11274097",
                    "10.1016/s0166-3542(03)00111-6",
                    "pmc2279930",
                    "pmc3391012",
                    "9469931",
                    "2229005",
                    "10.1074/jbc.273.11.6395",
                    "19707441",
                    "9887272",
                    "12927308",
                    "10606723",
                    "10.1006/jmbi.1998.2362",
                    "10.1016/j.jmb.2003.12.051",
                    "9681864",
                    "18821118",
                    "10.1093/protein/13.4.299",
                    "10.1107/s0907444901021187",
                    "10.1016/s1470-2045(09)70227-x",
                    "10698267",
                    "3371267",
                    "12805914",
                    "18673287",
                    "2682640",
                    "7945354"
                ]
            },
            {
                "index": "22",
                "publicationKey": "US_2015_0376584_A1",
                "lensId": "119-830-198-720-431",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0376584 A1",
                "publicationDate": "2016-12-31",
                "filingNumber": "US 201514736170 A",
                "filingDate": "2015-06-10",
                "priorityFilingKeysActive": [
                    "US 201514736170 A 20150610",
                    "US 201514667282 A 20150324",
                    "US 201414316893 A 20140627",
                    "US 201414247723 A 20140408",
                    "US 201562147209 P 20150414",
                    "US 201562102671 P 20150113",
                    "US 201462063551 P 20141014",
                    "US 201462040885 P 20140822"
                ],
                "earliestPriorityDate": "2014-04-08",
                "title": "Methods Of Treating Viral Infections, Particularly Rabies, Mers-cov, Influenza, Ebola, Chikungunya, Venezuelan Equine Encephalitus, Canine Parvovirus, Adenovirus, Respiratory Syncytial Virus, Rhinovirus, And Poxvirus In Mammalian Patients",
                "applicants": [
                    "TAMIR BIOTECHNOLOGY INC"
                ],
                "inventors": [
                    "HODGE III THOMAS W"
                ],
                "owners": [
                    {
                        "name": "TAMIR BIOTECHNOLOGY INC",
                        "executionDate": "2015-06-08"
                    }
                ],
                "url": "https://lens.org/119-830-198-720-431",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 2,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K38/465",
                    "A01N63/00",
                    "C12N9/22",
                    "C12Y301/27",
                    "C12Y301/27005"
                ],
                "ipcrClassifications": [
                    "C12N9/22"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "23",
                "publicationKey": "US_2016_0296617_A1",
                "lensId": "098-012-700-548-362",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0296617 A1",
                "publicationDate": "2016-10-13",
                "filingNumber": "US 201414375083 A",
                "filingDate": "2014-02-28",
                "priorityFilingKeysActive": [
                    "US 201361771561 P 20130301",
                    "US 201461941076 P 20140218"
                ],
                "earliestPriorityDate": "2013-03-01",
                "title": "Immunogenic Composition For Mers Coronavirus Infection",
                "applicants": [
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU",
                    "NEW YORK BLOOD CENTER INC"
                ],
                "inventors": [
                    "JIANG SHIBO",
                    "DU LANYING",
                    "ZHOU YUSEN",
                    "ZHAO GUANGYU"
                ],
                "owners": [
                    {
                        "name": "NEW YORK BLOOD CENTER INC",
                        "executionDate": "2016-01-18"
                    }
                ],
                "url": "https://lens.org/098-012-700-548-362",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 5,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 24,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/55561",
                    "A61K2039/55566",
                    "A61K2039/575",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2319/21",
                    "C07K2319/30",
                    "C12N7/00",
                    "C12N2770/20021",
                    "C12N2770/20022",
                    "C12N2770/20034"
                ],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C07K14/005",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "Edmund et al. Arch. Immunol. Ther. Exp. 2009, Vol. 57, pp. 311-323."
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "045-897-557-709-319"
                ],
                "nplResolvedExternalIDs": [
                    "19688186",
                    "10.1007/s00005-009-0040-y"
                ]
            },
            {
                "index": "24",
                "publicationKey": "US_2017_0096455_A1",
                "lensId": "186-435-322-275-495",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0096455 A1",
                "publicationDate": "2017-04-06",
                "filingNumber": "US 201515124992 A",
                "filingDate": "2015-03-20",
                "priorityFilingKeysActive": [
                    "US 201461968279 P 20140320"
                ],
                "earliestPriorityDate": "2014-03-20",
                "title": "Methods And Compositions For Chimeric Coronavirus Spike Proteins",
                "applicants": [
                    "UNIV NORTH CAROLINA CHAPEL HILL"
                ],
                "inventors": [
                    "BARIC RALPH",
                    "AGNIHOTHRAM SUDHAKAR",
                    "YOUNT BOYD"
                ],
                "owners": [
                    {
                        "name": "THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL",
                        "executionDate": "2016-10-05"
                    }
                ],
                "url": "https://lens.org/186-435-322-275-495",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 8,
                "cpcClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K2039/5256",
                    "A61K2039/5258",
                    "A61K2039/70",
                    "C07K16/10",
                    "C07K2317/34",
                    "C07K2317/76",
                    "C12N7/00",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "C12N2770/36123",
                    "C12N2770/36143",
                    "C12N2770/36144"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "C07K16/10",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "25",
                "publicationKey": "WO_2015_184356_A1",
                "lensId": "027-137-895-934-354",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/184356 A1",
                "publicationDate": "2015-12-03",
                "filingNumber": "US 2015/0033331 W",
                "filingDate": "2015-05-29",
                "priorityFilingKeysActive": [
                    "US 201462005817 P 20140530"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Treatment Of Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "ANSUN BIOPHARMA INC"
                ],
                "inventors": [
                    "MOSS RONALD D"
                ],
                "owners": [],
                "url": "https://lens.org/027-137-895-934-354",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 3,
                "seqCount": 14,
                "cpcClassifications": [
                    "A61K38/47",
                    "A61K9/0019",
                    "A61K9/0048",
                    "A61K9/007",
                    "A61K39/12",
                    "A61K47/183",
                    "A61K47/26",
                    "C07K14/485",
                    "C07K2319/20",
                    "C12N9/2402",
                    "C12N2770/20034",
                    "C12Y302/01018"
                ],
                "ipcrClassifications": [
                    "A61K39/00",
                    "A61K9/50",
                    "A61K38/00",
                    "A61K38/16"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "HAYDEN: \"Advances in antivirals for non-influenza respiratory virus infections.\", INFLUENZA OTHER RESPIR VIRUSES., vol. 7, no. 3, 2013, pages 36 - 43, XP055228651",
                    "WIT ET AL.: \"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques.\", PROC NATL ACAD SCI USA., vol. 110, no. 41, 2013, pages 16598 - 603, XP055239202"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "084-664-258-959-729",
                    "050-671-752-937-471",
                    "076-701-180-458-616"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3799368",
                    "pmc6492651",
                    "10.1073/pnas.1310744110",
                    "24215380",
                    "24062443",
                    "10.1111/irv.12173"
                ]
            },
            {
                "index": "26",
                "publicationKey": "WO_2016_007653_A2",
                "lensId": "097-791-400-877-497",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2016/007653 A2",
                "publicationDate": "2016-01-14",
                "filingNumber": "US 2015/0039586 W",
                "filingDate": "2015-07-08",
                "priorityFilingKeysActive": [
                    "US 201462022191 P 20140708"
                ],
                "earliestPriorityDate": "2014-07-08",
                "title": "Psgl-1 Modulators And Uses Thereof",
                "applicants": [
                    "SANFORD BURNHAM MED RES INST"
                ],
                "inventors": [
                    "BRADLEY LINDA M",
                    "TINOCO ROBERTO"
                ],
                "owners": [],
                "url": "https://lens.org/097-791-400-877-497",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 8,
                "familySize": 8,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K16/2854",
                    "A61K48/00",
                    "A61K2039/505",
                    "C07K14/70596",
                    "C07K16/2896",
                    "C07K2317/76"
                ],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K39/40"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "27",
                "publicationKey": "US_2017_0119859_A1",
                "lensId": "036-482-691-255-724",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0119859 A1",
                "publicationDate": "2017-05-04",
                "filingNumber": "US 201515314782 A",
                "filingDate": "2015-05-29",
                "priorityFilingKeysActive": [
                    "US 201462005817 P 20140530"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Treatment Of Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "ANSUN BIOPHARMA INC"
                ],
                "inventors": [
                    "MOSS RONALD D"
                ],
                "owners": [
                    {
                        "name": "ANSUN BIOPHARMA INC",
                        "executionDate": "2014-06-16"
                    }
                ],
                "url": "https://lens.org/036-482-691-255-724",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 3,
                "seqCount": 14,
                "cpcClassifications": [
                    "A61K38/47",
                    "A61K9/0019",
                    "A61K9/0048",
                    "A61K9/007",
                    "A61K39/12",
                    "A61K47/183",
                    "A61K47/26",
                    "C07K14/485",
                    "C07K2319/20",
                    "C12N9/2402",
                    "C12N2770/20034",
                    "C12Y302/01018"
                ],
                "ipcrClassifications": [
                    "A61K38/47",
                    "A61K9/00",
                    "C07K14/485",
                    "C12N9/24"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "28",
                "publicationKey": "US_2017_0198047_A1",
                "lensId": "113-597-190-477-864",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0198047 A1",
                "publicationDate": "2017-07-13",
                "filingNumber": "US 201515324262 A",
                "filingDate": "2015-07-08",
                "priorityFilingKeysActive": [
                    "US 201462022191 P 20140708"
                ],
                "earliestPriorityDate": "2014-07-08",
                "title": "Psgl-1 Modulators And Uses Thereof",
                "applicants": [
                    "SANFORD-BURNHAM MEDICAL RES INST"
                ],
                "inventors": [
                    "BRADLEY LINDA M",
                    "TINOCO ROBERTO"
                ],
                "owners": [
                    {
                        "name": "SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE",
                        "executionDate": "2017-03-13"
                    },
                    {
                        "name": "SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE",
                        "executionDate": "2015-06-24"
                    }
                ],
                "url": "https://lens.org/113-597-190-477-864",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 8,
                "familySize": 8,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K16/2854",
                    "A61K48/00",
                    "A61K2039/505",
                    "C07K14/70596",
                    "C07K16/2896",
                    "C07K2317/76"
                ],
                "ipcrClassifications": [
                    "C07K16/28"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "29",
                "publicationKey": "US_2017_0281966_A1",
                "lensId": "137-398-381-894-459",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0281966 A1",
                "publicationDate": "2017-10-05",
                "filingNumber": "US 201715471882 A",
                "filingDate": "2017-03-28",
                "priorityFilingKeysActive": [
                    "US 201662390486 P 20160401"
                ],
                "earliestPriorityDate": "2016-04-01",
                "title": "Device To Kill Micro-organisms Inside The Respiratory Tract",
                "applicants": [
                    "BASIONY MOHAMED A"
                ],
                "inventors": [
                    "BASIONY MOHAMED A"
                ],
                "owners": [],
                "url": "https://lens.org/137-398-381-894-459",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61N5/0603",
                    "A61M16/0463",
                    "A61M16/0486",
                    "A61M2202/0208",
                    "A61M2205/053",
                    "A61M2205/581",
                    "A61M2205/583",
                    "A61N5/0624",
                    "A61N2005/0604",
                    "A61N2005/0626",
                    "A61N2005/0651",
                    "A61N2005/0661",
                    "A61M2202/0007"
                ],
                "ipcrClassifications": [
                    "A61N5/06",
                    "A61M16/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "30",
                "publicationKey": "US_10010718_B2",
                "lensId": "017-705-551-397-049",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10010718 B2",
                "publicationDate": "2018-07-03",
                "filingNumber": "US 201715471882 A",
                "filingDate": "2017-03-28",
                "priorityFilingKeysActive": [
                    "US 201662390486 P 20160401"
                ],
                "earliestPriorityDate": "2016-04-01",
                "title": "Device To Kill Micro-organisms Inside The Respiratory Tract",
                "applicants": [
                    "BASIONY MOHAMED A"
                ],
                "inventors": [
                    "BASIONY MOHAMED A"
                ],
                "owners": [],
                "url": "https://lens.org/017-705-551-397-049",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61N5/0603",
                    "A61M16/0463",
                    "A61M16/0486",
                    "A61M2202/0208",
                    "A61M2205/053",
                    "A61M2205/581",
                    "A61M2205/583",
                    "A61N5/0624",
                    "A61N2005/0604",
                    "A61N2005/0626",
                    "A61N2005/0651",
                    "A61N2005/0661",
                    "A61M2202/0007"
                ],
                "ipcrClassifications": [
                    "A61M16/00",
                    "A61M16/04",
                    "A61N5/06",
                    "A62B9/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "31",
                "publicationKey": "KR_101857684_B1",
                "lensId": "082-272-030-757-578",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101857684 B1",
                "publicationDate": "2018-05-14",
                "filingNumber": "KR 20170116514 A",
                "filingDate": "2017-09-12",
                "priorityFilingKeysActive": [
                    "KR 20170116514 A 20170912"
                ],
                "earliestPriorityDate": "2017-09-12",
                "title": "Primers And Probe For Detection Of Middle East Respiratory Syndrome Coronavirus And Detecting Method For Middle East Respiratory Syndrome Coronavirus Using The Same",
                "applicants": [
                    "KOGENE BIOTECH CO LTD",
                    "KOREA CENTER FOR DISEASE CONTROL AND PREVENTION"
                ],
                "inventors": [
                    "KIM SUNG SOON",
                    "YANG JEONG SUN",
                    "NAM YONG SUK",
                    "KIM SOO BOK",
                    "OH JUNG HWA"
                ],
                "owners": [],
                "url": "https://lens.org/082-272-030-757-578",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 1,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "32",
                "publicationKey": "WO_2016_123318_A2",
                "lensId": "001-776-747-524-561",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2016/123318 A2",
                "publicationDate": "2016-08-04",
                "filingNumber": "US 2016/0015327 W",
                "filingDate": "2016-01-28",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design Synthesis And Methods Of Use Of Acyclic Fleximer Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND",
                    "KATHOLIEK UNIVERSITEIT LEUVEN",
                    "LIEDEN UNIVERSITY MEDICAL CT"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH L",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/001-776-747-524-561",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "C07D403/04",
                    "A61K31/506",
                    "A61P31/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "33",
                "publicationKey": "IL_240488_D0",
                "lensId": "006-167-845-257-178",
                "jurisdiction": "IL",
                "kindCode": "D0",
                "displayKey": "IL 240488 D0",
                "publicationDate": "2015-09-24",
                "filingNumber": "IL 24048815 A",
                "filingDate": "2015-08-10",
                "priorityFilingKeysActive": [
                    "US 201361771561 P 20130301",
                    "US 201461941076 P 20140218"
                ],
                "earliestPriorityDate": "2013-03-01",
                "title": "Immunogenic Composition For Mers Coronavirus Infection",
                "applicants": [
                    "NEW YORK BLOOD CT INC",
                    "SHIBO JIANG",
                    "LANYING DU",
                    "GUANGYU ZHAO",
                    "YUSEN ZHOU"
                ],
                "inventors": [],
                "owners": [],
                "url": "https://lens.org/006-167-845-257-178",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K2039/55561",
                    "A61K2039/55566",
                    "A61K2039/575",
                    "C07K14/005",
                    "C07K16/10",
                    "C07K2319/21",
                    "C07K2319/30",
                    "C12N7/00",
                    "C12N2770/20021",
                    "C12N2770/20022",
                    "C12N2770/20034"
                ],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "34",
                "publicationKey": "CN_104447986_A",
                "lensId": "169-793-996-172-947",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 104447986 A",
                "publicationDate": "2015-03-25",
                "filingNumber": "CN 201410812405 A",
                "filingDate": "2014-12-23",
                "priorityFilingKeysActive": [
                    "CN 201410812405 A 20141223"
                ],
                "earliestPriorityDate": "2014-12-23",
                "title": "Middle East Respiratory Syndrome Coronavirus (mers-cov) Neutralizing Antibody And Preparation Method Thereof",
                "applicants": [
                    "CHINESE ACAD INST MICROBIOLOGY"
                ],
                "inventors": [
                    "YAN JINGHUA",
                    "GAO FU",
                    "LI YAN",
                    "WAN YUHUA"
                ],
                "owners": [],
                "url": "https://lens.org/169-793-996-172-947",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 4,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61P31/14",
                    "C12N5/10",
                    "C12N15/13",
                    "G01N33/569",
                    "G01N33/577"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "WANG QH.\u7b49: \"Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26\", \u300aCELL HOST & MICROBE\u300b",
                    "MOU HH.\u7b49: \"The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies\", \u300aJOURNAL OF VIROLOGY\u300b"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "35",
                "publicationKey": "US_2018_0303768_A1",
                "lensId": "181-913-390-114-177",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0303768 A1",
                "publicationDate": "2018-10-25",
                "filingNumber": "US 201816025284 A",
                "filingDate": "2018-07-02",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design, Synthesis And Methods Of Use Of Acyclic Flexmier Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/181-913-390-114-177",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "C07D403/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "36",
                "publicationKey": "CN_104846125_A",
                "lensId": "176-196-083-169-696",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 104846125 A",
                "publicationDate": "2015-08-19",
                "filingNumber": "CN 201510328748 A",
                "filingDate": "2015-06-15",
                "priorityFilingKeysActive": [
                    "CN 201510328748 A 20150615"
                ],
                "earliestPriorityDate": "2015-06-15",
                "title": "Fluorescent Rt-pcr (reverse Transcription-polymerase Chain Reaction) Primers, Probe And Kit For Detecting Mers (middle East Respiratory Syndrome), And Detection Method Thereof",
                "applicants": [
                    "SHENZHEN BIOEASY BIOTECHNOLOGIES CO LTD"
                ],
                "inventors": [
                    "ZHU HAI",
                    "HUANG CHAOJIE",
                    "YOU TENGFEI",
                    "LU HEHUA"
                ],
                "owners": [],
                "url": "https://lens.org/176-196-083-169-696",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [
                    "Y02A50/451"
                ],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12N15/11",
                    "C12Q1/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "CENTERS FOR DISEASE CONTROL AND PREVENTION: \"\u201cNovel coronavirus 2012 real-time rt-pcr assay\u201d\", \u300aCENTERS FOR DISEASE CONTROL AND PREVENTION\u300b"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "37",
                "publicationKey": "WO_2018_164573_A1",
                "lensId": "074-479-815-323-575",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/164573 A1",
                "publicationDate": "2018-09-13",
                "filingNumber": "NL 2018050137 W",
                "filingDate": "2018-03-06",
                "priorityFilingKeysActive": [
                    "EP 17159420 A 20170306"
                ],
                "earliestPriorityDate": "2017-03-06",
                "title": "Viral Polypeptide Inhibitors",
                "applicants": [
                    "ACADEMISCH ZIEKENHUIS LEIDEN",
                    "GOVERNING COUNCIL UNIV TORONTO",
                    "UNIV OF MANITOBA"
                ],
                "inventors": [
                    "KIKKERT MARJOLEIN",
                    "KNAAP ROBERT CORNELLS MARTINUS",
                    "SIDHU SACHDEV SINGH",
                    "ZHANG WEI",
                    "MARK BRIAN LEONARD",
                    "BAILEY-ELKIN BEN ALLAN"
                ],
                "owners": [],
                "url": "https://lens.org/074-479-815-323-575",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 22,
                "cpcClassifications": [
                    "A61K38/55"
                ],
                "ipcrClassifications": [
                    "A61K38/55",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 65,
                "nplCitations": [
                    "\"PROGRESS IN MEDICINAL CHEMISTRY.\", vol. 55, 1 January 2016, ELSEVIER, AMSTERDAM., NL, ISSN: 0079-6468, article MARK KEMP ET AL: \"Recent Advances in the Discovery of Deubiquitinating Enzyme Inhibitors\", pages: 149 - 192, XP055333853, DOI: 10.1016/bs.pmch.2015.10.002",
                    "BURROUGHS ET AL.: \"Methods in Molecular Biology\", vol. 832, 2012",
                    "VAN HOOIJDONK BMC NEUROSCIENCE, vol. 10, 2009, pages 2",
                    "DZAU ET AL., TRENDS IN BIOTECHNOLOGY, vol. 11, 1993, pages 205 - 210",
                    "ERNST ET AL., SCIENCE, vol. 339, 2013, pages 590 - 595",
                    "WIMMER; SCHREINER, VIRUSES, vol. 7, 2015, pages 4854 - 4872",
                    "ZHANG, W.; BAILEY-ELKIN, B. A.; KNAAP, R. C. M.; KHARE, B.; DALEBOUT, T. J.; JOHNSON, G. G.; VAN KASTEREN, P. B.; MCLEISH, N. J.;: \"Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants\", PLOS PATHOGENS, vol. 13, 2017, pages el006372",
                    "CHEN, P. Y.; GOPALACUSHINA, B. G.; YANG, C. C.; CHAN, S. I.; EVANS, P. A.: \"The role of a beta-bulge in the folding of the beta-hairpin structure in ubiquitin\", PROTEIN SCI., vol. 10, 2001, pages 2063 - 2074",
                    "PIANA, S.; LINDORFF-LARSEN, K.; SHAW, D. E.: \"Atomic-level description of ubiquitin folding\", vol. 110, 2013, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, pages: 5915 - 5920",
                    "PANTOLIANO, M. W.; PETRELLA, E. C.; KWASNOSKI, J. D.; LOBANOV, V. S.; MYSLIK, J.; GRAF, E.; CARVER, T.; ASEL, E.; SPRINGER, B. A.;: \"High-density miniaturized thermal shift assays as a general strategy for drug discovery\", J BIOMOL SCREEN, vol. 6, 2001, pages 429 - 440, XP055027496, DOI: doi:10.1177/108705710100600609",
                    "KOMANDER D; RAPE M, THE UBIQUITIN CODE. ANNUAL REVIEW OF BIOCHEMISTRY, vol. 81, 2012, pages 203 - 29",
                    "YAU R; RAPE M: \"The increasing complexity of the ubiquitin code\", NAT CELL BIOL., vol. 18, no. 6, 2016, pages 579 - 86",
                    "JIANG X; CHEN ZJ: \"The role of ubiquitylation in immune defence and pathogen evasion\", NATURE REVIEWS IMMUNOLOGY, vol. 12, no. 1, 2012, pages 35 - 48",
                    "MIELECH AM; CHEN Y; MESECAR AD; BAKER SC: \"Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities\", VIRUS RES., vol. 194, 2014, pages 184 - 90, XP029105621, DOI: doi:10.1016/j.virusres.2014.01.025",
                    "MORALES DJ; LENSCHOW DJ: \"The antiviral activities of ISG15\", JOURNAL OF MOLECULAR BIOLOGY, vol. 425, no. 24, 2013, pages 4995 - 5008, XP028775405, DOI: doi:10.1016/j.jmb.2013.09.041",
                    "CHENON M; CAMBORDE L; CHEMINANT S; JUPIN I: \"A viral deubiquitylating enzyme targets viral RNA-dependent RNA polymerase and affects viral infectivity\", THE EMBO JOURNAL, vol. 31, no. 3, 2012, pages 741 - 53",
                    "ISAACSON MK; PLOEGH HL: \"Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection\", CELL HOST & MICROBE, vol. 5, no. 6, 2009, pages 559 - 70",
                    "DE WIT E; VAN DOREMALEN N; FALZARANO D; MUNSTER VJ: \"SARS and MERS: recent insights into emerging coronaviruses\", NATURE REVIEWS MICROBIOLOGY, vol. 14, 2016, pages 523 - 34, XP055369190, DOI: doi:10.1038/nrmicro.2016.81",
                    "BAILEY-ELKIN BA; KNAAP RC; JOHNSON GG; DALEBOUT TJ; NINABER DK; VAN KASTEREN PB ET AL.: \"Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression\", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 289, no. 50, 2014, pages 34667 - 82",
                    "MIELECH AM; KILIANSKI A; BAEZ-SANTOS YM; MESECAR AD; BAKER SC: \"MERS-CoV papain-like protease has deISGylating and deubiquitinating activities\", VIROLOGY, vol. 450-451, 2014, pages 64 - 70",
                    "CLEMENTZ MA; CHEN Z; BANACH BS; WANG Y; SUN L; RATIA K ET AL.: \"Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases\", J VIROL., vol. 84, no. 9, 2010, pages 4619 - 29",
                    "XING Y; CHEN J; TU J; ZHANG B; CHEN X; SHI H ET AL.: \"The papain-like protease of porcine epidemic diarrhea virus negatively regulates type I interferon pathway by acting as a viral deubiquitinase\", THE JOURNAL OF GENERAL VIROLOGY, vol. 94, no. 7, 2013, pages 1554 - 67",
                    "DEVARAJ SG; WANG N; CHEN Z; CHEN Z; TSENG M; BARRETTO N ET AL.: \"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus\", J BIOL CHEM., vol. 282, no. 44, 2007, pages 32208 - 21",
                    "ZHENG D; CHEN G; GUO B; CHENG G; TANG H: \"PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production\", CELL RES., vol. 18, no. 11, 2008, pages 1105 - 13",
                    "BAEZ-SANTOS YM; ST JOHN SE; MESECAR AD: \"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds\", ANTIVIRAL RES., vol. 115, 2015, pages 21 - 38, XP029136855, DOI: doi:10.1016/j.antiviral.2014.12.015",
                    "HILGENFELD R: \"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design\", FEBS J., vol. 281, no. 18, 2014, pages 4085 - 96",
                    "FRIAS-STAHELI N; GIANNAKOPOULOS NV; KIKKERT M; TAYLOR SL; BRIDGEN A; PARAGAS J ET AL.: \"Ovarian tumor domain-containing viral proteases evade ubiquitin-and ISG15-dependent innate immune responses\", CELL HOST MICROBE, vol. 2, no. 6, 2007, pages 404 - 16, XP055049785, DOI: doi:10.1016/j.chom.2007.09.014",
                    "LEI J; MESTERS JR; DROSTEN C; ANEMULLER S; MA Q; HILGENFELD R: \"Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features\", ANTIVIRAL RESEARCH., vol. 109, 2014, pages 72 - 82, XP029045736, DOI: doi:10.1016/j.antiviral.2014.06.011",
                    "RATIA K; SAIKATENDU KS; SANTARSIERO BD; BARRETTO N; BAKER SC; STEVENS RC ET AL.: \"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 103, 2006, pages 5717 - 22",
                    "JAMES TW; FRIAS-STAHELI N; BACIK JP; LEVINGSTON MACLEOD JM; KHAJEHPOUR M; GARCIA-SASTRE A ET AL.: \"Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 108, 2011, pages 2222 - 7, XP055049784, DOI: doi:10.1073/pnas.1013388108",
                    "AKUTSU M; YE Y; VIRDEE S; CHIN JW; KOMANDER D: \"Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 108, 2011, pages 2228 - 33, XP055249441, DOI: doi:10.1073/pnas.1015287108",
                    "CALISTRI A; MUNEGATO D; CARLI I; PAROLIN C; PALU G: \"The ubiquitin-conjugating system: multiple roles in viral replication and infection\", CELLS, vol. 3, no. 2, 2014, pages 386 - 417",
                    "HEIDEKER J; WERTZ IE: \"DUBs, the regulation of cell identity and disease\", BIOCHEM J., vol. 465, no. 1, 2015, pages 1 - 26",
                    "KEMP M.: \"Recent Advances in the Discovery of Deubiquitinating Enzyme Inhibitors\", PROG MED CHEM., vol. 55, 2016, pages 149 - 92, XP055333853, DOI: doi:10.1016/bs.pmch.2015.10.002",
                    "ERNST A; AVVAKUMOV G; TONG J; FAN Y; ZHAO Y; ALBERTS P ET AL.: \"A strategy for modulation of enzymes in the ubiquitin system\", SCIENCE, vol. 339, no. 6119, 2013, pages 590 - 5",
                    "ZHANG W; WU KP; SARTORI MA; KAMADURAI HB; ORDUREAU A; JIANG C ET AL.: \"System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes\", MOLECULAR CELL, vol. 62, no. 1, 2016, pages 121 - 36, XP029496716, DOI: doi:10.1016/j.molcel.2016.02.005",
                    "KRISSINEL E; HENRICK K: \"Inference of macromolecular assemblies from crystalline state\", JOURNAL OF MOLECULAR BIOLOGY, vol. 372, no. 3, 2007, pages 774 - 97, XP022220069, DOI: doi:10.1016/j.jmb.2007.05.022",
                    "HAAGMANS BL; VAN DEN BRAND JM; RAJ VS; VOLZ A; WOHLSEIN P; SMITS SL ET AL.: \"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels\", SCIENCE, vol. 351, no. 6268, 2016, pages 77 - 81, XP055265765, DOI: doi:10.1126/science.aad1283",
                    "INN KS; LEE SH; RATHBUN JY; WONG LY; TOTH Z; MACHIDA K ET AL.: \"Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64\", J VIROL., vol. 85, no. 20, 2011, pages 10899 - 904",
                    "WANG S; WANG K; LI J; ZHENG C: \"Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3\", J VIROL., vol. 87, no. 21, 2013, pages 11851 - 60",
                    "BARRETTO N; JUKNELIENE D; RATIA K; CHEN Z; MESECAR AD; BAKER SC: \"The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity\", J VIROL., vol. 79, no. 24, 2005, pages 15189 - 98",
                    "CHEN Z; WANG Y; RATIA K; MESECAR AD; WILKINSON KD; BAKER SC: \"Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63\", J VIROL., vol. 81, no. 11, 2007, pages 6007 - 18",
                    "LINDNER HA; FOTOUHI-ARDAKANI N; LYTVYN V; LACHANCE P; SULEA T; MENARD R: \"The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme\", J VIROL., vol. 79, no. 24, 2005, pages 15199 - 208",
                    "ZIEBUHR J; SCHELLE B; KARL N; MINSKAIA E; BAYER S; SIDDELL SG ET AL.: \"Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication\", J VIROL., vol. 81, no. 8, 2007, pages 3922 - 32",
                    "BERGERON E; ALBARINO CG; KHRISTOVA ML; NICHOL ST: \"Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function\", J VIROL., vol. 84, no. 1, 2010, pages 216 - 26, XP055249446, DOI: doi:10.1128/JVI.01859-09",
                    "LOMBARDI C; AYACH M; BEAUREPAIRE L; CHENON M; ANDREANI J; GUEROIS R ET AL.: \"A compact viral processing proteinase/ubiquitin hydrolase from the OTU family\", PLOS PATHOG., vol. 9, no. 8, 2013, pages elO03560",
                    "MIAO X.: \"Recent advances in the development of new transgenic animal technology\", CELLULAR AND MOLECULAR LIFE SCIENCES : CMLS, vol. 70, no. 5, 2013, pages 815 - 28, XP055073911, DOI: doi:10.1007/s00018-012-1081-7",
                    "AUGER A; PARK M; NITSCHKE F; MINASSIAN LM; BEILHARTZ GL; MINASSIAN BA ET AL.: \"Efficient Delivery of Structurally Diverse Protein Cargo into Mammalian Cells by a Bacterial Toxin\", MOL PHARM., vol. 12, no. 8, 2015, pages 2962 - 71, XP055332136, DOI: doi:10.1021/acs.molpharmaceut.5b00233",
                    "D'ASTOLFO DS; PAGLIERO RJ; PRAS A; KARTHAUS WR; CLEVERS H; PRASAD V ET AL.: \"Efficient intracellular delivery of native proteins\", CELL, vol. 161, no. 3, 2015, pages 674 - 90, XP055338589, DOI: doi:10.1016/j.cell.2015.03.028",
                    "GAJ T; LIU J; ANDERSON KE; SIRK SJ; BARBAS CF: \"3rd. Protein delivery using Cys2-His2 zinc-finger domains\", ACS CHEM BIOL., vol. 9, no. 8, 2014, pages 1662 - 7",
                    "SCHOTT JW; MORGAN M; GALLA M; SCHAMBACH A: \"Viral and Synthetic RNA Vector Technologies and Applications\", MOL THER., 2016",
                    "WADIA JS; STAN RV; DOWDY SF: \"Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis\", NAT MED., vol. 10, no. 3, 2004, pages 310 - 5, XP002477563, DOI: doi:10.1038/nm996",
                    "VAN DOREMALEN N; MUNSTER VJ: \"Animal models of Middle East respiratory syndrome coronavirus infection\", ANTIVIRAL RES., vol. 122, 2015, pages 28 - 38, XP029262472, DOI: doi:10.1016/j.antiviral.2015.07.005",
                    "COCKRELL AS; YOUNT BL; SCOBEY T; JENSEN K; DOUGLAS M; BEALL A ET AL.: \"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome\", NAT MICROBIOL, vol. 2, 2016, pages 16226",
                    "TONIKIAN R; ZHANG Y; BOONE C; SIDHU SS: \"Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries\", NATURE PROTOCOLS, vol. 2, no. 6, 2007, pages 1368 - 86, XP008167972, DOI: doi:10.1038/nprot.2007.151",
                    "D'ARCY A; VILLARD F; MARSH M: \"An automated microseed matrix-screening method for protein crystallization\", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, vol. 63, no. 4, 2007, pages 550 - 4",
                    "IRETON GC; STODDARD BL: \"Microseed matrix screening to improve crystals of yeast cytosine deaminase\", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, vol. 60, no. 3, 2004, pages 601 - 5",
                    "GEORGIEVA DG; KUIL ME; OOSTERKAMP TH; ZANDBERGEN HW; ABRAHAMS JP: \"Heterogeneous nucleation of three-dimensional protein nanocrystals\", ACTA CRYSTALLOGR D BIOL CRYSTALLOGR., vol. 63, no. 5, 2007, pages 564 - 70",
                    "CARLOTTI F; BAZUINE M; KEKARAINEN T; SEPPEN J; POGNONEC P; MAASSEN JA ET AL.: \"Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes\", MOL THER., vol. 9, no. 2, 2004, pages 209 - 17",
                    "VAN DEN WORM SH; ERIKSSON KK; ZEVENHOVEN JC; WEBER F; ZUST R; KURI T ET AL.: \"Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination\", PLOS ONE, vol. 7, no. 3, 2012, pages e32857",
                    "SCHRODINGER, LLC, THE PYMOL MOLECULAR GRAPHICS SYSTEM, 2015",
                    "HEMSLEY A; ARNHEIM N, TONEY MD; CORTOPASSI G; GALAS DJ: \"A simple method for site-directed mutagenesis using the polymerase chain reaction\", NUCLEIC ACIDS RES., vol. 17, 1989, pages 6545 - 51, XP002027312",
                    "GRAHAM FL; VAN DER EB AJ: \"A new technique for the assay of infectivity of human adenovirus 5 DNA\", VIROLOGY, vol. 52, 1973, pages 456 - 67, XP023052128, DOI: doi:10.1016/0042-6822(73)90341-3",
                    "SCHNEIDER CA; RASBAND WS; ELICEIRI KW: \"NIH Image to ImageJ: 25 years of image analysis\", NATURE METHODS, vol. 9, 2012, pages 671 - 5, XP055403257",
                    "CANCER RESEARCH, vol. 64, 2004, pages 5245 - 50"
                ],
                "nplResolvedCount": 66,
                "nplResolvedLensIDs": [
                    "114-964-897-022-095",
                    "024-318-224-229-965",
                    "005-298-110-675-698",
                    "052-726-708-480-011",
                    "101-743-503-932-627",
                    "072-366-322-919-406",
                    "036-868-925-283-835",
                    "059-583-354-909-122",
                    "126-564-848-863-317",
                    "051-310-823-539-220",
                    "066-811-889-923-241",
                    "078-259-908-118-109",
                    "118-587-590-089-222",
                    "123-880-690-838-255",
                    "014-189-817-974-441",
                    "131-153-593-230-765",
                    "029-188-012-110-005",
                    "049-744-366-450-584",
                    "051-035-066-702-786",
                    "062-247-380-633-444",
                    "152-789-448-284-148",
                    "030-820-278-374-034",
                    "078-104-784-735-44X",
                    "036-782-618-845-511",
                    "000-567-989-523-118",
                    "071-412-051-150-727",
                    "056-432-502-904-052",
                    "172-171-664-790-660",
                    "010-219-024-639-095",
                    "093-321-245-747-876",
                    "026-486-758-058-334",
                    "044-480-578-761-351",
                    "017-102-792-005-162",
                    "048-110-934-943-336",
                    "039-999-294-190-112",
                    "012-227-133-222-574",
                    "004-985-510-220-56X",
                    "020-441-798-387-741",
                    "098-589-983-993-779",
                    "008-868-281-317-271",
                    "091-518-359-484-580",
                    "005-697-684-554-770",
                    "017-606-259-428-289",
                    "056-385-580-015-163",
                    "105-695-255-226-679",
                    "008-100-412-815-097",
                    "159-329-767-442-147",
                    "107-516-982-192-993",
                    "000-689-120-517-809",
                    "014-995-358-199-891",
                    "038-318-025-421-071",
                    "021-986-748-450-702",
                    "033-427-366-787-582",
                    "022-644-269-040-219",
                    "038-023-187-031-246",
                    "025-250-299-448-570",
                    "002-309-125-864-020",
                    "036-237-551-499-058",
                    "066-741-088-563-900",
                    "031-005-301-131-571",
                    "083-381-538-598-781",
                    "057-960-261-636-194",
                    "048-396-769-070-290",
                    "051-768-949-935-987",
                    "023-053-797-481-28X",
                    "011-658-930-551-029"
                ],
                "nplResolvedExternalIDs": [
                    "11788061",
                    "pmc4092849",
                    "10.1128/jvi.02747-06",
                    "19864393",
                    "pmc3807349",
                    "10.1038/nrmicro.2016.81",
                    "10.1099/vir.0.051169-0",
                    "26343706",
                    "pmc318348",
                    "17681537",
                    "pmc4584293",
                    "22158412",
                    "10.1038/nm996",
                    "10.1371/journal.ppat.1006372",
                    "pmc2863753",
                    "10.1016/j.chom.2009.05.012",
                    "10.1158/0008-5472.can-04-0496",
                    "27344959",
                    "15289330",
                    "10.1128/jvi.02406-09",
                    "pmc4519095",
                    "10.1177/108705710100600609",
                    "10.1021/acs.molpharmaceut.5b00233",
                    "pmc3187500",
                    "pmc4263872",
                    "14993707",
                    "22833168",
                    "24095857",
                    "17392370",
                    "23966860",
                    "16306591",
                    "16306590",
                    "21835791",
                    "10.1073/pnas.1218321110",
                    "10.1371/journal.pone.0032857",
                    "10.1016/j.virusres.2014.01.025",
                    "pmc3957432",
                    "pmc3038727",
                    "10.1126/science.aad1283",
                    "23596270",
                    "pmc2647928",
                    "23503848",
                    "10.1093/nar/17.16.6545",
                    "10.1007/s00018-012-1081-7",
                    "25554382",
                    "pmc4811637",
                    "10.1128/jvi.01859-09",
                    "19527883",
                    "pmc2798392",
                    "pmc3744425",
                    "10.1016/j.molcel.2016.02.005",
                    "pmc1866161",
                    "23986588",
                    "11567097",
                    "24503068",
                    "10.3390/cells3020386",
                    "26949039",
                    "10.1016/j.antiviral.2014.12.015",
                    "10.1371/journal.ppat.1003560",
                    "22412934",
                    "10.1128/jvi.79.24.15199-15208.2005",
                    "25320088",
                    "19144149",
                    "10.1110/ps.07101",
                    "10.1016/j.virol.2013.11.040",
                    "10.1038/nmicrobiol.2016.226",
                    "10.1073/pnas.1015287108",
                    "10.1042/bj20140496",
                    "24936957",
                    "10.1038/emboj.2011.424",
                    "10.1128/jvi.00690-11",
                    "26192750",
                    "17372361",
                    "10.1111/febs.12936",
                    "25910214",
                    "22350875",
                    "10.1016/j.ymthe.2003.11.021",
                    "18957937",
                    "24992731",
                    "10.1038/nmeth.2089",
                    "10.1016/j.antiviral.2015.07.005",
                    "22524316",
                    "24805990",
                    "pmc3038750",
                    "10.1016/j.jmb.2007.05.022",
                    "18078692",
                    "10.1146/annurev-biochem-060310-170328",
                    "16581910",
                    "pmc1900296",
                    "10.1186/1471-2202-10-2",
                    "21245344",
                    "20181693",
                    "10.1038/nri3111",
                    "28542609",
                    "10.3390/v7092849",
                    "10.1073/pnas.0510851103",
                    "10.1016/0042-6822(73)90341-3",
                    "25793419",
                    "23287719",
                    "14759805",
                    "pmc3815447",
                    "10.1016/j.cell.2015.03.028",
                    "27377044",
                    "pmc1316033",
                    "17251282",
                    "10.1128/jvi.01211-13",
                    "pmc4090058",
                    "pmc3864900",
                    "pmc2756044",
                    "2674899",
                    "25631680",
                    "10.2210/pdb5hpl/pdb",
                    "14770178",
                    "17545975",
                    "17761676",
                    "021266548",
                    "26678878",
                    "10.1107/s0907444903029664",
                    "10.1016/j.antiviral.2014.06.011",
                    "21266548",
                    "26852935",
                    "10.1038/mt.2016.143",
                    "10.1016/0167-7799(93)90116-q",
                    "pmc1316023",
                    "10.1038/ncb3358",
                    "10.1126/science.1230161",
                    "pmc3625349",
                    "pmc1458639",
                    "pmc4125544",
                    "10.1016/j.jmb.2013.09.041",
                    "pmc3273391",
                    "10.1107/s0907444907007810",
                    "10.1038/nprot.2007.151",
                    "10.1038/cr.2008.294",
                    "pmc2184509",
                    "26103531",
                    "10.1107/s0907444907007652",
                    "24512893",
                    "10.1074/jbc.m114.609644",
                    "10.1074/jbc.m704870200",
                    "25039866",
                    "10.1021/cb500282g",
                    "pmc3296753",
                    "10.1073/pnas.1013388108",
                    "22930834",
                    "10.1089/108705701753364922",
                    "10.1016/j.chom.2007.09.014",
                    "10.1007/978-1-61779-474-2_2",
                    "22117220",
                    "27230526",
                    "17452781",
                    "27892925",
                    "10.1128/jvi.02091-06",
                    "10.1016/bs.pmch.2015.10.002",
                    "10.1128/jvi.79.24.15189-15198.2005",
                    "pmc2374220",
                    "4705382",
                    "7763813"
                ]
            },
            {
                "index": "38",
                "publicationKey": "US_10058516_B2",
                "lensId": "076-507-655-389-388",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10058516 B2",
                "publicationDate": "2018-08-28",
                "filingNumber": "US 201615546818 A",
                "filingDate": "2016-01-28",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design, Synthesis And Methods Of Use Of Acyclic Fleximer Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND",
                    "UNIV LEUVEN KATH",
                    "LEIDEN UNIV MEDICAL CENTER"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH L",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/076-507-655-389-388",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "C07D403/04",
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 38,
                "nplCitations": [
                    "Peters et al., Bioorganic & Medicinal Chemistry Letters, published online May 23, 2015, 25(15), pp. 2923-2926.",
                    "Chemical Abstracts Registry No. 550-33-4, Nov. 16, 1984.",
                    "Chemical Abstracts Registry No. 19186-33-5, Nov. 16, 1984.",
                    "Grant, R., Grant, C. (1987). Grant & Hackh's Chemical Dictionary (5th ed.). New York, NY: McGraw-Hill, p. 313.",
                    "Al-Hazmi, Saudi Journal of Biological Sciences, 2016, 23, 507-511.",
                    "Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An Overview of Their Replication and Pathogenesis. Methods in Molecular Biology (Clifton, N.J.), 1282, 1-23.",
                    "Niedzwicki et al., Biochemical Pharmacology, 1991, 41(11), pp. 1615-1624.",
                    "In Global alert and response. Middle East Respiratory syndrome coronavirus (MERS-CoV); World Health Organization: 2015; vol. 2014.",
                    "In Zovirax Prescribing Information; U.S. Food and Drug Administration: 2003; NDA 18-603/5-027.",
                    "Al-Tawfiq, J.A. et al. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study, Int. J. Infect. Dis., 20 (2014), pp. 42-46.",
                    "Boncel, A. et al. Novel 5-(N-Alkylaminouracil) Acyclic Nucleosides, Synthesis-Stuttgart (2011), pp. 603-610.",
                    "Chen, F. et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds, J. Clin. Virol., 31 (2004), pp. 69-75.",
                    "de Wilde, A.H. et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment, J. Gen. Virol., 94 (2013), pp. 1749-1760.",
                    "de Wilde, A.H. et al. Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture, Antimicrob. Agents Chemother, 58 (2014), pp. 4875-4884.",
                    "Falzarano, D. et al. Treatment with interferon-alpha 2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques Nat. Med., 19 (2013), pp. 1313-1317.",
                    "Fouchier, R. A. et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A 101 (2004), pp. 6212-6216.",
                    "Furman, P.A. et al. Acyclovir Triphosphate is a Suicide Inactivator of the Herpes-Simplex Virus DNA Polymerase, J. Biol. Chem., 259 (1984), pp. 9575-9579.",
                    "Jochmans, D. et al. A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE. J Virol Methods 183 (2012), pp. 176-179.",
                    "Kuiken, T. et al. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol, 164 (2004), pp. 1893-1900.",
                    "McGuigan, C. et al. Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus Bioorg. Med. Chem. Lett., 20 (2010), pp. 4850-4854.",
                    "McGuirt, P.V. et al. Acyclovir Inhibition of Viral DNA Chain Elongation in Herpes Simplex Virus-Infected Cells, Am. J. Med., 73 (1982), pp. 67-71.",
                    "Mee, S.P. et al. Significant enhancement of the Stille reaction with a new combination of reagents-copper(I) iodide with cesium fluoride, Chem. Eur. J., 11 (2005), pp. 3294-3308.",
                    "Momattin, H. et al. Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)\u2014possible lessons from a systematic review of SARS-CoV therapy, Int. J. Infect. Dis., 17 (2013), pp. e792-e798.",
                    "Morgenstern, B. et al. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines, Biochem. Biophys. Res. Commun., 326 (2005), pp. 905-908.",
                    "Peiris, J.S.M. et al. Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet, 361 (2003), pp. 1319-1325.",
                    "Pyrc, K. et al. Identification of new human coronaviruses, Expert Rev. Anti-infect. Ther., 5 (2007), pp. 245-253.",
                    "Quirk, S. et al. Substrate discrimination by the human GTP fucose pyrophosphorylase, Biochemistry, 44 (2005), pp. 10854-10863.",
                    "Quirk, S. et al. Identification of catalytic amino acids in the human GTP fucose pyrophosphorylase active site, Biochemistry, 44 (2005), pp. 13172-13178.",
                    "Salim, S. Molecular chameleons: design and synthesis of a second series of flexible nucleosides, Doctoral dissertation, Georgia Institute of Technology, 2004, pp. 1-149.",
                    "Schinazi, R. Synthesis of 5-(Dihydroxyboryl)-2\u2032deoxyuridine and Related Boron-Containing Pyrimidines, J. Org. Chem., 50 (1985), pp. 841-847.",
                    "Seley, K.L. et al. \u201cFleximers\u201d. Design and Synthesis of Two Novel Split Nucleosides, Org. Lett., 3 (2001), p. 3209-3210.",
                    "Seley, K.L. et al. \u201cFleximers\u201d. Design and Synthesis of a New Class of Novel Shape-Modified Nucleosies, 67 (2002), p. 3365, J. Org. Chem.",
                    "Seley, K. L. et al. Unexpected inhibition of S-adenosyl-L-homocysteine hydrolase by a guanosine nucleoside, Bioorg. Med. Chem. Lett., 13, (2003) pp. 1985-1988.",
                    "Seley, K. L. et al. \u201cMolecular chameleons\u201d. Design and synthesis of C-4-substituted imidazole fleximers, Org. Lett., 7 (2005), pp. 63-66.",
                    "Smith, E.C. et al. Coronavirus Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics, PLoS Pathog., 9 (2013), p. e1003565, 1-11.",
                    "Tan, E.L. et al. Inhibition of SARS Coronavirus Infection in Vitro with Clinically Approved Antiviral Drugs, Emerg. Infect. Dis., 10 (2004), pp. 581-586.",
                    "Vanpouille, C. et al. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2, J. Infect. Dis., 201 (2010), pp. 635-643.",
                    "Wauchope, O.R. et al. Synthetic Routes to a Series of Proximal and Distal 2\u2032-Deoxy Fleximers, Synthesis, 44 (2012), pp. 3496-3504."
                ],
                "nplResolvedCount": 35,
                "nplResolvedLensIDs": [
                    "057-617-477-665-56X",
                    "032-735-667-143-965",
                    "055-817-993-936-104",
                    "074-919-683-245-507",
                    "059-550-034-399-273",
                    "099-339-512-037-70X",
                    "043-175-443-728-67X",
                    "007-805-109-951-284",
                    "074-960-744-959-701",
                    "018-702-914-707-986",
                    "073-663-856-907-01X",
                    "057-080-756-583-519",
                    "062-192-092-753-972",
                    "016-754-916-865-234",
                    "094-485-484-823-984",
                    "054-117-964-555-982",
                    "017-883-043-691-040",
                    "052-650-110-852-468",
                    "009-403-958-653-100",
                    "002-808-749-577-966",
                    "020-090-218-931-826",
                    "025-992-623-190-843",
                    "108-229-899-337-383",
                    "081-307-021-537-929",
                    "084-893-855-384-248",
                    "102-808-548-863-662",
                    "071-349-856-440-802",
                    "002-163-468-775-047",
                    "080-897-630-292-177",
                    "185-700-349-724-543",
                    "127-574-272-971-002",
                    "062-634-123-022-634",
                    "035-834-171-631-191",
                    "017-689-034-509-674",
                    "129-401-973-660-415"
                ],
                "nplResolvedExternalIDs": [
                    "15161626",
                    "27298584",
                    "pmc4136071",
                    "pmc395948",
                    "10.1038/nm.3362",
                    "6285735",
                    "10.3201/eid1004.030458",
                    "16185085",
                    "pmc3323075",
                    "10.1016/j.bmcl.2015.05.039",
                    "10.1016/j.jviromet.2012.04.011",
                    "20637609",
                    "10.1016/s0002-9440(10)63750-9",
                    "24406736",
                    "10.1002/chem.200401162",
                    "pmc1615765",
                    "23993766",
                    "pmc4093902",
                    "10.1055/s-0032-1316791",
                    "10.1021/ol047895v",
                    "10.1021/bi051288d",
                    "24841269",
                    "10.1016/j.sjbs.2016.02.019",
                    "11574032",
                    "15073334",
                    "16086588",
                    "pmc4890194",
                    "10.1016/j.bbrc.2004.11.128",
                    "10.1021/jo00206a024",
                    "10.1016/0006-2952(91)90162-x",
                    "10.1016/s0960-894x(03)00331-7",
                    "10.1016/s1386-6532(04)00055-1",
                    "23966862",
                    "23620378",
                    "10.1128/aac.03011-14",
                    "15200845",
                    "26048809",
                    "10.1073/pnas.0400762101",
                    "10.1055/s-0030-1258397",
                    "10.1371/journal.ppat.1003565",
                    "10.1016/s0140-6736(03)13077-2",
                    "15624978",
                    "17402839",
                    "pmc4466200",
                    "pmc2811219",
                    "10.1016/j.bmcl.2010.06.094",
                    "15288617",
                    "15786503",
                    "24465059",
                    "10.1007/978-1-4939-2438-7_1",
                    "10.1586/14787210.5.2.245",
                    "12781179",
                    "10.1016/j.jcv.2004.03.003",
                    "24013700",
                    "22575574",
                    "6086640",
                    "pmc4369385",
                    "10.1021/bi0503605",
                    "10.1002/chin.201052201",
                    "2043151",
                    "12711465",
                    "10.1099/vir.0.052910-0",
                    "10.1016/0002-9343(82)90066-3",
                    "pmc3898542",
                    "pmc3744431",
                    "10.1016/j.ijid.2013.07.002",
                    "pmc3749523",
                    "12003548",
                    "25720466",
                    "10.1016/j.ijid.2013.12.003",
                    "10.1021/jo0255476",
                    "15607755",
                    "10.1086/650343",
                    "10.1021/ol0165443",
                    "20085496"
                ]
            },
            {
                "index": "39",
                "publicationKey": "KR_20160145813_A",
                "lensId": "096-317-418-301-272",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20160145813 A",
                "publicationDate": "2016-12-20",
                "filingNumber": "KR 20167032920 A",
                "filingDate": "2015-04-27",
                "priorityFilingKeysActive": [
                    "US 201461984243 P 20140425"
                ],
                "earliestPriorityDate": "2014-04-25",
                "title": "Middle East Respiratory Syndrome Coronavirus Neutralizing Antibodies And Methods Of Use Thereof",
                "applicants": [
                    "DANA-FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "TANG XIANCHUN"
                ],
                "owners": [],
                "url": "https://lens.org/096-317-418-301-272",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 2,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 188,
                "cpcClassifications": [
                    "C07K16/10",
                    "A61K2039/507",
                    "C07K2317/13",
                    "C07K2317/21",
                    "C07K2317/34",
                    "C07K2317/52",
                    "C07K2317/56",
                    "C07K2317/622",
                    "C07K2317/76",
                    "C07K2317/92",
                    "C07K2319/40",
                    "C07K2319/43",
                    "C12N2740/16043",
                    "C12N2770/20022",
                    "C12N2810/609",
                    "G01N33/56983",
                    "G01N33/577",
                    "G01N2333/165",
                    "G01N2469/10"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/00",
                    "A61K39/42",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "40",
                "publicationKey": "US_2017_0158752_A1",
                "lensId": "089-095-806-660-416",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0158752 A1",
                "publicationDate": "2017-06-08",
                "filingNumber": "US 201515306617 A",
                "filingDate": "2015-04-27",
                "priorityFilingKeysActive": [
                    "US 201461984243 P 20140425"
                ],
                "earliestPriorityDate": "2014-04-25",
                "title": "Middle East Respiratory Syndrome Coronavirus Neutralizing Antibodies And Methods Of Use Thereof",
                "applicants": [
                    "DANA-FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "TANG XIANGCHUN"
                ],
                "owners": [
                    {
                        "name": "DANA-FARBER CANCER INSTITUTE INC",
                        "executionDate": "2017-03-13"
                    }
                ],
                "url": "https://lens.org/089-095-806-660-416",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 94,
                "cpcClassifications": [
                    "C07K16/10",
                    "A61K2039/507",
                    "C07K2317/13",
                    "C07K2317/21",
                    "C07K2317/34",
                    "C07K2317/52",
                    "C07K2317/56",
                    "C07K2317/622",
                    "C07K2317/76",
                    "C07K2317/92",
                    "C07K2319/40",
                    "C07K2319/43",
                    "C12N2740/16043",
                    "C12N2770/20022",
                    "C12N2810/609",
                    "G01N33/56983",
                    "G01N33/577",
                    "G01N2333/165",
                    "G01N2469/10"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569",
                    "G01N33/577"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "41",
                "publicationKey": "US_2018_0015052_A1",
                "lensId": "071-023-173-107-488",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0015052 A1",
                "publicationDate": "2018-01-18",
                "filingNumber": "US 201615546818 A",
                "filingDate": "2016-01-28",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design, Synthesis And Methods Of Use Of Acyclic Flexmier Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND",
                    "UNIV LEUVEN KATH",
                    "LEIDEN UNIV MEDICAL CENTER"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH L",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/071-023-173-107-488",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "C07D403/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 7,
                "nplCitations": [
                    "Peters et al., Bioorganic & Medicinal Chemistry Letters, published online May 23, 2015, 25(15), pages 2923-2926.",
                    "Chemical Abstracts Registry Number 550-33-4, November 16, 1984.",
                    "Chemical Abstracts Registry Number 19186-33-5, November 16, 1984.",
                    "Grant, R., Grant, C. (1987). Grant & Hackh's Chemical Dictionary (5th ed.). New York, NY: McGraw-Hill, page 313.",
                    "Al-Hazmi, Saudi Journal of Biological Sciences, 2016, 23, 507-511.",
                    "Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An Overview of Their Replication and Pathogenesis. Methods in Molecular Biology (Clifton, N.J.), 1282, 1\u201323.",
                    "Niedzwicki et al., Biochemical Pharmacology, 1991, 41(11), pages 1615-1624."
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "057-617-477-665-56X",
                    "032-735-667-143-965",
                    "009-403-958-653-100",
                    "080-897-630-292-177"
                ],
                "nplResolvedExternalIDs": [
                    "10.1007/978-1-4939-2438-7_1",
                    "10.1016/0006-2952(91)90162-x",
                    "25720466",
                    "2043151",
                    "10.1016/j.sjbs.2016.02.019",
                    "27298584",
                    "10.1016/j.bmcl.2015.05.039",
                    "pmc4466200",
                    "26048809",
                    "pmc4890194",
                    "pmc4369385"
                ]
            },
            {
                "index": "42",
                "publicationKey": "US_10131704_B2",
                "lensId": "054-537-944-794-952",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10131704 B2",
                "publicationDate": "2018-11-20",
                "filingNumber": "US 201515306617 A",
                "filingDate": "2015-04-27",
                "priorityFilingKeysActive": [
                    "US 201461984243 P 20140425"
                ],
                "earliestPriorityDate": "2014-04-25",
                "title": "Middle East Respiratory Syndrome Coronavirus Neutralizing Antibodies And Methods Of Use Thereof",
                "applicants": [
                    "DANA FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "TANG XIANGCHUN"
                ],
                "owners": [
                    {
                        "name": "DANA-FARBER CANCER INSTITUTE INC",
                        "executionDate": "2017-03-13"
                    }
                ],
                "url": "https://lens.org/054-537-944-794-952",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 94,
                "cpcClassifications": [
                    "C07K16/10",
                    "A61K2039/507",
                    "C07K2317/13",
                    "C07K2317/21",
                    "C07K2317/34",
                    "C07K2317/52",
                    "C07K2317/56",
                    "C07K2317/622",
                    "C07K2317/76",
                    "C07K2317/92",
                    "C07K2319/40",
                    "C07K2319/43",
                    "C12N2740/16043",
                    "C12N2770/20022",
                    "C12N2810/609",
                    "G01N33/56983",
                    "G01N33/577",
                    "G01N2333/165",
                    "G01N2469/10"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/00",
                    "G01N33/569",
                    "G01N33/577"
                ],
                "usClassifications": [],
                "nplCitationCount": 135,
                "nplCitations": [
                    "International Search Report and Written Opinion for International Application No. PCT/US2015/027785, dated Sep. 9, 2015, 11 pages.",
                    "Zhao, G. et al., \u201cA safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV,\u201d Virol. J. Jan. 2013; 10:266, 8 pages. Published online Aug. 26, 2013. doi: 10.1186/1743-422X-10-266.",
                    "van Boheemen, S. et al., \u201cGenomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans,\u201d MBio., Nov. 20, 2012;3(6). pii: e00473-12, 9 pages. doi: 10.1128/mBio.00473-12.",
                    "Zaki, A. M. et al. (2012) \u201cIsolation of a novel coronavirus from a man with pneumonia in Saudi Arabia,\u201d N. Engl. J. Med. 367(19):1814-1820.",
                    "Breban, R. et al. (2013) \u201cInterhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk,\u201d Lancet, 382(9893):694-699.",
                    "The Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. \u201cEvidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, Feb. 2013,\u201d Euro Surveill. 2013;18(11):pii=20427. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20427.",
                    "Cotten, M. et al. (2014) Spread, circulation, and evolution of the middle East respiratory syndrome coronavirus, mBio 5(1):e01062-13. doi:10.1128/mBio.01062-13.",
                    "Li, W. et al. (2005) \u201cReceptor and viral determinants of SARS-coronavirus adaptation to human ACE2,\u201d The EMBO Journal, 24(8):1634-1643.",
                    "The Chinese SARS Molecular Epidemiology Consortium, Reports (2004) \u201cMolecular evolution of the SARS coronavirus during the course of the SARS epidemic in China,\u201d Science 303(5664):1666-1669.",
                    "Annan, A. et al. (2013) \u201cHuman betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe,\u201d Emerg Infect Dis 19(3):456-459.",
                    "Anthony, S. J. et al. (2013) \u201cCoronaviruses in bats from Mexico,\u201d J. Gen Virol., 94(Pt 5):1028-1038.",
                    "Woo, P. C. Y. et al. (2006) \u201cMolecular diversity of coronaviruses in bats,\u201d Virology 351(1):180-187.",
                    "Memish, Z. A. et al. (2013) \u201cMiddle East respiratory syndrome coronavirus in bats, Saudi Arabia,\u201d Emerg Infect Dis 19(11):1819-1823.",
                    "Perera, R. A. et al. (2013) \u201cSeroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, Jun. 2013,\u201d Euro Surveill, 18(36):pii=20574. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20574.",
                    "Reusken, C. B. E. M. et al. (2013) \u201cMiddle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study,\u201d Lancet Infect. Dis. 13(10):859-866. Published online Aug. 9, 2013 http://dx.doi.org/10.1016/S1473-3099(13)70164-6.",
                    "Haagmans, B. L. et al. (2014) \u201cMiddle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation,\u201d Lancet Infect Dis 14(2):140-145.",
                    "Meyer, B. et al. (2014) \u201cAntibodies against MERS coronavirus in dromedaries, United Arab Emirates, 2003 and 2013,\u201d Emerg. Infect. Dis. 20(4):552-559. doi: http://dx.doi.org/10.3201/eid2004.131746.",
                    "Alagaili, A. N. et al. (2014) \u201cMiddle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia,\u201d MBio 5(2):e00884-00914. doi:10.1128/mBio.00884-14.",
                    "Eckerle, I. et al. (2014) \u201cReplicative capacity of MERS coronavirus in livestock cell lines,\u201d Emerg. Infect. Dis. 20(2):276-279.",
                    "Muller, M. A. et al. (2012) \u201cHuman coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines,\u201d mBio 3(6):e00515-12. doi:10.1128/mBio.00515-12.",
                    "Hofmann, H. et al. (2004) \u201cS protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients,\u201d J. Virol. 78(12):6134-6142.",
                    "Chan, K-H et al. (2013) \u201cCross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests,\u201d J. Infect 67(2):130-140.",
                    "Gierer S. et al. (2013) \u201cThe spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies,\u201d J. Virol. 87(10):5502-5511.",
                    "Raj, V. S. et al. (2013) \u201cDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus\u2014EMC,\u201d Nature 495(7440):251-254.",
                    "Lu, G. et al. (2013) \u201cMolecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26,\u201d Nature, 500(7461):227-231.",
                    "Wang, N. et al. (2013) \u201cStructure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4,\u201d Cell Research, 23(8):986-993.",
                    "Falzarano, D. et al. (2013) \u201cTreatment with interferon-\u03b12b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques,\u201d Nature Medicine, 19(10):1313-1317. Published online Sep. 8, 2013; doi:10.1038/nm.3362.",
                    "Agnihothram, S. et al. (2014) \u201cEvaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses,\u201d J. Infect Dis., 209:995-1006. Electronically published Nov. 18, 2013.",
                    "Du, L. et al. (2013) \u201cA truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: Implication for developing therapeutics and vaccines,\u201d PLoS ONE 8(12):e81587. doi:10.1371/journal.pone.0081587.",
                    "Song, F. et al. (2013) \u201cMiddle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies,\u201d J. Virol. 87(21):11950-11954.",
                    "Marasco, W. A. et al. (2007) \u201cThe growth and potential of human antiviral monoclonal antibody therapeutics,\u201d Nat Biotech. 25(12):1421-1434. Published online Dec. 8, 2007; doi:10.1038/nbt1363.",
                    "Gould, L. H. et al. (2005) \u201cProtective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus,\u201d J. Virol. 79(23):14606-14613.",
                    "Kashyap, A. K. et al. (2008) \u201cCombinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies,\u201d PNAS USA, 105(16):5986-5991.",
                    "Traggiai, E. et al. (2004) \u201cAn efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus,\u201d Nat Med. 10(8):871-875. Published online Jul. 11, 2004; doi:10/1038/nm1080.",
                    "Corti, D. et al. (2011) \u201cA neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins,\u201d Science, 333(6044):850-856.",
                    "Throsby, M. et al. (2008) \u201cHeterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells,\u201d PLoS One 3(12):e3942. doi:10.1371/journal.pone.0003942.",
                    "Sui, J. et al. (2009) \u201cStructural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses,\u201d Nat. Struct. Mol. Biol., 16(3):265-273. Published online Feb. 22, 2009; doi:10.1038/nsmb.1566.",
                    "Sui, J. et al. (2004) \u201cPotent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association,\u201d PNAS USA, 101(8):2536-2541.",
                    "Mou, H. et al. (2013) \u201cThe receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies,\u201d J. Virol. 87(16):9379-9383.",
                    "Sui, J. et al. (2008) \u201cBroadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway,\u201d PLoS Pathog 4(11):e1000197. doi:10.1371/journal.ppat.1000197.",
                    "Wrammert, J. et al. (2008) \u201cRapid cloning of high-affinity human monoclonal antibodies against influenza virus,\u201d Nature, 453(7195):667-671.",
                    "Corti, D. et al. (2013) \u201cBroadly neutralizing antiviral antibodies,\u201d Annu Rev. Immunol., 31:705-742. doi: 10.1146/annurev-immunol-032712-095916. Epub Jan. 16, 2013.",
                    "Wu, X. et al. (2011) \u201cFocused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing,\u201d Science, 333(6049):1593-1602. doi:10.1126/science.1207532.",
                    "Chan, C. H. et al. (2001) \u201cVH1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen,\u201d Blood 97(4):1023-1026.",
                    "Huang, C. C. et al. (2004) \u201cStructural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120,\u201d PNAS USA, 101(9):2706-2711.",
                    "Boyd, S. D. et al. (2010) \u201cIndividual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements,\u201d J. Immunol. 184(12):6986-6992. Prepublished online May 21, 2010; doi: 10.4049/jimmunol.1000445.",
                    "Watson, C. T. et al. (2012) \u201cThe immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease,\u201d Genes and Immunity, 13(5):363-373.",
                    "Farci, P. et al. (2010) \u201cB cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure,\u201d PNAS USA, 107(19):8766-8771.",
                    "Assiri, A. et al. (2013) \u201cHospital outbreak of Middle East respiratory syndrome coronavirus,\u201d N. Eng. J. Med. 369(5):407-416.",
                    "Memish, Z. A. et al. (2013) \u201cFamily cluster of Middle East respiratory syndrome coronavirus infections,\u201d N. Engl. J. Med., 368(26):2487-2494.",
                    "Rani, M. et al. (2012) \u201cIncreased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus,\u201d J. Virol., 86(17):9113-9121.",
                    "Rockx, B. et al. (2010) \u201cEscape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus,\u201d J. Infect Dis., 201(6):946-955.",
                    "Cotten, M. et al. (2013) \u201cTransmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study,\u201d Lancet, 382(9909):1993-2002. Published online Sep. 20, 2013, http://dx.doi.org/10.1016/S0140-6736(13)61887-5.",
                    "Bermingham, A. et al. (2012) \u201cSevere respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East,\u201d Sep. 2012. Euro Surveill. 2012;17(40):pii=20290. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20290.",
                    "Cotten, M. et al. (2013) \u201cFull-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus,\u201d Emerg. Infect. Dis., 19(5):736-742B. doi: http://dx.doi.org/10.3201/eid1905.130057.",
                    "International Severe Acute Respiratory & Emerging Infection Consortium (ISARIC), \u201cTreatment of MERS-CoV: Decision Support Tool,\u201d Clinical Decision Making Tool for Treatment of MERS-CoV v.1.0, Jun. 18, 2013, 22 pages.",
                    "ter Meulen, J. et al. (2006) \u201cHuman monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants,\u201d PLoS Med 3(7):e237. doi: 10.1371/journal.pmed.0030237.",
                    "Bakker, A. B. H. et al. (2008) \u201cFirst administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity,\u201d Vaccine, 26(47):5922-5927.",
                    "Dimitrov, D. S. (2010) \u201cTherapeutic antibodies, vaccines and antibodyomes,\u201d mAbs, 2(3):347-356. doi: 10.4161/mabs.2.3.11779.",
                    "Taube, R. et al. (2008) \u201cLentivirus display: stable expression of human antibodies on the surface of human cells and virus particles,\u201d PLoS ONE 3(9):e3181. doi:10.1371/journal.pone.0003181.",
                    "Mirzabekov, T. et al. (2000) \u201cParamagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5,\u201d Nat Biotechnol. 18(6):649-654.",
                    "Xu, C. et al. (2007) \u201cHuman anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity,\u201d J. Immunol. 179(4):2408-2418. doi: 10.4049/jimmunol.179.4.2408.",
                    "Rockx, B. et al. (2008) \u201cStructural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge,\u201d J. Virol. 82(7):3220-3235. doi:10.1128/JVI.02377-07.",
                    "Bona, Constantin A., Sofia Casares, and Teodor-D. Brumeanu. \u201cTowards development of T-cell vaccines.\u201d Immunology today 19.3 (1998): 126-133.",
                    "Carrell, et al., \u201cA Novel Procedure for the Synthesis of Libraries ontaining Small Organic Molecules\u201d 1994. Angew. Chem. Int. Ed. Engl. 33: 2059.",
                    "Carrell, Thomas, et al. \u201cA solution-phase screening procedure for the isolation of active compounds from library of molecules.\u201d Angewandte Chemie International Edition in English 33.20 (1984): 2061-2064.",
                    "Casadecall, Nat. Biotechnol. 20:114 (2002).",
                    "Casares, Sofia, et al. \u201cProtective immunity elicited by vaccination with DNA encoding for a B cell and a T cell epitope of the A/PR/8/34 influenza virus.\u201d Viral immunology10.3 (1997): 129-136.",
                    "Cole, S. P. C., D. Kozbor, and J. C. Roder, \u201cThe EBV-hybridoma technique and its application to human lung cancer,\u201d Monoclonal Antibodies and Cancer Therapy 27 (1985): 77-96.Cote, et al., 1983. Proc Natl Acad Sci USA 80: 2026-2030.",
                    "Davidson, Beverly L., et al. \u201cA model system for in vivo gene transfer into the central nervous system using an adenoviral vector.\u201d Nature genetics 3.3 (1993): 219 Davies et al. (1990) Annual Rev Biochem 59:439-473.",
                    "Devlin, James J., Lucy C. Panganiban, and Patricia E. Devlin, \u201cRandom peptide libraries: a source of specific protein binding molecules.\u201d Science 249.4967 (1990): 404-406.",
                    "DeWitt, et al., 1993. Proc. Natl. Acad. Sci. U.S.A. 90: 6909.",
                    "Fischer, Rainer, Richard M. Twyman, and Stefan Schillberg. \u201cProduction of antibodies in plants and their use for global health.\u201d Vaccine 21.7-8 (2003): 820-825.",
                    "Fishwild, Dianne M., et al. \u201cHigh-avidity human IgG\u03ba monoclonal antibodies from a novel strain of minilocus transgenic mice.\u201d Nature biotechnology 14.7 (1998): 845.",
                    "Gallop, Mark A., et al. \u201cApplications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries.\u201d Journal of medicinal chemistry 37.9 (1994): 1233-1251.",
                    "Garrity, Robert R., et al. \u201cRefocusing neutralizing antibody response by targeted dampening of an immunodominant epitope.\u201d The journal of immunology 159.1 (1997): 279-289.",
                    "Gerloni, Mara, et al. \u201cImmunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization.\u201d Nature biotechnology 15.9 (1997): 876.",
                    "Gerloni, Mara, et al. \u201cSomatic transgene immunization with DNA encoding an immunoglobulin heavy chain.\u201d DNA and cell biology 16.5 (1997): 611-625.",
                    "Goding, James W. Monoclonal antibodies: principles and practice, Elsevier, 1996.",
                    "Hoogenboom, Hennie R., and Greg Winter. \u201cBy-passing immunisation: human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro.\u201d Journal of molecular biology 227.2 (1992): 381-388.",
                    "Houghten, Richard A., et al. \u201cThe use of synthetic peptide combinatorial libraries for the identification bioactive peptides,\u201d Biotechniques 13.3 (1992): 412-421.",
                    "Killen, J. A., and J. M. Lindstrom. \u201cSpecific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates.\u201d The Journal of Immunology 133.5 (1984): 2549-2553.",
                    "K\u00f6hler, Georges, and Cesar Milstein. \u201cContinuous cultures of fused cells secreting antibody of predefined specificity.\u201d Nature256.5517 (1975): 495.",
                    "Kozbor, Danuta, and John C. Roder. \u201cThe production of monoclonal antibodies from human lymphocytes.\u201d Immunology Today 4.3 (1983): 72-79.",
                    "Kozbor, Danuta, et al. \u201cA human hybrid myeloma or production of human monoclonal antibodies.\u201d The Journal of Immunology 133.6 (1984): 3001-3005.",
                    "La Salle, G. Le Gal, et al. \u201cAn adenovirus vector for gene transfer into neurons and glia in the brain,\u201d Science 259.5097 (1993): 986-990.",
                    "Lam, Kit S. \u201cMini-review. Application of combinatorial library methods in cancer research and drug discovery.\u201d Anti-cancer drug design 12.3 (1997): 145-167.",
                    "Lonberg, Nils, and Dennis Huszar. \u201cHuman antibodies from transgenic mice.\u201d International reviews of immunology 13.1 (1995): 65-93.",
                    "Malmqvist, Magnus. \u201cBiospecific interaction analysis using biosensor technology.\u201d Nature 361.6408 (1993): 186-187.",
                    "Marks et al., Bio/Technology 10, 779-783 (1992).",
                    "Morrison, Sherie L. \u201cImmunology-Success in Specification.\u201d Nature 368.6474 (1994): 812-813.",
                    "Muldoon, Mark T. \u201cELISA: Theory and practice. Methods in molecular biology, vol. 42: by John R. Crowther. Totowa, Humana, 1995, $59.95 (xi+ 223 pages), ISBN 0-89603-279-5.\u201d (1996): 352-353.",
                    "Neuberger, Michael. \u201cGenerating high-avidity human Mabs in mice.\u201d Nature biotechnology 14.7 (1996): 826.",
                    "Parren, Paul WHI, and Dennis R. Burton. \u201cThe antiviral activity of antibodies in vitro and in vivo.\u201d (2001): 195-262.",
                    "Shibata, Riri, et al. \u201cNeutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.\u201d Nature medicine 5.2 (1999): 204.",
                    "Shopes, Bob, \u201cA genetically engineered human. IgG mutant with enhanced cytolytic activity.\u201d The Journal of Immunology 148.9 (1992): 2918-2922.",
                    "Stevenson, G. T., A. Pindar, and C. J. Slade. \u201cA chimeric antibody with dual Fc regions (bisFabFc) prepared by manipulations at the IgG hinge.\u201d Anti-cancer drug design 3.4 (1989): 219-230.",
                    "Wilkinson, The Scientist Philadelphia Pa., vol. 14, No. 8 (Apr. 17, 2040), pp. 25-28.",
                    "Zanetti, Maurizio. \u201cAntigenized antibodies.\u201d Nature 355.6359 (1992):476-477.",
                    "Antibodies: A Laboratory Manual, Harlow E, and Lane D, 1988, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.",
                    "\u201cConjugate Vaccines\u201d, Contributions to Microbiology and Immunology, J. M. Cruse and R. E. Lewis, Jr (eds), Carger Press, New York, (1989).",
                    "Fodor, Stephen, et al. \u201cMultiplexed biochemical assays with biological chips.\u201d Nature 364 (1993): 555-556.",
                    "Bobo, R. Hunt, et al. \u201cConvection-enhanced delivery of macromolecules in the brain.\u201d Proceedings of the National Academy of Sciences 91.6 (1994): 2076-2080.",
                    "Burton, Dennis R. \u201cAntibodies, viruses and vaccines.\u201d Nature Reviews Immunology 2.9 (2002): 706.",
                    "Caron, Philip C., et al. \u201cEngineered humanized dimeric forms of IgG are more effective antibodies.\u201d Journal of Experimental Medicine 176.4 (1992): 1191-1195.",
                    "Cull, Millard G., Jeff F. Miller, and Peter J. Schatz. \u201cScreening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor.\u201d Proceedings of the National Academy of Sciences 89.5 (1992): 1865-1869.",
                    "Cwirla, Steven E., et al. \u201cPeptides on phage: a vast library of peptides for identifying ligands.\u201d Proceedings of the National Academy of Sciences 87.16 (1990): 6378-6382.",
                    "Eppstein, Deborah A., et al. \u201cBiological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor.\u201d Proceedings of the National Academy of Sciences 82.11 (1985): 3688-3692.",
                    "Erb, Eric, Kim D. Janda, and Sydney Brenner. \u201cRecursive deconvolution of combinatorial chemical libraries.\u201d Proceedings of the National Academy of Sciences 91.24 (1994): 11422-11426.",
                    "Felici, Franco, et al. \u201cSelection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector.\u201d Journal of molecular biology 222.2 (1991): 301-310.",
                    "Geller, Alfred I., and Andrew Freese. \u201cInfection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.\u201d Proceedings of the National Academy of Sciences 87.3 (1990): 1149-1153.",
                    "Geller, Alfred I., et al. \u201cAn HSV-1 Vector Expressing Tyrosine Hydroxylase Causes Production and Release of I-DOPA from Cultured Rat Striatal Cells.\u201d Journal of neurochemistry 64.2 (1995): 487-496.",
                    "Geller, Alfred I., et al. \u201cLong-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector\u201d Proceedings of the National Academy of Sciences 90.16 (1993): 7603-7607.",
                    "Hwang, Karl J., K. F. Luk, and Paul L. Beaumier. \u201cHepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study.\u201d Proceedings of the National Academy of Sciences 77.7 (1980): 4030-4034.",
                    "Igarashi, Tatsuhiko, et al. \u201cHuman immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma.\u201d Nature medicine 5.2 (1999): 211.",
                    "Kaplitt, Michael G., et al. \u201cLong-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.\u201d Nature genetics 8.2 (1994): 148.",
                    "Keller, Margaret A., and E. Richard Stiehm. \u201cPassive immunity in prevention and treatment of infectious diseases.\u201d Clinical microbiology reviews 13.4 (2000): 602-614.",
                    "Ko, K., R. Brodzik, and Z. Steplewski. \u201cProduction of antibodies in plants: approaches and perspectives.\u201d Plant-produced Microbial Vaccines. Springer, Berlin, Heidelberg, 2009. 55-78.",
                    "Lam, Kit S., et al. \u201cA new type of synthetic peptide library for identifying ligand-binding activity.\u201d Nature 354.6348 (1991): 82.",
                    "Lanza, Paola, et al. \u201cActive immunity against the CD4 receptor by using an antibody antigenized with residues 41-55 of the first extracellular domain.\u201d Proceedings of the National Academy of Sciences 90.24 (1993): 11683-11687.",
                    "Lonberg, Nils, et al. \u201cAntigen-specific human antibodies from mice comprising four distinct genetic modifications.\u201d Nature368.6474 (1994): 856.",
                    "Lunde, E., et al. \u201cTroybodies and pepbodies.\u201d Biochem Soc Trans. Aug. 2002;30(4):500-6.",
                    "Marasco, Wayne A., William A. Haseltine, and SiYi Chen. \u201cDesign, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody.\u201d Proceedings of the National Academy of Sciences90.16 (1993): 7889-7893.",
                    "Marks, James D., et al. \u201cBy-passing immunization: human antibodies from V-gene libraries displayed on phage.\u201d Journal of molecular biology 222.3 (1991): 581-597.",
                    "Martin, Francis J., and Demetrios Papahadjopoulos. \u201cIrreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting.\u201d Journal of Biological Chemistry 257.1 (1982): 286-288.",
                    "Morrison, Paul F., et al. \u201cHigh-flow microinfusion: tissue penetration and pharmacodynamics.\u201d American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 266.1 (1994): R292-R305.",
                    "Munson, Peter J., and David Rodbard. \u201cLigand: a versatile computerized approach for characterization of ligand-binding systems.\u201d Analytical biochemistry 107.1 (1980): 220-239.",
                    "Ramakrishnan, S., and L. L. Houston. \u201cComparison of the selective cytotoxic effects of immunotoxins containing ricin A chain or pokeweed antiviral protein and anti-Thy 1.1 monoclonal antibodies.\u201d Cancer research 44.1 (1984): 201-208.",
                    "Scott, Jamie K., and George P. Smith. \u201cSearching for peptide ligands with an epitope library.\u201d Science 249.4967 (1990): 386-390.",
                    "Steward, M. W., C. M. Stanley, and O. E. Obeid. \u201cA mimotope from a solid-phase peptide library induces a measles virus-neutralizing and protective antibody response.\u201d Journal of virology 69.12 (1995): 7668-7673.",
                    "Vitetta, Ellen S., et al. \u201cRedesigning nature's poisons to create anti-tumor reagents.\u201d Science 238.4830 (1987): 1098-1104.",
                    "Yang, Yiping, et al. \u201cCellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.\u201d Journal of virology 69A (1995): 2004-2015.",
                    "You, Zhaoyang, et al. \u201cTargeting dendritic cells to enhance DNA vaccine potency.\u201d Cancer research 61.9 (2001): 3704-3711.",
                    "Zaghouani, Habib, et al. \u201cInduction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein.\u201d Proceedings of the National Academy of Sciences 92.2 (1995): 631-635.",
                    "Zuckermann, Ronald N., et al. \u201cDiscovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted) glycine peptoid library.\u201d Journal of medicinal chemistry 37.17 (1994): 2678-2685."
                ],
                "nplResolvedCount": 126,
                "nplResolvedLensIDs": [
                    "039-798-912-970-378",
                    "070-669-133-204-810",
                    "040-805-283-891-682",
                    "115-440-304-483-056",
                    "020-404-483-834-41X",
                    "032-071-991-081-664",
                    "079-918-189-127-692",
                    "083-019-407-395-691",
                    "020-855-322-534-259",
                    "034-498-755-334-91X",
                    "041-066-683-986-277",
                    "102-366-465-825-112",
                    "048-564-471-521-204",
                    "045-797-239-878-426",
                    "089-588-647-216-099",
                    "018-275-105-296-01X",
                    "007-647-156-101-708",
                    "010-916-105-450-247",
                    "024-786-305-318-123",
                    "073-597-782-113-635",
                    "019-226-413-187-224",
                    "026-140-875-197-837",
                    "109-155-880-448-590",
                    "108-995-131-384-572",
                    "089-633-612-001-004",
                    "108-171-296-335-638",
                    "073-649-029-337-454",
                    "009-471-901-851-880",
                    "032-820-729-763-323",
                    "002-316-452-094-946",
                    "009-069-193-386-694",
                    "023-778-565-001-548",
                    "083-238-822-188-518",
                    "156-701-588-492-623",
                    "041-194-807-252-395",
                    "130-151-032-772-614",
                    "007-047-414-654-825",
                    "014-496-290-157-356",
                    "101-575-504-070-651",
                    "039-618-960-524-080",
                    "013-242-768-882-463",
                    "181-995-345-726-803",
                    "019-055-424-431-057",
                    "022-347-333-346-706",
                    "044-201-328-679-836",
                    "048-286-798-016-050",
                    "018-873-944-653-858",
                    "070-032-092-668-61X",
                    "079-060-001-665-743",
                    "080-029-256-629-875",
                    "060-459-542-715-007",
                    "042-144-218-091-088",
                    "000-260-465-562-523",
                    "108-496-730-562-485",
                    "062-825-278-526-054",
                    "028-854-336-119-298",
                    "044-851-918-540-636",
                    "052-083-752-569-893",
                    "082-670-193-611-235",
                    "126-216-458-383-35X",
                    "107-172-829-863-600",
                    "119-048-306-528-579",
                    "110-516-365-148-442",
                    "019-384-736-460-911",
                    "071-186-762-480-148",
                    "020-026-345-586-213",
                    "084-688-197-295-776",
                    "086-409-425-521-658",
                    "038-993-273-741-436",
                    "009-186-473-238-939",
                    "000-499-911-678-177",
                    "024-768-689-005-88X",
                    "069-794-620-623-016",
                    "062-630-820-896-11X",
                    "025-246-608-570-632",
                    "003-973-981-797-846",
                    "008-568-997-311-428",
                    "089-209-533-057-090",
                    "078-081-005-787-445",
                    "136-598-677-978-205",
                    "114-114-185-080-165",
                    "013-970-492-790-060",
                    "030-206-317-283-136",
                    "014-370-526-812-297",
                    "063-964-321-294-196",
                    "060-501-577-846-679",
                    "073-933-138-549-235",
                    "023-939-052-489-028",
                    "020-009-029-407-493",
                    "003-376-346-248-551",
                    "145-146-407-738-040",
                    "016-741-112-113-368",
                    "074-966-156-398-343",
                    "021-308-838-406-286",
                    "086-808-737-760-162",
                    "036-220-225-475-260",
                    "048-718-914-737-127",
                    "043-108-278-056-872",
                    "044-135-659-393-274",
                    "018-947-428-245-97X",
                    "041-161-768-559-376",
                    "018-429-338-700-465",
                    "048-284-820-855-67X",
                    "115-945-089-332-354",
                    "070-164-729-669-981",
                    "104-429-687-342-27X",
                    "078-897-295-334-074",
                    "073-841-796-580-64X",
                    "092-993-197-911-840",
                    "056-635-956-830-238",
                    "071-437-116-021-960",
                    "073-682-937-516-081",
                    "153-203-408-850-761",
                    "009-507-053-935-564",
                    "055-600-609-923-599",
                    "124-015-908-295-75X",
                    "023-671-383-084-282",
                    "016-772-377-304-76X",
                    "182-727-351-621-480",
                    "117-012-020-789-100",
                    "106-753-778-592-300",
                    "150-515-489-797-539",
                    "093-342-184-971-366",
                    "078-623-278-359-183",
                    "020-580-355-024-431",
                    "017-966-980-619-952"
                ],
                "nplResolvedExternalIDs": [
                    "10.1021/jm00035a001",
                    "pmc43312",
                    "10.1073/pnas.91.6.2076",
                    "pmc3731569",
                    "10.1128/mbio.00884-14",
                    "10.1016/s0167-5699(98)80011-x",
                    "6092464",
                    "pmc356985",
                    "24355866",
                    "pmc3648152",
                    "10.1126/science.1696028",
                    "10.1073/pnas.0308527100",
                    "10.1073/pnas.91.24.11422",
                    "10.1038/256495a0",
                    "6140077",
                    "pmc349762",
                    "10.1128/jvi.69.12.7668-7673.1995",
                    "18199635",
                    "pmc3647518",
                    "10.3410/f.1164711.626517",
                    "10.1007/978-3-540-70868-1_4",
                    "10.1126/science.1205669",
                    "8265609",
                    "23831647",
                    "10.1016/j.virol.2006.02.041",
                    "10.1056/nejmoa1303729",
                    "11023960",
                    "12196123",
                    "10.1038/76501",
                    "24253287",
                    "10.1371/journal.pone.0081587",
                    "15791205",
                    "18784843",
                    "pmc365685",
                    "6933450",
                    "pmc397852",
                    "pmc1287547",
                    "23170002",
                    "pmc48554",
                    "10.1038/5568",
                    "10.1038/cr.2013.92",
                    "15163706",
                    "pmc2692245",
                    "1696028",
                    "10.1089/dna.1997.16.611",
                    "16796401",
                    "10.1016/s0167-5699(97)01218-8",
                    "8387378",
                    "8102799",
                    "1720463",
                    "pmc1142572",
                    "14983044",
                    "9540272",
                    "8134351",
                    "10.1073/pnas.89.5.1865",
                    "10.1038/nbt1363",
                    "10.1038/361186a0",
                    "10.1038/5576",
                    "9631000",
                    "17675502",
                    "pmc3516815",
                    "10.1038/354082a0",
                    "pmc2527531",
                    "10.1128/jvi.69.4.2004-2015.1995",
                    "1402660",
                    "20400863",
                    "10.1056/nejmx130042",
                    "1944576",
                    "10.1016/0167-5699(83)90123-8",
                    "pmc2268459",
                    "10.1371/journal.pone.0003942",
                    "24206838",
                    "pmc54537",
                    "10.1128/cmr.13.4.602",
                    "24055451",
                    "8382374",
                    "pmc4029105",
                    "11159532",
                    "10.3201/eid2002.131182",
                    "10.1046/j.1471-4159.1995.64020487.x",
                    "10.1042/bst0300500",
                    "pmc42796",
                    "23232719",
                    "10.3109/08830189509061738",
                    "10.1016/0022-2836(91)90498-u",
                    "10.1128/jvi.01277-13",
                    "10.1182/blood.v97.4.1023",
                    "10.1016/j.vaccine.2008.08.050",
                    "10.1126/science.1207532",
                    "23517868",
                    "10.1152/ajpregu.1994.266.1.r292",
                    "8356098",
                    "10.1016/s0264-410x(02)00607-2",
                    "9174166",
                    "10.1128/jvi.00128-13",
                    "10.1016/s1473-3099(13)70164-6",
                    "10.1126/science.2143033",
                    "1370860",
                    "10.1038/ng1094-148",
                    "10.1073/pnas.0307140101",
                    "10.1038/364555a0",
                    "16647731",
                    "23978242",
                    "10.1146/annurev-immunol-032712-095916",
                    "22696652",
                    "pmc3647674",
                    "2930624",
                    "6254391",
                    "10.1038/nri891",
                    "19234466",
                    "23075143",
                    "10.1073/pnas.0801367105",
                    "8176700",
                    "10.1126/science.1092002",
                    "23718156",
                    "24570370",
                    "10.3410/f.1019175.217453",
                    "10.1056/nejmoa1211721",
                    "10.1016/s0065-2776(01)77018-6",
                    "10.1186/1743-422x-10-266",
                    "8304553",
                    "23622767",
                    "10.1128/jvi.02377-07",
                    "1404359",
                    "10.1128/mbio.01062-13",
                    "10.1086/651022",
                    "10.1038/nature12005",
                    "1172191",
                    "15247913",
                    "10.1038/nbt0796-826a",
                    "10.1073/pnas.77.7.4030",
                    "10.3201/eid1911.131172",
                    "10.1128/cmr.13.4.602-614.2000",
                    "23835475",
                    "10.1021/jm00043a007",
                    "19079604",
                    "pmc3898949",
                    "10.1038/nbt0202-114",
                    "pmc47248",
                    "10.1016/0022-2836(92)90894-p",
                    "7687751",
                    "10.1038/355476a0",
                    "pmc4281569",
                    "9154108",
                    "2153970",
                    "10.1016/s0140-6736(13)61887-5",
                    "10835604",
                    "10.4049/jimmunol.179.4.2408",
                    "12531368",
                    "7830040",
                    "6332854",
                    "20421498",
                    "10.4161/mabs.2.3.11779",
                    "24079378",
                    "16282460",
                    "3159018",
                    "9930870",
                    "10.1128/jvi.00233-12",
                    "pmc48048",
                    "pmc3837665",
                    "7842013",
                    "9200464",
                    "7494109",
                    "pmc47190",
                    "1573276",
                    "pmc2596486",
                    "9930869",
                    "pmc3952667",
                    "pmc3416138",
                    "10.1016/s1473-3099(13)70690-x",
                    "1347427",
                    "23693015",
                    "pmc2826557",
                    "23486063",
                    "12209139",
                    "20495067",
                    "10.2807/1560-7917.es2013.18.36.20574",
                    "10.1016/0003-2697(80)90515-1",
                    "9344335",
                    "14752165",
                    "1748994",
                    "8159246",
                    "23364191",
                    "10.1073/pnas.90.16.7603",
                    "8064796",
                    "10.1016/s0140-6736(13)61492-0",
                    "pmc188865",
                    "10.1016/0168-9525(95)90594-4",
                    "10.1099/vir.0.049759-0",
                    "11293117",
                    "23986586",
                    "10.2807/ese.18.11.20427-en",
                    "2143033",
                    "pmc3754068",
                    "10.1016/0022-2836(91)90213-p",
                    "10.1038/nature12328",
                    "pmc1483912",
                    "8159237",
                    "10.1038/368856a0",
                    "7972077",
                    "14981267",
                    "11325842",
                    "10.1073/pnas.90.24.11683",
                    "7678451",
                    "10.1073/pnas.1003854107",
                    "18989460",
                    "pmc3709589",
                    "pmc189707",
                    "pmc47044",
                    "18413603",
                    "7831341",
                    "23933067",
                    "pmc2515609",
                    "10.1128/jvi.79.23.14606-14613.2005",
                    "10.1038/nm1080",
                    "8394002",
                    "10.1371/journal.pmed.0030237",
                    "pmc3765664",
                    "3317828",
                    "10.3201/eid1903.121503",
                    "10.1073/pnas.87.3.1149",
                    "10.1128/mbio.00473-12",
                    "pmc2329690",
                    "23330954",
                    "11821846",
                    "2201029",
                    "10.1128/mbio.00515-12",
                    "10.3201/eid1905.130057",
                    "25291284",
                    "21835983",
                    "19401821",
                    "10.1371/journal.ppat.1000197",
                    "9306403",
                    "10.1016/j.jinf.2013.03.015",
                    "22551722",
                    "pmc3807317",
                    "1368267",
                    "pmc3852489",
                    "10.1038/ng0393-219",
                    "23785207",
                    "pmc53428",
                    "pmc2572002",
                    "10.1073/pnas.82.11.3688",
                    "10.1126/science.8382374",
                    "23468491",
                    "18449194",
                    "10.1128/mbio.01002-14",
                    "1382470",
                    "7494275",
                    "10.1038/gene.2012.12",
                    "pmc2581875",
                    "pmc45243",
                    "10.1128/jvi.01672-13",
                    "10.1089/vim.1997.10.129",
                    "10.1038/sj.emboj.7600640",
                    "18804136",
                    "10.1038/nature06890",
                    "23782161",
                    "10.1056/nejmoa1306742",
                    "pmc416513",
                    "10.1073/pnas.90.16.7889",
                    "10.1126/science.3317828",
                    "10.1073/pnas.92.2.631",
                    "10.1093/infdis/jit609",
                    "7884845",
                    "pmc3901466",
                    "23831141",
                    "7053372",
                    "10.1038/nbt0997-876",
                    "10.1073/pnas.90.15.6909",
                    "21798894",
                    "10.4049/jimmunol.1000445",
                    "23583636",
                    "24457147",
                    "10.1038/nbt0792-779",
                    "20144042",
                    "24549846",
                    "10.1128/jvi.78.12.6134-6142.2004",
                    "10.1073/pnas.87.16.6378",
                    "23078800",
                    "10.1038/368812a0",
                    "pmc2889296",
                    "10.1084/jem.176.4.1191",
                    "24324708",
                    "10.1371/journal.pone.0003181",
                    "pmc88952",
                    "10.1038/nsmb.1566",
                    "18066039"
                ]
            },
            {
                "index": "43",
                "publicationKey": "KR_20180054029_A",
                "lensId": "154-249-386-213-39X",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20180054029 A",
                "publicationDate": "2018-05-24",
                "filingNumber": "KR 20160151313 A",
                "filingDate": "2016-11-14",
                "priorityFilingKeysActive": [
                    "KR 20160151313 A 20161114"
                ],
                "earliestPriorityDate": "2016-11-14",
                "title": "Composition For Improving Immunity Comprising Exopolysaccharide Derived From Weissella Cibaria",
                "applicants": [
                    "NAT UNIV CHONBUK IND COOP FOUND"
                ],
                "inventors": [
                    "LEE SANG MYEONG",
                    "OH EUN YOUNG"
                ],
                "owners": [],
                "url": "https://lens.org/154-249-386-213-39X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [
                    "Y02A50/385",
                    "Y02A50/391"
                ],
                "ipcrClassifications": [
                    "A23L33/00",
                    "A23K20/163",
                    "A23L33/125",
                    "A61K35/744"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "Kwak SH, et al., Cancer preventive potential of kimchi lactic acid bacteria(Weissella cibaria, Lactobacillus plantarum). J. Cancer Prevention 19(4): 253~258 (2014.12.30.)"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "091-232-351-704-100"
                ],
                "nplResolvedExternalIDs": [
                    "10.15430/jcp.2014.19.4.253",
                    "pmc4285955",
                    "25574459"
                ]
            },
            {
                "index": "44",
                "publicationKey": "WO_2017_040316_A1",
                "lensId": "186-083-318-857-488",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/040316 A1",
                "publicationDate": "2017-03-09",
                "filingNumber": "US 2016/0049071 W",
                "filingDate": "2016-08-26",
                "priorityFilingKeysActive": [
                    "US 201562211541 P 20150828"
                ],
                "earliestPriorityDate": "2015-08-28",
                "title": "Sample Analysis, Presence Determination Of A Target Sequence",
                "applicants": [
                    "BROAD INST INC",
                    "MASSACHUSETTS INST TECHNOLOGY",
                    "SABETI PARDIS"
                ],
                "inventors": [
                    "SABETI PARDIS",
                    "METSKY HAYDEN",
                    "GNIRKE ANDREAS",
                    "MATRANGA CHRISTIAN",
                    "PARK DANIEL"
                ],
                "owners": [],
                "url": "https://lens.org/186-083-318-857-488",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 452330,
                "cpcClassifications": [
                    "C12Q1/686",
                    "C07H21/04",
                    "C12Q1/6806",
                    "C12Q1/6809",
                    "C12Q1/6816",
                    "C12Q1/701",
                    "Y02A50/51",
                    "Y02A50/53",
                    "Y02A50/54",
                    "Y02A50/60"
                ],
                "ipcrClassifications": [
                    "C40B30/04",
                    "C12Q1/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "JABADO ET AL.: \"Comprehensive viral oligonucleotide probe design using conserved protein regions\", NUCLEIC ACIDS RESEARCH, vol. 36, no. 1, 2008, pages 1 - 10, XP055366340",
                    "TAGHIPOUR ET AL.: \"Applying surface-based DNA computing for solving the dominating set problem\", AMERICAN JOURNAL OF MOLECULAR BIOLOGY, vol. 2, no. 3, July 2012 (2012-07-01), pages 286 - 290, XP055366355"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "178-230-553-419-469",
                    "001-544-300-732-126"
                ],
                "nplResolvedExternalIDs": [
                    "pmc2248741",
                    "18079152",
                    "10.1093/nar/gkm1106",
                    "10.4236/ajmb.2012.23030"
                ]
            },
            {
                "index": "45",
                "publicationKey": "US_10086063_B2",
                "lensId": "179-929-644-817-02X",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10086063 B2",
                "publicationDate": "2018-10-02",
                "filingNumber": "US 201615274491 A",
                "filingDate": "2016-09-23",
                "priorityFilingKeysActive": [
                    "US 201562222322 P 20150923"
                ],
                "earliestPriorityDate": "2015-09-23",
                "title": "Methods Of Making And Using Live Attenuated Viruses",
                "applicants": [
                    "UNIV MINNESOTA"
                ],
                "inventors": [
                    "LANGLOIS RYAN ANDREW",
                    "FIEGE JESSICA KAREN",
                    "SJAASTAD LOUISA ELIZABETH",
                    "WARING BARBARA MAE"
                ],
                "owners": [
                    {
                        "name": "REGENTS OF THE UNIVERSITY OF MINNESOTA",
                        "executionDate": "2019-04-26"
                    }
                ],
                "url": "https://lens.org/179-929-644-817-02X",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 4,
                "seqCount": 2,
                "cpcClassifications": [
                    "C12N7/00",
                    "C12N15/111",
                    "C12N2310/113",
                    "C12N2330/50",
                    "C12N2760/16034",
                    "C12N2760/16051",
                    "C12N2760/16062",
                    "Y02A50/51"
                ],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K31/7088",
                    "A61K39/00",
                    "A61K39/145",
                    "C07H21/02",
                    "C07H21/04",
                    "C12N5/00",
                    "C12N7/00",
                    "C12N15/85"
                ],
                "usClassifications": [],
                "nplCitationCount": 12,
                "nplCitations": [
                    "Barnes et al., \u201cHarnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virusvaccines,\u201d Cell Host Microbe., 4(3):239-48, Sep. 11, 2008.",
                    "Bartel, \u201cMicroRNA Target Recognition and Regulatory Functions,\u201d Cell., 136(2):215-233, Jan. 23, 2009.",
                    "Chenna et al., \u201cMultiple sequence alignment with the Clustal series of program,\u201d Nucleic Acids Res., 31(13):3497-3500, 2003.",
                    "Fodor et al., \u201cRescue of Influenza A Virus from Recombinant DNA,\u201d J Virol., 73(11):9679-9682, Nov. 1999.",
                    "Kelly et al, \u201cEngineering microRNA responsiveness to decrease virus pathogenicity,\u201d Nature Medicine., 14(11):1278-1283, Nov. 2008.",
                    "Langlois et al., \u201cIn vivo delivery of cytoplasmic RNA virus-derived miRNAs,\u201d Mol.Therapy., 20(2):367-375, Feb. 2012.",
                    "Langlois et al., \u201cHematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses,\u201d PNAS., 109(30): 12117-12122, Jul. 24, 2012.",
                    "Langlois et al., \u201cMicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies,\u201d Nature Biotechnology 31(9):844-847, Aug. 11, 2013.",
                    "Perez et al., \u201cMicroRNA-mediated species-specific attenuation of influenza A virus,\u201d Nature Biotechnology 27:572-576, 2009.",
                    "Pfeffer et al., \u201cIdentification of microRNAs of the herpesvirus family,\u201d Nat Methods., 2(4):269-276, 2005.",
                    "Pham et al., \u201cReplication in Cells of Hematopoietic Origin Is Necessary for Dengue Virus Dissemination,\u201d PLoS Pathogens., 8(1):e1002465, 10 pages, Jan. 5, 2012.",
                    "Shapiro et al., \u201cNoncanonical cytoplasmic processing of viral microRNAs,\u201d RNA. 16(11):2068-2074, Nov. 2010."
                ],
                "nplResolvedCount": 12,
                "nplResolvedLensIDs": [
                    "026-956-603-588-975",
                    "062-926-743-070-156",
                    "057-727-756-782-512",
                    "144-376-770-423-358",
                    "040-649-149-362-761",
                    "014-462-529-725-525",
                    "089-587-704-837-170",
                    "014-993-888-050-374",
                    "090-174-138-652-509",
                    "067-288-941-479-970",
                    "092-203-218-432-170",
                    "057-124-103-401-53X"
                ],
                "nplResolvedExternalIDs": [
                    "19483680",
                    "10.1261/rna.2303610",
                    "pmc3808852",
                    "18779050",
                    "12824352",
                    "22778433",
                    "pmc3277236",
                    "10.1038/nbt.1542",
                    "pmc2045542",
                    "19167326",
                    "10.1371/journal.ppat.1002465",
                    "pmc113010",
                    "15782219",
                    "10.1038/nmeth746",
                    "10.1073/pnas.1206039109",
                    "pmc2605097",
                    "10.1038/mt.2011.244",
                    "22086233",
                    "10.1016/j.chom.2008.08.003",
                    "10516084",
                    "20841420",
                    "23934176",
                    "pmc3409765",
                    "10.1016/j.cell.2009.01.002",
                    "10.1093/nar/gkg500",
                    "pmc3252368",
                    "10.1038/nm.1776",
                    "pmc168907",
                    "22241991",
                    "18953352",
                    "10.1038/nbt.2666",
                    "pmc2957047",
                    "pmc3794896"
                ]
            },
            {
                "index": "46",
                "publicationKey": "US_2017_0080079_A1",
                "lensId": "130-719-068-655-806",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0080079 A1",
                "publicationDate": "2017-03-23",
                "filingNumber": "US 201615274491 A",
                "filingDate": "2016-09-23",
                "priorityFilingKeysActive": [
                    "US 201562222322 P 20150923"
                ],
                "earliestPriorityDate": "2015-09-23",
                "title": "Methods Of Making And Using Live Attenuated Viruses",
                "applicants": [
                    "UNIV MINNESOTA"
                ],
                "inventors": [
                    "LANGLOIS RYAN ANDREW"
                ],
                "owners": [
                    {
                        "name": "REGENTS OF THE UNIVERSITY OF MINNESOTA",
                        "executionDate": "2019-04-26"
                    }
                ],
                "url": "https://lens.org/130-719-068-655-806",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 4,
                "seqCount": 2,
                "cpcClassifications": [
                    "C12N7/00",
                    "C12N15/111",
                    "C12N2310/113",
                    "C12N2330/50",
                    "C12N2760/16034",
                    "C12N2760/16051",
                    "C12N2760/16062",
                    "Y02A50/51"
                ],
                "ipcrClassifications": [
                    "A61K39/145",
                    "C12N5/00",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "47",
                "publicationKey": "KR_101916899_B1",
                "lensId": "158-452-189-256-939",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101916899 B1",
                "publicationDate": "2018-11-08",
                "filingNumber": "KR 20170111227 A",
                "filingDate": "2017-08-31",
                "priorityFilingKeysActive": [
                    "KR 20170111227 A 20170831"
                ],
                "earliestPriorityDate": "2017-08-31",
                "title": "Sars Mers Primer For Simultaneous Detection Of Sars-related Corona Virus And Mers-related Corona Virus And Detecting Method Using The Same",
                "applicants": [
                    "KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY",
                    "BIONANO HEALTH GUARD RES CENTER"
                ],
                "inventors": [
                    "KIM HYE KWON",
                    "NOH JI YEONG",
                    "JEONG DAE GWIN",
                    "KIM JI HYUNG",
                    "YOON SUN WOO"
                ],
                "owners": [],
                "url": "https://lens.org/158-452-189-256-939",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 2,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "48",
                "publicationKey": "KR_20180079136_A",
                "lensId": "165-595-955-357-766",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20180079136 A",
                "publicationDate": "2018-07-10",
                "filingNumber": "KR 20160184595 A",
                "filingDate": "2016-12-31",
                "priorityFilingKeysActive": [
                    "KR 20160184595 A 20161231"
                ],
                "earliestPriorityDate": "2016-12-31",
                "title": "Sarsmers Compositions For Anti-avian Influenza Virus Sars Mers Coronavirus By Micro Encapsulized Natural Herbs",
                "applicants": [
                    "GREEN T IND CO LTD"
                ],
                "inventors": [
                    "YOO HAE HYUN"
                ],
                "owners": [],
                "url": "https://lens.org/165-595-955-357-766",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01N25/28",
                    "A01N65/22",
                    "A61K9/48",
                    "A61K36/53",
                    "A61K36/63"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "49",
                "publicationKey": "WO_2017_044507_A2",
                "lensId": "092-874-904-147-131",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2017/044507 A2",
                "publicationDate": "2017-03-16",
                "filingNumber": "US 2016/0050590 W",
                "filingDate": "2016-09-07",
                "priorityFilingKeysActive": [
                    "US 201562215565 P 20150908"
                ],
                "earliestPriorityDate": "2015-09-08",
                "title": "Sirna/nanoparticle Formulations For Treatment Of Middle-east Respiratory Syndrome Coronaviral Infection",
                "applicants": [
                    "SIRNAOMICS INC"
                ],
                "inventors": [
                    "LU PATRICK Y",
                    "SIMONENKO VERA",
                    "CAI YIBIN",
                    "XU JOHN",
                    "EVANS DAVID"
                ],
                "owners": [],
                "url": "https://lens.org/092-874-904-147-131",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K48/0066",
                    "A61K9/127",
                    "A61K9/5153",
                    "A61K47/28",
                    "A61K47/543",
                    "A61K48/0008",
                    "A61P31/14",
                    "B82Y5/00",
                    "C12N15/1131",
                    "C12N15/88",
                    "C12N2310/14",
                    "C12N2320/31",
                    "C12N2320/32"
                ],
                "ipcrClassifications": [
                    "A61K48/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "50",
                "publicationKey": "WO_2017_044507_A3_20170526",
                "lensId": "046-195-326-188-499",
                "jurisdiction": "WO",
                "kindCode": "A3",
                "displayKey": "WO 2017/044507 A3",
                "publicationDate": "2017-05-26",
                "filingNumber": "US 2016/0050590 W",
                "filingDate": "2016-09-07",
                "priorityFilingKeysActive": [
                    "US 201562215565 P 20150908"
                ],
                "earliestPriorityDate": "2015-09-08",
                "title": "Sirna/nanoparticle Formulations For Treatment Of Middle-east Respiratory Syndrome Coronaviral Infection",
                "applicants": [
                    "SIRNAOMICS INC"
                ],
                "inventors": [
                    "LU PATRICK Y",
                    "SIMONENKO VERA",
                    "CAI YIBIN",
                    "XU JOHN",
                    "EVANS DAVID"
                ],
                "owners": [],
                "url": "https://lens.org/046-195-326-188-499",
                "docType": "Search report",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K48/0066",
                    "A61K9/127",
                    "A61K9/5153",
                    "A61K47/28",
                    "A61K47/543",
                    "A61K48/0008",
                    "A61P31/14",
                    "B82Y5/00",
                    "C12N15/1131",
                    "C12N15/88",
                    "C12N2310/14",
                    "C12N2320/31",
                    "C12N2320/32"
                ],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/215",
                    "C07K16/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "YANG, X ET AL.: \"Proteolytic Processing, Deubiquitinase And Interferon Antagonist Activities Of Middle East Respiratory Syndrome Coronavirus Papain-Like Protease\", JOURNAL OF GENERAL VIROLOGY, vol. 95, no. 3, 2014, pages 614 - 626, XP055383781",
                    "MEVEL, M ET AL.: \"DODAG; A Versatile New Cationic Lipid That Mediates Efficient Delivery Of pDNA And siRNA'.\", JOURNAL OF CONTROLLED RELEASE, vol. 143, no. 2, 2010, pages 222 - 232, XP055383792"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "021-573-480-762-16X",
                    "076-565-915-152-084",
                    "049-417-442-331-045"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/j.jconrel.2009.12.001",
                    "24362959",
                    "10.1099/vir.0.059014-0",
                    "19969034"
                ]
            },
            {
                "index": "51",
                "publicationKey": "WO_2015_192077_A1",
                "lensId": "008-342-999-301-854",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/192077 A1",
                "publicationDate": "2015-12-17",
                "filingNumber": "US 2015/0035658 W",
                "filingDate": "2015-06-12",
                "priorityFilingKeysActive": [
                    "US 201462011462 P 20140612"
                ],
                "earliestPriorityDate": "2014-06-12",
                "title": "Heterocyclic Compounds And Methods Of Use Thereof",
                "applicants": [
                    "US HEALTH",
                    "UNIV KANSAS"
                ],
                "inventors": [
                    "LIANG TSANYANG",
                    "HU ZONGYI",
                    "MARUGAN JUAN JOSE",
                    "SOUTHALL NOEL TERRENCE",
                    "HE SHANSHAN",
                    "HU XIN",
                    "XIAO JINGBO",
                    "FERRER MARC",
                    "ZHENG WEI",
                    "FRANKOWSKI KEVIN J",
                    "SCHOENEN FRANK J",
                    "LI KELIN"
                ],
                "owners": [],
                "url": "https://lens.org/008-342-999-301-854",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 10,
                "familySize": 10,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07D413/06",
                    "A61K31/4178",
                    "A61K31/454",
                    "A61K31/4545",
                    "A61K31/496",
                    "A61K31/5377",
                    "A61K31/7056",
                    "A61K31/7068",
                    "A61K38/07",
                    "A61K38/13",
                    "A61K38/212",
                    "C07D413/14",
                    "C07D417/14",
                    "C07D471/08",
                    "Y02A50/385"
                ],
                "ipcrClassifications": [
                    "C07D413/14",
                    "A61K31/553",
                    "A61P31/14",
                    "C07D471/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "52",
                "publicationKey": "US_2019_0030187_A1",
                "lensId": "027-117-701-172-454",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0030187 A1",
                "publicationDate": "2019-01-31",
                "filingNumber": "US 201615758312 A",
                "filingDate": "2016-09-07",
                "priorityFilingKeysActive": [
                    "US 201562215565 P 20150908"
                ],
                "earliestPriorityDate": "2015-09-08",
                "title": "Sirna/nanoparticle Formulations For Treatment Of Middle-east Respiratory Syndrome Coronaviral Infection",
                "applicants": [
                    "SIRNAOMICS INC"
                ],
                "inventors": [
                    "LU PATRICK Y",
                    "SIMONENKO VERA",
                    "CAI YIBIN",
                    "XU JOHN",
                    "EVANS DAVID"
                ],
                "owners": [
                    {
                        "name": "SIRNAOMICS INC",
                        "executionDate": "2017-02-28"
                    }
                ],
                "url": "https://lens.org/027-117-701-172-454",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 1059,
                "cpcClassifications": [
                    "A61K48/0066",
                    "A61K9/127",
                    "A61K9/5153",
                    "A61K47/28",
                    "A61K47/543",
                    "A61K48/0008",
                    "A61P31/14",
                    "B82Y5/00",
                    "C12N15/1131",
                    "C12N15/88",
                    "C12N2310/14",
                    "C12N2320/31",
                    "C12N2320/32"
                ],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K47/28",
                    "A61K47/54",
                    "A61P31/14",
                    "C12N15/113"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "53",
                "publicationKey": "US_2017_0114053_A1",
                "lensId": "194-597-687-028-253",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0114053 A1",
                "publicationDate": "2017-04-27",
                "filingNumber": "US 201515317864 A",
                "filingDate": "2015-06-12",
                "priorityFilingKeysActive": [
                    "US 201462011462 P 20140612"
                ],
                "earliestPriorityDate": "2014-06-12",
                "title": "Heterocyclic Compounds And Methods Of Use Thereof",
                "applicants": [
                    "US HEALTH",
                    "UNIV OF KANSAS"
                ],
                "inventors": [
                    "LIANG TSANYANG",
                    "HU ZONGYI",
                    "MARUGAN JUAN JOSE",
                    "SOUTHALL NOEL TERRENCE",
                    "HE SHANSHAN",
                    "HU XIN",
                    "XIAO JINGBO",
                    "FERRER MARC",
                    "ZHENG WEI",
                    "FRANKOWSKI KEVIN J",
                    "SCHOENEN FRANK J",
                    "LI KELIN"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                        "executionDate": "2017-07-24"
                    },
                    {
                        "name": "UNIVERSITY OF KANSAS",
                        "executionDate": "2017-07-24"
                    }
                ],
                "url": "https://lens.org/194-597-687-028-253",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 10,
                "familySize": 10,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07D413/06",
                    "A61K31/4178",
                    "A61K31/454",
                    "A61K31/4545",
                    "A61K31/496",
                    "A61K31/5377",
                    "A61K31/7056",
                    "A61K31/7068",
                    "A61K38/07",
                    "A61K38/13",
                    "A61K38/212",
                    "C07D413/14",
                    "C07D417/14",
                    "C07D471/08",
                    "Y02A50/385"
                ],
                "ipcrClassifications": [
                    "C07D413/06",
                    "A61K31/4178",
                    "A61K31/454",
                    "A61K31/4545",
                    "A61K31/496",
                    "A61K31/5377",
                    "A61K31/7056",
                    "A61K31/7068",
                    "A61K38/07",
                    "A61K38/13",
                    "A61K38/21",
                    "C07D413/14",
                    "C07D417/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "CA registry No.902500-07-6, entered into CA registry File on 8/17/06,supplied by Aurora Fine Chemicals.",
                    "Aurora Fine Chemicals Product Guide.1 page, retrieved from the Internet at http://www.aurorafinechemicals.com/abouthtml on 4/28/15.",
                    "Goldfarb I, Chemical Abstracts vol.151. No.92849 and 92847, abstracts for US 2009/0163545 (2009).",
                    "Goldfarb II, Chemical Abstracts vol.151. No.92845,92840,70320, abstracts for US 2009/0163545 (2009)."
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "54",
                "publicationKey": "CN_106478814_A",
                "lensId": "103-725-895-468-926",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 106478814 A",
                "publicationDate": "2017-03-08",
                "filingNumber": "CN 201510525915 A",
                "filingDate": "2015-08-25",
                "priorityFilingKeysActive": [
                    "CN 201510525915 A 20150825"
                ],
                "earliestPriorityDate": "2015-08-25",
                "title": "De-fucosylated Fully Humanized Monoclonal Antibody And Applications Thereof",
                "applicants": [
                    "UNIV FUDAN"
                ],
                "inventors": [
                    "YING TIANLEI",
                    "DIMITER S DIMITROV",
                    "JIANG SHIBO"
                ],
                "owners": [],
                "url": "https://lens.org/103-725-895-468-926",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61P31/14",
                    "C12N15/13",
                    "G01N33/569",
                    "G01N33/577",
                    "G01N33/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "MORI K ET AL: \"Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies\", \u300aCYTOTECHNOLOGY\u300b",
                    "TIANLEI YING ET AL: \"Exceptionally potent neutralizaiton of Middle East Respiratory Syndrome Coronavirus by human monoclonal antibodies\", \u300aJOURNAL OF VIROLOGY\u300b",
                    "\u6641\u9633 \u7b49: \"\u6cbb\u7597\u6027\u6297\u4f53\u7cd6\u57fa\u5316\u7814\u7a76\u8fdb\u5c55\u53ca\u5e94\u7528\", \u300a\u5c71\u4e1c\u5316\u5de5\u300b",
                    "\u4e8e\u8679 \u7b49: \"\u5177\u5907\u4e2d\u548c\u4e2d\u4e1c\u547c\u5438\u7efc\u5408\u5f81\u51a0\u72b6\u75c5\u6bd2\u6d3b\u6027\u7684\u5355\u514b\u9686\u6297\u4f53\u7684\u5236\u5907\", \u300a\u89e3\u653e\u519b\u9884\u9632\u533b\u5b66\u6742\u5fd7\u300b"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "055-005-586-964-518",
                    "035-470-429-840-042"
                ],
                "nplResolvedExternalIDs": [
                    "pmc2104554",
                    "pmc4097770",
                    "19003000",
                    "10.1128/jvi.00912-14",
                    "24789777",
                    "10.1007/s10616-007-9103-2"
                ]
            },
            {
                "index": "55",
                "publicationKey": "US_2019_0062785_A1",
                "lensId": "115-286-759-285-758",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0062785 A1",
                "publicationDate": "2019-02-28",
                "filingNumber": "US 201716091005 A",
                "filingDate": "2017-03-31",
                "priorityFilingKeysActive": [
                    "US 201662318087 P 20160404"
                ],
                "earliestPriorityDate": "2016-04-04",
                "title": "Multivalent Vaccines For Rabies Virus And Coronoviruses",
                "applicants": [
                    "THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVIC",
                    "UNIV JEFFERSON",
                    "UNIV MARYLAND"
                ],
                "inventors": [
                    "JOHNSON REED F",
                    "SCHNELL MATTHIAS",
                    "HENSLEY LISA E",
                    "WIRBLICH CHRISTOPH",
                    "COLEMAN CHRISTOPHER M",
                    "FRIEMAN MATTHEW B"
                ],
                "owners": [
                    {
                        "name": "UNIVERSITY OF MARYLAND BALTIMORE",
                        "executionDate": "2017-04-26"
                    }
                ],
                "url": "https://lens.org/115-286-759-285-758",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 24,
                "cpcClassifications": [
                    "C12N15/86",
                    "A61K39/12",
                    "A61K39/205",
                    "A61K39/215",
                    "A61K2039/5254",
                    "A61K2039/5256",
                    "C12N2760/20034",
                    "C12N2760/20043",
                    "C12N2760/20134",
                    "C12N2760/20143",
                    "C12N2770/20022",
                    "C12N2770/20034"
                ],
                "ipcrClassifications": [
                    "C12N15/86",
                    "A61K39/205",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "56",
                "publicationKey": "CN_104958755_A",
                "lensId": "035-706-170-320-993",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 104958755 A",
                "publicationDate": "2015-10-07",
                "filingNumber": "CN 201510343520 A",
                "filingDate": "2015-06-19",
                "priorityFilingKeysActive": [
                    "CN 201510343520 A 20150619"
                ],
                "earliestPriorityDate": "2015-06-19",
                "title": "Application Of Teicoplanin In Preparation Of Drugs For Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "UNIV SUN YAT SEN"
                ],
                "inventors": [
                    "PAN TING",
                    "ZHOU NAN",
                    "ZHANG HUI"
                ],
                "owners": [],
                "url": "https://lens.org/035-706-170-320-993",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/14",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "PINTER G. ET AL.: \"Diazo transger-click reaction reaction route to new lipophilic teicoplanin and ristocetin aglycon dervatives with high antibacterial and anti-influenza viurs activity\uff1aan aggregation and receptor binding study\", \u300aJ MED CHEM\u300b",
                    "BERECZKI I ET AL: \"Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitrors: synthesis and antiviral studies\", \u300aBIOORGANIC AND MEDICINAL CHEMISTRY LETTERS\u300b",
                    "ALBERTO BERNAREGGI: \"Teicoplanin Metabolism in Humans\", \u300aANTIMICROBIAL AGENTS AND CHEMOTHERAPY\u300b",
                    "JAN BALZARINI: \"Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics\", \u300aANTIVIRAL RESEARCH\u300b"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "001-390-057-920-901",
                    "108-695-275-247-687",
                    "028-152-943-833-809",
                    "028-396-349-936-216"
                ],
                "nplResolvedExternalIDs": [
                    "10.1021/jm900950d",
                    "10.1016/j.antiviral.2006.03.005",
                    "10.1016/j.bmcl.2014.06.018",
                    "19791806",
                    "pmc192040",
                    "16675038",
                    "10.1128/aac.36.8.1744",
                    "1416858",
                    "24974341"
                ]
            },
            {
                "index": "57",
                "publicationKey": "WO_2019_046316_A1",
                "lensId": "190-724-549-141-163",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/046316 A1",
                "publicationDate": "2019-03-07",
                "filingNumber": "US 2018/0048369 W",
                "filingDate": "2018-08-28",
                "priorityFilingKeysActive": [
                    "US 201762551047 P 20170828"
                ],
                "earliestPriorityDate": "2017-08-28",
                "title": "Pikfyve Kinase Inhibitors",
                "applicants": [
                    "ACURASTEM INC"
                ],
                "inventors": [
                    "SMRCINA MARTIN",
                    "LI RONGHUA",
                    "NAIR ANIL",
                    "AUGUST PAUL",
                    "BJERGARDE KIRSTEN"
                ],
                "owners": [],
                "url": "https://lens.org/190-724-549-141-163",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07D403/04",
                    "C07D407/14",
                    "C07D413/14",
                    "C07D417/14",
                    "C07D491/048"
                ],
                "ipcrClassifications": [
                    "C07D413/14",
                    "A61K31/506",
                    "A61P25/14",
                    "A61P25/16",
                    "A61P25/28",
                    "A61P31/12",
                    "A61P31/22",
                    "C07D403/04",
                    "C07D407/14",
                    "C07D417/14",
                    "C07D491/048"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "WADA ET AL., BLOOD, vol. 109, 2007, pages 1156 - 1164",
                    "CAI ET AL., CHEMISTRY AND BIOL., vol. 20, 2013, pages 912 - 921",
                    "BAIRD ET AL., FRONTIERS IN ONCOLOGY, vol. 3, no. 1, 2013",
                    "T. W. GREENE: \"Protective Groups in Organic Synthesis\", 1991, JOHN WILEY & SONS",
                    "HARDMA, ET AL.: \"Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed.,\", 1996, pages: 11 - 16",
                    "HIGUCHI ET AL.: \"Prodrugs as Novel Delivery Systems\", vol. 14, 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS, article \"Bioreversible Carriers in Drug Design\""
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "025-530-111-636-673",
                    "100-440-307-757-089"
                ],
                "nplResolvedExternalIDs": [
                    "10.3410/f.718050843.793481348",
                    "10.1016/j.chembiol.2013.05.010",
                    "pmc4878021",
                    "23890009",
                    "10.1182/blood-2006-04-019398",
                    "17053051"
                ]
            },
            {
                "index": "58",
                "publicationKey": "US_10226434_B2",
                "lensId": "084-877-761-320-438",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10226434 B2",
                "publicationDate": "2019-03-12",
                "filingNumber": "US 201816025284 A",
                "filingDate": "2018-07-02",
                "priorityFilingKeysActive": [
                    "US 201562109667 P 20150130",
                    "US 201562195968 P 20150723"
                ],
                "earliestPriorityDate": "2015-01-30",
                "title": "Design, Synthesis And Methods Of Use Of Acyclic Fleximer Nucleoside Analogues Having Anti-coronavirus Activity",
                "applicants": [
                    "UNIV MARYLAND",
                    "KATHOLIEKE UNIV LEUVEN/LIEDEN UNIV MEDICAL CENTER RC LEIDEN"
                ],
                "inventors": [
                    "RADTKE KATHERINE L",
                    "PETERS HANNAH",
                    "NEYTS JOHAN",
                    "JOCHMANS DIRK",
                    "SNIJDER ERIC J"
                ],
                "owners": [],
                "url": "https://lens.org/084-877-761-320-438",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06",
                    "A61K2300/00",
                    "C07D403/04",
                    "Y02P20/582"
                ],
                "ipcrClassifications": [
                    "C07D403/04",
                    "A61K31/08",
                    "A61K31/4178",
                    "A61K31/506",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 38,
                "nplCitations": [
                    "Chemical Abstracts Registry No. 550-33-4, Nov. 16, 1984.",
                    "Chemical Abstracts Registry No. 19186-33-5, Nov. 16, 1984.",
                    "In Global alert and response. Middle East Respiratory syndrome coronavirus (MERS-CoV); World Health Organization: 2015; vol. 2014.",
                    "In Zovirax Prescribing Information; U.S. Food and Drug Administration: 2003; NDA 18-603/5-027.",
                    "Al-Hazmi, A. Challenges presented by MERS corona virus, and SARS corona virus to global health, Saudi Journal of Biological Sciences, 23 (2016), pp. 507-511.",
                    "Al-Tawfiq, J.A. et al. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study, Int. J. Infect. Dis., 20 (2014), pp. 42-46.",
                    "Boncel, A. et al. Novel 5-(N-Alkylaminouracil) Acyclic Nucleosides, Synthesis-Stuttgart (2011), pp. 603-610.",
                    "Chen, F. et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds, J. Clin. Virol., 31 (2004), pp. 69-75.",
                    "De Wilde, A.H. et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment, J. Gen. Virol., 94 (2013), pp. 1749-1760.",
                    "De Wilde, A.H. et al. Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture, Antimicrob. Agents Chemother, 58 (2014), pp. 4875-4884.",
                    "Falzarano, D. et al. Treatment with interferon-alpha 2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques Nat. Med., 19 (2013), pp. 1313-1317.",
                    "Fehr, A.R. et al. Coronaviruses: An Overview of Their Replication and Pathogensis, Methods Mol. Biol. 1282 (2015) pp. 1-23.",
                    "Fouchier, R. A. et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A 101 (2004), pp. 6212-6216.",
                    "Furman, P.A. et al. Acyclovir Triphosphate is a Suicide Inactivator of the Herpes-Simplex Virus DNA Polymerase, J. Biol. Chem., 259 (1984), pp. 9575-9579.",
                    "Grant, R. et al. Grant & Hackh's Chemical Dictionary, 1987 (5th ed.) New York, NY; McGraw-Hill, p. 313.",
                    "Jochmans, D. et al. A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE. J Virol Methods 183 (2012), pp. 176-179.",
                    "Kuiken, T. et al. Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol, 164 (2004), pp. 1893-1900.",
                    "McGuigan, C. et al. Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus Bioorg. Med. Chem. Lett., 20 (2010), pp. 4850-4854.",
                    "McGuirt, P.V. et al. Acyclovir Inhibition of Viral DNA Chain Elongation in Herpes Simplex Virus-Infected Cells, Am. J. Med., 73 (1982), pp. 67-71.",
                    "Mee, S.P. et al. Significant enhancement of the Stille reaction with a new combination of reagents-copper(I) iodide with cesium fluoride, Chem. Eur. J., 11 (2005), pp. 3294-3308.",
                    "Momattin, H. et al. Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)\u2014possible lessons from a systematic review of SARS-CoV therapy, Int. J. Infect. Dis., 17 (2013), pp. e792-e798.",
                    "Morgenstern, B. et al. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines, Biochem. Biophys. Res. Commun., 326 (2005), pp. 905-908.",
                    "Niedzwicki, J.G. et al. Structure-Activity Relationship of Ligands of Human Plasma Adenosine Deaminase2, Biochemical Pharmacology, 41 (1991) pp. 1615-1624.",
                    "Peiris, J.S.M. et al. Coronavirus as a possible cause of severe acute respiratory syndrome, Lancet, 361 (2003), pp. 1319-1325.",
                    "Peters, H.L. Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronaviurs activity, Bioorganic & Medical Chemistry Letters, 25 (2015) pp. 2923-2926.",
                    "Pyrc, K. et al. Identification of new human coronaviruses, Expert Rev. Anti-infect. Ther., 5 (2007), pp. 245-253.",
                    "Quirk, S. et al. Substrate discrimination by the human GTP fucose pyrophosphorylase, Biochemistry, 44 (2005), pp. 10854-10863.",
                    "Quirk, S. et al. Identification of catalytic amino acids in the human GTP fucose pyrophosphorylase active site, Biochemistry, 44 (2005), pp. 13172-13178.",
                    "Salim, S. Molecular chameleons: design and synthesis of a second series of flexible nucleosides, Doctoral dissertation, Georgia Institute of Technology, 2004, pp. 1-149.",
                    "Schinazi, R. Synthesis of 5-(Dihydroxyboryl)-2\u2032 deoxyuridine and Related Boron-Containing Pyrimidines, J. Org. Chem., 50 (1985), pp. 841-847.",
                    "Seley, K.L. et al. \u201cFleximers\u201d. Design and Synthesis of Two Novel Split Nucleosides, Org. Lett., 3 (2001), p. 3209-3210.",
                    "Seley, K.L. et al. \u201cFleximers\u201d. Design and Synthesis of a New Class of Novel Shape-Modified Nucleosies, Org. Chem., 67 (2002), p. 3365.",
                    "Seley, K. L. et al. Unexpected inhibition of S-adenosyl-L-homocysteine hydrolase by a guanosine nucleoside, Bioorg. Med. Chem. Lett., 13, (2003) pp. 1985-1988.",
                    "Seley, K. L. et al. \u201cMolecular chameleons\u201d. Design and synthesis of C-4-substituted imidazole fleximers, Org. Lett., 7 (2005), pp. 63-66.",
                    "Smith, E.C. et al. Coronavirus Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics, PLoS Pathog., 9 (2013), p. e1003565, 1-11.",
                    "Tan, E.L. et al. Inhibition of SARS Coronavirus Infection in Vitro with Clinically Approved Antiviral Drugs, Emerg. Infect. Dis., 10 (2004), pp. 581-586.",
                    "Vanpouille, C. et al. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2, J. Infect. Dis., 201 (2010), pp. 635-643.",
                    "Wauchope, O.R. et al. Synthetic Routes to a Series of Proximal and Distal 2\u2032-Deoxy Fleximers, Synthesis, 44 (2012), pp. 3496-3504."
                ],
                "nplResolvedCount": 35,
                "nplResolvedLensIDs": [
                    "057-617-477-665-56X",
                    "032-735-667-143-965",
                    "055-817-993-936-104",
                    "074-919-683-245-507",
                    "059-550-034-399-273",
                    "099-339-512-037-70X",
                    "043-175-443-728-67X",
                    "007-805-109-951-284",
                    "074-960-744-959-701",
                    "018-702-914-707-986",
                    "073-663-856-907-01X",
                    "057-080-756-583-519",
                    "062-192-092-753-972",
                    "016-754-916-865-234",
                    "094-485-484-823-984",
                    "054-117-964-555-982",
                    "017-883-043-691-040",
                    "052-650-110-852-468",
                    "009-403-958-653-100",
                    "002-808-749-577-966",
                    "020-090-218-931-826",
                    "025-992-623-190-843",
                    "108-229-899-337-383",
                    "081-307-021-537-929",
                    "084-893-855-384-248",
                    "102-808-548-863-662",
                    "071-349-856-440-802",
                    "002-163-468-775-047",
                    "080-897-630-292-177",
                    "185-700-349-724-543",
                    "127-574-272-971-002",
                    "062-634-123-022-634",
                    "035-834-171-631-191",
                    "017-689-034-509-674",
                    "129-401-973-660-415"
                ],
                "nplResolvedExternalIDs": [
                    "15161626",
                    "27298584",
                    "pmc4136071",
                    "pmc395948",
                    "10.1038/nm.3362",
                    "6285735",
                    "10.3201/eid1004.030458",
                    "16185085",
                    "pmc3323075",
                    "10.1016/j.bmcl.2015.05.039",
                    "10.1016/j.jviromet.2012.04.011",
                    "20637609",
                    "10.1016/s0002-9440(10)63750-9",
                    "24406736",
                    "10.1002/chem.200401162",
                    "pmc1615765",
                    "23993766",
                    "pmc4093902",
                    "10.1055/s-0032-1316791",
                    "10.1021/ol047895v",
                    "10.1021/bi051288d",
                    "24841269",
                    "10.1016/j.sjbs.2016.02.019",
                    "11574032",
                    "15073334",
                    "16086588",
                    "pmc4890194",
                    "10.1016/j.bbrc.2004.11.128",
                    "10.1021/jo00206a024",
                    "10.1016/0006-2952(91)90162-x",
                    "10.1016/s0960-894x(03)00331-7",
                    "10.1016/s1386-6532(04)00055-1",
                    "23966862",
                    "23620378",
                    "10.1128/aac.03011-14",
                    "15200845",
                    "26048809",
                    "10.1073/pnas.0400762101",
                    "10.1055/s-0030-1258397",
                    "10.1371/journal.ppat.1003565",
                    "10.1016/s0140-6736(03)13077-2",
                    "15624978",
                    "17402839",
                    "pmc4466200",
                    "pmc2811219",
                    "10.1016/j.bmcl.2010.06.094",
                    "15288617",
                    "15786503",
                    "24465059",
                    "10.1007/978-1-4939-2438-7_1",
                    "10.1586/14787210.5.2.245",
                    "12781179",
                    "10.1016/j.jcv.2004.03.003",
                    "24013700",
                    "22575574",
                    "6086640",
                    "pmc4369385",
                    "10.1021/bi0503605",
                    "10.1002/chin.201052201",
                    "2043151",
                    "12711465",
                    "10.1099/vir.0.052910-0",
                    "10.1016/0002-9343(82)90066-3",
                    "pmc3898542",
                    "pmc3744431",
                    "10.1016/j.ijid.2013.07.002",
                    "pmc3749523",
                    "12003548",
                    "25720466",
                    "10.1016/j.ijid.2013.12.003",
                    "10.1021/jo0255476",
                    "15607755",
                    "10.1086/650343",
                    "10.1021/ol0165443",
                    "20085496"
                ]
            },
            {
                "index": "59",
                "publicationKey": "WO_2019_027501_A1",
                "lensId": "013-969-913-582-81X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/027501 A1",
                "publicationDate": "2019-02-07",
                "filingNumber": "US 2018/0015352 W",
                "filingDate": "2018-01-26",
                "priorityFilingKeysActive": [
                    "US 201762539034 P 20170731"
                ],
                "earliestPriorityDate": "2017-07-31",
                "title": "Flex-nucleoside Analogues, Novel Therapeutics Against Filoviruses And Flaviviruses",
                "applicants": [
                    "UNIV MARYLAND"
                ],
                "inventors": [
                    "RADTKE KATHERINE"
                ],
                "owners": [],
                "url": "https://lens.org/013-969-913-582-81X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 1,
                "cpcClassifications": [
                    "A61K45/06",
                    "A61K31/506",
                    "A61K31/675",
                    "A61K31/683",
                    "A61P31/12"
                ],
                "ipcrClassifications": [
                    "A61K31/506",
                    "A61K31/66",
                    "A61P31/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "PETERS, H. L. ET AL.: \"Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity\", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 25, no. 15, 2015, pages 2923 - 2926, XP029160589",
                    "SELEY, K. L. ET AL.: \"Molecular chameleons ''. Design and synthesis of a second series of flexible nucleosides\", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 70, no. 5, 2005, pages 1612 - 1619, XP055572460",
                    "TAN, E. L. C. ET AL.: \"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs\", EMERGING INFECTIOUS DISEASES, vol. 10, no. 4, 2004, pages 581 - 586, XP055572465"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "032-735-667-143-965",
                    "016-532-239-841-388",
                    "129-401-973-660-415"
                ],
                "nplResolvedExternalIDs": [
                    "10.3201/eid1004.030458",
                    "pmc3323075",
                    "10.1021/jo048218h",
                    "10.1016/j.bmcl.2015.05.039",
                    "pmc4466200",
                    "15730279",
                    "15200845",
                    "26048809"
                ]
            },
            {
                "index": "60",
                "publicationKey": "CN_105079226_A",
                "lensId": "070-520-407-436-083",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 105079226 A",
                "publicationDate": "2015-11-25",
                "filingNumber": "CN 201410217365 A",
                "filingDate": "2014-05-22",
                "priorityFilingKeysActive": [
                    "CN 201410217365 A 20140522"
                ],
                "earliestPriorityDate": "2014-05-22",
                "title": "Application Of Traditional Chinese Medicine Composition To Preparation Of Drug For Resisting Middle East Respiratory Syndrome Corona-virus (mers-cov)",
                "applicants": [
                    "BEIJING YILING PHARMACEUTICAL CO LTD"
                ],
                "inventors": [
                    "JIA ZHENHUA",
                    "WEI CONG",
                    "CHANG LIPING",
                    "YUAN GUOQIANG",
                    "ZHAO JUNHONG"
                ],
                "owners": [],
                "url": "https://lens.org/070-520-407-436-083",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K36/78",
                    "A61K31/045",
                    "A61K33/06",
                    "A61P31/14",
                    "A61P37/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "\u65b9\u6b63\u8bc1\u5238: \"\u533b\u836f\u751f\u7269\u884c\u4e1a\uff1a\u65e0\u60e7MERS\u75c5\u6bd2\uff0c\u4e2d\u836f\u6709\u7528\u6b66\u4e4b\u5730\", \u300aHTTPS://NEW.QQ.COM/CMSN/20130715/20130715006136\u300b"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "61",
                "publicationKey": "KR_101593641_B1",
                "lensId": "183-729-413-237-202",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101593641 B1",
                "publicationDate": "2016-02-12",
                "filingNumber": "KR 20150081986 A",
                "filingDate": "2015-06-10",
                "priorityFilingKeysActive": [
                    "KR 20140160059 A 20141117"
                ],
                "earliestPriorityDate": "2014-11-17",
                "title": "Antibody Recognizing Nucleocapsid Of Middle East Respiratory Syndrome Coronavirus And Use Thereof",
                "applicants": [
                    "BIONOTE INC"
                ],
                "inventors": [
                    "CHO YOUNG SIK",
                    "HA GUN WOO",
                    "JUNG SEUNG KYO",
                    "HAN SU HO",
                    "JANG SUNG GU",
                    "KIM JUNG HO"
                ],
                "owners": [],
                "url": "https://lens.org/183-729-413-237-202",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 2,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "62",
                "publicationKey": "KR_101895228_B1",
                "lensId": "166-947-771-735-42X",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101895228 B1",
                "publicationDate": "2018-10-30",
                "filingNumber": "KR 20170106836 A",
                "filingDate": "2017-08-23",
                "priorityFilingKeysActive": [
                    "KR 20170106836 A 20170823"
                ],
                "earliestPriorityDate": "2017-08-23",
                "title": "Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Therof",
                "applicants": [
                    "KOREA CENTER FOR DISEASE CONTROL AND PREVENTION"
                ],
                "inventors": [
                    "LEE HAN SAEM",
                    "CHOI JANG HOON",
                    "KIM SUNG SOON",
                    "WANG LINGSHU",
                    "GRAHAM BARNEY S",
                    "MASCOLA JOHN R"
                ],
                "owners": [],
                "url": "https://lens.org/166-947-771-735-42X",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 2,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K47/68",
                    "A61K2039/505",
                    "C07K16/10",
                    "C07K2317/24",
                    "C07K2317/565",
                    "C07K2317/76",
                    "C07K2317/92",
                    "G01N33/56983",
                    "G01N2333/165"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/00",
                    "A61K47/68",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "63",
                "publicationKey": "KR_101913789_B1",
                "lensId": "048-502-411-551-010",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101913789 B1",
                "publicationDate": "2018-10-31",
                "filingNumber": "KR 20170035178 A",
                "filingDate": "2017-03-21",
                "priorityFilingKeysActive": [
                    "KR 20170035178 A 20170321"
                ],
                "earliestPriorityDate": "2017-03-21",
                "title": "Compound For The Treatment Of Diseases Caused By Corona Virus Infection",
                "applicants": [
                    "\ud55c\uad6d\ud654\ud559\uc5f0\uad6c\uc6d0"
                ],
                "inventors": [
                    "\uace0\uc724\uc601",
                    "\uae40\ubbf8\ud604",
                    "\uc2e0\uc9c4\uc218",
                    "\uad6c\uadfc\ubcf8",
                    "\uc774\uacc4\ud615",
                    "\uc784\ud76c\uc885",
                    "\uc774\uc0c1\ud638"
                ],
                "owners": [],
                "url": "https://lens.org/048-502-411-551-010",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "A23L33/10",
                    "A61K31/09",
                    "A61K31/136",
                    "C07C213/08",
                    "C07C217/80"
                ],
                "ipcrClassifications": [
                    "A61K31/136",
                    "A23L33/10",
                    "A61K31/09",
                    "C07C213/08",
                    "C07C217/80"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "64",
                "publicationKey": "KR_20180058206_A",
                "lensId": "108-936-006-778-417",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20180058206 A",
                "publicationDate": "2018-05-31",
                "filingNumber": "KR 20170156624 A",
                "filingDate": "2017-11-22",
                "priorityFilingKeysActive": [
                    "KR 20160156610 A 20161123"
                ],
                "earliestPriorityDate": "2016-11-23",
                "title": "S Immunogenic Middle East Respiratory Syndrome Coronavirus Mers-cov S Protein Composition And Producing Method Thereof",
                "applicants": [
                    "SK CHEMICALS CO LTD"
                ],
                "inventors": [
                    "KIM HAK",
                    "HAM DONG SOO",
                    "KWON TEAWOO",
                    "KIM CHANG SHIN",
                    "KIM HUN",
                    "SEO KI WEON"
                ],
                "owners": [],
                "url": "https://lens.org/108-936-006-778-417",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/39",
                    "C07K1/14",
                    "C07K1/18",
                    "C07K1/22",
                    "C07K14/005",
                    "C12N15/85",
                    "C12P21/00"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/215",
                    "A61K39/39",
                    "C07K1/14",
                    "C07K1/18",
                    "C07K1/22",
                    "C12N15/85",
                    "C12P21/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "65",
                "publicationKey": "WO_2016_080701_A1",
                "lensId": "064-626-000-820-815",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2016/080701 A1",
                "publicationDate": "2016-05-26",
                "filingNumber": "KR 2015012164 W",
                "filingDate": "2015-11-12",
                "priorityFilingKeysActive": [
                    "KR 20140160059 A 20141117"
                ],
                "earliestPriorityDate": "2014-11-17",
                "title": "Antibody Recognizing Nucleocapsid Of Middle East Respiratory Syndrome Coronavirus And Use Thereof",
                "applicants": [
                    "BIONOTE INC"
                ],
                "inventors": [
                    "CHO YOUNG SIK",
                    "HA GUN WOO",
                    "JUNG SEUNG KYO",
                    "HAN SU HO",
                    "JANG SUNG GU",
                    "KIM JUNG HO"
                ],
                "owners": [],
                "url": "https://lens.org/064-626-000-820-815",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 6,
                "cpcClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 5,
                "nplCitations": [
                    "AGNIHOTHRAM ET AL.: \"Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronavirus to develop vaccine platforms for the rapid response to emerging coronaviruses\", JOURNAL OF INFECTIOUS DISEASES, vol. 209, no. 7, 18 November 2013 (2013-11-18), pages 995 - 1006, XP055227760, DOI: doi:10.1093/infdis/jit609",
                    "AGNIHOTHRAM ET AL.: \"Platform strategies for rapid response against emerging coronaviruses: MERS-CoV serologic and antigenic relationships in vaccine design\", JOURNAL OF INFECTIOUS DISEASES ADVANCE ACCESS, vol. 18, no. 22, 18 November 2013 (2013-11-18), pages 1 - 21",
                    "SHARMIN ET AL.: \"A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design\", BMC BIOINFORMATICS, vol. 15, no. 161, 29 May 2014 (2014-05-29), pages 1 - 10",
                    "MA ET AL.: \"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines\", VACCINE, vol. 32, no. 18, 18 February 2014 (2014-02-18), pages 2100 - 2108, XP028838491, DOI: doi:10.1016/j.vaccine.2014.02.004",
                    "SONG ET AL.: \"Development and validation of a rapid immunochromatographic assay for detection of middle east respiratory syndrome coronavirus antigen in dromedary camels\", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 53, no. 4, April 2015 (2015-04-01), pages 1178 - 1182"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "071-500-361-340-702",
                    "078-081-741-547-36X",
                    "089-209-533-057-090",
                    "012-139-741-288-788"
                ],
                "nplResolvedExternalIDs": [
                    "24560617",
                    "24253287",
                    "25631809",
                    "24884408",
                    "10.1128/jcm.03096-14",
                    "pmc4194189",
                    "pmc4041900",
                    "pmc3952667",
                    "10.1016/j.vaccine.2014.02.004",
                    "pmc4365254",
                    "10.1093/infdis/jit609",
                    "10.1186/1471-2105-15-161"
                ]
            },
            {
                "index": "66",
                "publicationKey": "WO_2016_080591_A1",
                "lensId": "043-860-662-104-424",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2016/080591 A1",
                "publicationDate": "2016-05-26",
                "filingNumber": "KR 2015000278 W",
                "filingDate": "2015-01-12",
                "priorityFilingKeysActive": [
                    "KR 20140160059 A 20141117"
                ],
                "earliestPriorityDate": "2014-11-17",
                "title": "Antibody Recognizing Nucleocapsid Of Middle East Respiratory Syndrome Coronavirus, And Use Thereof",
                "applicants": [
                    "BIONOTE INC"
                ],
                "inventors": [
                    "CHO YOUNG SIK",
                    "HA GUN WOO",
                    "JUNG SEUNG KYO",
                    "HAN SU HO",
                    "JANG SUNG GU",
                    "KIM JUNG HO"
                ],
                "owners": [],
                "url": "https://lens.org/043-860-662-104-424",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 6,
                "cpcClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "YING, T. ET AL.: \"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.\", J. VIROL., vol. 88, no. 14, pages 7796 - 7805, XP009181617, DOI: doi:10.1128/JVI.00912-14",
                    "AGNIHOTHRAM, S. ET AL.: \"Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronavuruses.\", J. INFECT. DIS., vol. 209, no. 7, 18 November 2013 (2013-11-18) - 18 November 2013 (2013-11-18), pages 995 - 1006, XP055227760, DOI: doi:10.1093/infdis/jit609",
                    "SHARMIN, R. ET AL.: \"A highly conserved WDYPKCDRA epitope in the RNA directed RNA polymerase of human coronaviruses can be used as epitope-based universal vaccine design.\", BMC BIOINFORMATICS., vol. 15, 29 May 2014 (2014-05-29), XP021187264, DOI: doi:10.1186/1471-2105-15-161",
                    "CORMAN, V. M. ET AL.: \"Antibodies against MERS coronavirus in dromedary camels\", EMERG. INFECT. DIS ., vol. 20, no. 8, 1992, Kenya, pages 1319 - 1322"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "032-473-332-018-196",
                    "071-500-361-340-702",
                    "089-209-533-057-090",
                    "055-005-586-964-518"
                ],
                "nplResolvedExternalIDs": [
                    "24253287",
                    "24884408",
                    "25075637",
                    "pmc4097770",
                    "pmc4041900",
                    "pmc3952667",
                    "10.1128/jvi.00912-14",
                    "pmc4111164",
                    "24789777",
                    "10.3201/eid2008.140596",
                    "10.1093/infdis/jit609",
                    "10.1186/1471-2105-15-161"
                ]
            },
            {
                "index": "67",
                "publicationKey": "WO_2017_080500_A1",
                "lensId": "132-536-055-933-484",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/080500 A1",
                "publicationDate": "2017-05-18",
                "filingNumber": "CN 2016105441 W",
                "filingDate": "2016-11-11",
                "priorityFilingKeysActive": [
                    "CN 2015094425 W 20151112"
                ],
                "earliestPriorityDate": "2015-11-12",
                "title": "Methods And Systems For Disease Monitoring And Assessment",
                "applicants": [
                    "COYOTE BIOSCIENCE CO LTD"
                ],
                "inventors": [
                    "LI XIANG"
                ],
                "owners": [],
                "url": "https://lens.org/132-536-055-933-484",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 5,
                "familySize": 5,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61B5/7275",
                    "A61B5/1112",
                    "A61B5/117",
                    "A61B5/4842",
                    "A61B5/7435",
                    "A61B5/746",
                    "A61B5/7475",
                    "G06F16/29",
                    "G06F16/951",
                    "G16H50/80",
                    "Y02A90/22",
                    "Y02A90/24"
                ],
                "ipcrClassifications": [
                    "G06F19/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "68",
                "publicationKey": "WO_2018_097603_A2",
                "lensId": "053-967-403-035-180",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2018/097603 A2",
                "publicationDate": "2018-05-31",
                "filingNumber": "KR 2017013365 W",
                "filingDate": "2017-11-22",
                "priorityFilingKeysActive": [
                    "KR 20160156610 A 20161123"
                ],
                "earliestPriorityDate": "2016-11-23",
                "title": "Middle East Respiratory Syndrome Coronavirus S Protein Immunogenic Composition And Method For Preparing Same",
                "applicants": [
                    "SK CHEMICALS CO LTD"
                ],
                "inventors": [
                    "KIM HAK",
                    "HAM DONG SOO",
                    "KWON TEAWOO",
                    "KIM CHANG SHIN",
                    "KIM HUN",
                    "SEO KI-WEON"
                ],
                "owners": [],
                "url": "https://lens.org/053-967-403-035-180",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 8,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/39",
                    "C07K1/14",
                    "C07K1/18",
                    "C07K1/22",
                    "C07K14/005",
                    "C12N15/85",
                    "C12P21/00"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/215",
                    "A61K39/39",
                    "C07K1/14",
                    "C07K1/18",
                    "C07K1/22",
                    "C12N15/85",
                    "C12P21/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "69",
                "publicationKey": "WO_2018_097603_A3_20190124",
                "lensId": "197-014-970-142-803",
                "jurisdiction": "WO",
                "kindCode": "A3",
                "displayKey": "WO 2018/097603 A3",
                "publicationDate": "2019-01-24",
                "filingNumber": "KR 2017013365 W",
                "filingDate": "2017-11-22",
                "priorityFilingKeysActive": [
                    "KR 20160156610 A 20161123"
                ],
                "earliestPriorityDate": "2016-11-23",
                "title": "Middle East Respiratory Syndrome Coronavirus S Protein Immunogenic Composition And Method For Preparing Same",
                "applicants": [
                    "SK BIOSCIENCE CO LTD"
                ],
                "inventors": [
                    "KIM HAK",
                    "HAM DONG SOO",
                    "KWON TEAWOO",
                    "KIM CHANG SHIN",
                    "KIM HUN",
                    "SEO KI-WEON"
                ],
                "owners": [],
                "url": "https://lens.org/197-014-970-142-803",
                "docType": "Search report",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 8,
                "cpcClassifications": [
                    "A61K39/215",
                    "A61K39/39",
                    "C07K1/14",
                    "C07K1/18",
                    "C07K1/22",
                    "C07K14/005",
                    "C12N15/85",
                    "C12P21/00"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/215",
                    "A61K39/39",
                    "C07K1/14",
                    "C07K1/18",
                    "C07K1/22",
                    "C12N15/85",
                    "C12P21/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "70",
                "publicationKey": "WO_2018_174442_A1",
                "lensId": "072-002-487-008-726",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/174442 A1",
                "publicationDate": "2018-09-27",
                "filingNumber": "KR 2018002762 W",
                "filingDate": "2018-03-08",
                "priorityFilingKeysActive": [
                    "KR 20170035178 A 20170321"
                ],
                "earliestPriorityDate": "2017-03-21",
                "title": "Compound For Treating Diseases Caused By Coronavirus Infection",
                "applicants": [
                    "KOREA RES INST CHEMICAL TECH"
                ],
                "inventors": [
                    "GO YUN YOUNG",
                    "KIM MEE HYEIN",
                    "SHIN JIN SOO",
                    "KU KEUNBON",
                    "LEE GE HYEONG",
                    "LIM HEE-JONG",
                    "LEE SANG HO"
                ],
                "owners": [],
                "url": "https://lens.org/072-002-487-008-726",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "A23L33/10",
                    "A61K31/09",
                    "A61K31/136",
                    "C07C213/08",
                    "C07C217/80"
                ],
                "ipcrClassifications": [
                    "A61K31/136",
                    "A23L33/10",
                    "A61K31/09",
                    "C07C213/08",
                    "C07C217/80"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "ASENSIO, X. ET AL.: \"A Theoretical Study of the Competitive Homolytic/heterolytic Aniomesolytic Cleavages of C-O Alky! Ether Bonds\", JOURNAL OF ORGANIC CHEMISTRY, vol. 70, no. 2, 2005, pages 540 - 548, XP055558996"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "067-245-318-449-083"
                ],
                "nplResolvedExternalIDs": [
                    "10.1021/jo040208t",
                    "15651799"
                ]
            },
            {
                "index": "71",
                "publicationKey": "WO_2019_039891_A1",
                "lensId": "155-705-225-352-519",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/039891 A1",
                "publicationDate": "2019-02-28",
                "filingNumber": "KR 2018009754 W",
                "filingDate": "2018-08-23",
                "priorityFilingKeysActive": [
                    "KR 20170106836 A 20170823"
                ],
                "earliestPriorityDate": "2017-08-23",
                "title": "Monoclonal Antibody For Spike Protein Of Middle East Respiratory Syndrome Coronavirus, And Use Thereof",
                "applicants": [
                    "KOREA CENTER FOR DISEASE CONTROL AND PREVENTION"
                ],
                "inventors": [
                    "LEE HANSAEM",
                    "CHOI JANGHOON",
                    "KIM SUNGSOON",
                    "WANG LINGSHU",
                    "GRAHAM BARNEY",
                    "MASCOLA JOHN"
                ],
                "owners": [],
                "url": "https://lens.org/155-705-225-352-519",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 23,
                "cpcClassifications": [
                    "A61K47/68",
                    "A61K2039/505",
                    "C07K16/10",
                    "C07K2317/24",
                    "C07K2317/565",
                    "C07K2317/76",
                    "C07K2317/92",
                    "G01N33/56983",
                    "G01N2333/165"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/00",
                    "A61K47/68",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "JIANG, L. ET AL.: \"Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\", SCIENCE TRANSLATIONAL MEDICINE, vol. 6, no. 234, 30 April 2014 (2014-04-30), pages 1 - 10, XP009182042, DOI: doi:10.1126/scitranslmed.3008140",
                    "YING, T. ET AL.: \"Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies\", JOURNAL OF VIROLOGY, vol. 88, no. 14, July 2014 (2014-07-01), pages 7796 - 7805, XP009181617, DOI: doi:10.1128/JVI.00912-14",
                    "LEE, HANSAEM ET AL.: \"Trend in Human Therapeutic MERS-CoV Antibody Development\", PUBLIC HEALTH WEEKLY REPORT, vol. 9, no. 37, 8 September 2016 (2016-09-08), pages 727 - 732, XP055576995"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "055-005-586-964-518",
                    "043-148-481-331-661"
                ],
                "nplResolvedExternalIDs": [
                    "pmc4097770",
                    "10.1128/jvi.00912-14",
                    "24789777",
                    "10.1126/scitranslmed.3008140",
                    "24778414"
                ]
            },
            {
                "index": "72",
                "publicationKey": "WO_2019_067671_A1",
                "lensId": "098-388-076-635-213",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/067671 A1",
                "publicationDate": "2019-04-04",
                "filingNumber": "US 2018/0053044 W",
                "filingDate": "2018-09-27",
                "priorityFilingKeysActive": [
                    "US 201762564177 P 20170927"
                ],
                "earliestPriorityDate": "2017-09-27",
                "title": "Dna Antibody Constructs For Use Against Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "WEINER DAVID",
                    "SMITH TREVOR RF"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "SMITH TREVOR"
                ],
                "owners": [],
                "url": "https://lens.org/098-388-076-635-213",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 7,
                "cpcClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61K2039/53",
                    "C12N15/63"
                ],
                "ipcrClassifications": [
                    "A61K39/42",
                    "C07K16/10",
                    "C12N15/63"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "LI, Y ET AL.: \"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein\", CELL RESEARCH, vol. 25, no. 11, 22 September 2015 (2015-09-22), pages 1237 - 1249, XP055587421"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "008-237-414-214-209"
                ],
                "nplResolvedExternalIDs": [
                    "26391698",
                    "10.1038/cr.2015.113"
                ]
            },
            {
                "index": "73",
                "publicationKey": "US_2019_0194299_A1",
                "lensId": "185-078-440-857-008",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0194299 A1",
                "publicationDate": "2019-06-27",
                "filingNumber": "US 201816195116 A",
                "filingDate": "2018-11-19",
                "priorityFilingKeysActive": [
                    "US 201461984243 P 20140425"
                ],
                "earliestPriorityDate": "2014-04-25",
                "title": "Middle East Respiratory Syndrome Coronavirus Neutralizing Antibodies And Methods Of Use Thereof",
                "applicants": [
                    "DANA FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "TANG XIANCHUN"
                ],
                "owners": [
                    {
                        "name": "DANA-FARBER CANCER INSTITUTE INC",
                        "executionDate": "2017-03-13"
                    }
                ],
                "url": "https://lens.org/185-078-440-857-008",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 96,
                "cpcClassifications": [
                    "C07K16/10",
                    "A61K2039/507",
                    "C07K2317/13",
                    "C07K2317/21",
                    "C07K2317/34",
                    "C07K2317/52",
                    "C07K2317/56",
                    "C07K2317/622",
                    "C07K2317/76",
                    "C07K2317/92",
                    "C07K2319/40",
                    "C07K2319/43",
                    "C12N2740/16043",
                    "C12N2770/20022",
                    "C12N2810/609",
                    "G01N33/56983",
                    "G01N33/577",
                    "G01N2333/165",
                    "G01N2469/10"
                ],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569",
                    "G01N33/577"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "74",
                "publicationKey": "US_10143709_B2",
                "lensId": "037-143-268-651-498",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10143709 B2",
                "publicationDate": "2018-12-04",
                "filingNumber": "US 201514705895 A",
                "filingDate": "2015-05-06",
                "priorityFilingKeysActive": [
                    "US 201461989459 P 20140506",
                    "US 201462077824 P 20141110"
                ],
                "earliestPriorityDate": "2014-05-06",
                "title": "Use Of Asc And Asc-cm To Treat Ards, Sars, And Mers",
                "applicants": [
                    "INDIANA UNIV RESEARCH AND TECHNOLOGY CORP",
                    "UNIV INDIANA RES & TECH CORP",
                    "THE UNITED STATES OF AMERICA DEPARTMENT OF VETERAN AFFAIRS AS REPRESENTED BY THE TECH TRANSFER PROGR"
                ],
                "inventors": [
                    "MARCH KEITH",
                    "BOGATCHEVA NATALIA"
                ],
                "owners": [
                    {
                        "name": "INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION",
                        "executionDate": "2018-09-15"
                    },
                    {
                        "name": "UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS",
                        "executionDate": "2018-09-15"
                    },
                    {
                        "name": "U.S. DEPARTMENT OF VETERAN AFFAIRS AS REPRESENTED BY THE TECHNOLOGY TRANSFER PROGRAM",
                        "executionDate": "2018-09-15"
                    },
                    {
                        "name": "INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION",
                        "executionDate": "2015-09-03"
                    }
                ],
                "url": "https://lens.org/037-143-268-651-498",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [
                    "A61K35/28"
                ],
                "ipcrClassifications": [
                    "A61K35/28"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "dos Santos et al., Cell Therapy in Acute Lung Injury, Pulmao RJ 2011; 20(1): 64-68.",
                    "Ionescu et al., Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action, NCBI (2012).",
                    "Zheng et al., Treatment of acute respiratory distress syndrom with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study, Respiratory Research 2014, 15:39."
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "074-645-906-971-341",
                    "063-822-209-142-48X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1152/ajplung.00144.2011",
                    "pmc3532523",
                    "24708472",
                    "10.1186/1465-9921-15-39",
                    "pmc3994204",
                    "23023971"
                ]
            },
            {
                "index": "75",
                "publicationKey": "US_2018_0334480_A1",
                "lensId": "030-828-546-807-446",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0334480 A1",
                "publicationDate": "2018-11-22",
                "filingNumber": "US 201615760878 A",
                "filingDate": "2016-09-15",
                "priorityFilingKeysActive": [
                    "US 201562219926 P 20150917"
                ],
                "earliestPriorityDate": "2015-09-17",
                "title": "Coronaviruses Epitope-based Vaccines",
                "applicants": [
                    "UNIV RAMOT"
                ],
                "inventors": [
                    "GERSHONI JONATHAN"
                ],
                "owners": [
                    {
                        "name": "RAMOT AT TEL-AVIV UNIVERSITY LTD",
                        "executionDate": "2017-01-02"
                    }
                ],
                "url": "https://lens.org/030-828-546-807-446",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 110,
                "cpcClassifications": [
                    "C07K14/005",
                    "A61K39/12",
                    "A61K39/215",
                    "A61P31/14",
                    "C07K2319/735",
                    "C12N2770/20022",
                    "C12N2770/20034",
                    "C12N2770/20051"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/215",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "76",
                "publicationKey": "CN_105543248_A",
                "lensId": "156-421-934-679-516",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 105543248 A",
                "publicationDate": "2016-05-04",
                "filingNumber": "CN 201510109558 A",
                "filingDate": "2015-03-13",
                "priorityFilingKeysActive": [
                    "CN 201510109558 A 20150313"
                ],
                "earliestPriorityDate": "2015-03-13",
                "title": "Mers-cov Spike Protein Coding Gene Optimization-based Recombinant 5-type Adenovirus Vector Vaccine",
                "applicants": [
                    "INST FOR VIRAL DISEASE CONTROL AND PREVENTION CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION"
                ],
                "inventors": [
                    "TAN WENJIE",
                    "LU ZHUOZHUANG",
                    "GUO XIAOJUAN",
                    "LAN JIAMING",
                    "DENG YAO",
                    "CHEN HONG",
                    "HONG TAO"
                ],
                "owners": [],
                "url": "https://lens.org/156-421-934-679-516",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 1,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N15/50",
                    "A61K39/215",
                    "A61K48/00",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "EUN KIM\u7b49: \"Immunogenicity of an adenoviral-based Middle East RespiratorySyndrome coronavirus vaccine in BALB/c mice\", \u300aVACCINE\u300b",
                    "\u674e\u7433: \"\u4e2d\u4e1c\u547c\u5438\u7efc\u5408\u5f81\u51a0\u72b6\u75c5\u6bd2S1\u86cb\u767d\u7684\u91cd\u7ec4\u8868\u8fbe\u4e0e\u514d\u75ab\u5b66\u529f\u80fd\u7814\u7a76\", \u300a\u4e2d\u56fd\u4f18\u79c0\u7855\u58eb\u5b66\u4f4d\u8bba\u6587\u5168\u6587\u6570\u636e\u5e93 \u533b\u836f\u536b\u751f\u79d1\u6280\u8f91\u300b",
                    "\u738b\u5e73\u5174\u7b49: \"\u8868\u8fbe\u4e2d\u4e1c\u547c\u5438\u7efc\u5408\u5f81\u51a0\u72b6\u75c5\u6bd2S\u86cb\u767d\u7684\u91cd\u7ec4\u75d8\u82d7\u75c5\u6bd2\u7684\u6784\u5efa\u53ca\u514d\u75ab\u6548\u679c\u521d\u6b65\u8bc4\u4ef7\", \u300a\u751f\u7269\u6280\u672f\u901a\u8baf\u300b"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "77",
                "publicationKey": "EP_3134111_A1",
                "lensId": "085-653-719-022-641",
                "jurisdiction": "EP",
                "kindCode": "A1",
                "displayKey": "EP 3134111 A1",
                "publicationDate": "2017-03-01",
                "filingNumber": "EP 15720556 A",
                "filingDate": "2015-04-27",
                "priorityFilingKeysActive": [
                    "US 201461984243 P 20140425"
                ],
                "earliestPriorityDate": "2014-04-25",
                "title": "Middle East Respiratory Syndrome Coronavirus Neutralizing Antibodies And Methods Of Use Thereof",
                "applicants": [
                    "DANA-FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "TANG XIANCHUN"
                ],
                "owners": [],
                "url": "https://lens.org/085-653-719-022-641",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K16/10",
                    "A61K2039/507",
                    "C07K2317/13",
                    "C07K2317/21",
                    "C07K2317/34",
                    "C07K2317/52",
                    "C07K2317/56",
                    "C07K2317/622",
                    "C07K2317/76",
                    "C07K2317/92",
                    "C07K2319/40",
                    "C07K2319/43",
                    "C12N2740/16043",
                    "C12N2770/20022",
                    "C12N2810/609",
                    "G01N33/56983",
                    "G01N33/577",
                    "G01N2333/165",
                    "G01N2469/10"
                ],
                "ipcrClassifications": [
                    "A61K39/00",
                    "C07K14/165",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "78",
                "publicationKey": "WO_2015_164865_A1",
                "lensId": "068-789-082-389-767",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/164865 A1",
                "publicationDate": "2015-10-29",
                "filingNumber": "US 2015/0027785 W",
                "filingDate": "2015-04-27",
                "priorityFilingKeysActive": [
                    "US 201461984243 P 20140425"
                ],
                "earliestPriorityDate": "2014-04-25",
                "title": "Middle East Respiratory Syndrome Coronavirus Neutralizing Antibodies And Methods Of Use Thereof",
                "applicants": [
                    "DANA FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "TANG XIANCHUN"
                ],
                "owners": [],
                "url": "https://lens.org/068-789-082-389-767",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 94,
                "cpcClassifications": [
                    "C07K16/10",
                    "A61K2039/507",
                    "C07K2317/13",
                    "C07K2317/21",
                    "C07K2317/34",
                    "C07K2317/52",
                    "C07K2317/56",
                    "C07K2317/622",
                    "C07K2317/76",
                    "C07K2317/92",
                    "C07K2319/40",
                    "C07K2319/43",
                    "C12N2740/16043",
                    "C12N2770/20022",
                    "C12N2810/609",
                    "G01N33/56983",
                    "G01N33/577",
                    "G01N2333/165",
                    "G01N2469/10"
                ],
                "ipcrClassifications": [
                    "A61K39/00",
                    "C07K14/165",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 146,
                "nplCitations": [
                    "GUANGYU ZHAO ET AL: \"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV\", VIROLOGY JOURNAL, vol. 10, no. 1, 1 January 2013 (2013-01-01), pages 266 - 266, XP055129672, ISSN: 1743-422X, DOI: 10.1186/1742-4690-7-37",
                    "S. VAN BOHEEMEN ET AL: \"Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans\", MBIO, vol. 3, no. 6, 20 November 2012 (2012-11-20), pages e00473 - 12, XP055128733, ISSN: 2150-7511, DOI: 10.1128/mBio.00473-12",
                    "NATURE, vol. 361, 1993, pages 186 - 87",
                    "DAVIES ET AL., ANNUAL REV BIOCHEM, vol. 59, 1990, pages 439 - 473",
                    "HARLOW E; LANE D: \"Antibodies: A Laboratory Manual\", 1988, COLD SPRING HARBOR LABORATORY PRESS",
                    "D. WILKINSON: \"The Scientist\", vol. 14, 17 April 2000, THE SCIENTIST, INC., pages: 25 - 28",
                    "KOHLER; MILSTEIN, NATURE, vol. 256, 1975, pages 495",
                    "GODING: \"Monoclonal Antibodies: Principles and Practice\", 1986, ACADEMIC PRESS, pages: 59 - 103",
                    "KOZBOR, J. IMMUNOL., vol. 133, 1984, pages 3001",
                    "BRODEUR ET AL.: \"Monoclonal Antibody Production Techniques and Applications\", 1987, MARCEL DEKKER, INC., pages: 51 - 63",
                    "MUNSON; POLLARD, ANAL. BIOCHEM., vol. 107, 1980, pages 220",
                    "MORRISON, NATURE, vol. 368, 1994, pages 812 - 13",
                    "KOZBOR ET AL., IMMUNOL TODAY, vol. 4, 1983, pages 72",
                    "COLE ET AL.: \"MONOCLONAL ANTIBODIES AND CANCER THERAPY\", 1985, ALAN R. LISS, INC., pages: 77 - 96",
                    "COTE ET AL., PROC NATL ACAD SCI USA, vol. 80, 1983, pages 2026 - 2030",
                    "COLE ET AL.: \"M ANTIBODIES AND CANCER THERAPY\", 1985, ALAN R. LISS, INC., pages: 77 - 96",
                    "FISCHER ET AL., VACCINE, 2003, pages 21820 - 5",
                    "KO ET AL., CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY, vol. 332, 2009, pages 55 - 78",
                    "HOOGENBOOM; WINTER, J. MOL. BIOL., vol. 227, 1991, pages 381",
                    "MARKS ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581",
                    "MARKS ET AL., BIO/TECHNOLOGY, vol. 10, 1992, pages 779 - 783",
                    "LONBERG ET AL., NATURE, vol. 368, 1994, pages 856 - 859",
                    "FISHWILD ET AL., NATURE BIOTECHNOLOGY, vol. 14, 1996, pages 845 - 51",
                    "NEUBERGER, NATURE BIOTECHNOLOGY, vol. 14, 1996, pages 826",
                    "LONBERG; HUSZAR, INTERN. REV. IMMUNOL., vol. 13, 1995, pages 65 - 93",
                    "GELLER, A. 1. ET AL., J. NEUROCHEM, vol. 64, 1995, pages 487",
                    "LIM, F. ET AL.: \"DNA Cloning: Mammalian Systems\", 1995, OXFORD UNIV. PRESS",
                    "GELLER, A. I ET AL., PROC NATL. ACAD. SCI.: U.S.A., vol. 90, 1993, pages 7603",
                    "PROC NATL. ACAD. SCI USA, vol. 87, 1990, pages 1149",
                    "LEGAL LASALLE ET AL., SCIENCE, vol. 259, 1993, pages 988",
                    "DAVIDSON ET AL., NAT. GENET, vol. 3, 1993, pages 219",
                    "YANG ET AL., J. VIROL., vol. 69, 1995, pages 2004",
                    "KAPLITT, M. G. ET AL., NAT. GENET., vol. 8, 1994, pages 148",
                    "BOBO ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 2076 - 2080",
                    "MORRISON ET AL., AM. J. PHYSIOL., vol. 266, 1994, pages 292 - 305",
                    "CARON ET AL., J. EXP MED., vol. 176, 1992, pages 1191 - 1195",
                    "SHOPES, J. IMMUNOL., vol. 148, 1992, pages 2918 - 2922",
                    "STEVENSON ET AL., ANTI-CANCER DRUG DESIGN, vol. 3, 1989, pages 219 - 230",
                    "\"Contributions to Microbiology and Immunology\", 1989, CARGER PRESS, article \"Conjugate Vaccines\"",
                    "KILLEN; LINDSTROM, JOUR. IMMUN., vol. 133, 1984, pages 1335 - 2549",
                    "JANSEN ET AL., IMMUNOLOGICAL REVIEWS, vol. 62, 1982, pages 185 - 216",
                    "VITETTA ET AL., SCIENCE, vol. 238, 1987, pages 1098",
                    "RAMAKRISHNAN, S. ET AL., CANCER RES., vol. 44, 1984, pages 201 - 208",
                    "EPSTEIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 3688",
                    "HWANG ET AL., PROC. NATL ACAD. SCI. USA, vol. 77, 1980, pages 4030",
                    "MARTIN ET AL., J. BIOL. CHEM., vol. 257, 1982, pages 286 - 288",
                    "\"Remington: The Science And Practice Of Pharmacy\", 1995, MACK PUB. CO.",
                    "\"Drug Absorption Enhancement: Concepts, Possibilities, Limitations, And Trends\", 1994, HARWOOD ACADEMIC PUBLISHERS",
                    "\"Peptide And Protein Drug Delivery\", vol. 4, 1991, M. DEKKER",
                    "MARASCO ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 7889 - 7893",
                    "\"ELISA: Theory and Practice: Methods in Molecular Biology\", vol. 42, 1995, HUMAN PRESS",
                    "E. DIAMANDIS; T. CHRISTOPOULUS: \"Immunoassay\", 1996, ACADEMIC PRESS, INC.",
                    "P. TIJSSEN: \"Practice and Theory of Enzyme Immunoassays\", 1985, ELSEVIER SCIENCE",
                    "DEWITT ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 90, 1993, pages 6909",
                    "ERB ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 91, 1994, pages 11422",
                    "ZUCKERMANN ET AL., J. MED. CHEM., vol. 37, 1994, pages 2678",
                    "CHO ET AL., SCIENCE, vol. 261, 1993, pages 1303",
                    "CARRELL ET AL., ANGEW. CHEM. INT. ED. ENGL., vol. 33, 1994, pages 2059",
                    "CARELL ET AL., ANGEW. CHEM. INT. ED. ENGL., vol. 33, 1994, pages 2061",
                    "GALLOP ET AL., J. MED. CHEM., vol. 37, 1994, pages 1233",
                    "HOUGHTEN, BIOTECHNIQUES, vol. 13, 1992, pages 412 - 421",
                    "LAM, NATURE, vol. 354, 1991, pages 82 - 84",
                    "FODOR, NATURE, vol. 364, 1993, pages 555 - 556",
                    "PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 1865 - 1869",
                    "SCOTT; SMITH, SCIENCE, vol. 249, 1990, pages 386 - 390",
                    "DEVLIN, SCIENCE, vol. 249, 1990, pages 404 - 406",
                    "CWIRLA ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 87, 1990, pages 6378 - 6382",
                    "FELICI, J. MOL. BIOL., vol. 222, 1991, pages 301 - 310",
                    "KELLER ET AL., CLIN. MICROBIOL. REV., vol. 13, 2000, pages 602 - 14",
                    "CASADEVALL, NAT. BIOTECHNOL., vol. 20, 2002, pages 114",
                    "SHIBATA ET AL., NAT. MED., vol. 5, 1999, pages 204 - 10",
                    "IGARASHI ET AL., NAT. MED., vol. 5, 1999, pages 211 - 16",
                    "STEWARD ET AL., J. VIROL., vol. 69, 1995, pages 7668",
                    "GARRITY ET AL., J. IMMUNOL., vol. 159, 1997, pages 279",
                    "BURTON, NATL. REV. IMMUNOL., vol. 2, 2002, pages 706 - 13",
                    "PARREN ET AL., ADV. IMMUNOL., vol. 77, 2001, pages 195 - 262",
                    "ZANETTI, NATURE, vol. 355, 1992, pages 476 - 77",
                    "ZAGHOUANI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 92, 1995, pages 631 - 35",
                    "BONA ET AL., IMMUNOL. TODAY, vol. 19, 1998, pages 126 - 33",
                    "LANZA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 11683 - 87",
                    "LUNDE ET AL., BIOCHEM. SOC. TRANS., vol. 30, 2002, pages 500 - 6",
                    "YOU ET AL., CANCER RES., vol. 61, 2001, pages 3704 - 11",
                    "CASARES ET AL., VIRAL IMMUNOL., vol. 10, 1997, pages 129 - 36",
                    "GERLONI ET AL., NAT. BIOTECH., vol. 15, 1997, pages 876 - 81",
                    "GERLONI ET AL., DNA CELL BIOL., vol. 16, 1997, pages 611 - 25",
                    "CASARES ET AL., VIRAL. IMMUNOL., vol. 10, 1997, pages 129 - 36",
                    "ZAKI AM; VAN BOHEEMEN S; BESTEBROER TM; OSTERHAUS AD; FOUCHIER RA: \"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia\", N ENGL J MED, vol. 367, no. 19, 2012, pages 1814 - 1820",
                    "BREBAN R; RIOU J; FONTANET A: \"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk\", LANCET, vol. 382, no. 9893, 2013, pages 694 - 699",
                    "\"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom\", EURO SURVEILL, vol. 18, no. 11, February 2013 (2013-02-01), pages 20427",
                    "COTTEN M ET AL.: \"Spread, circulation, and evolution of the middle East respiratory syndrome coronavirus\", MBIO, vol. 5, no. 1, 2014, pages E01062 - 01013",
                    "LI W ET AL.: \"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2\", EMBO J, vol. 24, no. 8, 2005, pages 1634 - 1643",
                    "\"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China\", SCIENCE, vol. 303, no. 5664, 2004, pages 1666 - 1669",
                    "ANNAN A ET AL.: \"Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe\", EMERG INFECT DIS, vol. 19, no. 3, 2013, pages 456 - 459",
                    "ANTHONY SJ ET AL.: \"Coronaviruses in bats from Mexico\", J GEN VIROL, vol. 94, 2013, pages 1028 - 1038",
                    "WOO PC ET AL.: \"Molecular diversity of coronaviruses in bats\", VIROLOGY, vol. 351, no. 1, 2006, pages 180 - 187",
                    "MEMISH ZA ET AL.: \"Middle East respiratory syndrome coronavirus in bats, Saudi Arabia\", EMERG INFECT DIS, vol. 19, no. 11, 2013, pages 1819 - 1823",
                    "PERERA RA ET AL.: \"Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt\", EURO SURVEILL, vol. 18, no. 36, June 2013 (2013-06-01), pages 20574",
                    "REUSKEN CB ET AL.: \"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study\", LANCET INFECT DIS, vol. 13, no. 10, 2013, pages 859 - 866",
                    "HAAGMANS BL ET AL.: \"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation\", LANCET INFECT DIS, vol. 14, no. 2, 2014, pages 140 - 145",
                    "MEYER B ET AL.: \"Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013\", EMERG INFECT DIS, no. 4, 2014",
                    "ALAGAILI AN ET AL.: \"Middle East respiratory syndrome coronavirus infection in dromedary camels in saudi arabia\", MBIO, vol. 5, no. 2, 2014, pages E00884 - 00814",
                    "ECKERLE I ET AL.: \"Replicative Capacity of MERS Coronavirus in Livestock Cell Lines\", EMERG INFECT DIS, vol. 20, no. 2, 2014, pages 276 - 279",
                    "MULLER MA ET AL.: \"Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines\", MBIO, vol. 3, no. 6, 2012, pages E00515 - 00512",
                    "HOFMANN H ET AL.: \"S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients\", J VIROL, vol. 78, no. 12, 2004, pages 6134 - 6142",
                    "CHAN KH ET AL.: \"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests\", J INFECT, vol. 67, no. 2, 2013, pages 130 - 140",
                    "GIERER S ET AL.: \"The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies\", J VIROL, vol. 87, no. 10, 2013, pages 5502 - 5511",
                    "RAJ VS ET AL.: \"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC\", NATURE, vol. 495, no. 7440, 2013, pages 251 - 254",
                    "LU G ET AL.: \"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26\", NATURE, vol. 500, no. 7461, 2013, pages 227 - 231",
                    "WANG N ET AL.: \"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4\", CELL RES, vol. 23, no. 8, 2013, pages 986 - 993",
                    "FALZARANO D ET AL.: \"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques\", NAT MED, vol. 19, no. 10, 2013, pages 1313 - 1317",
                    "AGNIHOTHRAM S ET AL.: \"Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses\", J INFECT DIS, 2013",
                    "DU L ET AL.: \"A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines\", PLOS ONE, vol. 8, no. 12, 2013, pages E81587",
                    "SONG F ET AL.: \"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies\", J VIROL, vol. 87, no. 21, 2013, pages 11950 - 11954",
                    "MARASCO WA; SUI J: \"The growth and potential of human antiviral monoclonal antibody therapeutics\", NAT BIOTECHNOL, vol. 25, no. 12, 2007, pages 1421 - 1434",
                    "GOULD LH ET AL.: \"Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus\", J VIROL, vol. 79, no. 23, 2005, pages 14606 - 14613",
                    "KASHYAP AK ET AL.: \"Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies\", PROC NATLACAD SCI USA, vol. 105, no. 16, 2008, pages 5986 - 5991",
                    "TRAGGIAI E ET AL.: \"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus\", NAT MED, vol. 10, no. 8, 2004, pages 871 - 875",
                    "CORTI D ET AL.: \"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins\", SCIENCE, vol. 333, no. 6044, 2011, pages 850 - 856",
                    "THROSBY M ET AL.: \"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells\", PLOS ONE, vol. 3, no. 12, 2008, pages E3942",
                    "SUI J ET AL.: \"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses\", NAT STRUCT MOL BIOL, vol. 16, no. 3, 2009, pages 265 - 273",
                    "SUI J ET AL.: \"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association\", PROC NATL ACAD SCI USA, vol. 101, no. 8, 2004, pages 2536 - 2541",
                    "MOU H ET AL.: \"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies\", J VIROL, vol. 87, no. 16, 2013, pages 9379 - 9383",
                    "SUI J ET AL.: \"Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway\", PLOS PATHOG, vol. 4, no. 11, 2008, pages 1000197",
                    "WRAMMERT J ET AL.: \"Rapid cloning of high-affinity human monoclonal antibodies against influenza virus\", NATURE, vol. 453, no. 7195, 2008, pages 667 - 671",
                    "CORTI D; LANZAVECCHIA A: \"Broadly neutralizing antiviral antibodies\", ANNU REV IMMUNOL, 2013, pages 31705 - 742",
                    "WU X ET AL.: \"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing\", SCIENCE, vol. 333, no. 6049, 2011, pages 1593 - 1602",
                    "CHAN CH; HADLOCK KG; FOUNG SK; LEVY S: \"V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen\", BLOOD, vol. 97, no. 4, 2001, pages 1023 - 1026",
                    "HUANG CC ET AL.: \"Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120\", PROC NATL ACAD SCI USA, vol. 101, no. 9, 2004, pages 2706 - 2711",
                    "BOYD SD ET AL.: \"Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements\", J IMMUNOL, vol. 184, no. 12, 2010, pages 6986 - 6992",
                    "WATSON CT; BREDEN F: \"The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease\", GENES IMMUN, vol. 13, no. 5, 2012, pages 363 - 373",
                    "FARCI P ET AL.: \"B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure\", PROC NATL ACAD SCI U SA, vol. 107, no. 19, 2010, pages 8766 - 8771",
                    "ASSIRI A ET AL.: \"Hospital outbreak of Middle East respiratory syndrome coronavirus\", N ENGL J MED, vol. 369, no. 5, 2013, pages 407 - 416",
                    "MEMISH ZA; ZUMLA AI; AL-HAKEEM RF; AL-RABEEAH AA; STEPHENS GM: \"Family cluster of Middle East respiratory syndrome coronavirus infections\", N ENGL J MED, vol. 368, no. 26, 2013, pages 2487 - 2494",
                    "RANI M ET AL.: \"Increased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus\", J VIROL, vol. 86, no. 17, 2012, pages 9113 - 9121",
                    "ROCKX B ET AL.: \"Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus\", J INFECT DIS, vol. 201, no. 6, 2010, pages 946 - 955",
                    "COTTEN M ET AL.: \"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study\", LANCET, vol. 382, no. 9909, 2013, pages 1993 - 2002",
                    "BERMINGHAM A ET AL.: \"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East\", EURO SURVEILL, vol. 17, no. 40, September 2012 (2012-09-01), pages 20290",
                    "COTTEN M ET AL.: \"Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus\", EMERG INFECT DIS, vol. 19, no. 5, 2013, pages 736 - 742B",
                    "TREATMENT OF MERS-COV: DECISION SUPPORT TOOL, 2013",
                    "TER MEULEN J ET AL.: \"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants\", PLOS MED, vol. 3, no. 7, 2006, pages E237",
                    "BAKKER AB ET AL.: \"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity\", VACCINE, vol. 26, no. 47, 2008, pages 5922 - 5927",
                    "DIMITROV DS: \"Therapeutic antibodies, vaccines and antibodyomes\", MABS, vol. 2, no. 3, 2010, pages 347 - 356",
                    "TAUBE R ET AL.: \"Lentivirus display: stable expression of human antibodies on the surface of human cells and virus particles\", PLOS ONE, vol. 3, no. 9, 2008, pages E3181",
                    "MIRZABEKOV T; KONTOS H; FARZAN M; MARASCO W; SODROSKI J: \"Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5\", NATBIOTECHNOL, vol. 18, no. 6, 2000, pages 649 - 654",
                    "XU C; SUI J; TAO H; ZHU Q; MARASCO WA: \"Human anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity\", J IMMUNOL, vol. 179, no. 4, 2007, pages 2408 - 2418",
                    "ROCKX B ET AL.: \"Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge\", J VIROL, vol. 82, no. 7, 2008, pages 3220 - 3235"
                ],
                "nplResolvedCount": 124,
                "nplResolvedLensIDs": [
                    "039-798-912-970-378",
                    "070-669-133-204-810",
                    "073-446-761-167-644",
                    "040-805-283-891-682",
                    "115-440-304-483-056",
                    "020-404-483-834-41X",
                    "032-071-991-081-664",
                    "083-019-407-395-691",
                    "020-855-322-534-259",
                    "034-498-755-334-91X",
                    "102-366-465-825-112",
                    "048-564-471-521-204",
                    "045-797-239-878-426",
                    "089-588-647-216-099",
                    "018-275-105-296-01X",
                    "007-647-156-101-708",
                    "010-916-105-450-247",
                    "024-786-305-318-123",
                    "073-597-782-113-635",
                    "019-226-413-187-224",
                    "026-140-875-197-837",
                    "109-155-880-448-590",
                    "108-995-131-384-572",
                    "089-633-612-001-004",
                    "108-171-296-335-638",
                    "073-649-029-337-454",
                    "009-471-901-851-880",
                    "032-820-729-763-323",
                    "002-316-452-094-946",
                    "009-069-193-386-694",
                    "023-778-565-001-548",
                    "083-238-822-188-518",
                    "156-701-588-492-623",
                    "041-194-807-252-395",
                    "130-151-032-772-614",
                    "007-047-414-654-825",
                    "014-496-290-157-356",
                    "039-618-960-524-080",
                    "013-242-768-882-463",
                    "181-995-345-726-803",
                    "019-055-424-431-057",
                    "022-347-333-346-706",
                    "044-201-328-679-836",
                    "018-873-944-653-858",
                    "041-912-334-961-960",
                    "070-032-092-668-61X",
                    "079-060-001-665-743",
                    "060-459-542-715-007",
                    "042-144-218-091-088",
                    "018-702-914-707-986",
                    "000-260-465-562-523",
                    "108-496-730-562-485",
                    "038-613-711-274-229",
                    "062-825-278-526-054",
                    "028-854-336-119-298",
                    "044-851-918-540-636",
                    "052-083-752-569-893",
                    "082-670-193-611-235",
                    "126-216-458-383-35X",
                    "107-172-829-863-600",
                    "119-048-306-528-579",
                    "110-516-365-148-442",
                    "019-384-736-460-911",
                    "071-186-762-480-148",
                    "020-026-345-586-213",
                    "086-409-425-521-658",
                    "027-079-724-921-441",
                    "019-067-182-140-449",
                    "090-949-702-877-890",
                    "038-993-273-741-436",
                    "009-186-473-238-939",
                    "000-499-911-678-177",
                    "024-768-689-005-88X",
                    "062-630-820-896-11X",
                    "025-246-608-570-632",
                    "003-973-981-797-846",
                    "008-568-997-311-428",
                    "089-209-533-057-090",
                    "078-081-005-787-445",
                    "114-114-185-080-165",
                    "013-970-492-790-060",
                    "030-206-317-283-136",
                    "014-370-526-812-297",
                    "063-964-321-294-196",
                    "060-501-577-846-679",
                    "073-933-138-549-235",
                    "023-939-052-489-028",
                    "020-009-029-407-493",
                    "003-376-346-248-551",
                    "145-146-407-738-040",
                    "016-741-112-113-368",
                    "074-966-156-398-343",
                    "021-308-838-406-286",
                    "086-808-737-760-162",
                    "036-220-225-475-260",
                    "048-718-914-737-127",
                    "043-108-278-056-872",
                    "044-135-659-393-274",
                    "018-947-428-245-97X",
                    "041-161-768-559-376",
                    "018-429-338-700-465",
                    "048-284-820-855-67X",
                    "115-945-089-332-354",
                    "070-164-729-669-981",
                    "104-429-687-342-27X",
                    "078-897-295-334-074",
                    "073-841-796-580-64X",
                    "092-993-197-911-840",
                    "056-635-956-830-238",
                    "071-437-116-021-960",
                    "073-682-937-516-081",
                    "153-203-408-850-761",
                    "009-507-053-935-564",
                    "055-600-609-923-599",
                    "124-015-908-295-75X",
                    "023-671-383-084-282",
                    "016-772-377-304-76X",
                    "182-727-351-621-480",
                    "117-012-020-789-100",
                    "106-753-778-592-300",
                    "093-342-184-971-366",
                    "078-623-278-359-183",
                    "020-580-355-024-431",
                    "017-966-980-619-952"
                ],
                "nplResolvedExternalIDs": [
                    "10.1021/jm00035a001",
                    "pmc43312",
                    "10.1073/pnas.91.6.2076",
                    "pmc3731569",
                    "10.1128/mbio.00884-14",
                    "10.1016/s0167-5699(98)80011-x",
                    "6092464",
                    "pmc356985",
                    "24355866",
                    "pmc3648152",
                    "10.1126/science.1696028",
                    "10.1073/pnas.0308527100",
                    "7689747",
                    "10.1073/pnas.91.24.11422",
                    "10.1038/256495a0",
                    "6140077",
                    "pmc349762",
                    "10.1128/jvi.69.12.7668-7673.1995",
                    "18199635",
                    "pmc3647518",
                    "10.3410/f.1164711.626517",
                    "10.1007/978-3-540-70868-1_4",
                    "10.1126/science.1205669",
                    "8265609",
                    "23831647",
                    "10.1016/j.virol.2006.02.041",
                    "10.1056/nejmoa1303729",
                    "11023960",
                    "12196123",
                    "10.1038/76501",
                    "24253287",
                    "10.1371/journal.pone.0081587",
                    "15791205",
                    "18784843",
                    "pmc365685",
                    "6933450",
                    "pmc1287547",
                    "23170002",
                    "10.1038/5568",
                    "10.1038/cr.2013.92",
                    "15163706",
                    "pmc2692245",
                    "1696028",
                    "10.1089/dna.1997.16.611",
                    "16796401",
                    "10.1016/s0167-5699(97)01218-8",
                    "8387378",
                    "8102799",
                    "1720463",
                    "pmc1142572",
                    "14983044",
                    "9540272",
                    "9631008",
                    "8134351",
                    "10.1038/nbt1363",
                    "9631000",
                    "17675502",
                    "pmc3516815",
                    "10.1038/354082a0",
                    "pmc2527531",
                    "10.1128/jvi.69.4.2004-2015.1995",
                    "1402660",
                    "20400863",
                    "10.1056/nejmx130042",
                    "1944576",
                    "10.1016/0167-5699(83)90123-8",
                    "pmc2268459",
                    "10.1371/journal.pone.0003942",
                    "24206838",
                    "pmc54537",
                    "10.1128/cmr.13.4.602",
                    "24055451",
                    "8382374",
                    "pmc4029105",
                    "11159532",
                    "10.3201/eid2002.131182",
                    "10.1046/j.1471-4159.1995.64020487.x",
                    "10.1042/bst0300500",
                    "23232719",
                    "10.3109/08830189509061738",
                    "10.1016/0022-2836(91)90498-u",
                    "10.1128/jvi.01277-13",
                    "10.1182/blood.v97.4.1023",
                    "10.1016/j.vaccine.2008.08.050",
                    "10.1126/science.1207532",
                    "10.1038/nm.3362",
                    "23517868",
                    "10.1152/ajpregu.1994.266.1.r292",
                    "8356098",
                    "6572959",
                    "9174166",
                    "10.1128/jvi.00128-13",
                    "10.1016/s1473-3099(13)70164-6",
                    "10.1126/science.2143033",
                    "1370860",
                    "10.1038/ng1094-148",
                    "10.1073/pnas.0307140101",
                    "10.1038/364555a0",
                    "16647731",
                    "23978242",
                    "10.1146/annurev-immunol-032712-095916",
                    "7042538",
                    "22696652",
                    "pmc3647674",
                    "2930624",
                    "6254391",
                    "10.1038/nri891",
                    "19234466",
                    "23075143",
                    "10.1073/pnas.0801367105",
                    "8176700",
                    "10.1126/science.1092002",
                    "23718156",
                    "pmc393745",
                    "24570370",
                    "10.3410/f.1019175.217453",
                    "10.1056/nejmoa1211721",
                    "10.1016/s0065-2776(01)77018-6",
                    "10.1186/1743-422x-10-266",
                    "8304553",
                    "23622767",
                    "10.1128/jvi.02377-07",
                    "24013700",
                    "1404359",
                    "10.1128/mbio.01062-13",
                    "10.1086/651022",
                    "10.1038/nature12005",
                    "1172191",
                    "15247913",
                    "10.1146/annurev.biochem.59.1.439",
                    "10.1038/nbt0796-826a",
                    "10.3201/eid2004.131746",
                    "24655412",
                    "10.1073/pnas.77.7.4030",
                    "10.3201/eid1911.131172",
                    "10.1128/cmr.13.4.602-614.2000",
                    "23835475",
                    "10.1021/jm00043a007",
                    "19079604",
                    "pmc3898949",
                    "10.1038/nbt0202-114",
                    "pmc47248",
                    "10.1016/0022-2836(92)90894-p",
                    "7687751",
                    "10.1038/355476a0",
                    "pmc4281569",
                    "10.1016/s0140-6736(13)61887-5",
                    "10835604",
                    "10.4049/jimmunol.179.4.2408",
                    "7830040",
                    "20421498",
                    "10.4161/mabs.2.3.11779",
                    "24079378",
                    "16282460",
                    "10.1128/jvi.00233-12",
                    "pmc48048",
                    "pmc3837665",
                    "7842013",
                    "9200464",
                    "7494109",
                    "pmc47190",
                    "1573276",
                    "pmc2596486",
                    "9930869",
                    "pmc3952667",
                    "pmc3416138",
                    "10.1016/s1473-3099(13)70690-x",
                    "23693015",
                    "pmc2826557",
                    "23486063",
                    "12209139",
                    "20495067",
                    "10.2807/1560-7917.es2013.18.36.20574",
                    "10.1016/0003-2697(80)90515-1",
                    "9344335",
                    "14752165",
                    "1748994",
                    "8159246",
                    "23364191",
                    "10.1073/pnas.90.16.7603",
                    "8064796",
                    "10.1016/s0140-6736(13)61492-0",
                    "pmc188865",
                    "10.1016/0168-9525(95)90594-4",
                    "10.1099/vir.0.049759-0",
                    "11293117",
                    "23986586",
                    "10.2807/ese.18.11.20427-en",
                    "2143033",
                    "10.1038/nbt0796-845",
                    "pmc3754068",
                    "10.1016/0022-2836(91)90213-p",
                    "10.1111/j.1600-065x.1982.tb00394.x",
                    "10.1038/nature12328",
                    "pmc1483912",
                    "8159237",
                    "10.1038/368856a0",
                    "7972077",
                    "14981267",
                    "11325842",
                    "10.1073/pnas.90.24.11683",
                    "10.1073/pnas.1003854107",
                    "18989460",
                    "pmc3709589",
                    "pmc189707",
                    "pmc47044",
                    "18413603",
                    "23933067",
                    "pmc2515609",
                    "10.1128/jvi.79.23.14606-14613.2005",
                    "10.1038/nm1080",
                    "8394002",
                    "10.1371/journal.pmed.0030237",
                    "pmc3765664",
                    "3317828",
                    "10.3201/eid1903.121503",
                    "10.1128/mbio.00473-12",
                    "pmc2329690",
                    "23330954",
                    "11821846",
                    "10.1073/pnas.80.7.2026",
                    "2201029",
                    "10.1128/mbio.00515-12",
                    "10.3201/eid1905.130057",
                    "25291284",
                    "21835983",
                    "19401821",
                    "pmc4093902",
                    "10.1371/journal.ppat.1000197",
                    "9306403",
                    "10.1146/annurev.bi.59.070190.002255",
                    "10.1016/j.jinf.2013.03.015",
                    "22551722",
                    "pmc3807317",
                    "1368267",
                    "pmc3966379",
                    "pmc3852489",
                    "10.1038/ng0393-219",
                    "23785207",
                    "pmc2572002",
                    "10.1126/science.8382374",
                    "23468491",
                    "18449194",
                    "10.1128/mbio.01002-14",
                    "1382470",
                    "7494275",
                    "10.1038/gene.2012.12",
                    "pmc2581875",
                    "pmc45243",
                    "10.1128/jvi.01672-13",
                    "10.1089/vim.1997.10.129",
                    "10.1038/sj.emboj.7600640",
                    "18804136",
                    "10.1126/science.7689747",
                    "10.1038/nature06890",
                    "23782161",
                    "10.1056/nejmoa1306742",
                    "pmc416513",
                    "10.1073/pnas.90.16.7889",
                    "10.1126/science.3317828",
                    "10.1093/infdis/jit609",
                    "7884845",
                    "pmc3901466",
                    "23831141",
                    "7053372",
                    "10.1038/nbt0997-876",
                    "10.1073/pnas.90.15.6909",
                    "21798894",
                    "10.4049/jimmunol.1000445",
                    "23583636",
                    "24457147",
                    "10.1038/nbt0792-779",
                    "20144042",
                    "24549846",
                    "2197980",
                    "10.1128/jvi.78.12.6134-6142.2004",
                    "10.1073/pnas.87.16.6378",
                    "23078800",
                    "10.1038/368812a0",
                    "pmc2889296",
                    "10.1084/jem.176.4.1191",
                    "24324708",
                    "10.1371/journal.pone.0003181",
                    "pmc88952",
                    "10.1038/nsmb.1566",
                    "18066039"
                ]
            },
            {
                "index": "79",
                "publicationKey": "KR_101969696_B1",
                "lensId": "064-086-791-193-12X",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101969696 B1",
                "publicationDate": "2019-04-16",
                "filingNumber": "KR 20190008913 A",
                "filingDate": "2019-01-23",
                "priorityFilingKeysActive": [
                    "KR 20190008913 A 20190123"
                ],
                "earliestPriorityDate": "2019-01-23",
                "title": "S2 Monoclonal Antibodies Of Specifically Binding To Spike S2 Protein Of Mers-cov",
                "applicants": [
                    "KOREA CENTER FOR DISEASE CONTROL AND PREVENTION",
                    "OSONG MEDICAL INNOVATION FOUND"
                ],
                "inventors": [
                    "DAE YOUNG KIM",
                    "YOON JI KIM",
                    "KEUN WAN PARK",
                    "SUNG SOON KIM",
                    "JOO YEON LEE",
                    "HAN SAEM LEE",
                    "HYE MIN WOO",
                    "HYEMIN KO"
                ],
                "owners": [],
                "url": "https://lens.org/064-086-791-193-12X",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "Scientific Reports. 2015, 5:13133.",
                    "(\uc120\ud589\ubb38\ud5cc 4) Lingshu Wang et al. Nature communications (2015) 6:7712"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "000-071-082-467-040"
                ],
                "nplResolvedExternalIDs": [
                    "10.1038/srep13133",
                    "26281793",
                    "pmc4539535"
                ]
            },
            {
                "index": "80",
                "publicationKey": "KR_20190035542_A",
                "lensId": "076-650-783-800-92X",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20190035542 A",
                "publicationDate": "2019-04-03",
                "filingNumber": "KR 20180112836 A",
                "filingDate": "2018-09-20",
                "priorityFilingKeysActive": [
                    "KR 20170124394 A 20170926"
                ],
                "earliestPriorityDate": "2017-09-26",
                "title": "N- C- Nc Nc Fusion Protein Comprising N-terminus Domain Fragments And C-terminus Domain Fragments Of Mers-cov Nucleocapsid Protein And Kit For Diagnosing Infection Of Mers-cov Using The Same",
                "applicants": [
                    "KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY"
                ],
                "inventors": [
                    "JEONG DAE GWIN",
                    "YOON SUN WOO",
                    "KIM HYE KWON",
                    "SONG DAESUB",
                    "NOH JIYEONG",
                    "AHN MIN JU"
                ],
                "owners": [],
                "url": "https://lens.org/076-650-783-800-92X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 14,
                "cpcClassifications": [
                    "C07K14/005",
                    "C07K16/10",
                    "G01N33/569"
                ],
                "ipcrClassifications": [
                    "C07K14/005",
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "Azhar EI, Hashem AM, El-Kafrawy SA, Sohrab SS, Aburizaiza AS, Farraj SA, Hassan AM, Al-Saeed MS, Jamjoom GA, Madani TA. 2014. Detection of the middle east respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient. mBio 5(4):e01450-14. doi:10.1128/mBio.01450-14."
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "008-876-457-044-44X"
                ],
                "nplResolvedExternalIDs": [
                    "25053787",
                    "10.1128/mbio.01450-14"
                ]
            },
            {
                "index": "81",
                "publicationKey": "CN_109666070_A",
                "lensId": "048-096-020-877-047",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 109666070 A",
                "publicationDate": "2019-04-23",
                "filingNumber": "CN 201710951002 A",
                "filingDate": "2017-10-13",
                "priorityFilingKeysActive": [
                    "CN 201710951002 A 20171013"
                ],
                "earliestPriorityDate": "2017-10-13",
                "title": "Monoclonal Antibody Mers-4v2 And Encoding Gene And Application Thereof",
                "applicants": [
                    "UNIV TSINGHUA"
                ],
                "inventors": [
                    "ZHANG LINQI",
                    "WANG XINQUAN",
                    "JIANG LIWEI",
                    "ZUO TENG",
                    "SHI XUANLING",
                    "ZHOU PANPAN"
                ],
                "owners": [],
                "url": "https://lens.org/048-096-020-877-047",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61P11/00",
                    "A61P31/14",
                    "C12N15/13"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "82",
                "publicationKey": "US_2019_0085024_A1",
                "lensId": "149-867-692-101-537",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0085024 A1",
                "publicationDate": "2019-03-21",
                "filingNumber": "US 201816132794 A",
                "filingDate": "2018-09-17",
                "priorityFilingKeysActive": [
                    "US 201762559200 P 20170915"
                ],
                "earliestPriorityDate": "2017-09-15",
                "title": "Alpha-ketoamide Inhibitors Of Cysteine Proteases",
                "applicants": [
                    "PHELIX THERAPEUTICS"
                ],
                "inventors": [
                    "GREENBAUM DORON",
                    "ADDIS RUSS",
                    "GABOURY JANET",
                    "KULKAMI SWAPNIL",
                    "MEINHARDT NATALINE"
                ],
                "owners": [],
                "url": "https://lens.org/149-867-692-101-537",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [
                    "C07K5/06052",
                    "C07B2200/07",
                    "C07C237/22",
                    "C07C255/29",
                    "C07C255/60",
                    "C07C271/18",
                    "C07C271/22",
                    "C07C275/16",
                    "C07C275/24",
                    "C07C279/12",
                    "C07C279/14",
                    "C07C2601/02",
                    "C07C2601/08",
                    "C07D205/04",
                    "C07D209/20",
                    "C07D211/62",
                    "C07D213/56",
                    "C07D233/64",
                    "C07D403/12",
                    "C07K5/0202",
                    "C07K5/0205",
                    "C07K5/06165"
                ],
                "ipcrClassifications": [
                    "C07K5/062",
                    "C07C237/22",
                    "C07C271/18",
                    "C07C275/24",
                    "C07C279/12",
                    "C07D205/04",
                    "C07D209/20",
                    "C07D211/62",
                    "C07D213/56",
                    "C07D233/64",
                    "C07D403/12",
                    "C07K5/078"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "83",
                "publicationKey": "KR_20180052317_A",
                "lensId": "157-407-548-522-882",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20180052317 A",
                "publicationDate": "2018-05-18",
                "filingNumber": "KR 20160149494 A",
                "filingDate": "2016-11-10",
                "priorityFilingKeysActive": [
                    "KR 20160149494 A 20161110"
                ],
                "earliestPriorityDate": "2016-11-10",
                "title": "Primer Set For Detection Of Mers-coronavirus And Uses Thereof",
                "applicants": [
                    "NAT UNIV CHUNGBUK IND ACAD COOP FOUND"
                ],
                "inventors": [
                    "AHN JI YOUNG",
                    "SONG MIN SUK",
                    "BAEK YUN HEE",
                    "LEE SE HEE"
                ],
                "owners": [],
                "url": "https://lens.org/157-407-548-522-882",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [
                    "Y02A50/451"
                ],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12Q1/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "84",
                "publicationKey": "WO_2019_136824_A1",
                "lensId": "181-064-537-748-913",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/136824 A1",
                "publicationDate": "2019-07-18",
                "filingNumber": "CN 2018079474 W",
                "filingDate": "2018-03-19",
                "priorityFilingKeysActive": [
                    "CN 201810035685 A 20180115"
                ],
                "earliestPriorityDate": "2018-01-15",
                "title": "Mers-cov Infection Inhibiting Polypeptide",
                "applicants": [
                    "ACAD OF MILITARY MEDICAL SCIENCES"
                ],
                "inventors": [
                    "WANG CHAO",
                    "LIU KELIANG",
                    "ZHANG PEIYU",
                    "MENG GUANGPENG",
                    "LIANG GUODONG"
                ],
                "owners": [],
                "url": "https://lens.org/181-064-537-748-913",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 89,
                "cpcClassifications": [
                    "A61K38/00",
                    "A61K47/60",
                    "A61P11/00",
                    "A61P31/14",
                    "C07K14/001"
                ],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K38/16",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "85",
                "publicationKey": "KR_20180125141_A",
                "lensId": "103-564-545-346-318",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20180125141 A",
                "publicationDate": "2018-11-22",
                "filingNumber": "KR 20180138125 A",
                "filingDate": "2018-11-12",
                "priorityFilingKeysActive": [
                    "KR 20180138125 A 20181112"
                ],
                "earliestPriorityDate": "2018-11-12",
                "title": "Primer Set For Detection Of Mers-coronavirus And Uses Thereof",
                "applicants": [
                    "NAT UNIV CHUNGBUK IND ACAD COOP FOUND"
                ],
                "inventors": [
                    "AHN JI YOUNG",
                    "SONG MIN SUK",
                    "BAEK YUN HEE",
                    "LEE SE HEE"
                ],
                "owners": [],
                "url": "https://lens.org/103-564-545-346-318",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 12,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12Q1/6844"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "Shirato \ub4f1. Virology Journal Vol. 11, No. 139, \ud398\uc774\uc9c0 1-11 (2014.08.08.)*",
                    "GenBank Accession Number KU851863 (2016.06.27.)*"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "86",
                "publicationKey": "KR_20190044006_A",
                "lensId": "048-105-266-630-230",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20190044006 A",
                "publicationDate": "2019-04-29",
                "filingNumber": "KR 20180123551 A",
                "filingDate": "2018-10-17",
                "priorityFilingKeysActive": [
                    "KR 20170135754 A 20171019"
                ],
                "earliestPriorityDate": "2017-10-19",
                "title": "An Antibody Against Mers-cov And Method Of Determining Titration For Antibody To Mers-cov Using The Same",
                "applicants": [
                    "ATGEN CO LTD",
                    "UNIV YONSEI IACF"
                ],
                "inventors": [
                    "LEE JAE MYUN",
                    "LEE HYE JA",
                    "PARK PIL GU",
                    "SHIM DOO HEE",
                    "KIM NA RI",
                    "LEE JUNG EUN",
                    "PARK JI EUN",
                    "LEE HYO KYUNG",
                    "KIM HYE RIM"
                ],
                "owners": [],
                "url": "https://lens.org/048-105-266-630-230",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 18,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/005",
                    "C12N15/86",
                    "G01N33/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "VACCINE, VOL. 32 (2014) P. 6170_6176"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "120-822-127-937-671"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/j.vaccine.2014.08.086",
                    "25240756",
                    "pmc4194190"
                ]
            },
            {
                "index": "87",
                "publicationKey": "KR_102017217_B1",
                "lensId": "135-338-129-659-230",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 102017217 B1",
                "publicationDate": "2019-09-02",
                "filingNumber": "KR 20180123551 A",
                "filingDate": "2018-10-17",
                "priorityFilingKeysActive": [
                    "KR 20170135754 A 20171019"
                ],
                "earliestPriorityDate": "2017-10-19",
                "title": "An Antibody Against Mers-cov And Method Of Determining Titration For Antibody To Mers-cov Using The Same",
                "applicants": [
                    "\uc8fc\uc2dd\ud68c\uc0ac \uc5d4\ucf00\uc774\ub9e5\uc2a4",
                    "\uc5f0\uc138\ub300\ud559\uad50 \uc0b0\ud559\ud611\ub825\ub2e8"
                ],
                "inventors": [
                    "\uc774\uc7ac\uba74",
                    "\uc774\ud61c\uc790",
                    "\ubc15\ud544\uad6c",
                    "\ubc15\uc0c1\uc6b0",
                    "\uc2ec\ub450\ud76c",
                    "\uc774\uc815\uc740",
                    "\ubc15\uc9c0\uc740",
                    "\uae40\ud61c\ub9bc"
                ],
                "owners": [],
                "url": "https://lens.org/135-338-129-659-230",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 18,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/005",
                    "C12N15/86",
                    "G01N33/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "88",
                "publicationKey": "KR_102018079_B1",
                "lensId": "077-189-670-585-091",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 102018079 B1",
                "publicationDate": "2019-09-04",
                "filingNumber": "KR 20180138125 A",
                "filingDate": "2018-11-12",
                "priorityFilingKeysActive": [
                    "KR 20180138125 A 20181112"
                ],
                "earliestPriorityDate": "2018-11-12",
                "title": "Primer Set For Detection Of Mers-coronavirus And Uses Thereof",
                "applicants": [
                    "\ucda9\ubd81\ub300\ud559\uad50 \uc0b0\ud559\ud611\ub825\ub2e8"
                ],
                "inventors": [
                    "\uc548\uc9c0\uc601",
                    "\uc1a1\ubbfc\uc11d",
                    "\ubc31\uc724\ud76c",
                    "\uc774\uc138\ud76c"
                ],
                "owners": [],
                "url": "https://lens.org/077-189-670-585-091",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 12,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12Q1/6844"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "89",
                "publicationKey": "WO_2015_057942_A1",
                "lensId": "194-338-981-044-186",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/057942 A1",
                "publicationDate": "2015-04-23",
                "filingNumber": "US 2014/0060863 W",
                "filingDate": "2014-10-16",
                "priorityFilingKeysActive": [
                    "US 201361892750 P 20131018"
                ],
                "earliestPriorityDate": "2013-10-18",
                "title": "Human Monoclonal Antibodies Against The Middle East Respiratory Syndrome Coronavirus (mers-cov) And Engineered Bispecific Fusions With Inhibitory Peptides",
                "applicants": [
                    "US HEALTH",
                    "UNIV HONG KONG"
                ],
                "inventors": [
                    "DIMITROV DIMITER S",
                    "YING TIANLEI",
                    "JU TINA W",
                    "YUEN KWOK YUNG"
                ],
                "owners": [],
                "url": "https://lens.org/194-338-981-044-186",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 5,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 28,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "H. MOU ET AL: \"The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies\", JOURNAL OF VIROLOGY, vol. 87, no. 16, 15 August 2013 (2013-08-15), pages 9379 - 9383, XP055162922, ISSN: 0022-538X, DOI: 10.1128/JVI.01277-13",
                    "ZHU ZHONGYU ET AL: \"Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1\", VIROLOGICA SINICA, SPRINGER, DE, vol. 28, no. 2, 11 April 2013 (2013-04-11), pages 71 - 80, XP035335178, ISSN: 1674-0769, [retrieved on 20130411], DOI: 10.1007/S12250-013-3313-X",
                    "GUANGWEN LU ET AL: \"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26\", NATURE, vol. 500, no. 7461, 7 July 2013 (2013-07-07), pages 227 - 231, XP055162686, ISSN: 0028-0836, DOI: 10.1038/nature12328",
                    "YING TIANLEI ET AL: \"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies\", JOURNAL OF VIROLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 88, no. 14, 1 July 2014 (2014-07-01), pages 7796 - 7805, XP009181617, ISSN: 1098-5514, DOI: 10.1128/JVI.00912-14",
                    "JIANG LIWEI ET AL: \"Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\", SCIENCE TRANSLATIONAL MEDICINE, vol. 6, no. 234, April 2014 (2014-04-01), XP009182042",
                    "X.-C. TANG ET AL: \"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 111, no. 19, 13 May 2014 (2014-05-13), pages E2018 - E2026, XP055162782, ISSN: 0027-8424, DOI: 10.1073/pnas.1402074111"
                ],
                "nplResolvedCount": 6,
                "nplResolvedLensIDs": [
                    "055-005-586-964-518",
                    "145-146-407-738-040",
                    "015-835-148-354-287",
                    "043-148-481-331-661",
                    "009-507-053-935-564",
                    "079-080-784-051-77X"
                ],
                "nplResolvedExternalIDs": [
                    "24778221",
                    "10.1038/nature12328",
                    "23575729",
                    "23785207",
                    "24789777",
                    "23831647",
                    "10.1128/jvi.01277-13",
                    "10.1126/scitranslmed.3008140",
                    "10.1073/pnas.1402074111",
                    "pmc4097770",
                    "pmc4024880",
                    "10.1128/jvi.00912-14",
                    "24778414",
                    "10.1007/s12250-013-3313-x",
                    "pmc3754068"
                ]
            },
            {
                "index": "90",
                "publicationKey": "WO_2017_046801_A1",
                "lensId": "089-741-935-592-222",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/046801 A1",
                "publicationDate": "2017-03-23",
                "filingNumber": "IL 2016051029 W",
                "filingDate": "2016-09-15",
                "priorityFilingKeysActive": [
                    "US 201562219926 P 20150917"
                ],
                "earliestPriorityDate": "2015-09-17",
                "title": "Coronaviruses Epitope-based Vaccines",
                "applicants": [
                    "RAMOT AT TEL-AVIV UNIV LTD"
                ],
                "inventors": [
                    "GERSHONI JONATHAN"
                ],
                "owners": [],
                "url": "https://lens.org/089-741-935-592-222",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 110,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/16",
                    "A61K39/215",
                    "C07K14/165",
                    "C12N15/50",
                    "C40B30/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "FREUND, N. T. ET AL.: \"Reconstitution of the receptor-binding motif of the SARS coronavirus.\", PROTEIN ENGINEERING DESIGN AND SELECTION, vol. 28, no. 12, 20 October 2015 (2015-10-20), pages 567 - 575, XP055370532, Retrieved from the Internet <URL:http://peds.oxfordjournalsorg/content/28/12/567.short>",
                    "LIN, S. C. ET AL., BIOTECHNOLOGY PROGRESS, vol. 26, no. 6, 31 August 2010 (2010-08-31), pages 1733 - 1740, Retrieved from the Internet <URL:https://www.researchgate.net/profile/Suh-Chin_Wu/publication/46109219_Generating_Stable_Chinese_Hamster_Ovary_Cell_Clones_to_Produce_a_Truncated_SARS-CoV_Spike_Protein_for_Vaccine_Development/links/56c1200a08ae44da37fc207d.pdf>",
                    "DU, L. ET AL.: \"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS- CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines.\", PLOS ONE, vol. 8, no. 12, 4 December 2013 (2013-12-04), pages e81587, XP009182022, Retrieved from the Internet <URL:http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081587>",
                    "DU, L. ET AL.: \"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.\", VIROLOGY, vol. 393, no. 1, 15 August 2009 (2009-08-15), pages 144 - 150, XP026641695, Retrieved from the Internet <URL:http://www.sciencedirect.com/science/article/pii/S0042682209004516>"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "031-376-558-706-943",
                    "062-391-440-922-675",
                    "003-376-346-248-551",
                    "023-661-639-958-635"
                ],
                "nplResolvedExternalIDs": [
                    "10.1371/journal.pone.0081587",
                    "24324708",
                    "pmc3852489",
                    "10.1002/btpr.480",
                    "20809484",
                    "10.1016/j.virol.2009.07.018",
                    "10.1093/protein/gzv052",
                    "26487711",
                    "pmc2753736",
                    "19683779"
                ]
            },
            {
                "index": "91",
                "publicationKey": "WO_2019_078600_A1",
                "lensId": "152-045-622-905-850",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/078600 A1",
                "publicationDate": "2019-04-25",
                "filingNumber": "KR 2018012226 W",
                "filingDate": "2018-10-17",
                "priorityFilingKeysActive": [
                    "KR 20170135754 A 20171019"
                ],
                "earliestPriorityDate": "2017-10-19",
                "title": "Antibody For Middle East Respiratory Syndrome Coronavirus, And Method For Measuring Antibody Titer By Using Same",
                "applicants": [
                    "ATGEN CO LTD",
                    "UNIV YONSEI IACF"
                ],
                "inventors": [
                    "LEE JAE MYUN",
                    "LEE HYE JA",
                    "PARK PIL GU",
                    "SHIM DOO HEE",
                    "KIM NA RI",
                    "LEE JUNG EUN",
                    "PARK JI EUN",
                    "LEE HYO KYUNG",
                    "KIM HYE RIM"
                ],
                "owners": [],
                "url": "https://lens.org/152-045-622-905-850",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 9,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/005",
                    "C12N15/86",
                    "G01N33/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "LI, YAN: \"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein\", CELL RESEARCH, vol. 25, 2015, pages 1237 - 1249, XP055587421, DOI: doi:10.1038/cr.2015.113"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "008-237-414-214-209"
                ],
                "nplResolvedExternalIDs": [
                    "26391698",
                    "10.1038/cr.2015.113"
                ]
            },
            {
                "index": "92",
                "publicationKey": "US_2016_0264647_A1",
                "lensId": "179-979-259-103-78X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0264647 A1",
                "publicationDate": "2016-09-15",
                "filingNumber": "US 201415030165 A",
                "filingDate": "2014-10-16",
                "priorityFilingKeysActive": [
                    "US 201361892750 P 20131018"
                ],
                "earliestPriorityDate": "2013-10-18",
                "title": "Human Monoclonal Antibodies Against The Middle East Respiratory Syndrome Coronavirus (mers-cov) And Engineered Bispecific Fusions With Inhibitory Peptides",
                "applicants": [
                    "US HEALTH",
                    "UNIV HONG KONG"
                ],
                "inventors": [
                    "DIMITROV DIMITER S",
                    "YING TIANLEI",
                    "JU TINA W",
                    "YUEN KWOK YUNG"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                        "executionDate": "2018-07-09"
                    },
                    {
                        "name": "VERSITECH LIMITED",
                        "executionDate": "2014-10-17"
                    },
                    {
                        "name": "THE UNIVERSITY OF HONG KONG",
                        "executionDate": "2013-10-21"
                    }
                ],
                "url": "https://lens.org/179-979-259-103-78X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 28,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61K45/06",
                    "C07K14/005",
                    "C12N7/00",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "93",
                "publicationKey": "US_10421802_B2",
                "lensId": "100-694-947-051-113",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10421802 B2",
                "publicationDate": "2019-09-24",
                "filingNumber": "US 201415030165 A",
                "filingDate": "2014-10-16",
                "priorityFilingKeysActive": [
                    "US 201361892750 P 20131018"
                ],
                "earliestPriorityDate": "2013-10-18",
                "title": "Human Monoclonal Antibodies Against The Middle East Respiratory Syndrome Coronavirus (mers-cov) And Engineered Bispecific Fusions With Inhibitory Peptides",
                "applicants": [
                    "US HEALTH",
                    "VERSITECH LTD",
                    "VERITECH LTD"
                ],
                "inventors": [
                    "DIMITROV DIMITER S",
                    "YING TIANLEI",
                    "JU TINA W",
                    "YUEN KWOK YUNG"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                        "executionDate": "2018-07-09"
                    },
                    {
                        "name": "VERSITECH LIMITED",
                        "executionDate": "2014-10-17"
                    },
                    {
                        "name": "THE UNIVERSITY OF HONG KONG",
                        "executionDate": "2013-10-21"
                    }
                ],
                "url": "https://lens.org/100-694-947-051-113",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 28,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61K45/06",
                    "C07K14/005",
                    "C12N7/00",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 20,
                "nplCitations": [
                    "Paul. Fundamental Immunology, 3rd Edition, Raven Press, New York, Chapter 8, pp. 292-295, 1993 (Year: 1993).",
                    "MacCallum et al. Antibody-antigen Interactions: Contact Analysis and Binding Site Topography. Journal of Molecular Biology, 262: 732-745,1996 (Year: 1996).",
                    "Casset et al. A peptide mimetic of an anti-CD4 monoclonal antibody by rational design. Biochemical and Biophysical Research Communications, 307:198-205, 2003 (Year: 2003).",
                    "Vajdos et al. Comprehensive Functional Maps of the Antigenbinding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis. Journal of Molecular Biology, Jul. 5, 2002;320(2):415-28 (Year: 2002).",
                    "Brown et al. Tolerance to Single, but Not Multiple, Amino Acid Replacements in Antibody VH CDR2. Journal of Immunology. May 1996; 156(9):3285-91 (Year: 1996).",
                    "Rudikoff et al. Single amino acid substitution altering antigen-binding specificity. Proc. Natl. Acad. Sci. USA, 79(6):1979-1983, Mar. 1982 (Year: 1982).",
                    "Colman. Effects of amino acid sequence changes on antibody-antigen interactions. Research in Immunology, 145:33-36, 1994 (Year: 1994).",
                    "Gussow et al. Humanization of monoclonal antibodies.1991, Methods in Enzymology 203:99-121 (Year: 1991).",
                    "Falzarano et al., \u201cInterferon-\u03b12b and ribavirin treatment improves outcome in MERS-CoV-infected rhesus macaques,\u201d Nat. Med., 19 (10), 1313-1317 (2013) author manuscript.",
                    "International Preliminary Report on Patentability, Application No. PCT/US2014/060863, dated Apr. 19, 2016.",
                    "International Search Report, Application No. PCT/US2014/060863, dated Feb. 2, 2015.",
                    "Jiang et al., \u201cPotent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein,\u201d Sci. Transl. Med., 6 (234), 234ra59 (2014).",
                    "Lu et al., \u201cMolecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26,\u201d Nature, 500 (7461), 227-231 (2013).",
                    "Momattin et al., \u201cTherapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)\u2014possible lessons from a systematic review of SARS-CoV therapy,\u201d Int. J. Infect. Dis., 17 (10), e792-e798 (2013).",
                    "Mou et al., \u201cThe receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies,\u201d J. Virol., 87 (16), 9379-9383 (2013).",
                    "Tang et al., \u201cIdentification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution,\u201d Proc. Natl. Acad. Sci. U.S.A., 111 (19), E2018-E2026 (2014).",
                    "Written Opinion of the International Searching Authority, Application No. PCT/US2014/060863, dated Feb. 2, 2015.",
                    "Ying et al., \u201cExceptionally potent neutralizalion of Middle East respiratory syndrome coronavirus by human monoclonal antibodies,\u201d J. Virol., 88 (14), 7796-7805 (2014).",
                    "Zaki et al., \u201cIsolation of a novel coronavirus from a man with pneumonia in Saudi Arabia \u201d N. Engl. J. Med., 367 (19), 1814-1820 (2012).",
                    "Zhu et al., \u201cHuman monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1,\u201d Virol. Sin., 28 (2), 71-80 (2013)."
                ],
                "nplResolvedCount": 15,
                "nplResolvedLensIDs": [
                    "035-104-987-435-228",
                    "062-170-867-080-500",
                    "051-707-000-800-833",
                    "027-477-313-726-928",
                    "029-611-134-469-353",
                    "045-942-104-775-903",
                    "002-808-749-577-966",
                    "055-005-586-964-518",
                    "095-334-545-560-259",
                    "145-146-407-738-040",
                    "015-835-148-354-287",
                    "043-148-481-331-661",
                    "009-507-053-935-564",
                    "023-671-383-084-282",
                    "079-080-784-051-77X"
                ],
                "nplResolvedExternalIDs": [
                    "23075143",
                    "12079396",
                    "10.1128/jvi.01277-13",
                    "1762576",
                    "10.1073/pnas.1402074111",
                    "10.1056/nejmoa1211721",
                    "10.1006/jmbi.1996.0548",
                    "10.1016/s0022-2836(02)00264-4",
                    "23993766",
                    "pmc3754068",
                    "8876650",
                    "10.1016/0076-6879(91)03007-4",
                    "24778221",
                    "10.1073/pnas.79.6.1979",
                    "10.1038/nature12328",
                    "23575729",
                    "10.1016/s0923-2494(94)80039-1",
                    "23785207",
                    "10.1016/s0006-291x(03)01131-8",
                    "24789777",
                    "23831647",
                    "6804947",
                    "10.1126/scitranslmed.3008140",
                    "10.1016/j.ijid.2013.07.002",
                    "pmc346105",
                    "pmc4097770",
                    "pmc4024880",
                    "10.1128/jvi.00912-14",
                    "24778414",
                    "7516563",
                    "10.1007/s12250-013-3313-x",
                    "8617951",
                    "12850000"
                ]
            },
            {
                "index": "94",
                "publicationKey": "EP_3261665_A1",
                "lensId": "033-677-690-208-783",
                "jurisdiction": "EP",
                "kindCode": "A1",
                "displayKey": "EP 3261665 A1",
                "publicationDate": "2018-01-03",
                "filingNumber": "EP 16711059 A",
                "filingDate": "2016-02-24",
                "priorityFilingKeysActive": [
                    "US 201562120353 P 20150224"
                ],
                "earliestPriorityDate": "2015-02-24",
                "title": "Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use",
                "applicants": [
                    "US HEALTH"
                ],
                "inventors": [
                    "GRAHAM BARNEY",
                    "KONG WING-PUI",
                    "MODJARRAD KAYVON",
                    "WANG LINGSHU",
                    "SHI WEI",
                    "JOYCE MICHAEL GORDON",
                    "KANEKIYO MASARU",
                    "MASCOLA JOHN"
                ],
                "owners": [],
                "url": "https://lens.org/033-677-690-208-783",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "C07K14/165",
                    "C07K16/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "95",
                "publicationKey": "EP_3541419_A1",
                "lensId": "011-887-016-941-219",
                "jurisdiction": "EP",
                "kindCode": "A1",
                "displayKey": "EP 3541419 A1",
                "publicationDate": "2019-09-25",
                "filingNumber": "EP 17872582 A",
                "filingDate": "2017-11-17",
                "priorityFilingKeysActive": [
                    "US 201662424309 P 20161118"
                ],
                "earliestPriorityDate": "2016-11-18",
                "title": "Immunogenic Composition For Mers Coronavirus Infection",
                "applicants": [
                    "NEW YORK BLOOD CENTER INC"
                ],
                "inventors": [
                    "DU LANYING",
                    "LI FANG",
                    "JIANG SHIBO",
                    "ZHOU YUSEN"
                ],
                "owners": [],
                "url": "https://lens.org/011-887-016-941-219",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 3,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K47/64",
                    "C07K14/165",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "96",
                "publicationKey": "US_2015_0017207_A1",
                "lensId": "085-537-359-212-944",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0017207 A1",
                "publicationDate": "2015-01-15",
                "filingNumber": "US 201414327439 A",
                "filingDate": "2014-07-09",
                "priorityFilingKeysActive": [
                    "US 201361844022 P 20130709"
                ],
                "earliestPriorityDate": "2013-07-09",
                "title": "Methods And Compositions For Activation Of Innate Immune Responses Through Rig-i Like Receptor Signaling",
                "applicants": [
                    "UNIV WASHINGTON CT COMMERCIALI"
                ],
                "inventors": [
                    "GALE JR MICHAEL J",
                    "SCHNELL GRETJA",
                    "LOO YUEH-MING"
                ],
                "owners": [
                    {
                        "name": "UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION",
                        "executionDate": "2014-08-18"
                    }
                ],
                "url": "https://lens.org/085-537-359-212-944",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 99,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/39",
                    "A61K39/12",
                    "A61K39/155",
                    "A61K39/205",
                    "A61K39/29",
                    "C07H21/04",
                    "C12N7/00"
                ],
                "usClassifications": [
                    "424/211.1",
                    "536/23.1",
                    "424/281.1",
                    "424/218.1",
                    "424/228.1",
                    "424/224.1"
                ],
                "nplCitationCount": 2,
                "nplCitations": [
                    "Kishine et al., Biochemical and Biophysical Research Communications, 2002, 293(3):993-999.",
                    "GenBank Accession Number AB080299.1, submitted 2002."
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "054-259-000-032-929"
                ],
                "nplResolvedExternalIDs": [
                    "12051758",
                    "10.1016/s0006-291x(02)00342-x"
                ]
            },
            {
                "index": "97",
                "publicationKey": "US_2018_0104325_A1",
                "lensId": "037-247-957-520-06X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0104325 A1",
                "publicationDate": "2018-04-19",
                "filingNumber": "US 201715711934 A",
                "filingDate": "2017-09-21",
                "priorityFilingKeysActive": [
                    "US 201361844022 P 20130709"
                ],
                "earliestPriorityDate": "2013-07-09",
                "title": "Methods And Compositions For Activation Of Innate Immune Responses Through Rig-i Like Receptor Signaling",
                "applicants": [
                    "UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION"
                ],
                "inventors": [
                    "GALE JR MICHAEL J",
                    "SCHNELL GRETJA",
                    "LOO YUEH-MING"
                ],
                "owners": [],
                "url": "https://lens.org/037-247-957-520-06X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 99,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K31/00",
                    "A61K39/00",
                    "A61K39/39",
                    "A61K45/06",
                    "C07H21/04",
                    "C12N15/117"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "98",
                "publicationKey": "US_10434164_B2",
                "lensId": "144-590-078-499-820",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10434164 B2",
                "publicationDate": "2019-10-08",
                "filingNumber": "US 201715711934 A",
                "filingDate": "2017-09-21",
                "priorityFilingKeysActive": [
                    "US 201361844022 P 20130709"
                ],
                "earliestPriorityDate": "2013-07-09",
                "title": "Methods And Compositions For Activation Of Innate Immune Responses Through Rig-i Like Receptor Signaling",
                "applicants": [
                    "UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION"
                ],
                "inventors": [
                    "GALE JR MICHAEL J",
                    "SCHNELL GRETJA",
                    "LOO YUEH-MING"
                ],
                "owners": [],
                "url": "https://lens.org/144-590-078-499-820",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 99,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/39",
                    "A61K31/00",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K45/06",
                    "C07H21/04",
                    "C12N15/117"
                ],
                "usClassifications": [],
                "nplCitationCount": 62,
                "nplCitations": [
                    "John Walgren, Infection Ecology and Epidemiology, 2011, 1:6004, 7 pages. (Year: 2011).",
                    "Alter, M.J., \u201cEpidemiology of Hepatitis C Virus Infection,\u201d World Journal of Gastroenterology 13(17):2436-2441, May 2007.",
                    "Blight, K.J., \u201cHighly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication,\u201d Journal of Virology 76(24):13001-13014, Dec. 2002.",
                    "Cui, S., et al., \u201cThe C-Terminal Regulatory Domain Is the RNA 5\u2032-Triphosphate Sensor of RIG-I,\u201d Molecular Cell 29(2):169-179, Feb. 2008.",
                    "Fischer, M., and Ehlers, M., \u201cToll-Like Receptors in Autoimmunity,\u201d Annals of the New York Academy of Sciences 1143:21-34, Nov. 2008.",
                    "Foy, E., et al., \u201cRegulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease,\u201d Science 300(5622):1145-1148, May 2003.",
                    "Fredericksen B.L., et al., \u201cThe Host Response to West Nile Virus Infection Limits Viral Spread Through the Activation of the Interferon Regulatory Factor 3 Pathway,\u201d Journal of Virology 78(14):7737-7747, Jul. 2004.",
                    "Friebe, P., and R. Bartenschlager, \u201cGenetic Analysis of Sequences in the 3\u2032 Nontranslated Region of Hepatitis C Virus That Are Important for RNA Replication,\u201d Journal of Virology 76(11):5326-5338, Jun. 2002.",
                    "Friebe, P., et al. \u201cKissing-Loop Interaction in the 3\u2032 End of the Hepatitis C Virus Genome Essential for RNA Replication,\u201d Journal of Virology 79(1):380 392, Jan. 2005.",
                    "Gack, M., et al. \u201cTRIM25 Ring-Finger E3 Ubiquitin Ligase Is Essential for RIG-I-Mediated Antiviral Activity,\u201d Nature 146(7138):916-920, Apr. 2007.",
                    "Gale, Jr., M. and Foy, E.M., \u201cEvasion of Intracellular Host Defence by Hepatitis C Virus,\u201d Nature 436(7053):939-945, Aug. 2005.",
                    "Gale, Jr., M., \u201cEffector Genes of Interferon Action Against Hepatitis C Virus,\u201d Hepatology 37(5):975-978, May 2003.",
                    "Horner, S.M., and Gale, Jr., M., \u201cIntracellular Innate Immune Cascades and Interferon Defenses That Control Hepatitis C Virus,\u201d Journal of Interferon & Cytokine Research 29(9):489-498, Sep. 2009.",
                    "Horner, S.M., et al. \u201cMitochondrial-Associated Endoplasmic Reticulum Membranes (MAM) Form Innate Immune Synapses and Are Targeted by Hepatitis C Virus,\u201d Proceedings of the National Academy of Sciences USA 108(35):14590-14595, Aug. 2011.",
                    "Hornung, V., et al., \u201c5\u2032-Triphosphate RNA Is the Ligand for RIG-I,\u201d Science 314(5801):994-997, Nov. 2006.",
                    "Jiang, F., et al., \u201cStructural Basis of RNA Recognition and Activation by Innate Immune Receptor RIG-I,\u201d Nature 479(7373):423-427, Sep. 2011. (Author Manuscript provided, PMCID: PMC3430514, available in PMC Aug. 29, 2012, 15 pages.).",
                    "Kageyama, M., et al. \u201c55 Amino Acid Linker Between Helicase and Carboxyl Terminal Domains of RIG-I Functions as a Critical Repression Domain and Determines Inter-Domain Conformation,\u201d Biochemical and Biophysical Research communications 415(1):75-81, Nov. 2011.",
                    "Kato, H., et al. \u201cDifferential Roles of MDA5 and RIG-I Helicases in the Recognition of RNA Viruses,\u201d Nature 441(7089):101-105, May 2006.",
                    "Kawai, T., et al., \u201cIPS-1, an Adaptor Triggering RIG-I- and Mda5-Mediated Type I Interferon Induction,\u201d Nature Immunology 6(10):981-988, Oct. 2005.",
                    "Kawasaki, T., et al., \u201cRecognition of Nucleic Acids by Pattern-Recognition Receptors and Its Relevance in Autoimmunity,\u201d Immunological Reviews 243(1):61-73, Sep. 2011.",
                    "Keller, B.C., et al., \u201cResistance to Alpha/Beta Interferon Is a Determinant of West Nile Virus Replication Fitness and Virulence,\u201d Journal of Virology, 80(19):9424-9434, Oct. 2006.",
                    "Kowalinski, E., et al., \u201cStructural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA,\u201d Cell 147(2):423-435, Oct. 2011.",
                    "Krieg, A.M., and Vollmer, J., \u201cToll-Like Receptors 7,8 and 9: Linking Innate Immunity to Autoimmunity,\u201d Immunological Reviews 220(1):251-269, Dec. 2007.",
                    "Loo, Y.M., and Gale, Jr., M. \u201cImmune Signaling by RIG-I-Like Receptors,\u201d Immunity 34(5):680-692, May 2011.",
                    "Loo, Y.M., et al. \u201cViral and Therapeutic Control of IFN-Beta Promoter Stimulator 1 During Hepatitis C Virus Infection,\u201d Proceedings of the National Academy of Sciences USA 103(15):6001-6006, Apr. 2006.",
                    "Loo, Y.-M., et al., \u201cDistinct RIG-I and MDA5 Signaling by RNA Viruses in Innate Immunity,\u201d Journal of Virology 82(1):335-345, Jan. 2008.",
                    "Lu, C. et al. \u201cCrystal Structure of RIG-I C-Terminal Domain Bound to Blunt-Ended Double-Strand RNA Without 5\u2032 Triphosphate,\u201d Nucleic Acids Research 39(4):1565-1575, Mar. 2011.",
                    "Lu, C., et al., \u201cThe Structural Basis of 5\u2032 Triphosphate Double-Stranded RNA Recognition by RIG-I C-Terminal Domain,\u201d Structure 18(8):1032-1043, Aug. 2010.",
                    "Luo, D., et al., \u201cStructural Insights Into RNA Recognition by RIG-I,\u201d Cell 147(2):409-422, Oct. 2011.",
                    "Marques, J.T., et al., \u201cA Structural Basis for Discriminating Between Self and Nonself Double-Stranded RNAs in Mammalian Cells,\u201d Nature Biotechnology 24(5):559-565, May 2006.",
                    "Meylan, E., et al., \u201cCardif Is an Adaptor Protein in the RIG-I Antiviral Pathway and Is Targeted by Hepatitis C Virus,\u201d Nature 437(7062):1167-1172, Oct. 2005.",
                    "Milligan, J.F., et al., \u201cOligoribonucleotide Synthesis Using T7 RNA Polymerase and Synthetic DNA Templates,\u201d Nucleic Acids Research 15(21):8783-8798, Nov. 1987.",
                    "Myong, S., et al., \u201cCytosolic Viral Sensor RIG-I is a 5\u2032-Triphosphate-Dependent Translocase on Double-Stranded RNA,\u201d Science 323(5917):1070-1074, Feb. 2009.",
                    "Pawlotsky, J.M., \u201cHepatitis C Virus Genetic Variability: Pathogenic and Clinical Implications,\u201d Clinics in Liver Disease 7(1):45-66, Feb. 2003.",
                    "Pawlotsky, J.M., \u201cHepatitis C Virus Resistance to Antiviral Therapy,\u201d Hepatology 32(5):889-896, Nov. 2000.",
                    "Pawlotsky, J.M., et al. \u201cInterferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations,\u201d Journal of Virology 72(4):2795-2805, Apr. 1998.",
                    "Pichlmair, A., et al., \u201cRIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5\u2032-Phosphates,\u201d Science 314(5801):997-1001, Nov. 2006.",
                    "Saito, T., et al., \u201cInnate Immunity Induced by Composition-Dependent RIG-I Recognition of Hepatitis C Virus RNA,\u201d Nature 454(7203):523-527, Jul. 2008. (Author Manuscript provided, PMCID: PMC 2856441, available in PMC Apr. 19, 2010, 10 pages.).",
                    "Saito, T., et al., \u201cRegulation of Innate Antiviral Defenses Through a Shared Repressor Domain in RIG-I and LGP2,\u201d Proceedings of the National Academy of Sciences 104(2):582-587, Jan. 2007.",
                    "Schlee, M., et al., \u201cRecognition of 5\u2032 Triphosphate by RIG-I Helicase Requires Short Blunt Double-Stranded RNA as Contained in Panhandle of Negative-Strand Virus,\u201d Immunity 31(1):25-34, Jul. 2009.",
                    "Schmidt, A., et al. \u201c5\u2032-Triphosphate RNA Requires Base-Paired Structures to Activate Antiviral Signaling via RIG-I,\u201d Proceedings of the National Academy of Sciences USA 106(29):12067-12072, Jul. 2009.",
                    "Schnell, G., et al., \u201cUridine Composition of the Poly-U/UC Tract of HCV RNA Defines Non-Self Recognition by RIG-I,\u201d PLoS Pathogens 8(8):e1002839, Aug. 2012, 13 pages.",
                    "Seth, R.B., et al., \u201cIdentification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein That Activates NF-kappaB and IRF 3,\u201d Cell 122(5):669-682, Sep. 2005.",
                    "Shepard, C.W., et al., \u201cGlobal Epidemiology of Hepatitis C Virus Infection,\u201d The Lancet Infectious Diseases 5(9):558-567, Sep. 2005.",
                    "Stepinski, J., et al., \u201cSynthesis and Properties of mRNAs Containing the Novel \u201cAnti-Reverse\u201d Cap Analogs 7-methy (39-O-methyl)GpppG and 7-methyl(39-deoxy)GpppG,\u201d RNA 7(10):1486-1495, Oct. 2001.",
                    "Sumpter, R., Jr., et al., \u201cRegulating Intracellular Antiviral Defense and Permissiveness to Hepatitis C Virus RNA Replication Through a Cellular RNA Helicase, RIG-I,\u201d Journal of Virology 79(5)2689-2699, Mar. 2005.",
                    "Suthar, M.S., et al., \u201cInfectious Clones of Novel Lineage 1 and Lineage 2 West Nile Virus Strains WNV-TX02 and WNV-Madagascar,\u201d Journal of Virology 86(14):7704-7709, Jul. 2012.",
                    "Suthar, M.S., et al., \u201cIPS-1 Is Essential for the Control of West Nile Virus Infection and Immunity,\u201d PLoS Pathogens 6(2):e1000757, Feb. 2010, 15 pages.",
                    "Takahasi, K., et al., \u201cNonself RNA-Sensing Mechanism of RIG-I Helicase and Activation of Antiviral Immune Responses,\u201d Molecular Cell 29(4):428-440, Feb. 2008.",
                    "Third-Party Letter mailed Oct. 28, 2016, to Thomas S. Nowak, regarding U.S. Appl. No. 14/327,439, filed Jul. 9, 2014, 8 pages; Applicant makes no assertion as to the accuracy of any statement made in this letter.",
                    "Uzri, D., and L. Gehrke, \u201cNucleotide Sequences and Modifications That Determine RIG-I/RNA Binding and Signaling Activities,\u201d Journal of Virology 83(9):4174-4184, May 2009.",
                    "Wakita, T., et al., \u201cProduction of Infectious Hepatitis C Virus in Tissue Culture From a Cloned Viral Genome,\u201d Nature Medicine 11(7):791-796, Jul. 2005.",
                    "Wang, Y., et al., \u201cStructural and Functional Insights Into 5\u2032-ppp RNA Pattern Recognition by the Innate Immune Receptor RIG-I,\u201d Nature Structural & Molecular Biology 17(7):781-787, Jul. 2010.",
                    "Wasley, A. and Alter, M.J., \u201cEpidemiology of Hepatitis C: Geographic Differences and Temporal Trends,\u201d Seminars in Liver Disease 20(1):1-16, 2000.",
                    "Xu, L-G, et al., \u201cVISA Is an Adapter Protein Required for Virus-Triggered IFN Beta Signaling,\u201d Molecular Cell 19(6):727-740, Sep. 2005.",
                    "Yi, M., and Lemon, S.M., \u201c3\u2032 Nontranslated RNA Signals Required for Replication of Hepatitis C Virus RNA,\u201d Journal of Virology 77(6):3557-3568, Mar. 2003.",
                    "Yoneyama, M., et al., \u201cThe RNA Helicase RIG-I Has an Essential Function in Double-Stranded RNA-Induced Innate Antiviral Responses,\u201d Nature Immunology 5(7):730-737, Jul. 2004.",
                    "Yoneyama, M., et al., \u201cShared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity,\u201d Journal of Immunology 175(5):2851-2858, Sep. 2005.",
                    "You, S., and C.M. Rice, \u201c3\u2032 RNA Elements in Hepatitis C Virus Replication: Kissing Partners and Long Poly(U),\u201d Journal of Virology 82(1):184-195, Jan. 2008.",
                    "Zhong, J., et al., \u201cRobust Hepatitis C Virus Infection In Vitro,\u201d Proceedings of the National Academy of Sciences USA 102(26):9294-9299, Jun. 2005.",
                    "Gen Bank Accession No. AB080299.1, submitted 2002.",
                    "Kishine et al., Biochemical and Biophysical Research Communications, 2002, 293(3):993-999."
                ],
                "nplResolvedCount": 61,
                "nplResolvedLensIDs": [
                    "094-940-584-935-862",
                    "054-259-000-032-929",
                    "159-978-206-145-716",
                    "028-465-074-907-243",
                    "022-742-011-949-790",
                    "090-002-094-173-766",
                    "051-008-708-924-898",
                    "157-027-876-572-657",
                    "017-650-870-523-756",
                    "074-791-724-881-914",
                    "071-360-500-888-822",
                    "012-953-414-333-55X",
                    "083-137-546-638-486",
                    "099-848-692-017-591",
                    "075-723-253-766-54X",
                    "013-693-513-550-515",
                    "147-671-049-394-329",
                    "041-217-188-865-270",
                    "116-596-323-581-96X",
                    "004-290-278-642-459",
                    "042-005-703-236-455",
                    "012-845-344-032-533",
                    "002-781-828-763-102",
                    "071-266-956-601-630",
                    "035-743-665-706-68X",
                    "045-756-374-179-264",
                    "076-440-605-021-733",
                    "007-281-862-233-720",
                    "057-314-676-465-933",
                    "168-231-236-052-618",
                    "007-576-710-382-346",
                    "031-141-371-062-694",
                    "007-228-697-464-775",
                    "174-542-864-203-910",
                    "026-066-089-552-114",
                    "011-426-207-018-660",
                    "104-701-255-885-078",
                    "000-263-231-076-323",
                    "165-386-985-580-01X",
                    "019-248-670-317-795",
                    "162-088-904-628-196",
                    "085-626-242-968-128",
                    "093-587-294-573-161",
                    "003-994-329-970-09X",
                    "179-474-415-281-518",
                    "120-164-364-560-159",
                    "044-709-851-805-865",
                    "071-554-150-318-605",
                    "028-239-923-556-834",
                    "004-273-416-655-078",
                    "055-961-145-484-279",
                    "028-955-298-256-736",
                    "001-808-192-423-444",
                    "019-166-743-983-731",
                    "019-231-459-111-141",
                    "016-602-672-296-959",
                    "066-741-098-198-732",
                    "138-395-961-462-292",
                    "019-324-074-056-64X",
                    "121-508-880-333-350",
                    "038-648-738-384-807"
                ],
                "nplResolvedExternalIDs": [
                    "16107833",
                    "15220448",
                    "pmc1458687",
                    "19574455",
                    "pmc149512",
                    "10.1128/jvi.02449-08",
                    "10.1016/j.bbrc.2011.10.015",
                    "11050035",
                    "10.1073/pnas.1110133108",
                    "10.1038/nature10537",
                    "15596831",
                    "10.3410/f.1163082.623738",
                    "12702807",
                    "10.1093/nar/gkq974",
                    "21616437",
                    "10.1111/j.1600-065x.2007.00572.x",
                    "16585524",
                    "19224987",
                    "pmc3177755",
                    "10.1053/jhep.2000.19150",
                    "16625202",
                    "10.1128/jvi.79.1.380-392.2005",
                    "10.1038/nature05732",
                    "pmc2668486",
                    "10.1016/j.cell.2011.09.023",
                    "10.1016/j.immuni.2011.05.003",
                    "16122679",
                    "pmc109724",
                    "21884167",
                    "17979852",
                    "pmc306405",
                    "10.1016/j.cell.2005.08.012",
                    "16153868",
                    "10.1038/nsmb.1863",
                    "pmc1617238",
                    "12717377",
                    "22573862",
                    "pmc2919622",
                    "12610131",
                    "10.1128/jvi.76.24.13001-13014.2002",
                    "16116171",
                    "10.1016/s1473-3099(05)70216-4",
                    "pmc1166622",
                    "20581823",
                    "17552026",
                    "10.1038/nm1268",
                    "10.1073/pnas.0601523103",
                    "10.1016/j.cell.2011.09.039",
                    "19708811",
                    "10.1016/j.molcel.2007.10.032",
                    "pmc3416286",
                    "16177806",
                    "10.1128/jvi.77.6.3557-3568.2003",
                    "20961956",
                    "016177806",
                    "10.1089/jir.2009.0063",
                    "15951748",
                    "16127453",
                    "pmc2918402",
                    "15708988",
                    "pmc1370192",
                    "16648842",
                    "10.1073/pnas.0900971106",
                    "10.1128/jvi.72.4.2795-2805.1998",
                    "pmc2705279",
                    "10.3748/wjg.v13.i17.2436",
                    "pmc3567915",
                    "pmc3410852",
                    "18242112",
                    "10.1016/j.str.2010.05.007",
                    "pmc136668",
                    "10.1073/pnas.0503596102",
                    "21947008",
                    "10.1128/jvi.78.14.7737-7747.2004",
                    "pmc434084",
                    "17038589",
                    "10.1016/s0006-291x(02)00342-x",
                    "19576794",
                    "11991961",
                    "10.1128/jvi.76.11.5326-5338.2002",
                    "10.1128/jvi.01796-07",
                    "15939869",
                    "10.1038/nature04734",
                    "12438626",
                    "18243112",
                    "10895428",
                    "10.1371/journal.ppat.1000757",
                    "pmc3167523",
                    "10.4049/jimmunol.175.5.2851",
                    "pmc137049",
                    "19119185",
                    "17038590",
                    "pmc2224383",
                    "17190814",
                    "10.1073/pnas.0606699104",
                    "pmc3045611",
                    "pmc3222294",
                    "17942554",
                    "20637642",
                    "pmc2824854",
                    "22020100",
                    "10.3410/f.1024053.286706",
                    "10.1016/s1089-3261(02)00065-x",
                    "22912574",
                    "pmc2856441",
                    "10.1196/annals.1443.012",
                    "16125763",
                    "10.1038/nature04193",
                    "21844353",
                    "10.1038/nature04078",
                    "10.1038/nature07106",
                    "10.1126/science.1132505",
                    "10.1126/science.1082604",
                    "10.1053/jhep.2003.50201",
                    "pmc2224404",
                    "10.1371/journal.ppat.1002839",
                    "10.1038/ni1087",
                    "10.1055/s-2000-9506",
                    "10.1016/j.molcel.2005.08.014",
                    "19076342",
                    "10.1038/ni1243",
                    "12051758",
                    "10.1093/nar/15.21.8783",
                    "10.1016/j.molcel.2007.11.028",
                    "pmc1766428",
                    "10.1128/jvi.00401-12",
                    "pmc548482",
                    "12691458",
                    "9525599",
                    "18548002",
                    "10.1128/jvi.79.5.2689-2699.2005",
                    "10.1038/nbt1205",
                    "10.1111/j.1600-065x.2011.01048.x",
                    "10.1093/nar/gkq1331",
                    "3684574",
                    "10.1126/science.1168352",
                    "16973548",
                    "10.1016/j.immuni.2009.05.008",
                    "17942531",
                    "pmc3744876",
                    "10.1126/science.1132998",
                    "pmc2816698",
                    "10.1128/jvi.00768-06",
                    "22000018",
                    "pmc2956657",
                    "pmc538730",
                    "20140199",
                    "11680853",
                    "15208624",
                    "10.1128/jvi.01080-07",
                    "17392790",
                    "22000019",
                    "pmc4146761"
                ]
            },
            {
                "index": "99",
                "publicationKey": "CN_105273067_A",
                "lensId": "191-414-435-093-442",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 105273067 A",
                "publicationDate": "2016-01-27",
                "filingNumber": "CN 201510109559 A",
                "filingDate": "2015-03-13",
                "priorityFilingKeysActive": [
                    "CN 201510109559 A 20150313"
                ],
                "earliestPriorityDate": "2015-03-13",
                "title": "Recombinant 41-type Adenovirus Vector Vaccine Coding Mers-cov Spike Protein",
                "applicants": [
                    "INST VIRAL DISEASE CONTROL & PREVENTION CHINESE CT"
                ],
                "inventors": [
                    "TAN WENJIE",
                    "LU ZHUOZHUANG",
                    "GUO XIAOJUAN",
                    "LAN JIAMING",
                    "DENG YAO",
                    "CHEN HONG",
                    "HONG TAO"
                ],
                "owners": [],
                "url": "https://lens.org/191-414-435-093-442",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K39/215",
                    "A61K48/00",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "EUN KIM \u7b49: \"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice\", \u300aVACCINE\u300b",
                    "XIAOJUAN GUO \u7b49: \"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus\", \u300aIMMUNOLOGY\u300b"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "100",
                "publicationKey": "KR_20170140180_A",
                "lensId": "181-231-801-590-955",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20170140180 A",
                "publicationDate": "2017-12-20",
                "filingNumber": "KR 20177027105 A",
                "filingDate": "2016-02-24",
                "priorityFilingKeysActive": [
                    "US 201562120353 P 20150224"
                ],
                "earliestPriorityDate": "2015-02-24",
                "title": "Middle East Respiratory Syndrome Coronavirus Immunogens Antibodies And Their Use",
                "applicants": [
                    "US HEALTH"
                ],
                "inventors": [
                    "GRAHAM BARNEY",
                    "KONG WING PUI",
                    "MODJARRAD KAYVON",
                    "WANG LINGSHU",
                    "SHI WEI",
                    "JOYCE MICHAEL GORDON",
                    "KANEKIYO MASARU",
                    "MASCOLA JOHN"
                ],
                "owners": [],
                "url": "https://lens.org/181-231-801-590-955",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 308,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/00",
                    "A61K39/215",
                    "C07K14/165",
                    "C07K16/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "101",
                "publicationKey": "WO_2016_138160_A1",
                "lensId": "100-132-660-706-843",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2016/138160 A1",
                "publicationDate": "2016-09-01",
                "filingNumber": "US 2016/0019395 W",
                "filingDate": "2016-02-24",
                "priorityFilingKeysActive": [
                    "US 201562120353 P 20150224"
                ],
                "earliestPriorityDate": "2015-02-24",
                "title": "Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use",
                "applicants": [
                    "US HEALTH"
                ],
                "inventors": [
                    "GRAHAM BARNEY",
                    "KONG WING-PUI",
                    "MODJARRAD KAYVON",
                    "WANG LINGSHU",
                    "SHI WEI",
                    "JOYCE MICHAEL GORDON",
                    "KANEKIYO MASARU",
                    "MASCOLA JOHN"
                ],
                "owners": [],
                "url": "https://lens.org/100-132-660-706-843",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 8,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 154,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "C07K14/165",
                    "C07K16/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 246,
                "nplCitations": [
                    "ZHANG NARU ET AL: \"Current advancements and potential strategies in the development of MERS-CoV vaccines\", EXPERT REVIEW OF VACCINES, EXPERT REVIEWS LTD, GB, vol. 13, no. 6, 1 June 2014 (2014-06-01), pages 761 - 774, XP009181616, ISSN: 1744-8395, DOI: 10.1586/14760584.2014.912134",
                    "JIAMING LAN ET AL: \"Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen\", PLOS ONE, vol. 9, no. 11, 18 November 2014 (2014-11-18), pages e112602, XP055272022, DOI: 10.1371/journal.pone.0112602",
                    "COLEMAN CHRISTOPHER M ET AL: \"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice\", VACCINE, vol. 32, no. 26, 13 April 2014 (2014-04-13), pages 3169 - 3174, XP028654166, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2014.04.016",
                    "CHEN YI-NING ET AL: \"A DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge\", VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, ELSEVIER BV, AMSTERDAM, NL, vol. 152, no. 3, 1 February 2013 (2013-02-01), pages 359 - 369, XP028990055, ISSN: 0165-2427, DOI: 10.1016/J.VETIMM.2013.01.009",
                    "WOO P C Y ET AL: \"SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus\", VACCINE, ELSEVIER LTD, GB, vol. 23, no. 42, 10 October 2005 (2005-10-10), pages 4959 - 4968, XP027652024, ISSN: 0264-410X, [retrieved on 20051010]",
                    "JIANG SHIBO ET AL: \"Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome\", EXPERT REVIEW OF VACCINES, EXPERT REVIEWS LTD, GB, vol. 11, no. 12, 1 December 2012 (2012-12-01), pages 1405 - 1403, XP009189955, ISSN: 1744-8395, DOI: 10.1586/ERV.12.126",
                    "L. DU ET AL: \"A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein\", JOURNAL OF VIROLOGY, vol. 88, no. 12, 9 April 2014 (2014-04-09), pages 7045 - 7053, XP055162783, ISSN: 0022-538X, DOI: 10.1128/JVI.00433-14",
                    "YING TIANLEI ET AL: \"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies\", JOURNAL OF VIROLOGYUNITED STATES1 MAY 2016,, vol. 88, no. 14, 1 July 2014 (2014-07-01), pages 7796 - 7805, XP009181617, ISSN: 1098-5514, DOI: 10.1128/JVI.00912-14",
                    "JIANG LIWEI ET AL: \"Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\", SCIENCE TRANSLATIONAL MEDICINE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC, vol. 6, no. 234, 30 April 2014 (2014-04-30), pages - 9, XP009182042, ISSN: 1946-6234",
                    "X.-C. TANG ET AL: \"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 111, no. 19, 13 May 2014 (2014-05-13), pages E2018 - E2026, XP055162782, ISSN: 0027-8424, DOI: 10.1073/pnas.1402074111",
                    "TIANLEI YING ET AL: \"Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections\", MICROBES AND INFECTION, vol. 17, no. 2, 29 November 2014 (2014-11-29), FR, pages 142 - 148, XP055272026, ISSN: 1286-4579, DOI: 10.1016/j.micinf.2014.11.008",
                    "WEIXU MENG ET AL: \"Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases\", PLOS ONE, vol. 8, no. 6, 18 June 2013 (2013-06-18), pages e66276, XP055271629, DOI: 10.1371/journal.pone.0066276",
                    "LINGSHU WANG ET AL: \"Evaluation of candidate vaccine approaches for MERS-CoV\", NATURE COMMUNICATIONS, vol. 6, 28 July 2015 (2015-07-28), United Kingdom, pages 7712, XP055271251, ISSN: 2041-1723, DOI: 10.1038/ncomms8712",
                    "PRABAKARAN ET AL., J BIOL CHEM, vol. 281, 2006, pages 15829",
                    "ZHU ET AL., PNAS, vol. 104, 2007, pages 12123",
                    "PAK ET AL., J MOL BIOL, vol. 388, 2009, pages 815",
                    "HWANG ET AL., J BIOL CHEM, vol. 281, 2006, pages 34610",
                    "GRAHAM ET AL., NATURE REVIEWS. MICROBIOLOGY, vol. 11, 2013, pages 836",
                    "BENJAMIN LEWIN: \"Genes X\", 2009, JONES & BARTLETT PUBLISHERS",
                    "MEYERS ET AL.: \"The Encyclopedia of Cell Biology and Molecular Medicine\", vol. 16, 2008, WILEY-VCH",
                    "SINGH: \"Vaccine Adjuvants and Delivery Systems\", 2007, WILEY-INTERSCIENCE",
                    "HARLOW; LANE: \"Antibodies, A Laboratory Manual, 2nd ed.\", 2013, COLD SPRING HARBOR PUBLICATIONS",
                    "KINDT ET AL.: \"Kuby Immunology, 6.sup.th ed.,\", 2007, W.H. FREEMAN AND CO., pages: 91",
                    "HAMERS-CASTERMAN ET AL., NATURE, vol. 363, 1993, pages 446 - 448",
                    "SHERIFF ET AL., NAT. STRUCT. BIOT., vol. 3, 1996, pages 733 - 736",
                    "KABAT ET AL.: \"Sequences of Proteins of Immunological Interest\", 1991",
                    "KABAT ET AL.: \"Sequences of Proteins of Immunological Interest 5th Ed.\", 1991, NATIONAL INSTITUTES OF HEALTH",
                    "AL-LAZIKANI ET AL., JMB, vol. 273, 1997, pages 927 - 948",
                    "LEFRANC ET AL.: \"IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains\", DEV. COMP. IMMUNOL., vol. 27, 2003, pages 55 - 77, XP055144492, DOI: doi:10.1016/S0145-305X(02)00039-3",
                    "KONTERMANN AND DUBEL: \"Antibody Engineering, 2nd Ed.,\", vol. 1-2, 2010, SPRINGER PRESS",
                    "BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426",
                    "HUSTON ET AL., PROC. NATL. ACAD. SCI., vol. 85, 1988, pages 5879 - 5883",
                    "AHMAD ET AL., CLIU. DEV. 1NNNNNOL., 2012",
                    "MARBRY, IDRUGS, vol. 13, 2010, pages 543 - 549",
                    "HOLLIGER ET AL., PROC. NATL. ACAD. SCI., vol. 90, 1993, pages 6444 - 6448",
                    "POLJAK ET AL., STRUCTURE, vol. 2, 1994, pages 1121 - 1123",
                    "\"Pierce Catalog and Handbook\", 1994, PIERCE CHEMICAL CO.",
                    "KUBY, J.: \"Immunology\", 1997, W.H. FREEMAN & CO.",
                    "HUSE ET AL., SCIENCE, vol. 246, 1989, pages 1275 - 1281",
                    "WINTER; HARRIS, IMMUNOL. TODAY, vol. 14, 1993, pages 243 - 246",
                    "WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546",
                    "HILYARD ET AL.: \"Protein Engineering: A practical approach\", 1992, IRL PRESS",
                    "BORRABECK: \"Antibody Engineering, 2d ed.\", 1995, OXFORD UNIVERSITY PRESS",
                    "BARBAS ET AL.: \"Phage display: A Laboratory Manuel\", 2004, COLD SPRING HARBOR LABORATORY PRESS",
                    "LONBERG, NAT. BIOTECH., vol. 23, 2005, pages 1117 - 1125",
                    "LONENBERG, CURR. OPIN. IMMUNOL., vol. 20, 2008, pages 450 - 459",
                    "SAMBROOK ET AL.: \"Molecular Cloning: A Laboratory Manual, 4th ed,\", 2012, COLD SPRING HARBOR",
                    "AUSUBEL ET AL.: \"Current Protocols in Molecular Biology\", vol. 104, 2013, JOHN WILEY & SONS",
                    "BITTER ET AL., METHODS IN ENZYMOLOGY, vol. 153, 1987, pages 516 - 544",
                    "SAMPATHKUMAR P, MAYO CLIN PROC., vol. 89, no. 8, August 2014 (2014-08-01), pages 1153 - 8",
                    "E. W. MARTIN: \"Remington's Pharmaceutical Sciences, 19th Edition,\", 1995, MACK PUBLISHING CO.",
                    "SPATOLA: \"Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins\", 1983, MARCEL DEKKER, pages: 267",
                    "SPATOLA, A. F.: \"Vega Data\", PEPTIDE BACKBONE MODIFICATIONS, vol. 1, no. 3, March 1983 (1983-03-01)",
                    "MORLEY, TRENDS PHARM SCI, 1980, pages 463 - 468",
                    "HUDSON ET AL., INT J PEPT PROT RES, vol. 14, 1979, pages 177 - 185",
                    "SPATOLA ET AL., LIFE SCI, vol. 38, 1986, pages 1243 - 1249",
                    "HARM J., CHEM. SOC PERKIN TRANS., 1982, pages 1307 - 314",
                    "ALMQUIST ET AL., J. MED. CHEM., vol. 23, 1980, pages 1392 - 1398",
                    "JENNINGS-WHITE E, TETRAHEDRON LETT, vol. 23, 1982, pages 2533",
                    "HOLLADAY ET AL., TETRAHEDRON. LETT, vol. 24, 1983, pages 4401 - 4404",
                    "HRUBY, LIFE SCI, vol. 31, 1982, pages 189 - 199",
                    "ZHANG, Y, INT. J. MOL. SCI., vol. 12, 2011, pages 5406 - 5421",
                    "SUTTER ET AL., NATURE STRUCT. AND MOL. BIOL., vol. 15, 2008, pages 939 - 947",
                    "SCIENCE, vol. 311, 2006, pages 996 - 1000",
                    "ZHANG ET AL., J. MOL. BIOL., vol. 306, 2001, pages 1099 - 1114",
                    "IZARD ET AL., PNAS, vol. 96, 1999, pages 1240 - 1245",
                    "SMITH; WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482",
                    "NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443",
                    "PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 2444",
                    "HIGGINS; SHARP, GENE, vol. 73, 1988, pages 237 - 44",
                    "HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151 - 3",
                    "CORPET, NUC. ACIDS RES., vol. 16, 1988, pages 10881 - 90",
                    "HUANG ET AL., COMPUTER APPLS. IN THE BIOSCIENCES, vol. 8, 1992, pages 155 - 65",
                    "PEARSON ET AL., METH. MOL. BIO., vol. 24, 1994, pages 307 - 31",
                    "ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10",
                    "PEARSON; LIPMAN, PROC. NAT'L. ACAD. SCI. USA, vol. 85, 1988, pages 2444",
                    "FENG; DOOLITTLE, J. MOL. EVOL., vol. 35, 1987, pages 351 - 360",
                    "HIGGINS; SHARP, CABIOS, vol. 5, 1989, pages 151 - 153",
                    "DEVEREAUX ET AL., NUC. ACIDS RES., vol. 12, 1984, pages 387 - 395",
                    "ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410",
                    "ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1977, pages 3389 - 3402",
                    "HENIKOFF; HENIKOFF, PROC. NATL. ACAD. SCI. USA, vol. 89, 1989, pages 10915",
                    "BAKER ET AL., BIOPHYS. J., vol. 60, 1991, pages 1445 - 1456",
                    "HAGENSEE ET AL., J. VIROL., vol. 68, 1994, pages 4503 - 4505",
                    "VINCENTE, J INVERTEBR PATHOL., 2011",
                    "SCHNEIDER-OHRUM; ROSS, CURR. TOP. MICROBIOL. IMMUNOL., vol. 354, 2012, pages 53073",
                    "JONES ET AL., NATURE, vol. 321, 1986, pages 522",
                    "RIECHMANN ET AL., NATURE, vol. 332, 1988, pages 323",
                    "VERHOEYEN ET AL., SCIENCE, vol. 239, 1988, pages 1534",
                    "CARTER ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 89, 1992, pages 4285",
                    "SANDHU, CRIT. REV. BIOTECH., vol. 12, 1992, pages 437",
                    "CHEN ET AL., J. MOL. BIOL., vol. 293, 1999, pages 865 - 881",
                    "PRESTA ET AL., CANCER RES., vol. 57, 1997, pages 4593 - 4599",
                    "MACK, J. IMMUNOL., vol. 158, 1997, pages 3965 - 3970",
                    "MACK, PNAS, vol. 92, 1995, pages 7021 - 7025",
                    "KUFER, CANCER IMMUNOL. IMMUNOTHER., vol. 45, 1997, pages 193 - 197",
                    "LOFFLER, BLOOD, vol. 95, 2000, pages 2098 - 2103",
                    "BRUHL, J. IMMUNOL., vol. 166, 2001, pages 2420 - 2426",
                    "J. IMMUNOL., vol. 165, 2000, pages 7050 - 57",
                    "WILLEMS ET AL., J CHROMATOGR B ANALYT TECHNOL BIOMED LIFE SCI., vol. 786, 2003, pages 161 - 76",
                    "AHMAD ET AL., CLIN. DEV. IMMUNOL., 2012",
                    "HARLOW; LANE: \"Antibodies: A Laboratory Manual, 2nd ed .,\", 2013, COLD SPRING HARBOR LABORATORY",
                    "NISONHOFF ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 89, 1960, pages 230",
                    "PORTER, BIOCHEM. J., vol. 73, 1959, pages 119",
                    "EDELMAN ET AL.: \"Methods in Enzymology\", vol. 1, 1967, ACADEMIC PRESS, pages: 422",
                    "LIU ET AL., J. VIROLOGY, vol. 85, no. 17, 2011, pages 8467 - 8476",
                    "STIJLEMANS, B. ET AL., J BIOL CHEM, vol. 279, 2004, pages 1256 - 1261",
                    "DUMOULIN, M. ET AL., NATURE, vol. 424, 2003, pages 783 - 788",
                    "PLESCHBERGER, M. ET AL., BIOCONJUGATE CHEM, vol. 14, 2003, pages 440 - 448",
                    "CORTEZ-RETAMOZO, V ET AL., INT J CANCER, vol. 89, 2002, pages 456 - 62",
                    "LAUWEREYS, M. ET AL., EMBO J, vol. 17, 1998, pages 3512 - 3520",
                    "CHOWDHURY, METHODS MOL. BIOL., vol. 207, 2008, pages 179 - 196",
                    "HOOGENBOOM ET AL.: \"Methods in Molecular Biology\", vol. 178, 2001, HUMAN PRESS, pages: 1 - 37",
                    "CUNNINGHAM; WELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085",
                    "WRIGHT ET AL., TIBTECH, vol. 15, 1997, pages 26 - 32",
                    "OKAZAKI ET AL., J. MOL. BIOL., vol. 336, 2004, pages 1239 - 1249",
                    "YAMANE-OHNUKI ET AL., BIOTECH. BIOENG., vol. 87, 2004, pages 614",
                    "RIPKA ET AL., ARCH. BIOCHEM. BIOPHYS., vol. 249, 1986, pages 533 - 545",
                    "KANDA, Y. ET AL., BIOTECHNOL. BIOENG., vol. 94, no. 4, 2006, pages 680 - 688",
                    "HINTON ET AL., J IMMUNOL., vol. 176, 2006, pages 346 - 356",
                    "ZALEVSKY ET AL., NATURE BIOTECHNOLOGY, vol. 28, 2010, pages 157 - 159",
                    "PETKOVA ET AL., INT. IMMUNOL., vol. 18, 2006, pages 1759 - 1769",
                    "DALL'ACQUA ET AL., J. BIOL. CHEM., vol. 281, 2006, pages 23514 - 23524",
                    "LAZAR ET AL., PROC. NATL., ACAD. SCI. U.S.A., vol. 103, 2006, pages 4005 - 4010",
                    "HUNIG ET AL., CHEM. BER., vol. 100, 1974, pages 3039 - 3044",
                    "BASAK, BIOCONJUG. CHEM., vol. 5, 1994, pages 301 - 305",
                    "KANEKIYO ET AL., NATURE, vol. 499, 2013, pages 102 - 106",
                    "ZHANG, INT. J. MOL. SCI., vol. 12, 2011, pages 5406 - 5421",
                    "SUTTER, NATURE STRUCT. AND MOL. BIOL., vol. 15, 2008, pages 939 - 947",
                    "URICH, SCIENCE, vol. 311, 2006, pages 996 - 1000",
                    "KANG ET AL., BIOL. CHEM., vol. 380, 1999, pages 353 - 64",
                    "NOTKA ET AL., BIOL. CHEM., vol. 380, 1999, pages 341 - 52",
                    "AKAHATA, NAT. MED., vol. 16, 2010, pages 334 - 338",
                    "GOLDMANN, J. VIROL., vol. 73, 1999, pages 4465 - 9",
                    "JIANG ET AL., VACCINE, vol. 17, 1999, pages 1005 - 13",
                    "CASAL, BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, vol. 29, 1999, pages 141 - 150",
                    "HURTADO ET AL., J. VIROL., vol. 70, 1996, pages 5422 - 9",
                    "LI ET AL., J. VIROL., vol. 71, 1997, pages 7207 - 13",
                    "MADZAK ET AL., J. GEN. VIROL., vol. 73, 1992, pages 1533 - 1536",
                    "BERKNER, CUR. TOP. MICROBIOL. IMMUNOL., vol. 158, 1992, pages 39 - 6",
                    "BERLINER ET AL., BIO TECHNIQUES, vol. 6, 1988, pages 616 - 629",
                    "GORZIGLIA ET AL., J. VIROL., vol. 66, 1992, pages 4407 - 4412",
                    "QUANTIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 2581 - 2584",
                    "ROSENFELD ET AL., CELL, vol. 68, 1992, pages 143 - 155",
                    "WILKINSON ET AL., NUCL. ACIDS RES., vol. 20, 1992, pages 2233 - 2239",
                    "STRATFORD-PERRICAUDET ET AL., HUM. GENE THER., vol. 1, 1990, pages 241 - 256",
                    "MACKETT, BIOTECHNOLOGY, vol. 24, 1992, pages 495 - 499",
                    "MUZYCZKA, CURR. TOP. MICROBIOL. IMMUNOL., vol. 158, 1992, pages 91 - 123",
                    "ON ET AL., GENE, vol. 89, 1990, pages 279 - 282",
                    "MARGOLSKEE, CURR. TOP. MICROBIOL. IMMUNOL., vol. 158, 1992, pages 67 - 90",
                    "JOHNSON, J. VIROL., vol. 66, 1992, pages 2952 - 2965",
                    "FINK, HUM. GENE THER, vol. 3, 1992, pages 11 - 19",
                    "BREAKFIELD, MOL. NEUROBIOL., vol. 1, 1987, pages 337 - 371",
                    "FRESSE ET AL., BIOCHEM. PHARMACOL., vol. 40, 1990, pages 2189 - 2199",
                    "H. HERWEIJER, HUMAN GENE THERAPY, vol. 6, 1995, pages 1161 - 1167",
                    "S. SCHLESINGER, TRENDS BIOTECHNOL., vol. 11, 1993, pages 18 - 22",
                    "1. FROLOV ET AL., PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 11371 - 11377",
                    "BRANDYOPADHYAY ET AL., MOL. CELL BIOL., vol. 4, 1984, pages 749 - 754",
                    "PETROPOUPLOS ET AL., J. VIROL., vol. 66, 1992, pages 3391 - 3397",
                    "MILLER, CURR. TOP. MICROBIOL. IMMUNOL., vol. 158, 1992, pages 1 - 24",
                    "MILLER, MOL. CELL BIOL., vol. 5, 1985, pages 431 - 437",
                    "SORGE, MOL. CELL BIOL., vol. 4, 1984, pages 1730 - 1737",
                    "MANN ET AL., J. VIROL., vol. 54, 1985, pages 401 - 407",
                    "PAGE ET AL., J. VIROL., vol. 64, 1990, pages 5370 - 5276",
                    "BUCHSCHALCHER, J. VIROL., vol. 66, 1992, pages 2731 - 2739",
                    "JOHNSON ET AL., MOL THER., vol. 22, no. 1, January 2014 (2014-01-01), pages 196 - 205",
                    "PERUZZI ET AL., VACCINE, vol. 27, 2009, pages 1293 - 1300",
                    "\"Remingtons Pharmaceutical Sciences, 19th Ed.,\", 1995, MACK PUBLISHING COMPANY",
                    "MOWAT; DONACHIE, IMMUNOL. TODAY, vol. 12, 1991, pages 383",
                    "TAKAHASHI ET AL., NATURE, vol. 344, 1990, pages 873",
                    "LUNDSTROM, VIRUSES, vol. 7, no. 5, 2015, pages 2321 - 2333",
                    "STOVER, NATURE, vol. 351, 1991, pages 456 - 460",
                    "NARANG ET AL., METH. ENZYMOL., vol. 68, 1979, pages 90 - 99",
                    "BROWN ET AL., METH. ENZYMOL., vol. 68, 1979, pages 109 - 151",
                    "BEAUCAGE ET AL., TETRA. LETT., vol. 22, 1981, pages 1859 - 1862",
                    "BEAUCAGE; CARUTHERS, TETRA. LETTS., vol. 22, no. 20, 1981, pages 1859 - 1862",
                    "NEEDHAM-VANDEVANTER ET AL., NUCL. ACIDS RES., vol. 12, 1984, pages 6159 - 6168",
                    "AUSUBEL ET AL.: \"Current Protocols in Molecular Biology\", JOHN WILEY & SONS",
                    "HELGASON AND MILLER: \"Basic Cell Culture Protocols (Methods in Molecular Biology, 4th Ed.,\", 2012, HUMANA PRESS",
                    "MUZYCZKA: \"Viral Expression Vectors\", 2011, SPRINGER PRESS",
                    "AL-RUBEAI: \"Antibody Expression and Production\", 2011, SPRINGER PRESS",
                    "HUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883",
                    "MCCAFFERTY ET AL., NATURE, vol. 348, 1990, pages 552 - 554",
                    "SIMPSON: \"Basic methods in Protein Purification and Analysis: A laboratory Manual\", 2008, COLD HARBOR PRESS",
                    "WARD, NATURE, vol. 341, 1989, pages 544",
                    "BAROUCH ET AL., J. VIROL, vol. 79, 2005, pages 8828 - 8834",
                    "BIOCHEMISTRY, vol. 9, 1970, pages 5015 - 5021",
                    "BARANY; MERRIFIELD, THE PEPTIDES: ANALYSIS, SYNTHESIS, BIOLOGY, vol. 2, pages 3 - 284",
                    "MERRIFIELD ET AL., J. AM CHEM. SOC., vol. 85, 1963, pages 2149 - 2156",
                    "STEWART ET AL.: \"Solid Phase Peptide Synthesis, 2nd ed.,\", 1984, PIERCE CHEM. CO.",
                    "\"Remington's Pharmaceutical Science, 19th ed.,\", 1995, MACK PUBLISHING COMPANY",
                    "POWELL AND NEWMAN,: \"Pharmaceutical Biotechnology\", vol. 61, 1995, PLENUM PRESS",
                    "VOLLER ET AL.: \"New Trends and Developments in Vaccines\", 1978, UNIVERSITY PARK PRESS",
                    "BANGA, A.J.: \"Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems\", 1995, TECHNOMIC PUBLISHING COMPANY, INC.",
                    "KREUTER, J.: \"Colloidal Drug Delivery Systems\", 1994, MARCEL DEKKER, INC., pages: 219 - 342",
                    "TICE; TABIBI: \"Treatise on Controlled Drug Delivery\", 1992, MARCEL DEKKER, INC, pages: 315 - 339",
                    "LANGER, ACCOUNTS CHEM. RES., vol. 26, 1993, pages 537 - 542",
                    "JOHNSTON ET AL., PHARM. RES., vol. 9, 1992, pages 425 - 434",
                    "PEC ET AL., J. PARENT. SCI. TECH., vol. 44, no. 2, 1990, pages 58 - 65",
                    "IJNTEMA ET AL., INT. J. P/ 7M., vol. 112, 1994, pages 215 - 224",
                    "BETAGERI ET AL.: \"Liposome Drug Delivery Systems\", 1993, TECHNOMIC PUBLISHING CO., INC.",
                    "CAVANAGH, J GENERAL VIROLOGY, vol. 64, 1983, pages 2577",
                    "BUCHHOLZ ET AL., PNAS, vol. 101, 2004, pages 9804",
                    "COLEMAN ET AL., VACCINE, vol. 32, 2014, pages 3169",
                    "DU ET AL., PLOS ONE, vol. 8, 2013, pages E81587",
                    "MA ET AL., VACCINE, vol. 32, 2014, pages 2100",
                    "MOU ET AL., J VIROLOGY, vol. 87, 2013, pages 9379",
                    "DU ET AL., J VIROLOGY, vol. 88, 2014, pages 7045",
                    "OHNUMA ET AL., J VIROLOGY, vol. 87, 2013, pages 13892",
                    "YING ET AL., J VIROLOGY, vol. 88, 2014, pages 7796",
                    "JIANG ET AL., SCIENCE TRANSLATIONAL MEDICINE, vol. 6, 2014, pages 234RA59",
                    "BRIESE ET AL., MBIO, vol. 5, 2014, pages E01146",
                    "MARTIN ET AL., VACCINE, vol. 26, 2008, pages 6338",
                    "YANG ET AL., NATURE, vol. 428, 2004, pages 561",
                    "NALDINI ET AL., PNAS, vol. 93, 1996, pages 11382",
                    "YANG ET AL., PNAS, vol. 102, 2005, pages 797",
                    "STEVENS ET AL., NATURE, vol. 334, 1988, pages 255",
                    "DAVIS ET AL., HUMAN GENE THERAPY, vol. 6, 1995, pages 1447",
                    "SHEDLOCK ET AL., J LEUKOCYTE BIOLOGY, vol. 68, 2000, pages 793",
                    "CARGNELUTTI, THE NEW MICROBIOLOGICA, vol. 36, 2013, pages 145",
                    "CHAITRA ET AL., VACCINE, vol. 25, 2007, pages 7168",
                    "DU, J VIROLOGY, vol. 88, 2014, pages 7045",
                    "OHNUMA, J VIROLOGY, vol. 87, 2013, pages 13892",
                    "NATURE, vol. 500, 2013, pages 227 - 231",
                    "MANSOOR ET AL., IEEE TRANSACTIONS ON MEDICAL IMAGING, vol. 33, 2014, pages 2293 - 2310",
                    "TANG ET AL., PNAS, vol. 111, 2014, pages E2018 - 2026",
                    "CAULFIELD ET AL., J VIROLOGY, vol. 76, 2002, pages 10038",
                    "LEDGERWOOD ET AL., LANCET INFECTIOUS DISEASES, vol. 11, 2011, pages 916",
                    "LEDGERWOOD ET AL., J INFECTIOUS DISEASES, vol. 208, 2013, pages 418",
                    "KHURANA ET AL., J OF INFECTIOUS DISEASES, vol. 208, 2013, pages 413",
                    "YANG ET AL., J VIROL., vol. 78, 2004, pages 5642 - 5650",
                    "BAROUCH ET AL., J VIROLOGY, vol. 79, 2005, pages 8828",
                    "CATANZARO ET AL., VACCINE, vol. 25, 2007, pages 4085",
                    "ZHU ET AL., PNAS, vol. 104, 2007, pages 12123 - 12128",
                    "TOMARAS ET AL., PNAS, vol. 110, 2013, pages 9019 - 9024",
                    "KONG ET AL., J. VIROL., vol. 86, 2012, pages 12115 - 12128",
                    "OTWINOWSKI ET AL., METHODS ENZYMOL., vol. 276, 1997, pages 307",
                    "MCCOY ET AL., J APPLIED CRYSTALLOGRAPHY, vol. 40, 2007, pages 658",
                    "EMSLEY ET AL., ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, vol. 66, 2010, pages 486",
                    "BLANC ET AL., ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, vol. 60, 2004, pages 2210",
                    "NATURE, vol. 500, 2013, pages 227",
                    "FAN ET AL., J MOL BIOL, vol. 228, 1992, pages 188",
                    "ADAMS ET AL., ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, vol. 66, 2010, pages 213",
                    "CHEN, ACTA CRYSTALLOGRAPHICA. SECTION D, BIOLOGICAL CRYSTALLOGRAPHY, vol. 66, 2010, pages 12",
                    "SCOBEY ET AL., PNAS, vol. 110, 2013, pages 16157",
                    "WU ET AL., SCIENCE, 2010"
                ],
                "nplResolvedCount": 174,
                "nplResolvedLensIDs": [
                    "130-870-309-662-129",
                    "045-500-830-356-334",
                    "126-670-872-645-263",
                    "031-729-641-207-089",
                    "019-037-168-645-793",
                    "034-345-578-106-977",
                    "035-887-489-355-317",
                    "067-968-492-468-107",
                    "082-259-797-755-133",
                    "116-767-209-544-755",
                    "034-328-650-978-645",
                    "015-467-638-461-61X",
                    "105-105-580-970-036",
                    "141-031-108-222-217",
                    "048-389-769-784-036",
                    "042-064-861-703-426",
                    "069-637-253-856-619",
                    "010-884-480-301-434",
                    "035-890-080-496-015",
                    "072-468-307-701-916",
                    "099-900-812-708-588",
                    "022-385-630-807-414",
                    "041-965-729-467-130",
                    "051-537-585-472-863",
                    "082-210-673-349-152",
                    "129-743-827-740-708",
                    "062-679-649-579-866",
                    "012-264-220-259-845",
                    "104-132-094-161-775",
                    "035-723-147-584-661",
                    "113-143-308-281-79X",
                    "045-094-249-115-990",
                    "001-779-867-387-972",
                    "026-634-789-611-309",
                    "007-426-700-052-93X",
                    "082-700-502-354-717",
                    "056-382-008-571-392",
                    "012-268-510-926-843",
                    "003-393-487-467-621",
                    "040-307-220-582-194",
                    "037-600-511-600-799",
                    "111-602-669-712-02X",
                    "152-978-735-478-562",
                    "002-911-689-401-496",
                    "050-246-204-785-836",
                    "036-746-145-798-090",
                    "009-732-181-810-150",
                    "123-474-152-390-023",
                    "081-177-071-539-997",
                    "005-354-868-074-208",
                    "042-458-651-550-70X",
                    "078-135-961-116-992",
                    "035-362-670-138-614",
                    "078-432-639-041-575",
                    "074-235-844-036-582",
                    "066-749-017-721-197",
                    "078-081-741-547-36X",
                    "006-035-768-214-419",
                    "058-313-617-778-309",
                    "089-353-071-323-759",
                    "009-483-512-107-343",
                    "023-968-952-017-264",
                    "063-786-591-916-259",
                    "017-150-654-990-340",
                    "115-789-063-931-955",
                    "066-141-497-990-023",
                    "097-694-869-419-018",
                    "044-876-143-907-404",
                    "078-227-590-332-589",
                    "085-764-009-624-439",
                    "006-819-881-646-075",
                    "032-496-293-605-153",
                    "001-171-324-377-852",
                    "046-168-955-011-967",
                    "088-851-255-233-972",
                    "109-175-133-197-204",
                    "030-088-151-483-183",
                    "060-928-640-668-012",
                    "042-204-626-457-327",
                    "003-663-667-600-837",
                    "129-588-069-141-396",
                    "022-899-518-024-071",
                    "043-271-014-136-772",
                    "003-434-920-063-133",
                    "023-485-474-759-717",
                    "058-124-894-825-860",
                    "129-273-407-931-838",
                    "018-694-084-068-187",
                    "020-924-696-164-172",
                    "010-953-281-569-514",
                    "056-201-471-905-934",
                    "058-522-492-925-838",
                    "053-333-370-639-425",
                    "062-118-852-464-802",
                    "033-797-614-829-293",
                    "064-968-246-716-831",
                    "011-174-345-245-142",
                    "123-244-124-088-579",
                    "016-525-147-386-650",
                    "032-728-154-591-070",
                    "004-828-255-207-755",
                    "006-574-964-805-278",
                    "134-030-034-621-902",
                    "009-841-837-271-501",
                    "001-147-941-858-547",
                    "039-515-794-348-090",
                    "050-086-153-406-428",
                    "047-448-941-251-436",
                    "046-628-575-045-641",
                    "001-467-559-709-949",
                    "043-968-156-521-588",
                    "014-686-084-244-632",
                    "060-690-417-053-376",
                    "037-445-639-149-821",
                    "158-261-806-420-924",
                    "074-817-300-512-106",
                    "027-043-089-978-283",
                    "016-617-627-772-41X",
                    "073-622-562-721-761",
                    "057-659-314-168-759",
                    "050-959-366-576-084",
                    "133-937-184-150-076",
                    "040-834-970-282-128",
                    "071-152-541-652-393",
                    "075-426-376-647-072",
                    "055-005-586-964-518",
                    "038-383-743-124-048",
                    "048-315-448-162-242",
                    "120-113-979-825-387",
                    "033-588-559-144-185",
                    "052-507-092-115-672",
                    "003-376-346-248-551",
                    "020-126-213-879-311",
                    "017-980-004-624-253",
                    "145-146-407-738-040",
                    "011-604-339-472-637",
                    "009-275-403-380-31X",
                    "070-296-445-348-347",
                    "106-138-575-366-798",
                    "082-151-267-963-934",
                    "041-144-393-062-157",
                    "013-836-730-694-422",
                    "063-469-288-339-138",
                    "006-772-167-939-860",
                    "033-542-963-142-911",
                    "023-907-179-348-058",
                    "076-774-944-138-418",
                    "035-746-725-150-104",
                    "027-150-334-287-405",
                    "009-253-604-595-037",
                    "143-306-732-579-95X",
                    "034-994-634-633-262",
                    "056-681-930-672-283",
                    "044-522-255-085-902",
                    "180-914-023-267-719",
                    "119-678-450-376-625",
                    "002-264-966-090-625",
                    "043-148-481-331-661",
                    "028-862-168-091-90X",
                    "030-630-100-818-462",
                    "019-967-851-030-751",
                    "009-507-053-935-564",
                    "040-363-636-264-022",
                    "117-552-761-069-626",
                    "010-537-288-097-385",
                    "064-799-052-071-305",
                    "079-080-784-051-77X",
                    "100-876-606-929-853",
                    "076-921-778-471-668",
                    "026-944-353-804-488",
                    "028-835-710-133-898",
                    "041-548-559-329-087",
                    "032-720-983-972-675",
                    "029-627-399-633-530"
                ],
                "nplResolvedExternalIDs": [
                    "10.2210/pdb1igm/pdb",
                    "2428310",
                    "pmc46948",
                    "1447781",
                    "24766432",
                    "25405618",
                    "10.1126/science.1120306",
                    "23831647",
                    "10.1107/s0021889807021206",
                    "10.1023/a:1015815624334",
                    "10.1038/nature02463",
                    "10.1371/journal.pone.0081587",
                    "8207824",
                    "10.1128/jvi.00912-14",
                    "10.1128/jvi.66.5.2731-2739.1992",
                    "10.1016/j.vaccine.2014.02.004",
                    "2531466",
                    "10.1073/pnas.96.4.1240",
                    "10.1007/s002620050431",
                    "10.1038/nrmicro3143",
                    "16597622",
                    "pmc38064",
                    "5420325",
                    "pmc38066",
                    "10.1042/bj0730119",
                    "8573617",
                    "pmc3586247",
                    "14434282",
                    "10.3390/v7052321",
                    "pmc4054355",
                    "24719424",
                    "pmc41463",
                    "10.1128/jvi.66.7.4407-4412.1992",
                    "21715497",
                    "19162112",
                    "15993989",
                    "24789777",
                    "16609957",
                    "10.1073/pnas.85.8.2444",
                    "pmc3838260",
                    "pmc49066",
                    "pmc4236105",
                    "10.1016/s0145-305x(02)00039-3",
                    "24778414",
                    "16537476",
                    "10.4049/jimmunol.176.1.346",
                    "pmc2855492",
                    "3989912",
                    "2471267",
                    "1423650",
                    "10.1128/jvi.01277-13",
                    "10.1073/pnas.0701000104",
                    "10223338",
                    "10223337",
                    "10.1126/science.3140379",
                    "10067709",
                    "10.1007/978-94-011-6630-0",
                    "10.1038/nsb0996-733",
                    "10.1021/ja00897a025",
                    "10.1073/pnas.0403492101",
                    "23428360",
                    "10.1073/pnas.1311542110",
                    "1316260",
                    "15994776",
                    "pmc415834",
                    "10.1016/s0040-4039(01)90461-7",
                    "10.1107/s0907444904016427",
                    "10.1006/jmbi.2000.4435",
                    "10.1007/bf02603120",
                    "pmc3670311",
                    "16365427",
                    "10.1006/jmbi.1997.1354",
                    "16151405",
                    "pmc366734",
                    "24067970",
                    "9254694",
                    "pmc470755",
                    "10.1016/j.vaccine.2007.02.050",
                    "10.1016/s0022-2836(05)80360-2",
                    "1370653",
                    "10.1038/ncomms8712",
                    "24043791",
                    "10.1016/j.micinf.2014.11.008",
                    "10.1016/s0264-410x(98)00317-x",
                    "3127726",
                    "10.1089/hum.1995.6.9-1161",
                    "10.1089/hum.1990.1.3-241",
                    "8764053",
                    "25961488",
                    "1582242",
                    "1560523",
                    "1318411",
                    "10.1128/jvi.78.11.5642-5650.2004",
                    "pmc241119",
                    "10.1385/1-59259-240-6:001",
                    "10.1074/jbc.m603275200",
                    "10.3410/f.1020100.229441",
                    "7948095",
                    "2184369",
                    "2451287",
                    "10.3109/07388559209114235",
                    "10.1016/0006-2952(90)90711-s",
                    "10.1128/jvi.00520-11",
                    "12477501",
                    "1557362",
                    "20111039",
                    "pmc241248",
                    "pmc4024880",
                    "10.1093/nar/16.22.10881",
                    "pmc3165811",
                    "10.1002/9780470134931",
                    "pmc2815670",
                    "15642942",
                    "8876142",
                    "8876144",
                    "10.1073/pnas.92.15.7021",
                    "10.1128/jvi.02448-13",
                    "pmc48705",
                    "10.1016/0024-3205(82)90578-1",
                    "10.1016/s0006-3495(91)82181-6",
                    "521205",
                    "2828848",
                    "1317548",
                    "pmc2483472",
                    "pmc136497",
                    "7624362",
                    "10.1038/nature12202",
                    "10.1038/nature12328",
                    "25456101",
                    "9103467",
                    "23752342",
                    "9367782",
                    "26218507",
                    "pmc241028",
                    "10.1126/science.2451287",
                    "pmc1170688",
                    "9377574",
                    "10.1038/348552a0",
                    "12208982",
                    "11920600",
                    "10.1016/j.vaccine.2014.04.016",
                    "9311793",
                    "10.1007/978-3-642-01147-4",
                    "5593847",
                    "pmc192060",
                    "6092935",
                    "10.1111/j.1399-3011.1979.tb01923.x",
                    "3243435",
                    "24217413",
                    "6546423",
                    "19461840",
                    "10.1016/0076-6879(79)68010-2",
                    "10.1182/blood.v95.6.2098",
                    "10.1038/351456a0",
                    "23785207",
                    "10.1073/pnas.89.22.10915",
                    "pmc281868",
                    "15037082",
                    "9649422",
                    "10.1016/0378-1119(88)90330-7",
                    "10.1016/0378-5173(94)90357-3",
                    "12917687",
                    "pmc104235",
                    "10.1038/363446a0",
                    "15210961",
                    "10.1586/14760584.2014.912134",
                    "10.1128/mcb.5.3.431",
                    "1438297",
                    "pmc3179174",
                    "10.1073/pnas.85.16.5879",
                    "10.1016/0022-2836(92)90500-j",
                    "10.1128/jvi.73.5.4465-4469.1999",
                    "10.1016/0076-6879(87)53076-2",
                    "pmc3978801",
                    "3713831",
                    "1786069",
                    "10.1016/j.vaccine.2008.12.051",
                    "pmc241054",
                    "11160301",
                    "10.1093/nar/12.15.6159",
                    "10.1007/978-3-642-75608-5_1",
                    "10.1007/978-3-642-75608-5_4",
                    "6325895",
                    "10.1089/hum.1995.6.11-1447",
                    "10.1007/bf02388594",
                    "1314100",
                    "10.1038/nature01870",
                    "24324708",
                    "6126794",
                    "6473105",
                    "1663794",
                    "10.1128/jvi.66.6.3391-3397.1992",
                    "3162770",
                    "10.1021/ar00034a004",
                    "10.1038/334255a0",
                    "2456466",
                    "16484493",
                    "2231712",
                    "10.1128/jvi.54.2.401-407.1985",
                    "20721825",
                    "10.1016/0092-8674(92)90213-v",
                    "15140961",
                    "pmc4194189",
                    "19324051",
                    "10.1089/hum.1992.3.1-11",
                    "7764041",
                    "10.1038/341544a0",
                    "10.1073/pnas.89.10.4285",
                    "10.1016/0022-2836(70)90057-4",
                    "23824680",
                    "10.1128/jvi.79.14.8828-8834.2005",
                    "10.1093/nar/12.1part1.387",
                    "pmc146917",
                    "10.1038/344873a0",
                    "10.1099/0022-1317-64-12-2577",
                    "17391815",
                    "pmc3688872",
                    "10.1126/science.2471267",
                    "2247164",
                    "16954221",
                    "23661056",
                    "23686120",
                    "pmc4241375",
                    "10.1371/journal.pone.0112602",
                    "10.1586/erv.12.126",
                    "24736006",
                    "10.1073/pnas.0409065102",
                    "pmc4525294",
                    "2720464",
                    "pmc2612543",
                    "2677748",
                    "10.1002/bit.20880",
                    "pmc2852313",
                    "1637416",
                    "10.1038/mt.2013.142",
                    "10.1038/nbt1135",
                    "pmc3791741",
                    "10.1093/nar/25.17.3389",
                    "10.1016/0167-5699(93)90039-n",
                    "17620608",
                    "10.1093/intimm/dxl110",
                    "10.1016/j.jmb.2004.01.007",
                    "11129646",
                    "pmc15447",
                    "10.1007/82_2011_135",
                    "pmc320064",
                    "2849754",
                    "10.1016/0024-3205(86)90416-9",
                    "10.1073/pnas.1301456110",
                    "10.1201/9781498710565",
                    "10.1016/j.mayocp.2014.06.008",
                    "1591611",
                    "pmc545557",
                    "10.1016/s0040-4039(00)85908-0",
                    "10.1021/bc025603+",
                    "10.1016/s1570-0232(02)00813-9",
                    "10.1021/jm00186a020",
                    "10.1093/bioinformatics/8.2.155",
                    "10.1074/jbc.m600697200",
                    "10.1007/978-94-007-1257-7",
                    "10.1073/pnas.90.14.6444",
                    "8784342",
                    "2173924",
                    "10.1093/bioinformatics/5.2.151",
                    "20124702",
                    "pmc280013",
                    "10.1093/nar/20.9.2233",
                    "10.1128/jvi.70.8.5422-5429.1996",
                    "27754618",
                    "10.1128/mcb.4.4.749",
                    "10.1021/bc00028a003",
                    "22933274",
                    "10.1016/0167-5699(91)90133-e",
                    "19172747",
                    "10.1073/pnas.1402074111",
                    "10.1128/mcb.4.9.1730",
                    "20081867",
                    "3140379",
                    "10.1515/bc.1999.047",
                    "10.1515/bc.1999.046",
                    "pmc338945",
                    "10.1006/jmbi.1990.9999",
                    "pmc312336",
                    "10.1128/jvi.76.19.10038-10043.2002",
                    "pmc4097770",
                    "6256550",
                    "10.1126/science.2531466",
                    "21744306",
                    "23698367",
                    "10.1038/332323a0",
                    "pmc4058772",
                    "12643755",
                    "27799103",
                    "10.1038/nsmb.1473",
                    "10.1016/s0076-6879(97)76066-x",
                    "10196348",
                    "10.1073/pnas.89.7.2581",
                    "11968478",
                    "12651012",
                    "17077181",
                    "10.3390/ijms12085406",
                    "pmc4452908",
                    "10.1128/jvi.68.7.4503-4505.1994",
                    "10.1002/ijc.10212",
                    "14527957",
                    "10.1128/mbio.01146-14",
                    "pmc3486499",
                    "pmc368793",
                    "25034307",
                    "8502296",
                    "16793771",
                    "10.1074/jbc.m604292200",
                    "10.1038/321522a0",
                    "396436",
                    "10.1128/jvi.66.5.2952-2965.1992",
                    "10.1128/jvi.00433-14",
                    "10.1107/s0907444910007493",
                    "10.1016/j.vaccine.2005.05.023",
                    "10.1016/j.jmb.2009.03.042",
                    "11237620",
                    "pmc321012",
                    "3045807",
                    "pmc3754068",
                    "9990008",
                    "pmc190499",
                    "10.1074/jbc.m307341200",
                    "10075910",
                    "8527474",
                    "10.1006/jmbi.1999.3192",
                    "10543973",
                    "3959753",
                    "10.1016/s0969-2126(94)00113-8",
                    "pmc50453",
                    "23252385",
                    "15024391",
                    "10.1016/j.vetimm.2013.01.009",
                    "10.4049/jimmunol.166.4.2420",
                    "10.1002/cber.19671000929",
                    "10.1371/journal.pone.0066276",
                    "24781747",
                    "10.1073/pnas.93.21.11382",
                    "pmc1389705",
                    "10.1093/emboj/17.13.3512",
                    "10.1016/0167-7799(93)90070-p",
                    "20383002",
                    "10.1109/tmi.2014.2337057",
                    "10.1016/j.vaccine.2008.09.026",
                    "10.1128/jvi.71.10.7207-7213.1997",
                    "10.1016/0378-1119(90)90018-m",
                    "8397764",
                    "pmc3852489",
                    "pmc1924550",
                    "10.1073/pnas.93.21.11371",
                    "25020069",
                    "10706880",
                    "pmc236376",
                    "24560617",
                    "10.1016/j.vaccine.2007.07.026",
                    "pmc1260204",
                    "10.1016/0003-9861(86)90031-7",
                    "1422060",
                    "10.1038/nbt.1601",
                    "pmc254810",
                    "21954367",
                    "18824060",
                    "1350088",
                    "8341653",
                    "9435872",
                    "1614979",
                    "6319549",
                    "pmc4308519",
                    "2165023",
                    "pmc368980",
                    "3118049",
                    "7704521",
                    "24778221",
                    "1373198",
                    "pmc2834826",
                    "10.1073/pnas.0508123103",
                    "10.1126/scitranslmed.3008140",
                    "pmc1197021",
                    "pmc1168733",
                    "10.1038/nm.2105",
                    "17709160",
                    "1904554",
                    "2985952",
                    "15572774",
                    "10.1128/jvi.01632-12",
                    "2081192"
                ]
            },
            {
                "index": "102",
                "publicationKey": "WO_2018_094241_A1",
                "lensId": "097-630-358-457-917",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/094241 A1",
                "publicationDate": "2018-05-24",
                "filingNumber": "US 2017/0062354 W",
                "filingDate": "2017-11-17",
                "priorityFilingKeysActive": [
                    "US 201662424309 P 20161118"
                ],
                "earliestPriorityDate": "2016-11-18",
                "title": "Immunogenic Composition For Mers Coronavirus Infection",
                "applicants": [
                    "NEW YORK BLOOD CENTER INC"
                ],
                "inventors": [
                    "DU LANYING",
                    "LI FANG",
                    "JIANG SHIBO",
                    "ZHOU YUSEN"
                ],
                "owners": [],
                "url": "https://lens.org/097-630-358-457-917",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 3,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K47/64",
                    "C07K14/165",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "KIM ET AL.: \"Variations in Spike Glycoprotein Gene of MERS-CoV, South Korea , 2015\", EMERGING INFECTIOUS DISEASES, vol. 22, no. 1, 31 January 2016 (2016-01-31), pages 100 - 104, XP055486935",
                    "KIM ET AL.: \"Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD 26 during the South Korean Outbreak\", MBIO, vol. 7, no. 2, 1 March 2016 (2016-03-01), pages e00019 - 16, XP055486946, Retrieved from the Internet <URL:doi:10.1128/mBio.00019-16>",
                    "DU ET AL.: \"Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines\", NATURE COMMUNICATIONS, vol. 7, no. 13473, 22 November 2016 (2016-11-22), pages 1 - 9, XP055486939, Retrieved from the Internet <URL:DOI:10.1038/ncomms13473>"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "019-275-525-170-110",
                    "035-608-195-211-68X",
                    "045-034-895-672-383"
                ],
                "nplResolvedExternalIDs": [
                    "26933050",
                    "10.1038/ncomms13473",
                    "26691200",
                    "10.1128/mbio.00019-16",
                    "27874853",
                    "10.3201/eid2201.151055",
                    "pmc4696701"
                ]
            },
            {
                "index": "103",
                "publicationKey": "US_10301377_B2",
                "lensId": "188-765-157-754-859",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10301377 B2",
                "publicationDate": "2019-05-28",
                "filingNumber": "US 201615553466 A",
                "filingDate": "2016-02-24",
                "priorityFilingKeysActive": [
                    "US 201562120353 P 20150224"
                ],
                "earliestPriorityDate": "2015-02-24",
                "title": "Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use",
                "applicants": [
                    "US HEALTH"
                ],
                "inventors": [
                    "GRAHAM BARNEY",
                    "KONG WING-PUI",
                    "MODJARRAD KAYVON",
                    "WANG LINGSHU",
                    "SHI WEI",
                    "JOYCE MICHAEL GORDON",
                    "KANEKIYO MASARU",
                    "MASCOLA JOHN"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                        "executionDate": "2016-03-22"
                    }
                ],
                "url": "https://lens.org/188-765-157-754-859",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 155,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/00",
                    "A61K39/215",
                    "C07K14/005",
                    "C07K14/165",
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 17,
                "nplCitations": [
                    "Chen, et al. \u201cA DNA prime-protein boost vaccination strategy targeting turkey coronavirus spike protein fragment containing neutralizing epitope against infectious challenge.\u201d Veterinary Immunology and Immunopathology 152, No. 3 (2013): 359-369.",
                    "Coleman, et al. \u201cPurified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.\u201d Vaccine 32, No. 26 (2014): 3169-3174.",
                    "Du, et al. \u201cA conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East raspiratory syndrome coronavirus spike protein.\u201d Journal of Virology 88, No. 12, (2014): 7045-7053.",
                    "Du, et al. A truncated receptor-binding domain of MERS-CoV spike protein 515 potently inhibits MERS-CoV infection and induces strong neutralizing antibody 516 responses: implication for developing therapeutics and vaccines. PloS One 8 (2013): e81587.",
                    "Jiang, et al. \u201cPotent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.\u201d Science Translational Medicine 6, No. 234 (2014): 2334ra59-234ra59.",
                    "Jiang, et al. \u201cRoadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome.\u201d Expert Review of Vaccines 11, No. 12 (2012): 1405-1413.",
                    "Lan, et al. \u201cTailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.\u201d PLoS One 9, No. 11 (2014): e112602.",
                    "Ma, et al. \u201cIntranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines.\u201d Vaccine 32, No. 18 (2014): 2100-2108.",
                    "Meng, et al. \u201cRapid generation of human-like neutralizing monoclonal antibodies in urgent preparedness for influenza pandemics and virulent infectious diseases.\u201d PloS One 8, No. 6 (2013): e66276.",
                    "Ohnuma, et al. \u201cInhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.\u201d Journal of Virology 87, No. 24 (2013): 13892-13899.",
                    "Song, et al. \u201cMiddle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.\u201d Journal of Virology 87, No. 21 (2013): 11950-11954.",
                    "Tang, et al. \u201cIdentification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.\u201d Proceedings of the National Academy of Sciences 111, No. 19 (2014): E2018-E2026.",
                    "Wang, et al. \u201cEvaluation of candidate vaccine approaches for MERS-CoV.\u201d Nature Communications 6 (2015): 7712.",
                    "Woo, et al. \u201cSARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.\u201d Vaccine 23, No. 42 (2005): 4959-4968.",
                    "Ying, et al. \u201cDevelopment of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.\u201d Microbes and Infection 17, No. 2 (2015): 142-148.",
                    "Ying, et al. \u201cExceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.\u201d Journal of Virology 88, No. 14 (2014): 7796-7805.",
                    "Zhang, et al. \u201cCuirent advancements and potential strategies in the development of MERS-CoV vaccines.\u201d Expert Review of Vaccines 13, No. 6 (2014): 761-774."
                ],
                "nplResolvedCount": 17,
                "nplResolvedLensIDs": [
                    "009-732-181-810-150",
                    "078-081-741-547-36X",
                    "006-819-881-646-075",
                    "030-088-151-483-183",
                    "003-663-667-600-837",
                    "022-899-518-024-071",
                    "134-030-034-621-902",
                    "047-448-941-251-436",
                    "114-114-185-080-165",
                    "055-005-586-964-518",
                    "003-376-346-248-551",
                    "033-542-963-142-911",
                    "034-994-634-633-262",
                    "043-148-481-331-661",
                    "010-537-288-097-385",
                    "079-080-784-051-77X",
                    "076-921-778-471-668"
                ],
                "nplResolvedExternalIDs": [
                    "10.1128/jvi.02448-13",
                    "pmc3688872",
                    "pmc4058772",
                    "10.1371/journal.pone.0066276",
                    "10.1128/jvi.00433-14",
                    "10.1016/j.vaccine.2005.05.023",
                    "10.1073/pnas.1402074111",
                    "pmc4308519",
                    "pmc4241375",
                    "24766432",
                    "23986586",
                    "10.1038/ncomms8712",
                    "pmc3586247",
                    "25405618",
                    "10.1371/journal.pone.0112602",
                    "pmc4054355",
                    "23428360",
                    "10.1586/erv.12.126",
                    "10.1016/j.micinf.2014.11.008",
                    "24719424",
                    "24736006",
                    "24778221",
                    "pmc4194189",
                    "pmc3807317",
                    "pmc4525294",
                    "pmc3852489",
                    "25456101",
                    "15993989",
                    "24789777",
                    "10.1126/scitranslmed.3008140",
                    "26218507",
                    "23252385",
                    "24560617",
                    "pmc4097770",
                    "pmc4024880",
                    "10.1371/journal.pone.0081587",
                    "24324708",
                    "pmc3838260",
                    "23824680",
                    "10.1128/jvi.00912-14",
                    "10.1016/j.vaccine.2014.02.004",
                    "10.1016/j.vetimm.2013.01.009",
                    "pmc4236105",
                    "10.1586/14760584.2014.912134",
                    "24067970",
                    "10.1128/jvi.01672-13",
                    "24778414",
                    "10.1016/j.vaccine.2014.04.016"
                ]
            },
            {
                "index": "104",
                "publicationKey": "US_10383844_B2",
                "lensId": "143-305-057-238-363",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10383844 B2",
                "publicationDate": "2019-08-20",
                "filingNumber": "US 201815986033 A",
                "filingDate": "2018-05-22",
                "priorityFilingKeysActive": [
                    "KR 20170063643 A 20170523"
                ],
                "earliestPriorityDate": "2017-05-23",
                "title": "Methods For Treating Pulmonary Fibrosis Using Chromenone Derivatives",
                "applicants": [
                    "COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY\u2014ACADEMIC COOPERATION FOUNDATION",
                    "EWHA UNIVERSITY\u2014INDUSTRY COLLABORATION FOUND",
                    "INDUSTRY\u2014ACADEMIC COOPERATION FOUNDATION YONSEI UNIV",
                    "COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY\u2014ACADEMIC COOPERATION",
                    "UNIV YONSEI IACF"
                ],
                "inventors": [
                    "NA YOUNGHWA",
                    "LEE YUN-SIL",
                    "CHO JAE HO"
                ],
                "owners": [
                    {
                        "name": "EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION",
                        "executionDate": "2018-06-28"
                    },
                    {
                        "name": "COLL MEDICINE POCHON CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION",
                        "executionDate": "2018-06-19"
                    },
                    {
                        "name": "INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY",
                        "executionDate": "2018-06-19"
                    }
                ],
                "url": "https://lens.org/143-305-057-238-363",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/353",
                    "A61K31/38",
                    "A61P11/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "CN1493571A, Abstract English translation (2004) (Year: 2004)."
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "105",
                "publicationKey": "US_2018_0244756_A1",
                "lensId": "171-622-821-892-796",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0244756 A1",
                "publicationDate": "2018-08-30",
                "filingNumber": "US 201615553466 A",
                "filingDate": "2016-02-24",
                "priorityFilingKeysActive": [
                    "US 201562120353 P 20150224"
                ],
                "earliestPriorityDate": "2015-02-24",
                "title": "Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use",
                "applicants": [
                    "US HEALTH"
                ],
                "inventors": [
                    "GRAHAM BARNEY",
                    "KONG WING-PUI",
                    "MODJARRAD KAYVON",
                    "WANG LINGSHU",
                    "SHI WEI",
                    "JOYCE MICHAEL GORDON",
                    "KANEKIYO MASARU",
                    "MASCOLA JOHN"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                        "executionDate": "2016-03-22"
                    }
                ],
                "url": "https://lens.org/171-622-821-892-796",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 155,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/215",
                    "C07K14/005",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "106",
                "publicationKey": "US_2018_0338948_A1",
                "lensId": "054-692-127-518-966",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0338948 A1",
                "publicationDate": "2018-11-29",
                "filingNumber": "US 201815986033 A",
                "filingDate": "2018-05-22",
                "priorityFilingKeysActive": [
                    "KR 20170063643 A 20170523"
                ],
                "earliestPriorityDate": "2017-05-23",
                "title": "Methods For Treating Pulmonary Fibrosis Using Chromenone Derivatives",
                "applicants": [
                    "COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION",
                    "EWHA UNIV INDUSTRY COLLABORATION FOUNDATION",
                    "UNIV YONSEI IACF"
                ],
                "inventors": [
                    "NA YOUNGHWA",
                    "LEE YUN-SIL",
                    "CHO JAE HO"
                ],
                "owners": [
                    {
                        "name": "EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION",
                        "executionDate": "2018-06-28"
                    },
                    {
                        "name": "COLL MEDICINE POCHON CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION",
                        "executionDate": "2018-06-19"
                    },
                    {
                        "name": "INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY",
                        "executionDate": "2018-06-19"
                    }
                ],
                "url": "https://lens.org/054-692-127-518-966",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/353",
                    "A61K31/38",
                    "A61P11/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "107",
                "publicationKey": "US_2019_0256579_A1",
                "lensId": "125-367-312-762-519",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0256579 A1",
                "publicationDate": "2019-08-22",
                "filingNumber": "US 201916403211 A",
                "filingDate": "2019-05-03",
                "priorityFilingKeysActive": [
                    "US 201562120353 P 20150224"
                ],
                "earliestPriorityDate": "2015-02-24",
                "title": "Middle East Respiratory Syndrome Coronavirus Immunogens, Antibodies, And Their Use",
                "applicants": [
                    "THE U S A AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES"
                ],
                "inventors": [
                    "GRAHAM BARNEY",
                    "KONG WING-PUI",
                    "MODJARRAD KAYVON",
                    "WANG LINGSHU",
                    "SHI WEI",
                    "JOYCE MICHAEL GORDON",
                    "KANEKIYO MASARU",
                    "MASCOLA JOHN"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES",
                        "executionDate": "2016-03-22"
                    }
                ],
                "url": "https://lens.org/125-367-312-762-519",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 6,
                "seqCount": 155,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/12",
                    "A61K39/215",
                    "C07K14/005",
                    "C07K14/165",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "108",
                "publicationKey": "US_2019_0262432_A1",
                "lensId": "192-142-722-311-81X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0262432 A1",
                "publicationDate": "2019-08-29",
                "filingNumber": "US 201916293589 A",
                "filingDate": "2019-03-05",
                "priorityFilingKeysActive": [
                    "US 201615314782 A 20161129",
                    "US 201462005817 P 20140530"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Treatment Of Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "ANSUN BIOPHARMA INC"
                ],
                "inventors": [
                    "MOSS RONALD B"
                ],
                "owners": [
                    {
                        "name": "ANSUN BIOPHARMA INC",
                        "executionDate": "2014-06-16"
                    }
                ],
                "url": "https://lens.org/192-142-722-311-81X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 3,
                "seqCount": 14,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/47",
                    "A61K9/00",
                    "A61K38/18",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "109",
                "publicationKey": "US_2019_0285632_A1",
                "lensId": "046-071-737-251-283",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0285632 A1",
                "publicationDate": "2019-09-19",
                "filingNumber": "US 201716300654 A",
                "filingDate": "2017-05-24",
                "priorityFilingKeysActive": [
                    "US 201662340624 P 20160524"
                ],
                "earliestPriorityDate": "2016-05-24",
                "title": "Metabalomics And Viral Diagnostics Suite",
                "applicants": [
                    "EXCISION BIOTHERAPEUTICS INC"
                ],
                "inventors": [
                    "MALCOLM THOMAS"
                ],
                "owners": [
                    {
                        "name": "EXCISION BIOTHERAPEUTICS INC",
                        "executionDate": "2016-06-19"
                    }
                ],
                "url": "https://lens.org/046-071-737-251-283",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 7,
                "familySize": 7,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "110",
                "publicationKey": "WO_2019_151632_A1",
                "lensId": "155-407-120-196-905",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/151632 A1",
                "publicationDate": "2019-08-08",
                "filingNumber": "KR 2018015141 W",
                "filingDate": "2018-11-30",
                "priorityFilingKeysActive": [
                    "KR 20180011776 A 20180131",
                    "KR 20180108125 A 20180911",
                    "KR 20180138228 A 20181112"
                ],
                "earliestPriorityDate": "2018-01-31",
                "title": "Binding Molecule Having Neutralizing Activity Against Middle East Respiratory Syndrome-coronavirus",
                "applicants": [
                    "CELLTRION INC"
                ],
                "inventors": [
                    "LEE SOO YOUNG",
                    "YI KYE SOOK",
                    "KIM CHEOL MIN",
                    "SONG KYUNG MIN",
                    "BAE YEON JIN",
                    "KIM WOO JOO",
                    "CHEONG HEE JIN",
                    "SONG JOON YOUNG",
                    "PARK MAN SEONG",
                    "NOH JI YUN"
                ],
                "owners": [],
                "url": "https://lens.org/155-407-120-196-905",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 4,
                "seqCount": 48,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "CHEN, Y. ET AL.: \"A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein\", EMERGING MICROBES & INFECTIONS, vol. 6, 24 May 2017 (2017-05-24), pages 1 - 7, XP055586083, doi:10.1038/emi.2017.18",
                    "JIANG, L. ET AL.: \"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein\", SCIENCE TRANSLATIONAL MEDICINE, vol. 6, no. 234, 30 April 2014 (2014-04-30), pages 234ra59, XP009182042, doi:10.1126/scitranslmed.3008140"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "043-148-481-331-661",
                    "091-978-442-637-24X",
                    "127-221-772-931-433"
                ],
                "nplResolvedExternalIDs": [
                    "pmc5520482",
                    "28536429",
                    "10.1126/scitranslmed.3008140",
                    "24778414",
                    "10.1038/emi.2017.18"
                ]
            },
            {
                "index": "111",
                "publicationKey": "WO_2018_112648_A1",
                "lensId": "113-044-931-681-169",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/112648 A1",
                "publicationDate": "2018-06-28",
                "filingNumber": "CA 2017051575 W",
                "filingDate": "2017-12-21",
                "priorityFilingKeysActive": [
                    "CA 2953159 A 20161223",
                    "CA 2953166 A 20161223",
                    "CA 2953168 A 20161223"
                ],
                "earliestPriorityDate": "2016-12-23",
                "title": "Matriptase Inhibitors And Uses Thereof",
                "applicants": [
                    "NEOMED INST"
                ],
                "inventors": [
                    "BOUDREAULT PIERRE-LUC",
                    "COLOMBO \u00c9LO\u00cfC",
                    "LEDUC RICHARD",
                    "MARSAULT ERIC",
                    "PLANCQ BAPTISTE",
                    "RICHTER MARTIN"
                ],
                "owners": [],
                "url": "https://lens.org/113-044-931-681-169",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K5/083",
                    "A61K38/06",
                    "A61K38/55",
                    "A61P31/12",
                    "A61P31/16",
                    "A61P35/00",
                    "C07K5/03",
                    "C07K5/08",
                    "C12N9/64"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "DUCHENE ET AL.: \"Analysis of Sub pocket Selectivity and identification of potent selective inhibitors for matriptase and matriptase-2\", JOURNAL OF MEDICINAL CHEMISTRY, vol. 57, 11 November 2014 (2014-11-11), pages 10198 - 10204, XP055429365",
                    "ZORATTI ET AL.: \"Targeting matriptase in breast cancer abrogates tumor progression via impairment of stromal-epithelial growth factor signalling\", NATURE COMMUNICATIONS, vol. 6, no. 6776, 15 April 2015 (2015-04-15), pages 1 - 13, XP055509519",
                    "MILNER ET AL.: \"Matriptase is a novel initiator of cartilage matrix degradation in osteoarthritis\", ARTHRITIS & RHEUMATISM, vol. 62, no. 7, 7 July 2010 (2010-07-07), pages 1955 - 1966, XP002608337",
                    "BARDOU ET AL.: \"Membrane-anchored serine protease matriptase is a trigger of pulmonary fibrogenesis\", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, vol. 193, no. 8, 15 April 2016 (2016-04-15), pages 847 - 860, XP055509527"
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "054-164-583-801-723",
                    "077-768-186-082-245",
                    "015-187-643-449-264",
                    "069-030-472-021-098",
                    "019-642-134-486-056"
                ],
                "nplResolvedExternalIDs": [
                    "10.1002/art.27476",
                    "26599507",
                    "10.1021/jm5015633",
                    "10.1038/ncomms7776",
                    "pmc4749267",
                    "20506309",
                    "10.1164/rccm.201502-0299oc",
                    "25873032",
                    "25387268"
                ]
            },
            {
                "index": "112",
                "publicationKey": "US_2019_0337981_A1",
                "lensId": "179-166-719-695-539",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0337981 A1",
                "publicationDate": "2019-11-07",
                "filingNumber": "US 201716471979 A",
                "filingDate": "2017-12-21",
                "priorityFilingKeysActive": [
                    "CA 2953159 A 20161223",
                    "CA 2953166 A 20161223",
                    "CA 2953168 A 20161223"
                ],
                "earliestPriorityDate": "2016-12-23",
                "title": "Matriptase Inhibitors And Uses Thereof",
                "applicants": [
                    "NEOMED INST"
                ],
                "inventors": [
                    "BOUDREAULT PIERRE-LUC",
                    "COLOMBO \u00c9LO\u00cfC",
                    "LEDUC RICHARD",
                    "MARSAULT ERIC",
                    "PLANCQ BAPTISTE",
                    "RICHTER MARTIN"
                ],
                "owners": [],
                "url": "https://lens.org/179-166-719-695-539",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K5/09",
                    "A61P11/00",
                    "A61P19/02",
                    "A61P31/16",
                    "C07K5/083"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "113",
                "publicationKey": "KR_20190078174_A",
                "lensId": "189-539-934-245-997",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20190078174 A",
                "publicationDate": "2019-07-04",
                "filingNumber": "KR 20170179939 A",
                "filingDate": "2017-12-26",
                "priorityFilingKeysActive": [
                    "KR 20170179939 A 20171226"
                ],
                "earliestPriorityDate": "2017-12-26",
                "title": "Pretreatment Method Of Sputum For Detecting Middle East Respiratory Syndrome Coronavirus",
                "applicants": [
                    "KOREA CENTER FOR DISEASE CONTROL AND PREVENTION",
                    "BIONOTE INC",
                    "KOREA UNIV RESEARCH AND BUSINESS FOUNDATION SEJONG CAMPUS"
                ],
                "inventors": [
                    "YANG JEONG SUN",
                    "KIM SUNG SOON",
                    "SONG DAESUB",
                    "NA WOONSUNG",
                    "KANG ARAM",
                    "YEOM MINJOO",
                    "HA GUN WOO",
                    "KIM JUNG HO",
                    "KIM DONG HYUK"
                ],
                "owners": [],
                "url": "https://lens.org/189-539-934-245-997",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/68",
                    "C12N15/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "Am J Respir Crit Care Med. 177(2):132-41 (2008.01.15.)*",
                    "\ub300\ud55c\uc778\uc218\uacf5\ud1b5\uc804\uc5fc\ubcd1\ud559\ud68c 2017(1): 232-232. (2017.05.)*"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "034-373-591-200-958"
                ],
                "nplResolvedExternalIDs": [
                    "17962642",
                    "10.1164/rccm.200603-311oc"
                ]
            },
            {
                "index": "114",
                "publicationKey": "KR_102033773_B1",
                "lensId": "186-901-282-628-158",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 102033773 B1",
                "publicationDate": "2019-10-17",
                "filingNumber": "KR 20170179939 A",
                "filingDate": "2017-12-26",
                "priorityFilingKeysActive": [
                    "KR 20170179939 A 20171226"
                ],
                "earliestPriorityDate": "2017-12-26",
                "title": "Pretreatment Method Of Sputum For Detecting Middle East Respiratory Syndrome Coronavirus",
                "applicants": [],
                "inventors": [],
                "owners": [],
                "url": "https://lens.org/186-901-282-628-158",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/68",
                    "C12N15/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "115",
                "publicationKey": "BR_112016025009_A2",
                "lensId": "008-694-349-069-650",
                "jurisdiction": "BR",
                "kindCode": "A2",
                "displayKey": "BR 112016025009 A2",
                "publicationDate": "2017-10-24",
                "filingNumber": "BR 112016025009 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Anticorpos Humanos Para A S\u00edndrome Respirat\u00f3ria Do Oriente M\u00e9dio - Prote\u00edna De Superf\u00edcie",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "CHRISTOS KYRATSOUS",
                    "NEIL STAHL",
                    "SUMATHI SIVAPALASINGAM"
                ],
                "owners": [],
                "url": "https://lens.org/008-694-349-069-650",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "C07K16/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "116",
                "publicationKey": "CL_2016002934_A1",
                "lensId": "044-260-842-665-947",
                "jurisdiction": "CL",
                "kindCode": "A1",
                "displayKey": "CL 2016002934 A1",
                "publicationDate": "2017-11-03",
                "filingNumber": "CL 2016002934 A",
                "filingDate": "2016-11-17",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Anticuerpos Humanos Frente A La Prote\u00edna De Anclaje Del Coronavirus Causante Del S\u00edndrome Respiratorio De Oriente Medio",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/044-260-842-665-947",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/00",
                    "A61K39/215",
                    "C07K16/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "117",
                "publicationKey": "CA_2949438_A1",
                "lensId": "025-030-969-531-29X",
                "jurisdiction": "CA",
                "kindCode": "A1",
                "displayKey": "CA 2949438 A1",
                "publicationDate": "2015-11-26",
                "filingNumber": "CA 2949438 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome - Coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/025-030-969-531-29X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61P31/14",
                    "C12N15/13",
                    "C12P21/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "118",
                "publicationKey": "EA_201691877_A1",
                "lensId": "061-691-231-528-119",
                "jurisdiction": "EA",
                "kindCode": "A1",
                "displayKey": "EA 201691877 A1",
                "publicationDate": "2017-03-31",
                "filingNumber": "EA 201691877 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "\u0427\u0435\u043b\u043e\u0432\u0435\u0447\u0435\u0441\u043a\u0438\u0435 \u0410\u043d\u0442\u0438\u0442\u0435\u043b\u0430 \u041a \u0421\u043f\u0430\u0439\u043a-\u0431\u0435\u043b\u043a\u0443 \u041a\u043e\u0440\u043e\u043d\u0430\u0432\u0438\u0440\u0443\u0441\u0430 \u0411\u043b\u0438\u0436\u043d\u0435\u0432\u043e\u0441\u0442\u043e\u0447\u043d\u043e\u0433\u043e \u0420\u0435\u0441\u043f\u0438\u0440\u0430\u0442\u043e\u0440\u043d\u043e\u0433\u043e \u0421\u0438\u043d\u0434\u0440\u043e\u043c\u0430",
                "applicants": [
                    "\u0420\u0418\u0414\u0416\u0415\u041d\u0415\u0420\u041e\u041d \u0424\u0410\u0420\u041c\u0410\u0421\u042c\u042e\u0422\u0418\u041a\u0410\u041b\u0417, \u0418\u041d\u041a."
                ],
                "inventors": [
                    "\u041a\u0438\u0440\u0430\u0442\u0441\u043e\u0443\u0441 \u041a\u0440\u0438\u0441\u0442\u043e\u0441",
                    "\u0428\u0442\u0430\u043b\u044c \u041d\u0435\u0439\u043b",
                    "\u0421\u0438\u0432\u0430\u043f\u0430\u043b\u0430\u0441\u0438\u043d\u0433\u0430\u043c \u0421\u0443\u043c\u0430\u0442\u0445\u0438"
                ],
                "owners": [],
                "url": "https://lens.org/061-691-231-528-119",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "C07K16/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "119",
                "publicationKey": "EP_3145539_A1",
                "lensId": "041-693-532-102-06X",
                "jurisdiction": "EP",
                "kindCode": "A1",
                "displayKey": "EP 3145539 A1",
                "publicationDate": "2017-03-29",
                "filingNumber": "EP 15726488 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/041-693-532-102-06X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "C07K16/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "120",
                "publicationKey": "IL_248392_D0",
                "lensId": "092-266-640-372-247",
                "jurisdiction": "IL",
                "kindCode": "D0",
                "displayKey": "IL 248392 D0",
                "publicationDate": "2016-11-30",
                "filingNumber": "IL 24839216 A",
                "filingDate": "2016-10-19",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [],
                "owners": [],
                "url": "https://lens.org/092-266-640-372-247",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "121",
                "publicationKey": "MX_2016015263_A",
                "lensId": "106-049-317-254-334",
                "jurisdiction": "MX",
                "kindCode": "A",
                "displayKey": "MX 2016015263 A",
                "publicationDate": "2017-03-23",
                "filingNumber": "MX 2016015263 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein.",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "NEIL STAHL",
                    "SUMATHI SIVAPALASINGAM",
                    "CHRISTOS KYRATSOUS"
                ],
                "owners": [],
                "url": "https://lens.org/106-049-317-254-334",
                "docType": "ambiguous",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "C07K16/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "122",
                "publicationKey": "KR_102007161_B1",
                "lensId": "029-123-216-751-472",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 102007161 B1",
                "publicationDate": "2019-08-07",
                "filingNumber": "KR 20180136210 A",
                "filingDate": "2018-11-07",
                "priorityFilingKeysActive": [
                    "KR 20180136210 A 20181107"
                ],
                "earliestPriorityDate": "2018-11-07",
                "title": "S1 Monoclonal Antibodies Of Specifically Binding To Spike S1 Protein Of Mers-cov",
                "applicants": [
                    "KOREA CENTER FOR DISEASE CONTROL AND PREVENTION"
                ],
                "inventors": [
                    "JOO YEON LEE",
                    "SUNG SOON KIM",
                    "HANSAEM LEE",
                    "HYE MIN WOO",
                    "HYEMIN KO",
                    "JOO AE KIM"
                ],
                "owners": [],
                "url": "https://lens.org/029-123-216-751-472",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61P31/14",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "Emerging Microbes & Infections. 2017, 6:e37.*"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "091-978-442-637-24X",
                    "127-221-772-931-433"
                ],
                "nplResolvedExternalIDs": [
                    "pmc5520482",
                    "28536429",
                    "10.1038/emi.2017.18"
                ]
            },
            {
                "index": "123",
                "publicationKey": "PH_12016502064_A1",
                "lensId": "087-819-750-992-101",
                "jurisdiction": "PH",
                "kindCode": "A1",
                "displayKey": "PH 12016502064 A1",
                "publicationDate": "2016-12-19",
                "filingNumber": "PH 12016502064 A",
                "filingDate": "2016-10-17",
                "priorityFilingKeysActive": [
                    "US 201462072716 P 20141030",
                    "US 201462051717 P 20140917",
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome-coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "CHRISTOS KYRATSOUS",
                    "NEIL STAHL",
                    "SUMATHI SIVAPALASINGAM"
                ],
                "owners": [],
                "url": "https://lens.org/087-819-750-992-101",
                "docType": "unknown",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/00",
                    "A61K39/215",
                    "C07K16/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "124",
                "publicationKey": "SG_11201608567Y_A",
                "lensId": "006-116-457-525-484",
                "jurisdiction": "SG",
                "kindCode": "A",
                "displayKey": "SG 11201608567Y A",
                "publicationDate": "2016-11-29",
                "filingNumber": "SG 11201608567Y A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/006-116-457-525-484",
                "docType": "unknown",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "C07K16/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "125",
                "publicationKey": "KR_20170005133_A",
                "lensId": "055-360-038-003-747",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20170005133 A",
                "publicationDate": "2017-01-11",
                "filingNumber": "KR 20167036178 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "- Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/055-360-038-003-747",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 5,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 916,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K39/395",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "126",
                "publicationKey": "KR_20190093107_A",
                "lensId": "011-351-757-256-627",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20190093107 A",
                "publicationDate": "2019-08-08",
                "filingNumber": "KR 20180108125 A",
                "filingDate": "2018-09-11",
                "priorityFilingKeysActive": [
                    "KR 20180011776 A 20180131"
                ],
                "earliestPriorityDate": "2018-01-31",
                "title": "A Binding Molecules Able To Neutralize Middle East Respiratory-syndrome Coronavirus",
                "applicants": [
                    "CELLTRION INC"
                ],
                "inventors": [
                    "LEE SOO YOUNG",
                    "YI KYE SOOK",
                    "KIM CHEOL MIN",
                    "SONG HANNA",
                    "BAE YEON JIN",
                    "KIM WOO JOO",
                    "CHEONG HEE JIN",
                    "SONG JOON YOUNG",
                    "PARK MAN SEONG",
                    "NOH JI YUN"
                ],
                "owners": [],
                "url": "https://lens.org/011-351-757-256-627",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "127",
                "publicationKey": "KR_20190093110_A",
                "lensId": "123-622-367-774-886",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20190093110 A",
                "publicationDate": "2019-08-08",
                "filingNumber": "KR 20180138228 A",
                "filingDate": "2018-11-12",
                "priorityFilingKeysActive": [
                    "KR 20180011776 A 20180131"
                ],
                "earliestPriorityDate": "2018-01-31",
                "title": "A Binding Molecules Able To Neutralize Middle East Respiratory-syndrome Coronavirus",
                "applicants": [
                    "CELLTRION INC"
                ],
                "inventors": [
                    "LEE SOO YOUNG",
                    "YI KYE SOOK",
                    "KIM CHEOL MIN",
                    "SONG HANNA",
                    "BAE YEON JIN",
                    "KIM WOO JOO",
                    "CHEONG HEE JIN",
                    "SONG JOON YOUNG",
                    "PARK MAN SEONG",
                    "NOH JI YUN"
                ],
                "owners": [],
                "url": "https://lens.org/123-622-367-774-886",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "128",
                "publicationKey": "KR_20190093114_A",
                "lensId": "098-214-298-755-552",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20190093114 A",
                "publicationDate": "2019-08-08",
                "filingNumber": "KR 20180152779 A",
                "filingDate": "2018-11-30",
                "priorityFilingKeysActive": [
                    "KR 20180011776 A 20180131"
                ],
                "earliestPriorityDate": "2018-01-31",
                "title": "A Binding Molecules Able To Neutralize Middle East Respiratory-syndrome Coronavirus",
                "applicants": [
                    "CELLTRION INC"
                ],
                "inventors": [
                    "LEE SOO YOUNG",
                    "YI KYE SOOK",
                    "KIM CHEOL MIN",
                    "SONG HANNA",
                    "BAE YEON JIN",
                    "KIM WOO JOO",
                    "CHEONG HEE JIN",
                    "SONG JOON YOUNG",
                    "PARK MAN SEONG",
                    "NOH JI YUN"
                ],
                "owners": [],
                "url": "https://lens.org/098-214-298-755-552",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "129",
                "publicationKey": "ZA_201607047_B",
                "lensId": "131-289-824-570-605",
                "jurisdiction": "ZA",
                "kindCode": "B",
                "displayKey": "ZA 201607047 B",
                "publicationDate": "2017-09-27",
                "filingNumber": "ZA 201607047 A",
                "filingDate": "2016-10-13",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "SIVAPALASINGAM SUMATHI",
                    "STAHL NEIL",
                    "KYRATSOUS CHRISTOS"
                ],
                "owners": [],
                "url": "https://lens.org/131-289-824-570-605",
                "docType": "unknown",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "130",
                "publicationKey": "WO_2015_179535_A1",
                "lensId": "057-128-608-970-373",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/179535 A1",
                "publicationDate": "2015-11-26",
                "filingNumber": "US 2015/0031800 W",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/057-128-608-970-373",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 4,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "C07K16/08"
                ],
                "usClassifications": [],
                "nplCitationCount": 44,
                "nplCitations": [
                    "X.-C. TANG ET AL: \"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 111, no. 19, 13 May 2014 (2014-05-13), pages E2018 - E2026, XP055162782, ISSN: 0027-8424, DOI: 10.1073/pnas.1402074111",
                    "YING TIANLEI ET AL: \"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies\", JOURNAL OF VIROLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 88, no. 14, 30 April 2014 (2014-04-30), pages 7796 - 7805, XP009181617, ISSN: 1098-5514, DOI: 10.1128/JVI.00912-14",
                    "JIANG LIWEI ET AL: \"Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\", SCIENCE TRANSLATIONAL MEDICINE,, vol. 6, no. 234, 30 April 2014 (2014-04-30), pages - 9, XP009182042, ISSN: 1946-6234",
                    "ZAKI ET AL., NEJM, vol. 367, 2012, pages 1814 - 1820",
                    "RAJ ET AL., NATURE, vol. 495, 2013, pages 251 - 256",
                    "LU ET AL., NATURE, vol. 500, 2013, pages 227 - 231",
                    "DU ET AL., J. VIROL., 2014",
                    "YING ET AL., J. VIROL., 2014",
                    "TANG ET AL., PNAS, 2014",
                    "JIANG ET AL., SCI. TRANSL. MED., vol. 6, 2014, pages 234RA59",
                    "REDDY ET AL., J. IMMUNOL., vol. 164, 2000, pages 1925 - 1933",
                    "KABAT, SEQUENCES OF PROTEINS OF IMMUNOLOGICAL INTEREST, 1991",
                    "AL-LAZIKANI ET AL., J. MOL. BIOL., vol. 273, 1997, pages 927 - 948",
                    "MARTIN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 9268 - 9272",
                    "SHIELD ET AL., JBC, vol. 277, 2002, pages 26733",
                    "RAJ ET AL., NATURE, vol. 495, 2013, pages 251 - 254",
                    "MOU ET AL., J. VIROLOGY, vol. 87, 2013, pages 9379 - 9383",
                    "PADLAN ET AL., FASEB J., vol. 9, 1995, pages 133 - 139",
                    "VAJDOS ET AL., J MOL BIOL, vol. 320, 2002, pages 415 - 428",
                    "PEARSON, METHODS MOL. BIOL., vol. 24, 1994, pages 307 - 331",
                    "GONNET ET AL., SCIENCE, vol. 256, 1992, pages 1443 - 45",
                    "ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 410",
                    "NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402",
                    "LLOYD, THE ART, SCIENCE AND TECHNOLOGY OF PHARMACEUTICAL COMPOUNDING, 1999",
                    "GOOD ET AL., CANCER, vol. 68, 1991, pages 1415 - 1421",
                    "MARASCO ET AL., NATURE BIOTECHNOLOGY, vol. 25, 2007, pages 1421 - 1434",
                    "HARLOW; LANE: \"Antibodies\", COLD SPRING HARBOR PRESS",
                    "REINEKE, METHODS MOL. BIOL., vol. 248, 2004, pages 443 - 63",
                    "TOMER, PROT. SCI., vol. 9, 2000, pages 487 - 496",
                    "EHRING, ANALYTICAL BIOCHEMISTRY, vol. 267, 1999, pages 252 - 259",
                    "ENGEN; SMITH, ANAL. CHEM., vol. 73, 2001, pages 256A - 265A",
                    "JUNGHANS ET AL., CANCER RES., vol. 50, 1990, pages 1495 - 1502",
                    "TUTT ET AL., J. IMMUNOL., vol. 147, 1991, pages 60 - 69",
                    "KUFER ET AL., TRENDS BIOTECHNOL., vol. 22, 2004, pages 238 - 244",
                    "KAZANE ET AL., J. AM. CHEM. SOC., 4 December 2012 (2012-12-04)",
                    "\"Remington's Pharmaceutical Sciences\", MACK PUBLISHING COMPANY",
                    "POWELL ET AL.: \"Compendium of excipients for parenteral formulations\", J PHARM SCI TECHNOL, vol. 52, 1998, pages 238 - 311, XP009119027",
                    "WU ET AL., J. BIOL. CHEM., vol. 262, 1987, pages 4429 - 4432",
                    "LANGER, SCIENCE, vol. 249, 1990, pages 1527 - 1533",
                    "ARRUEBO, M. ET AL.: \"Antibody-conjugated nanoparticles for biomedical applications\", J. NANOMAT., vol. 2009, 2009, pages 24",
                    "MALPICA ET AL., GENETICS, vol. 162, 2002, pages 1505 - 1511",
                    "JIANG ET AL., SCI. TRANSL. MED., 2014",
                    "VALENZUELA ET AL., NAT. BIOTECHNOL., vol. 21, 2003, pages 652 - 659",
                    "POUEYMIROU, NATURE BIOTECHNOLOGY, vol. 25, 2007, pages 91 - 99"
                ],
                "nplResolvedCount": 31,
                "nplResolvedLensIDs": [
                    "048-623-783-675-63X",
                    "108-511-801-833-75X",
                    "004-701-796-869-470",
                    "022-375-749-274-329",
                    "113-446-080-346-814",
                    "052-664-611-823-937",
                    "007-875-147-167-216",
                    "007-047-414-654-825",
                    "051-707-000-800-833",
                    "059-212-558-154-670",
                    "016-034-870-606-687",
                    "085-122-255-782-470",
                    "007-845-004-248-599",
                    "046-419-902-381-810",
                    "142-265-334-235-532",
                    "174-067-461-309-323",
                    "056-201-471-905-934",
                    "023-868-377-007-810",
                    "055-005-586-964-518",
                    "034-892-502-452-681",
                    "020-009-029-407-493",
                    "145-146-407-738-040",
                    "043-148-481-331-661",
                    "028-862-168-091-90X",
                    "009-507-053-935-564",
                    "045-149-256-448-908",
                    "023-671-383-084-282",
                    "026-221-045-144-327",
                    "079-080-784-051-77X",
                    "010-655-350-435-62X",
                    "032-720-983-972-675"
                ],
                "nplResolvedExternalIDs": [
                    "12079396",
                    "10.1128/jvi.01277-13",
                    "10.1006/abio.1998.3000",
                    "10.1073/pnas.86.23.9268",
                    "2231712",
                    "10.1038/nbt1263",
                    "1878838",
                    "3558345",
                    "2218494",
                    "10.1096/fasebj.9.1.7821752",
                    "23785207",
                    "23831647",
                    "10.4049/jimmunol.164.4.1925",
                    "10.1126/science.1604319",
                    "pmc4024880",
                    "10.1006/jmbi.1997.1354",
                    "10.1128/jvi.00912-14",
                    "10036128",
                    "8205202",
                    "pmc1462378",
                    "23486063",
                    "pmc146917",
                    "9254694",
                    "23075143",
                    "9846074",
                    "10.1021/ac012452f",
                    "10.1002/1097-0142(19910915)68:6+<1415::aid-cncr2820681402>3.0.co;2-0",
                    "10.1016/j.tibtech.2004.03.006",
                    "pmc298475",
                    "10.1016/s0022-2836(05)80360-2",
                    "10.1073/pnas.1402074111",
                    "10.1056/nejmoa1211721",
                    "10657642",
                    "12730667",
                    "10.1038/nbt1363",
                    "17187059",
                    "14970513",
                    "12524327",
                    "10.1016/s0022-2836(02)00264-4",
                    "10.1016/s0167-7799(04)00080-0",
                    "pmc3754068",
                    "10.1038/nbt822",
                    "15109810",
                    "1604319",
                    "10.1038/nature12005",
                    "24778221",
                    "10.1006/jmbi.1990.9999",
                    "10.1126/science.2218494",
                    "1675655",
                    "10.1038/nature12328",
                    "24789777",
                    "7821752",
                    "10.1126/scitranslmed.3008140",
                    "9367782",
                    "10.1385/1-59259-666-5:443",
                    "pmc4097770",
                    "10.1093/nar/25.17.3389",
                    "10.1385/0-89603-246-9:307",
                    "2406013",
                    "24778414",
                    "18066039",
                    "2594766",
                    "11354508"
                ]
            },
            {
                "index": "131",
                "publicationKey": "WO_2017_010835_A1",
                "lensId": "045-313-279-230-815",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/010835 A1",
                "publicationDate": "2017-01-19",
                "filingNumber": "KR 2016007719 W",
                "filingDate": "2016-07-15",
                "priorityFilingKeysActive": [
                    "KR 20150101046 A 20150716"
                ],
                "earliestPriorityDate": "2015-07-16",
                "title": "Use Of Radotinib For Prevention Or Treatment Of Viral Respiratory Disease",
                "applicants": [
                    "IL-YANG PHARM CO LTD"
                ],
                "inventors": [
                    "KIM DONG YEON",
                    "PARK MAN SEONG",
                    "CHO DAE JIN",
                    "LEE GONG YEAL",
                    "KIM HONG YOUB",
                    "LEE HEA UN",
                    "AHN CHOONG AM",
                    "BANG HYE JIN",
                    "SONG SONG EI",
                    "PARK JONG SEONG"
                ],
                "owners": [],
                "url": "https://lens.org/045-313-279-230-815",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/506",
                    "A61K31/4178",
                    "A61K31/497"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "DYALL, J. ET AL.: \"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.\", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 58, no. 8, 2014, pages 4885 - 4893, XP055321806",
                    "KIM, S.-H. ET AL.: \"Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors.\", HAEMATOLOGICA, vol. 99, no. 7, 2014, pages 1191 - 1196, XP055346578",
                    "KIM, D.-W.: \"Recent advances of management for chronic myeloid leukemia.\", THE KOREAN JOURNAL OF MEDICINE, vol. 83, no. 6, 2012, pages 718 - 723, XP055346584",
                    "HEO, S.-K. ET AL.: \"Radotinib induces apoptosis of CDllb+ cells differentiated from acute myeloid leukemia cells.\", PLOS ONE, vol. 10, no. 6, June 2015 (2015-06-01), pages 1 - 18, XP055346586"
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "084-056-283-121-611",
                    "060-128-920-862-316",
                    "034-799-376-806-357",
                    "078-927-472-648-096",
                    "026-518-238-956-425"
                ],
                "nplResolvedExternalIDs": [
                    "10.1371/journal.pone.0129853",
                    "10.3904/kjm.2012.83.6.718",
                    "pmc4077080",
                    "24705186",
                    "pmc4466365",
                    "pmc4136000",
                    "10.1128/aac.03036-14",
                    "26065685",
                    "10.3324/haematol.2014.123232",
                    "25740109",
                    "24841273",
                    "pmc4349295",
                    "10.3324/haematol.2013.096776"
                ]
            },
            {
                "index": "132",
                "publicationKey": "WO_2017_176596_A1",
                "lensId": "138-661-899-573-600",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/176596 A1",
                "publicationDate": "2017-10-12",
                "filingNumber": "US 2017/0025623 W",
                "filingDate": "2017-03-31",
                "priorityFilingKeysActive": [
                    "US 201662318087 P 20160404"
                ],
                "earliestPriorityDate": "2016-04-04",
                "title": "Multivalent Vaccines For Rabies Virus And Coronaviruses",
                "applicants": [
                    "THE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES",
                    "THE UNIV OF MARYLAND",
                    "UNIV JEFFERSON"
                ],
                "inventors": [
                    "JOHNSON REED F PH D",
                    "SCHNELL MATTHIAS",
                    "HENSLEY LISA E",
                    "WIRBLICH CHRISTOPH",
                    "COLEMAN CHRISTOPHER M",
                    "FRIEMAN MATTHEW B"
                ],
                "owners": [],
                "url": "https://lens.org/138-661-899-573-600",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 24,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/205",
                    "A61K39/215",
                    "C12N7/04",
                    "C12N15/86"
                ],
                "usClassifications": [],
                "nplCitationCount": 80,
                "nplCitations": [
                    "M. FABER: \"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies\", JOURNAL OF GENERAL VIROLOGY., vol. 86, no. 5, 1 May 2005 (2005-05-01), GB, pages 1435 - 1440, XP055380471, ISSN: 0022-1317, DOI: 10.1099/vir.0.80844-0",
                    "J. P. MCGETTIGAN ET AL: \"Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic\", JOURNAL OF VIROLOGY, vol. 77, no. 1, 1 January 2003 (2003-01-01), pages 237 - 244, XP055028019, ISSN: 0022-538X, DOI: 10.1128/JVI.77.1.237-244.2003",
                    "ANNA H. MALCZYK ET AL: \"A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform ABSTRACT\", JOURNAL OF VIROLOGY., vol. 89, no. 22, 9 September 2015 (2015-09-09), US, pages 11654 - 11667, XP055257597, ISSN: 0022-538X, DOI: 10.1128/JVI.01815-15",
                    "DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; January 2017 (2017-01-01), WIRBLICH CHRISTOPH ET AL: \"One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus\", XP009194667, Database accession no. PREV201700240013",
                    "\"Remington's Pharmaceutical Sciences\", MACK PUBLISHING COL, article \"Chapter 43\"",
                    "A. GENNARO: \"Remington: The Science and Practice of Pharmacy\", 2000, LIPPINCOTT, WILLIAMS, & WILKINS",
                    "\"Pharmaceutical Dosage Forms and Drug Delivery Systems\", 1999, LIPPINCOTT, WILLIAMS, & WILKINS",
                    "\"Handbook of Pharmaceutical Excipients\", 2000, AMER. PHARMACEUTICAL ASSOC.",
                    "BARRETT PN ET AL., EXPERT REV VACCINES, vol. 8, no. 5, May 2009 (2009-05-01), pages 607 - 618",
                    "TORDO N ET AL., DEV BIOL (BASEL, vol. 131, 2008, pages 467 - 476",
                    "TOOVEY S. ET AL., TRAVEL MED INFECT DIS., vol. 5, no. 6, November 2007 (2007-11-01), pages 327 - 348",
                    "CHELBI-ALIX MK, J INTERFERON CYTOKINE RES., vol. 26, no. 5, May 2006 (2006-05-01), pages 271 - 280",
                    "MORENWEISER R. ET AL., GENE THER., vol. 12, no. 1, October 2005 (2005-10-01), pages 103 - 110",
                    "MORIMOTO K ET AL., VIRUS RES., vol. 111, no. 1, 11 April 2005 (2005-04-11), pages 61 - 67",
                    "FINKE S ET AL., VIRUS RES., vol. 111, no. 2, August 2005 (2005-08-01), pages 120 - 131",
                    "HALDER M., ALTERN LAB ANIM., vol. 30, no. 1, January 2002 (2002-01-01), pages 93 - 108",
                    "MONTAGNON BJ ET AL., DEV BIOL STAND, vol. 93, 1998, pages 119 - 123",
                    "\"Current Protocols in Molecular Biology\", JOHN WILEY AND SONS, INC",
                    "MIYAO ET AL., DSRNA RES. DEV., vol. 5, 1995, pages 115 - 121",
                    "TAKAKURA ET AL., DSRNA & NUCL. ACID DRUG DEV., vol. 6, 1996, pages 177 - 183",
                    "\"The Merck Manual of Diagnosis and Therapy\", 1987, pages: 1206 - 1228",
                    "\"The Merck Manual of Diagnosis and Therapy\", 1987, pages: 2499 - 2506,46-",
                    "ZHANG ET AL., J. CONTROL RELEASE, vol. 100, 2004, pages 165 - 180",
                    "MILNE-PRICE S; MIAZGOWICZ KL; MUNSTER VJ.: \"The emergence of the Middle East respiratory syndrome coronavirus\", PATHOG DIS, vol. 71, 2014, pages 121 - 136",
                    "ZAKI AM ET AL: \"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.\", N ENGL J MED, vol. 367, 2012, pages 1814 - 1820, XP055274765, DOI: doi:10.1056/NEJMoa1211721",
                    "\"WHO Statement on the third meeting of the IHR Emergency committee concerning Middle East respiratory syndrome coronavirus (MERS-CoV\", WKLY EPIDEMIOL REC, vol. 88, 2013, pages 435 - 436",
                    "MEMISH ZA; ZUMLA AI; ASSIRI A.: \"Middle East respiratory syndrome coronavirus infections in health care workers\", N ENGL J MED, vol. 369, 2013, pages 884 - 886",
                    "DROSTEN C; KELLAM P; MEMISH ZA: \"Evidence for camel-to-human transmission of MERS coronavirus\", N ENGL J MED, vol. 371, 2014, pages 1359 - 1360",
                    "MADANI TA; AZHAR EI; HASHEM AM: \"Evidence for camel-to-human transmission of MERS coronavirus\", N ENGL J MED, vol. 371, 2014, pages 1360",
                    "AZHAR ET AL: \"Evidence for camel-to-human transmission of MERS coronavirus\", N ENGL J MED, vol. 370, 2014, pages 2499 - 2505",
                    "KHAN A; FAROOQUI A; GUAN Y; KELVIN DJ.: \"Lessons to learn from MERS-CoV outbreak in South Korea\", J INFECT DEV CTRIES, vol. 9, 2015, pages 543 - 546",
                    "PARK HY ET AL: \"Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea\", EURO SURVEILL, vol. 20, May 2015 (2015-05-01), pages 1 - 6",
                    "PETERSEN E; POLLACK MM; MADOFF LC.: \"Health-care associate transmission of Middle East Respiratory Syndrome Corona virus, MERS-CoV, in the Kingdom of Saudi Arabia\", INT J INFECT DIS, vol. 29, 2014, pages 299 - 300",
                    "CAUCHEMEZ S. ET AL: \"Transmission scenarios for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and how to tell them apart.\", EURO SURVEILL, 2013, pages 18",
                    "CHAN PK; MA S; NGAI SM.: \"Identification of T-cell epitopes of SARS-coronavirus for development of peptide-based vaccines and cellular immunity assessment methods\", HONG KONG MED J, vol. 17, no. 6, 2011, pages 26 - 30",
                    "ROPER RL; REHM KE: \"SARS vaccines: where are we?\", EXPERT REV VACCINES, vol. 8, 2009, pages 887 - 898",
                    "ZHU X. ET AL: \"Receptor-binding domain as a target for developing SARS vaccines.\", J THORAC DIS, vol. 5, no. 2, 2013, pages 142 - 148",
                    "DU L; JIANG S.: \"Middle East respiratory syndrome: current status and future prospects for vaccine development.\", EXPERT OPIN BIOL THER, vol. 15, 2015, pages 1647 - 1651",
                    "VOLZ A. ET AL: \"Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein\", J VIROL, vol. 89, 2015, pages 8651 - 8656, XP055257600, DOI: doi:10.1128/JVI.00614-15",
                    "MA C. ET AL: \"Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design\", VACCINE, vol. 32, 2014, pages 6170 - 6176, XP029049168, DOI: doi:10.1016/j.vaccine.2014.08.086",
                    "MA C.ET AL: \"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines\", VACCINE, vol. 32, 2014, pages 2100 - 2108, XP028838491, DOI: doi:10.1016/j.vaccine.2014.02.004",
                    "MUTHUMANI K. ET AL: \"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates.\", SCI TRANSL MED, vol. 7, 2015, pages 301RA132",
                    "COLEMAN CM ET AL: \"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.\", VACCINE, vol. 32, 2014, pages 3169 - 3174, XP028654166, DOI: doi:10.1016/j.vaccine.2014.04.016",
                    "MOU H. ET AL: \"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies\", J VIROL, vol. 87, 2013, pages 9379 - 9383, XP055162922, DOI: doi:10.1128/JVI.01277-13",
                    "DU L. ET AL: \"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development\", J VIROL, vol. 87, 2013, pages 9939 - 9942, XP055157122, DOI: doi:10.1128/JVI.01048-13",
                    "ZHANG N. ET AL: \"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus\", CELL MOL IMMUNOL, 2015",
                    "YANG Y. ET AL: \"The amino acids 736-761 of the MERS-CoV spike protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents\", VIRAL IMMUNOL, vol. 27, 2014, pages 543 - 550",
                    "KIM E. ET AL: \"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice\", VACCINE, vol. 32, 2014, pages 5975 - 5982, XP029069689, DOI: doi:10.1016/j.vaccine.2014.08.058",
                    "GUO X. ET AL: \"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus\", IMMUNOLOGY, vol. 145, 2015, pages 476 - 484",
                    "PFALLER CK; CATTANEO R; SCHNELL MJ.: \"Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics\", VIROLOGY, 2015",
                    "WILLET M. ET AL: \"Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses\", J INFECT DIS, 2015",
                    "HUTTNER A. ET AL: \"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial\", LANCET INFECT DIS, vol. 15, 2015, pages 1156 - 1166",
                    "BLANEY JE ET AL: \"Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine\", PLOS PATHOG, vol. 9, 2013, pages E1003389",
                    "BLANEY JE ET AL: \"Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses\", J VIROL, vol. 85, 2011, pages 10605 - 10616, XP055027816, DOI: doi:10.1128/JVI.00558-11",
                    "PAPANERI AB ET AL: \"A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence\", VIROLOGY, vol. 434, 2012, pages 18 - 26",
                    "PAPANERI AB ET AL: \"Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein\", VACCINE, vol. 30, 2012, pages 6136 - 6141",
                    "CLIQUET F; AUBERT M.: \"Elimination of terrestrial rabies in Western European countries\", DEV BIOL (BASEL, vol. 119, 2004, pages 185 - 204",
                    "RABIES, FACT SHEET, 2015, pages 99",
                    "MCGETTIGAN JP; POMERANTZ RJ; SILER CA; MCKENNA PM; FOLEY HD; DIETZSCHOLD B; SCHNELL MJ.: \"Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic\", J VIROL, vol. 77, 2003, pages 237 - 244, XP055028019, DOI: doi:10.1128/JVI.77.1.237-244.2003",
                    "PAPANERI AB; WIRBLICH C; MARISSEN WE; SCHNELL MJ.: \"Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment.\", VACCINE, vol. 31, 2013, pages 5897 - 5902, XP028776495, DOI: doi:10.1016/j.vaccine.2013.09.038",
                    "KURUP D; WIRBLICH C; FELDMANN H; MARZI A; SCHNELL MJ.: \"Rhabdoviral-Based Vaccine Platforms against Henipaviruses\", J VIROL, 2014",
                    "ZHAO J. ET AL: \"Rapid generation of a mouse model for Middle East respiratory syndrome\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 111, 2014, pages 4970 - 4975, XP055212024, DOI: doi:10.1073/pnas.1323279111",
                    "PASCAL KE E AL: \"Pre-and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 112, 2015, pages 8738 - 8743",
                    "COLEMAN CM; FRIEMAN MB.: \"Growth and Quantification of MERS-CoV Infection\", CURRENT PROTOCOLS IN MICROBIOLOGY, vol. 37, no. 15E 12, 2015, pages 11 - 19",
                    "CONZELMANN KK ET AL: \"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19\", VIROLOGY, vol. 175, 1990, pages 485 - 499, XP023056033, DOI: doi:10.1016/0042-6822(90)90433-R",
                    "HUDACEK AW ET AL: \"Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo\", MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2014, pages 1",
                    "MCGETTIGAN JP ET AL: \"Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome\", J VIROL, vol. 77, 2003, pages 10889 - 10899, XP055028016, DOI: doi:10.1128/JVI.77.20.10889-10899.2003",
                    "LONTOK E; CORSE E; MACHAMER CE.: \"Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site\", J VIROL, vol. 78, 2004, pages 5913 - 5922",
                    "SCHWEGMANN-WESSELS C. ET AL: \"Comparison of vesicular stomatitis virus pseudotyped with the S proteins from a porcine and a human coronavirus\", J GEN VIROL, vol. 90, 2009, pages 1724 - 1729",
                    "FUKUSHI S. ET AL: \"Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein\", J GEN VIROL, vol. 86, 2005, pages 2269 - 2274, XP055006010, DOI: doi:10.1099/vir.0.80955-0",
                    "SMITH ME ET AL: \"Rabies virus glycoprotein as a carrier for anthrax protective antigen\", VIROLOGY, vol. 353, 2006, pages 344 - 356, XP005654110, DOI: doi:10.1016/j.virol.2006.05.010",
                    "MCKENNA PM ET AL: \"Covalently linked human immunodeficiency virus type 1 gpl20/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopes\", J VIROL, vol. 77, 2003, pages 12782 - 12794, XP003015642, DOI: doi:10.1128/JVI.77.23.12782-12794.2003",
                    "SILER CA ET AL: \"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.\", VIROLOGY, vol. 292, 2002, pages 24 - 34",
                    "SCHNELL MJ ET AL: \"Recombinant rabies virus as potential live-viral vaccines for HIV-1\", PROC NATL ACAD SCI U S A, vol. 97, 2000, pages 3544 - 3549, XP002313400, DOI: doi:10.1073/pnas.050589197",
                    "WINTER C. ET AL: \"The spike protein of infectious bronchitis virus is retained intracellularly by a tyrosine motif\", J VIROL, vol. 82, 2008, pages 2765 - 2771",
                    "SCHWEGMANN-WESSELS C; REN X; HERRLER G.: \"Intracellular transport of the S proteins of coronaviruses\", ADV EXP MED BIOL, vol. 581, 2006, pages 271 - 275",
                    "SCHWEGMANN-WESSELS C ET AL: \"A novel sorting signal for intracellular localization is present in the S protein of a porcine coronavirus but absent from severe acute respiratory syndrome-associated coronavirus.\", J BIOL CHEM, vol. 279, 2004, pages 43661 - 43666",
                    "COLEMAN CM; MATTHEWS KL; GOICOCHEA L; FRIEMAN MB.: \"Wild type and innate immune deficient mice are not susceptible to the Middle East Respiratory Syndrome Coronavirus\", J GEN VIROL, 2013",
                    "\"Pneumonia from Human Coronavirus in a Macaque Model\", N ENGL J MED, vol. 368, 18 May 2013 (2013-05-18), pages 1560 - 1562, Retrieved from the Internet <URL:http://www.nejm.org/doi/abs/10.1056/NEJMcl215691>",
                    "WANG L. ET AL: \"Evaluation of candidate vaccine approaches for MERS-CoV\", NAT COMMUN, vol. 6, 2015, pages 7712, XP055271251, DOI: doi:10.1038/ncomms8712"
                ],
                "nplResolvedCount": 73,
                "nplResolvedLensIDs": [
                    "186-131-706-503-300",
                    "014-222-463-869-012",
                    "006-187-565-187-783",
                    "018-858-508-332-649",
                    "082-704-325-838-62X",
                    "100-328-832-278-211",
                    "030-812-431-486-64X",
                    "032-514-877-351-077",
                    "073-670-783-767-946",
                    "005-378-015-489-66X",
                    "014-259-866-982-422",
                    "035-760-912-363-624",
                    "048-932-226-325-353",
                    "055-844-457-938-708",
                    "005-156-329-511-387",
                    "111-186-753-527-695",
                    "083-386-037-387-452",
                    "003-252-406-340-268",
                    "144-348-691-534-756",
                    "078-081-741-547-36X",
                    "011-161-347-459-213",
                    "017-277-733-543-918",
                    "001-460-168-050-735",
                    "118-660-215-665-839",
                    "113-247-817-446-456",
                    "071-691-773-181-474",
                    "067-884-443-627-767",
                    "094-008-083-779-263",
                    "022-899-518-024-071",
                    "001-859-682-521-346",
                    "007-882-357-040-729",
                    "032-556-517-411-211",
                    "122-907-742-543-047",
                    "048-463-665-735-216",
                    "024-304-505-069-69X",
                    "022-578-530-537-710",
                    "036-021-099-803-216",
                    "054-391-011-603-49X",
                    "018-103-960-238-098",
                    "078-710-383-444-481",
                    "080-249-086-891-460",
                    "025-804-338-184-099",
                    "015-744-293-104-440",
                    "014-894-183-227-316",
                    "075-104-348-923-162",
                    "044-658-427-636-241",
                    "020-600-994-448-068",
                    "141-683-074-439-656",
                    "034-461-427-208-00X",
                    "013-621-572-895-916",
                    "018-385-072-135-339",
                    "120-822-127-937-671",
                    "017-640-080-650-989",
                    "095-622-383-143-992",
                    "092-050-659-074-634",
                    "002-010-068-713-43X",
                    "022-590-916-692-360",
                    "009-507-053-935-564",
                    "023-671-383-084-282",
                    "073-007-095-991-601",
                    "035-596-626-535-729",
                    "017-696-574-305-547",
                    "017-009-482-039-774",
                    "076-921-778-471-668",
                    "002-608-926-300-030",
                    "047-651-486-067-322",
                    "055-833-259-904-765",
                    "005-857-892-715-452",
                    "084-660-300-366-33X",
                    "035-522-277-138-087",
                    "091-916-363-696-037",
                    "007-306-206-076-93X",
                    "083-071-859-057-528"
                ],
                "nplResolvedExternalIDs": [
                    "10.3410/f.725599658.793535757",
                    "10.1371/journal.ppat.1003389",
                    "10.1002/9780471729259.mc15e02s37",
                    "17983973",
                    "pmc4058772",
                    "26355094",
                    "16820183",
                    "10.1177/026119290203000109",
                    "10.1016/j.virol.2015.01.029",
                    "2139267",
                    "pmc4735735",
                    "10.1016/j.vaccine.2012.07.073",
                    "19538115",
                    "pmc4645655",
                    "pmc4301098",
                    "10.1093/infdis/jiv251",
                    "10.1016/j.tmaid.2007.07.004",
                    "23787162",
                    "26018172",
                    "pmc4194190",
                    "pmc3667758",
                    "10.3855/jidc.7278",
                    "25702088",
                    "24896817",
                    "pmc4194189",
                    "26290414",
                    "26132766",
                    "10.1128/jvi.77.23.12782-12794.2003",
                    "9737386",
                    "10.1099/vir.0.80844-0",
                    "pmc224996",
                    "10.1016/s1473-3099(15)00154-1",
                    "10.1016/j.virusres.2005.03.011",
                    "24197535",
                    "24585737",
                    "10.1016/j.vaccine.2014.02.004",
                    "pmc4573558",
                    "pmc3807362",
                    "10.1128/jvi.02308-14",
                    "10.1111/imm.12462",
                    "pmc4557643",
                    "10.1073/pnas.1510830112",
                    "pmc16276",
                    "23824801",
                    "10.1007/978-0-387-33012-9_45",
                    "10.1126/scitranslmed.aac7462",
                    "10.1016/j.jconrel.2004.08.019",
                    "10.1056/nejmc1308698",
                    "19264610",
                    "22884661",
                    "pmc3187516",
                    "10.1111/2049-632x.12166",
                    "pmc4106996",
                    "26015984",
                    "16689655",
                    "25640653",
                    "23737747",
                    "pmc3754068",
                    "15831955",
                    "10.1016/j.virol.2012.07.020",
                    "24736006",
                    "pmc4259179",
                    "10.1056/nejmc1215691",
                    "pmc4525294",
                    "10.1016/j.vaccine.2014.08.086",
                    "17037541",
                    "10.1038/mtm.2014.46",
                    "10.1517/14712598.2015.1092518",
                    "21849459",
                    "15896403",
                    "14610200",
                    "pmc140592",
                    "26218507",
                    "14512539",
                    "10.1128/jvi.00614-15",
                    "10.2807/1560-7917.es2015.20.25.21169",
                    "pmc262580",
                    "10.1128/jvi.77.1.237-244.2003",
                    "26124093",
                    "10.1586/erv.09.19",
                    "10.1056/nejmoa1401505",
                    "pmc3754113",
                    "pmc3977243",
                    "10.1128/jvi.02064-07",
                    "10.1016/j.vaccine.2014.04.016",
                    "10.1016/j.vaccine.2013.09.038",
                    "10.1074/jbc.m407233200",
                    "pmc415842",
                    "pmc2258963",
                    "10.1089/vim.2014.0080",
                    "10.1006/viro.2001.1212",
                    "10.1128/jvi.01277-13",
                    "22889613",
                    "26414077",
                    "pmc3434297",
                    "10.1016/j.virusres.2005.04.004",
                    "pmc3484205",
                    "10.1128/jvi.00558-11",
                    "10.1128/jvi.78.11.5913-5922.2004",
                    "8915502",
                    "pmc4088931",
                    "12477829",
                    "pmc6624136",
                    "25387086",
                    "10.1089/jir.2006.26.271",
                    "10.1128/jvi.01815-15",
                    "23785207",
                    "pmc4507189",
                    "25320306",
                    "10706640",
                    "27807241",
                    "pmc4524222",
                    "26063224",
                    "15544865",
                    "24560617",
                    "pmc4515128",
                    "26248510",
                    "25461234",
                    "10.1016/j.vaccine.2014.08.058",
                    "11878905",
                    "pmc4362357",
                    "11827574",
                    "23075143",
                    "25271615",
                    "15140989",
                    "25271614",
                    "10.1128/jvi.77.20.10889-10899.2003",
                    "10.1016/0042-6822(90)90433-r",
                    "25240756",
                    "15747421",
                    "10.1128/jvi.01048-13",
                    "26344219",
                    "pmc1361274",
                    "pmc3815470",
                    "10.1073/pnas.050589197",
                    "18094153",
                    "16033974",
                    "10.1056/nejmoa1211721",
                    "10.1586/erv.09.43",
                    "10.1038/ncomms8712",
                    "10.1099/vir.0.009704-0",
                    "10.1089/ard.1995.5.115",
                    "pmc3917065",
                    "pmc1576297",
                    "15304515",
                    "10.1016/j.virol.2006.05.010",
                    "10.1016/j.ijid.2014.10.001",
                    "24159666",
                    "10.1073/pnas.97.7.3544",
                    "23550601",
                    "10.1056/nejmc1409847",
                    "22147356",
                    "10.1089/oli.1.1996.6.177",
                    "15885837",
                    "23923992",
                    "7580115",
                    "18634509",
                    "25192975",
                    "10.1038/cmi.2015.03",
                    "10.1099/vir.0.060640-0",
                    "19397417",
                    "pmc4564550",
                    "pmc4786625",
                    "24599590",
                    "24120673",
                    "25762305",
                    "10.1073/pnas.1323279111",
                    "26142661",
                    "10.1128/jvi.02040-16",
                    "10.1099/vir.0.80955-0"
                ]
            },
            {
                "index": "133",
                "publicationKey": "JP_2017524339_A",
                "lensId": "195-798-002-527-736",
                "jurisdiction": "JP",
                "kindCode": "A",
                "displayKey": "JP 2017524339 A",
                "publicationDate": "2017-08-31",
                "filingNumber": "JP 2016567890 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "\u4e2d\u6771\u547c\u5438\u5668\u75c7\u5019\u7fa4\u2212\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u30b9\u30d1\u30a4\u30af\u30bf\u30f3\u30d1\u30af\u8cea\u306b\u5bfe\u3059\u308b\u30d2\u30c8\u6297\u4f53",
                "applicants": [
                    "\u30ea\u30b8\u30a7\u30cd\u30ed\u30f3\u30fb\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u30fb\u30a4\u30f3\u30b3\u30fc\u30dd\u30ec\u30a4\u30c6\u30c3\u30c9\uff32\uff25\uff27\uff25\uff2e\uff25\uff32\uff2f\uff2e \uff30\uff28\uff21\uff32\uff2d\uff21\uff23\uff25\uff35\uff34\uff29\uff23\uff21\uff2c\uff33\uff0c \uff29\uff2e\uff23\uff0e"
                ],
                "inventors": [
                    "\u30af\u30ea\u30b9\u30c8\u30b9\u30fb\u30ad\u30e9\u30c8\u30a5\u30b9",
                    "\u30cd\u30a4\u30eb\u30fb\u30b9\u30bf\u30fc\u30eb",
                    "\u30b9\u30de\u30c6\u30a3\u30fb\u30b7\u30f4\u30a1\u30d1\u30e9\u30b7\u30f3\u30ac\u30e0"
                ],
                "owners": [],
                "url": "https://lens.org/195-798-002-527-736",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N15/09",
                    "A61K31/573",
                    "A61K39/395",
                    "A61K45/00",
                    "A61P1/12",
                    "A61P11/00",
                    "A61P29/00",
                    "A61P31/04",
                    "A61P31/12",
                    "C07K16/10",
                    "C12N1/15",
                    "C12N1/19",
                    "C12N1/21",
                    "C12N5/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "134",
                "publicationKey": "WO_2019_183362_A1",
                "lensId": "032-308-638-643-219",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/183362 A1",
                "publicationDate": "2019-09-26",
                "filingNumber": "US 2019/0023382 W",
                "filingDate": "2019-03-21",
                "priorityFilingKeysActive": [
                    "US 201862646053 P 20180321"
                ],
                "earliestPriorityDate": "2018-03-21",
                "title": "Fc Variant Compositions And Methods Of Use Thereof",
                "applicants": [
                    "DANA FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "ZHU QUAN KAREN",
                    "CHANG MATTHEW R"
                ],
                "owners": [],
                "url": "https://lens.org/032-308-638-643-219",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/395",
                    "A61K45/06",
                    "C07K16/28"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "135",
                "publicationKey": "US_9718872_B2",
                "lensId": "197-506-383-480-948",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9718872 B2",
                "publicationDate": "2017-08-01",
                "filingNumber": "US 201514717760 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome\u2014coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2016-04-11"
                    }
                ],
                "url": "https://lens.org/197-506-383-480-948",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K39/395",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 24,
                "nplCitations": [
                    "Coughlin MM, Prabhakar BS. Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential. Rev Med Virol. Jan. 2012;22(1):2-17. Epub Sep. 8, 2011.",
                    "Ying T, Li H, Lu L, Dimitrov DS, Jiang S. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections. Microbes Infect. Feb. 2015;17(2):142-8. Epub Nov. 29, 2014.",
                    "MERS-CoV (NCoV / Novel coronavirus) Spike Antibody, Mouse mab. Cat. #. 40070-MM04. Sino Biological Inc. Jun. 15, 2012.",
                    "van Boheemen S et. al. S protein [Human betacoronavirus 2c EMC/2012]. GenBank Acc. No. AFS88936.1. Dec. 4, 2012.",
                    "van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. Nov. 20, 2012;3(6). pii: e00473-12.",
                    "M\u00fcller MA, Raj VS, Muth D, Meyer B, Kallies S, Smits SL, Wollny R et. al. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capablity in mammalian cell lines. MBio. Dec. 11, 2012;3(6). pii: e00515-12.",
                    "Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect. Dec, 2012;65(6):477-89. Epub Oct. 13, 2012.",
                    "Corman VM, M\u00fcller MA, Costabel U, Timm J, Binger T, Meyer B, Kreher P, Lattwein E, Eschbach-Bludau M, Nitsche A, Bleicker T, Landt O, Schweiger B, Drexler JF, Osterhaus AD, Haagmans BL, Dittmer U, Bonin F, Wolff T, Drosten C. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. Dec. 6, 2012;17(49). pii:.",
                    "Bowie JU, Reidhaar-Olson JF, Lim WA, Sauer RT. Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science. Mar. 16, 1990;247(4948):1306-10.",
                    "MERS-CoV (NCoV / Novel coronavirus) Spike Antibody, Rabbit MAb. Cat. #. 40069-R723. Sino Biological Inc. Jun. 15, 2012. http://www.sinobiologicalcdn.com/reagent/40069-R723.pdf.",
                    "Murphy AJ, et. al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci U S A. Apr. 8, 2014;111(14):5153-8.",
                    "Corti, et al. (2015) PNAS, \u201cProphylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus\u201d.",
                    "Du, et al. (2013) Journal of Virology, 87(17):9939-9942, \u201cIdentification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development\u201d.",
                    "Du, et al. (2013) Plos One, 8(12), \u201cA Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines\u201d.",
                    "Gierer, et al. (2013) Journal of Virology 87(10):5502-5511, \u201cThe Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies\u201d.",
                    "Jiang, et al. (2014) Science Translational Medicine 6(234), \u201cPotent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\u201d.",
                    "Lu, et al., (2013) Nature 500:227-232, \u201cMolecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26\u201d.",
                    "Mou, et al., (2013) Journal of Virology 87(16):9379-9383, \u201cThe Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies\u201d.",
                    "Pascal, et al., (2015) PNAS 112(28), \u201cPre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection\u201d.",
                    "Raj, et al., (2013) Nature 495:251-256, \u201cDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC\u201d.",
                    "Tang, et al., (2014) PNAS, \u201cIdentification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution\u201d.",
                    "Tang and Marasco (2015) Immunotherapy 7(6):591-594, \u201cHuman neutralizing antibodies against MERS coronavirus: implications for future immunotherapy\u201d.",
                    "Ying, et al., (2014) Journal of Virology 88(14):7796-7805, \u201cExceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies\u201d.",
                    "Zaki, et al., (2012) The New England Journal of Medicine 367(19):1814-1820, \u201cIsolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia\u201d."
                ],
                "nplResolvedCount": 21,
                "nplResolvedLensIDs": [
                    "043-796-756-301-37X",
                    "067-540-921-290-283",
                    "035-760-912-363-624",
                    "067-884-443-627-767",
                    "048-188-266-680-461",
                    "027-359-098-622-423",
                    "025-246-608-570-632",
                    "055-005-586-964-518",
                    "026-513-003-919-117",
                    "023-939-052-489-028",
                    "020-009-029-407-493",
                    "003-376-346-248-551",
                    "145-146-407-738-040",
                    "095-041-202-864-526",
                    "016-741-112-113-368",
                    "073-586-665-992-024",
                    "034-994-634-633-262",
                    "043-148-481-331-661",
                    "009-507-053-935-564",
                    "023-671-383-084-282",
                    "079-080-784-051-77X"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3256278",
                    "10.3410/f.725599658.793535757",
                    "pmc4547275",
                    "10.1128/jvi.01277-13",
                    "10.1128/mbio.00473-12",
                    "10.1016/j.jinf.2012.10.002",
                    "pmc3648152",
                    "10.1128/mbio.00515-12",
                    "10.1128/jvi.00128-13",
                    "10.1126/science.2315699",
                    "pmc3852489",
                    "23785207",
                    "pmc4507189",
                    "24706856",
                    "23831647",
                    "10.2807/ese.17.49.20334-en",
                    "23468491",
                    "pmc4024880",
                    "10.1371/journal.pone.0081587",
                    "10.1128/jvi.00912-14",
                    "pmc3807362",
                    "23170002",
                    "21905149",
                    "26098703",
                    "23486063",
                    "10.1073/pnas.1510830112",
                    "23824801",
                    "23075143",
                    "26216974",
                    "10.1128/jvi.01048-13",
                    "23231891",
                    "10.1073/pnas.1402074111",
                    "pmc4308519",
                    "10.1056/nejmoa1211721",
                    "2315699",
                    "10.1073/pnas.1510199112",
                    "pmc3754068",
                    "10.1016/j.micinf.2014.11.008",
                    "10.1038/nature12005",
                    "24778221",
                    "10.1038/nature12328",
                    "25456101",
                    "24789777",
                    "10.1073/pnas.1324022111",
                    "10.1126/scitranslmed.3008140",
                    "pmc3986188",
                    "10.2217/imt.15.33",
                    "pmc4097770",
                    "24324708",
                    "26124093",
                    "23072791",
                    "24778414",
                    "10.1002/rmv.706",
                    "pmc3754113",
                    "23232719"
                ]
            },
            {
                "index": "136",
                "publicationKey": "US_10406222_B2",
                "lensId": "158-487-103-147-986",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10406222 B2",
                "publicationDate": "2019-09-10",
                "filingNumber": "US 201715633589 A",
                "filingDate": "2017-06-26",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome\u2014coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2016-04-11"
                    }
                ],
                "url": "https://lens.org/158-487-103-147-986",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K38/00",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K45/06",
                    "C07K14/165",
                    "C07K16/10",
                    "C12N7/00",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 27,
                "nplCitations": [
                    "Kyratsous CA, Olson W, Stahl N. Reply to Dimitrov et al.: VelociSuite technologies are a foundation for rapid therapeutic antibody development. Proc Natl Acad Sci U S A. Sep. 15, 2015;112(37):E5116. Epub Aug. 28, 2015.",
                    "Dimitrov DS, Jiang S, Ying T, Tseng CT, Zhang L, Yuen KY. No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses. Proc Natl Acad Sci U S A. Sep. 15, 2015;112(37):E5115. doi: 10.1073/pnas.1513441112. Epub Aug. 28, 2015.",
                    "Bowie et al. (1990) Science 247(4948):1306-10 \u201cDeciphering the message in protein sequences: tolerance to amino acid substitutions\u201d.",
                    "Chan et al. (2012) J Infect 65(6):477-489 \u201cIs the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?\u201d",
                    "Corman et al. (2012) Eurosurveillance 17(49) \u201cAssays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections\u201d.",
                    "Corti et al. (2015) PNAS \u201cProphylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus\u201d.",
                    "Coughlin and Prabhakar (2012) Reviews in Medical Virology 22(1):2-17. Epub Sep. 8, 2011. \u201cNeutralizing human momoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential\u201d http://onlinelibrary.wiley.com/doi/10.1002/rmv.706/pdf.",
                    "Du et al. (2013) Journal of Virology 87(17):9939-9942 \u201cIdentification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Develolpment\u201d.",
                    "Du et al. (2013) PLOS ONE 8(12) \u201cA Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits Mers-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines\u201d.",
                    "Gierer et al. (2013) Journal of Virology 87(10):5502-5511 \u201cThe Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies\u201d.",
                    "Jiang et al. (2014) Science Translational Medicine 6(234) \u201cPotent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\u201d.",
                    "Lu et al. (2013) Nature 500:227-232 \u201cMolecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26\u201d.",
                    "Mou et al. (2013) Journal of Virology 87(16):9379-9383 \u201cThe Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies\u201d.",
                    "Muller et al. (2012) Mbio. 3(6) Pii: e00515-12 \u201cHuman coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines\u201d.",
                    "Murphy et al. (2014) Proc. Natl. Acad. Sci. USA 111(14):5153-5158 \u201cMice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice\u201d.",
                    "Pascal et al. (2015) PNAS 112(28) \u201cPre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection\u201d.",
                    "Raj et al. (2013) Nature 495:251-256 \u201cDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC\u201d.",
                    "SinoBiological.com (Jun. 15, 2012) MERS-Cov (NCoV/Novel coronavirus) Spike Antibody, Mouse Mab. Cat. # 40070-MM04; [Online] Available Website: http://www.sinobiologicalcdn.com/reagent/40070-R723.pdf; Last Update: unknown; Accessed on: Apr. 4, 2017.",
                    "SinoBiological.com (Jun. 15, 2012) MERS-Cov (NCoV/Novel coronavirus) Spike Antibody, Rabbit Mab. Cat. # 40069-R723; [Online] Available Website: http://www.sinobiologicalcdn.com/reagent/40069-R723.pdf; Last Update: unknown; Accessed on Apr. 4, 2017.",
                    "Tang and Marasco (2015) Immunotherapy 7(6):591-594 \u201cHuman neutralizing antibodies against MERS coronavirus: implications for future immunotherapy\u201d.",
                    "Tang et al. (2014) PNAS 111(19):2022-2024 \u201cIdentification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution\u201d.",
                    "Van Boheemen et al. (2012) GenBank Acc. No. AFS88936.1 Dec. 4, 2012 \u201cS protein [Human betacoronavirus 2c EMC/2012]\u201d.",
                    "Van Boheemen et al. (2012) MBio. 3(6):e00473-12 \u201cGenomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans\u201d.",
                    "Ying et al. (2015) Microbes Infect. 17(2):142-8, Epub Nov. 29, 2014 \u201cDevelopment of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV Infections\u201d.",
                    "Ying et al. (2014) Journal of Virology 88(14):7796-7805 \u201cExceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies\u201d.",
                    "Zaki et al. (2012) The New England Journal of Medicine 367(19):1814-1820 \u201cIsolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia\u201d.",
                    "Reusken (2013) The Lancet 13(10); 859-86 \u201cMiddle East Respiratory Syndrome Coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study\u201d doi: 10.1016/S1473-3099(13)70164-6. Epub Aug. 9, 2013."
                ],
                "nplResolvedCount": 24,
                "nplResolvedLensIDs": [
                    "043-796-756-301-37X",
                    "067-540-921-290-283",
                    "027-877-315-782-213",
                    "043-286-403-135-353",
                    "035-760-912-363-624",
                    "067-884-443-627-767",
                    "048-188-266-680-461",
                    "027-359-098-622-423",
                    "025-246-608-570-632",
                    "055-005-586-964-518",
                    "026-513-003-919-117",
                    "023-939-052-489-028",
                    "020-009-029-407-493",
                    "003-376-346-248-551",
                    "145-146-407-738-040",
                    "095-041-202-864-526",
                    "016-741-112-113-368",
                    "073-586-665-992-024",
                    "034-994-634-633-262",
                    "043-148-481-331-661",
                    "073-682-937-516-081",
                    "009-507-053-935-564",
                    "023-671-383-084-282",
                    "079-080-784-051-77X"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3256278",
                    "10.3410/f.725599658.793535757",
                    "pmc4547275",
                    "10.1073/pnas.1513441112",
                    "10.1128/jvi.01277-13",
                    "10.1128/mbio.00473-12",
                    "10.1016/j.jinf.2012.10.002",
                    "pmc3648152",
                    "10.1128/mbio.00515-12",
                    "10.1073/pnas.1513935112",
                    "10.1128/jvi.00128-13",
                    "10.1016/s1473-3099(13)70164-6",
                    "10.1126/science.2315699",
                    "pmc4577199",
                    "pmc3852489",
                    "23785207",
                    "pmc4507189",
                    "24706856",
                    "23831647",
                    "10.2807/ese.17.49.20334-en",
                    "23468491",
                    "pmc4024880",
                    "10.1371/journal.pone.0081587",
                    "10.1128/jvi.00912-14",
                    "pmc3807362",
                    "23170002",
                    "21905149",
                    "26098703",
                    "23486063",
                    "10.1073/pnas.1510830112",
                    "23824801",
                    "23075143",
                    "26318165",
                    "26318164",
                    "26216974",
                    "10.1128/jvi.01048-13",
                    "23231891",
                    "10.1073/pnas.1402074111",
                    "pmc4308519",
                    "10.1056/nejmoa1211721",
                    "2315699",
                    "10.1073/pnas.1510199112",
                    "pmc3754068",
                    "10.1016/j.micinf.2014.11.008",
                    "10.1038/nature12005",
                    "24778221",
                    "pmc4577136",
                    "10.1038/nature12328",
                    "25456101",
                    "24789777",
                    "10.1073/pnas.1324022111",
                    "10.1126/scitranslmed.3008140",
                    "pmc3986188",
                    "10.2217/imt.15.33",
                    "pmc4097770",
                    "24324708",
                    "26124093",
                    "23072791",
                    "23933067",
                    "24778414",
                    "10.1002/rmv.706",
                    "pmc3754113",
                    "23232719"
                ]
            },
            {
                "index": "137",
                "publicationKey": "US_2015_0337029_A1",
                "lensId": "193-479-168-095-776",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0337029 A1",
                "publicationDate": "2015-11-26",
                "filingNumber": "US 201514717760 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome - Coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2016-04-11"
                    }
                ],
                "url": "https://lens.org/193-479-168-095-776",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 13,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/395",
                    "A61K45/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 11,
                "nplCitations": [
                    "Coughlin MM, Prabhakar BS. Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential. Rev Med Virol. 2012 Jan;22(1):2-17. Epub 2011 Sep 8.",
                    "Ying T, Li H, Lu L, Dimitrov DS, Jiang S. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections. Microbes Infect. 2015 Feb;17(2):142-8. Epub 2014 Nov 29.",
                    "MERS-CoV (NCoV / Novel coronavirus) Spike Antibody, Mouse MAb. Cat. #. 40070-MM04. Sino Biological Inc. 06/15/2012.",
                    "van Boheemen S et. al. S protein [Human betacoronavirus 2c EMC/2012]. GenBank Acc. No: AFS88936.1. 12/04/2012.",
                    "van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012 Nov 20;3(6). pii: e00473-12.",
                    "M\u00c3\u00bcller MA, Raj VS, Muth D, Meyer B, Kallies S, Smits SL, Wollny R et. al. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio. 2012 Dec 11;3(6). pii: e00515-12.",
                    "Chan JF, Li KS, To KK, Cheng VC, Chen H, Yuen KY. Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect. 2012 Dec;65(6):477-89. Epub 2012 Oct 13.",
                    "Corman VM, M\u00c3\u00bcller MA, Costabel U, Timm J, Binger T, Meyer B, Kreher P, Lattwein E, Eschbach-Bludau M, Nitsche A, Bleicker T, Landt O, Schweiger B, Drexler JF, Osterhaus AD, Haagmans BL, Dittmer U, Bonin F, Wolff T, Drosten C. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012 Dec 6;17(49). pii:",
                    "Bowie JU, Reidhaar-Olson JF, Lim WA, Sauer RT. Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science. 1990 Mar16;247(4948):1306-10.",
                    "MERS-CoV (NCoV / Novel coronavirus) Spike Antibody, Rabbit MAb. Cat. #. 40069-R723. Sino Biological Inc. 06/15/2012. http://www.sinobiologicalcdn.com/reagent/40069-R723.pdf.",
                    "Murphy AJ, et. al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5153-8."
                ],
                "nplResolvedCount": 8,
                "nplResolvedLensIDs": [
                    "043-796-756-301-37X",
                    "048-188-266-680-461",
                    "027-359-098-622-423",
                    "026-513-003-919-117",
                    "023-939-052-489-028",
                    "095-041-202-864-526",
                    "016-741-112-113-368",
                    "034-994-634-633-262"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3256278",
                    "25456101",
                    "10.1073/pnas.1324022111",
                    "24706856",
                    "10.1128/mbio.00473-12",
                    "10.2807/ese.17.49.20334-en",
                    "pmc3986188",
                    "10.1016/j.jinf.2012.10.002",
                    "23231891",
                    "pmc4308519",
                    "10.1128/mbio.00515-12",
                    "23072791",
                    "23170002",
                    "21905149",
                    "2315699",
                    "10.1002/rmv.706",
                    "23232719",
                    "10.1016/j.micinf.2014.11.008",
                    "10.1126/science.2315699"
                ]
            },
            {
                "index": "138",
                "publicationKey": "US_2017_0157219_A1",
                "lensId": "045-786-744-480-837",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0157219 A1",
                "publicationDate": "2017-06-08",
                "filingNumber": "US 201715429046 A",
                "filingDate": "2017-02-09",
                "priorityFilingKeysActive": [
                    "US 201715429046 A 20170209",
                    "US 201514736170 A 20150610",
                    "US 201514667282 A 20150324",
                    "US 201414316893 A 20140627",
                    "US 201414247723 A 20140408",
                    "US 201662295842 P 20160216",
                    "US 201562147209 P 20150414",
                    "US 201562102671 P 20150113",
                    "US 201462063551 P 20141014",
                    "US 201462040885 P 20140822"
                ],
                "earliestPriorityDate": "2014-04-08",
                "title": "Methods Of Treating Zika Virus, Mers-cov, Chikungunya, Venezuelan Equine Encephalitus, And Rhinovirus In Mammalian Patients",
                "applicants": [
                    "TAMIR BIOTECHNOLOGY INC"
                ],
                "inventors": [
                    "HODGE III THOMAS W"
                ],
                "owners": [
                    {
                        "name": "TAMIR BIOTECHNOLOGY INC",
                        "executionDate": "2017-02-15"
                    }
                ],
                "url": "https://lens.org/045-786-744-480-837",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 1,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/46"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "139",
                "publicationKey": "US_2017_0340728_A1",
                "lensId": "083-658-496-756-065",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0340728 A1",
                "publicationDate": "2017-11-30",
                "filingNumber": "US 201715633589 A",
                "filingDate": "2017-06-26",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome - Coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2016-04-11"
                    }
                ],
                "url": "https://lens.org/083-658-496-756-065",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K38/00",
                    "C07K14/165",
                    "C12N7/00",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "140",
                "publicationKey": "US_2019_0351049_A1",
                "lensId": "086-266-478-996-379",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0351049 A1",
                "publicationDate": "2019-11-21",
                "filingNumber": "US 201916530140 A",
                "filingDate": "2019-08-02",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome - Coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2016-04-11"
                    }
                ],
                "url": "https://lens.org/086-266-478-996-379",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 458,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "A61K45/06",
                    "C07K14/165",
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "141",
                "publicationKey": "KR_20170009276_A",
                "lensId": "049-460-108-815-945",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20170009276 A",
                "publicationDate": "2017-01-25",
                "filingNumber": "KR 20150101046 A",
                "filingDate": "2015-07-16",
                "priorityFilingKeysActive": [
                    "KR 20150101046 A 20150716"
                ],
                "earliestPriorityDate": "2015-07-16",
                "title": "Use Of Radotinib For Treatment Of Viral Respiratory Disease",
                "applicants": [
                    "IL YANG PHARM CO LTD"
                ],
                "inventors": [
                    "KIM DONG YEON",
                    "PARK MAN SEONG",
                    "CHO DAE JIN",
                    "LEE GONG YEAL",
                    "KIM HONG YOUB",
                    "LEE HEA UN",
                    "AHN CHOONG AM",
                    "BANG HYE JIN",
                    "SONG SONG EI",
                    "PARK JONG SEONG"
                ],
                "owners": [],
                "url": "https://lens.org/049-460-108-815-945",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 2,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/506",
                    "A61K31/4178",
                    "A61K31/497"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "142",
                "publicationKey": "WO_2018_115527_A2",
                "lensId": "015-503-809-635-588",
                "jurisdiction": "WO",
                "kindCode": "A2",
                "displayKey": "WO 2018/115527 A2",
                "publicationDate": "2018-06-28",
                "filingNumber": "EP 2017084564 W",
                "filingDate": "2017-12-22",
                "priorityFilingKeysActive": [
                    "EP 2016082669 W 20161223"
                ],
                "earliestPriorityDate": "2016-12-23",
                "title": "Mers Coronavirus Vaccine",
                "applicants": [
                    "CUREVAC AG"
                ],
                "inventors": [
                    "RAUCH SUSANNE"
                ],
                "owners": [],
                "url": "https://lens.org/015-503-809-635-588",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 4756,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 17,
                "nplCitations": [
                    "STEPINSKI ET AL., RNA, vol. 7, no. 10, 2001, pages 1486 - 95",
                    "KORE ET AL., BIOORG. MED. CHEM., vol. 21, no. 15, 2013, pages 4570 - 4",
                    "URRY ET AL.: \"Modern Physical Methods in Biochemistry\", 1985, ELSEVIER, article \"Absorption, Circular Dichroism and ORD of Polypeptides\"",
                    "KARLIN ET AL., PNAS USA, vol. 90, 1993, pages 5873 - 5877",
                    "ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402",
                    "GEALL ET AL., SEMIN. IMMUNOL., vol. 25, no. 2, 2013, pages 152 - 159",
                    "BRUNELLE ET AL., METHODS ENZYMOL., vol. 530, 2013, pages 101 - 14",
                    "AKASHI, CURR. OPIN. GENET. DEV., vol. 11, no. 6, 2001, pages 660 - 666",
                    "CAPUT ET AL., PROC. NATL. ACAD. SCI. USA, vol. 83, 1986, pages 1670 - 1674",
                    "BINDER ET AL., EMBO J., vol. 13, 1994, pages 1969 - 1980",
                    "SEMPLE ET AL., NATURE BIOTECH., vol. 28, 2010, pages 172 - 176",
                    "BASHA ET AL., MOL THER., vol. 19, 2011, pages 2186 - 2200",
                    "INT J NANOMEDICINE, vol. 9, 2014, pages 1833 - 1843",
                    "FRONT PHARMACOL., vol. 6, 1 December 2015 (2015-12-01), pages 286",
                    "LANDEN ET AL., CANCER BIOLOGY & THERAPY, vol. 5, no. 12, 2006, pages 1708 - 1713",
                    "ADV DRUG DELIV REV., vol. 66, February 2014 (2014-02-01), pages 110 - 116",
                    "LOVE ET AL., PNAS, vol. 107, no. 5, 2010, pages 1864 - 1869"
                ],
                "nplResolvedCount": 10,
                "nplResolvedLensIDs": [
                    "005-784-007-379-413",
                    "019-779-601-634-917",
                    "114-655-611-675-834",
                    "069-994-674-145-394",
                    "117-773-259-938-012",
                    "020-667-110-629-952",
                    "179-474-415-281-518",
                    "021-258-833-896-500",
                    "028-862-168-091-90X",
                    "095-536-434-459-399"
                ],
                "nplResolvedExternalIDs": [
                    "9254694",
                    "10.1038/mt.2011.190",
                    "pmc46825",
                    "10.1016/s0959-437x(00)00250-1",
                    "23777824",
                    "pmc3242662",
                    "10.1016/j.bmc.2013.05.041",
                    "10.1016/b978-0-12-420037-1.00005-1",
                    "10.1073/pnas.90.12.5873",
                    "10.1073/pnas.83.6.1670",
                    "24034317",
                    "pmc1370192",
                    "10.1002/j.1460-2075.1994.tb06466.x",
                    "21971424",
                    "17106249",
                    "2419912",
                    "pmc395039",
                    "7909515",
                    "11680853",
                    "10.4161/cbt.5.12.3468",
                    "10.1093/nar/25.17.3389",
                    "pmc323145",
                    "8390686",
                    "11682310",
                    "pmc146917"
                ]
            },
            {
                "index": "143",
                "publicationKey": "US_2019_0328865_A1",
                "lensId": "126-018-671-261-952",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0328865 A1",
                "publicationDate": "2019-10-31",
                "filingNumber": "US 201716462125 A",
                "filingDate": "2017-11-17",
                "priorityFilingKeysActive": [
                    "US 201716462125 A 20171117",
                    "US 201662424309 P 20161118"
                ],
                "earliestPriorityDate": "2016-11-18",
                "title": "Immunogenic Composition For Mers Coronavirus Infection",
                "applicants": [
                    "NEW YORK BLOOD CENTER INC"
                ],
                "inventors": [
                    "DU LANYING",
                    "LI FANG",
                    "JIANG SHIBO",
                    "ZHOU YUSEN"
                ],
                "owners": [
                    {
                        "name": "NEW YORK BLOOD CENTER INC",
                        "executionDate": "2018-01-30"
                    }
                ],
                "url": "https://lens.org/126-018-671-261-952",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 3,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61P31/14",
                    "C07K14/005",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "144",
                "publicationKey": "US_2019_0351048_A1",
                "lensId": "075-391-010-665-180",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0351048 A1",
                "publicationDate": "2019-11-21",
                "filingNumber": "US 201716471539 A",
                "filingDate": "2017-12-22",
                "priorityFilingKeysActive": [
                    "EP 2016082669 W 20161223"
                ],
                "earliestPriorityDate": "2016-12-23",
                "title": "Mers Coronavirus Vaccine",
                "applicants": [
                    "CUREVAC AG"
                ],
                "inventors": [
                    "RAUCH SUSANNE"
                ],
                "owners": [
                    {
                        "name": "CUREVAC AG",
                        "executionDate": "2019-10-01"
                    }
                ],
                "url": "https://lens.org/075-391-010-665-180",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 2378,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C07K14/165",
                    "C12N15/86"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "145",
                "publicationKey": "WO_2017_205460_A1",
                "lensId": "077-848-145-856-574",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/205460 A1",
                "publicationDate": "2017-11-30",
                "filingNumber": "US 2017/0034164 W",
                "filingDate": "2017-05-24",
                "priorityFilingKeysActive": [
                    "US 201662340624 P 20160524"
                ],
                "earliestPriorityDate": "2016-05-24",
                "title": "Metabalomics And Viral Diagnostics Suite",
                "applicants": [
                    "EXCISION BIOTHERAPEUTICS INC"
                ],
                "inventors": [
                    "MALCOLM THOMAS"
                ],
                "owners": [],
                "url": "https://lens.org/077-848-145-856-574",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 7,
                "familySize": 7,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "G01N33/573",
                    "G01N33/574"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "WHITE ET AL.: \"The CRISPR/Cas9 genome editing methodology as a weapon against human viruses\", DISCOV MED., vol. 19, no. 105, April 2015 (2015-04-01), pages 255 - 262, XP055335246",
                    "BALZARINI ET AL.: \"Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir\", ANTIVIR CHEM CHEMOTHER., vol. 12, no. 5, September 2001 (2001-09-01), pages 301 - 306, XP055440976",
                    "ZHANG ET AL.: \"Urinary Metabolic Biomarker and Pathway Study of Hepatitis B Virus Infected Patients Based on UPLC-MS System\", METABOLIC BIOMARKER AND PATHWAY STUDY OF HBV. PLOS ONE, vol. 8, no. 5, May 2013 (2013-05-01), pages 1 - 8, XP055440978, Retrieved from the Internet <URL:www.plosone.org>"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "166-982-863-126-49X",
                    "035-513-653-697-292",
                    "004-058-602-303-760"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3655955",
                    "25977188",
                    "10.1371/journal.pone.0064381",
                    "11900349",
                    "10.1177/095632020101200505",
                    "pmc4445958",
                    "23696887"
                ]
            },
            {
                "index": "146",
                "publicationKey": "WO_2018_145075_A1",
                "lensId": "120-812-090-506-157",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/145075 A1",
                "publicationDate": "2018-08-09",
                "filingNumber": "US 2018/0017027 W",
                "filingDate": "2018-02-06",
                "priorityFilingKeysActive": [
                    "US 201762455245 P 20170206"
                ],
                "earliestPriorityDate": "2017-02-06",
                "title": "Compositions And Methods For Augmenting Antibody Mediated Receptor Signaling",
                "applicants": [
                    "DANA FARBER CANCER INST INC"
                ],
                "inventors": [
                    "MARASCO WAYNE A",
                    "ZHU QUAN KAREN"
                ],
                "owners": [],
                "url": "https://lens.org/120-812-090-506-157",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 5,
                "familySize": 5,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/42",
                    "A61K39/395"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "LIU ET AL.: \"Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies\", JOURNAL BIOL CHEM, vol. 289, no. 6, 7 February 2014 (2014-02-07), pages 3571 - 3590, XP055170896"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "086-009-917-433-387"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3916558",
                    "24311787",
                    "10.1074/jbc.m113.513366"
                ]
            },
            {
                "index": "147",
                "publicationKey": "WO_2019_135003_A1",
                "lensId": "196-818-672-803-21X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/135003 A1",
                "publicationDate": "2019-07-11",
                "filingNumber": "EP 2019050266 W",
                "filingDate": "2019-01-07",
                "priorityFilingKeysActive": [
                    "GB 201800274 A 20180108"
                ],
                "earliestPriorityDate": "2018-01-08",
                "title": "Peptides Having Protease Activity For Use In The Treatment Or Prevention Of Coronavirus Infection",
                "applicants": [
                    "ENZYMATICA AB"
                ],
                "inventors": [
                    "GU\u00d0MUNDSD\u00d3TTIR \u00c1G\u00daSTA",
                    "STEF\u00c1NSSON BJARKI",
                    "SANDHOLT GUNNAR BIRGIR"
                ],
                "owners": [],
                "url": "https://lens.org/196-818-672-803-21X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 23,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/48",
                    "A61K9/00",
                    "A61K9/20",
                    "A61K9/68",
                    "A61K31/407",
                    "A61K31/43",
                    "A61K31/47",
                    "A61K31/545",
                    "A61K31/7036",
                    "A61K31/7048",
                    "A61K38/06",
                    "A61K47/10",
                    "A61P11/00",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 66,
                "nplCitations": [
                    "SZELAZEK BOZENA ET AL: \"Structural Characterization of Human Coronavirus NL63 N Protein.\", JOURNAL OF VIROLOGY 01 06 2017, vol. 91, no. 11, 1 June 2017 (2017-06-01), XP009512578, ISSN: 1098-5514",
                    "BERTRAM STEPHANIE ET AL: \"Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.\", JOURNAL OF VIROLOGY DEC 2011, vol. 85, no. 24, December 2011 (2011-12-01), pages 13363 - 13372, XP009512575, ISSN: 1098-5514",
                    "GRALINSKI; BARIC, J. PATHOL., vol. 235, 2015, pages 185 - 195",
                    "CAVANAGH: \"Coronaviruses with Special Emphasis on First Insights Concerning SARS 1\", 2005, BIRKHAUSER VERLAG BASEL, article \"Coronaviridae: a review of coronaviruses and toroviruses\"",
                    "STEFANSSON ET AL., COMPARATIVE BIOCHEM. PHYSIOL: PART B - BIOCHEM. & MOI. BIOL., vol. 155, no. 2, 2010, pages 186 - 194",
                    "ASGEIRSSON ET AL., EUR. J. BIOCHEM., vol. 180, 1989, pages 85 - 94",
                    "\"GenBank\", Database accession no. AC090397",
                    "STEFANSSON ET AL., COMP. BIOCHEM. PHYSIOL. B, BIOCHEM. MOL. BIOL., vol. 155, no. 2, 2010, pages 186 - 194",
                    "ASGEIRSSON; BJARNASON, COMP. BIOCHEM. PHYSIOL. B, vol. 998, 1991, pages 327 - 335",
                    "\"GenBank\", Database accession no. CAA55242.1",
                    "GU6MUNDSD6FTIR ET AL., EUR J BIOCHEM., vol. 217, no. 3, 1993, pages 1091 - 7",
                    "STEFANSSON, COMP. BIOCHEM. PHYSIOL. B, BIOCHEM. MOL. BIOL., vol. 155, no. 2, 2010, pages 186 - 194",
                    "STEFANSSON ET AL., BIOCHIM BIOPHYS ACTA., vol. 1865, no. 1, 2017, pages 11 - 19",
                    "GUDMUNDSDOTTIR, FOOD CHEM., vol. 111, no. 2, 2008, pages 408 - 14",
                    "ASGEIRSSON, EUR. J. BIOCHEM., vol. 180, 1989, pages 85 - 94",
                    "\"Genbank\", Database accession no. AC090397.1",
                    "\"Genbank\", Database accession no. AOX15769.1",
                    "\"Genbank\", Database accession no. AOX15770.1",
                    "\"Genbank\", Database accession no. AOX15771.1",
                    "\"Genbank\", Database accession no. CAD30563.1",
                    "STEFANSSON ET AL., COMP BIOCHEM PHYSIOL B BIOCHEM MOL BIOL., vol. 155, no. 2, 2010, pages 186 - 94",
                    "GREEN; SAMBROOK: \"Molecular Cloning: a Laboratory Manua\", 2012, COLD SPRING HARBOR LABORATORY PRESS",
                    "THOMPSON ET AL., NUC. ACID RES., vol. 22, 1994, pages 4673 - 4680",
                    "MEZIERE ET AL., J. IMMUNOL., vol. 159, 1997, pages 3230 - 3237",
                    "VEBER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 75, 1978, pages 2636",
                    "THORSETT, BIOCHEM. BIOPHYS. RES. COMM., vol. 111, 1983, pages 166",
                    "GREEN; SAMBROOK: \"Molecular Cloning, A Laboratory Manual\", 2012, COLD SPRING HARBOR",
                    "\"Remington's Pharmaceutical Sciences\", 1990, MACK PUBLISHING COMPANY",
                    "\"handbook of Pharmaceutical Excipients\", 2000, PHARMACEUTICAL PRESS",
                    "ASGEIRSSON, B.; P. CEKAN: \"Microscopic rate-constants for substrate binding and acylation in cold-adaptation of trypsin I from Atlantic cod\", FEBS LETT, vol. 580, no. 19, 2006, pages 4639 - 4644, XP028061322, DOI: doi:10.1016/j.febslet.2006.07.043",
                    "ASGEIRSSON, B.; J. W. FOX; J. B. BJARNASON: \"Purification and characterization of trypsin from the poikilotherm Gadus morhua\", EUR J BIOCHEM, vol. 180, no. 1, 1989, pages 85 - 94, XP001105360, DOI: doi:10.1111/j.1432-1033.1989.tb14618.x",
                    "ASGEIRSSON; BJARNASON: \"Structural and kinetic properties of chymotrypsin from Atlantic cod (Gadus morhua). Comparison with bovine chymotrypsin\", COMP. BIOCHEM. PHYSIOL. B, vol. 998, 1991, pages 327 - 335, XP025794920, DOI: doi:10.1016/0305-0491(91)90050-N",
                    "BACHOFEN, C.; B. BOLLINGER; E. PETERHANS; H. STALDER; M. SCHWEIZER: \"Diagnostic gap in Bovine viral diarrhea virus serology during the periparturient period in cattle\", J VET DIAON INVEST, vol. 25, no. 5, 2013, pages 655 - 661",
                    "BELOUZARD, S.; J. K. MILLET; B. N. LICITRA; G. R. WHITTAKER: \"Mechanisms of coronavirus cell entry mediated by the viral spike protein\", VIRUSES, vol. 4, no. 6, 2012, pages 1011 - 1033",
                    "BRADBURNE, A. F.; M. L. BYNOE; D. A. TYRRELL: \"Effects of a ''new'' human respiratory virus in volunteers\", BR MED J, vol. 3, no. 5568, 1967, pages 767 - 769",
                    "FEHR, A. R.; S. PERLMAN: \"Coronaviruses: an overview of their replication and pathogenesis\", METHODS MOL BIOL, vol. 1282, 2015, pages 1 - 23",
                    "FORNBACKE, M.; M. CLARSUND: \"Cold-adapted proteases as an emerging class of therapeutics\", INFECT DIS THER, vol. 2, no. 1, 2013, pages 15 - 26, XP055249597, DOI: doi:10.1007/s40121-013-0002-x",
                    "GALLAHER, W. R.; R. F. GARRY: \"Modeling of the Ebola virus delta peptide reveals a potential lytic sequence motif\", VIRUSES, vol. 7, no. 1, 2015, pages 285 - 305",
                    "GRAHAM, R. L.; R. S. BARIC: \"Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission\", J VIROL, vol. 84, no. 7, 2010, pages 3134 - 3146",
                    "GRALINSKI, L. E.; R. S. BARIC: \"Molecular pathology of emerging coronavirus infections\", J PATHOL, vol. 235, no. 2, 2015, pages 185 - 195",
                    "GREEN; SAMBROOK: \"Molecular Cloning: a Laboratory Manual\", 2012, COLD SPRING HARBOR LABORATORY PRESS",
                    "GUDMUNDSDOTTIR, A.; E. GUDMUNDSDOTTIR; S. OSKARSSON; B. BJARNASON; A. K. EAKIN; C. S. CRAIK: \"Isolation and characterization of cDNAs from Atlantic cod encoding two different forms of trypsinogen\", EUR J BIOCHEM, vol. 217, no. 3, 1993, pages 1091 - 1097, XP055200930, DOI: doi:10.1111/j.1432-1033.1993.tb18341.x",
                    "GUDMUNDSDOTTIR, A.; H. HILMARSSON; B. STEFANSSON: \"Potential use of Atlantic cod trypsin in biomedicine\", BIOMED RES INT, 2013, pages 749078",
                    "HEIKKINEN, T.; A. JARVINEN: \"The common cold\", LANCET, vol. 361, no. 9351, 2003, pages 51 - 59, XP004772755, DOI: doi:10.1016/S0140-6736(03)12162-9",
                    "HULL, D.; P. RENNIE; A. NORONHA; C. POORE; N. HARRINGTON; V. FEARNLEY; D. PASSALI: \"Effects of creating a non-specific, virus-hostile environment in the nasopharynx on symptoms and duration of common cold\", ACTA OTORHINOLARVNQOL ITAL, vol. 27, no. 2, 2007, pages 73 - 77",
                    "JIANG, J.; W. CUN; X. WU; Q. SHI; H. TANG; G. LUO: \"Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate\", J VIROL, vol. 86, no. 13, 2012, pages 7256 - 7267",
                    "JONSDOTTIR, H. R.; R. DIJKMAN: \"Coronaviruses and the human airway: a universal system for virus-host interaction studies\", VIROLOGY JOURNAL, vol. 13, no. 1, 2016, pages 24",
                    "KARBER, G.: \"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche\", NAUNVN-SCHMIEDEBERA'S ARCHIVES OF PHARMACOLOGY, vol. 162, no. 4, 1931, pages 480 - 483",
                    "KRAAIJEVELD, C. A.; S. E. REED; M. R. MACNAUGHTON: \"Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E\", J CLIN MICROBIOL, vol. 12, no. 4, 1980, pages 493 - 497",
                    "LIM, X. Y.; L. Y. NG; P. J. TAM; X. D. LIU: \"Human Coronaviruses: A Review of Virus-Host Interactions\", DISEASES, vol. 4, no. 3, 2016",
                    "LO, Y. S.; S. Y. LIN; S. M. WANG; C. T. WANG; Y. L. CHIU; T. H. HUANG; M. H. HOU: \"Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein\", FEBS LETT, vol. 587, no. 2, 2013, pages 120 - 127, XP028975221, DOI: doi:10.1016/j.febslet.2012.11.016",
                    "MACKAY, I. M.; K. E. ARDEN: \"MERS coronavirus: diagnostics, epidemiology and transmission\", VIROL J, vol. 12, 2015, pages 222",
                    "MEZIERE ET AL.: \"In vivo T helper cell response to retro-inverso peptidomimetics\", J. IMMUNOL., vol. 159, 1997, pages 3230 - 3237",
                    "PARK, J. E.; K. LI; A. BARLAN; A. R. FEHR; S. PERLMAN; P. B. MCCRAY, JR.; T. GALLAGHER: \"Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism\", PROC NATL ACAD SCI U S A, vol. 113, no. 43, 2016, pages 12262 - 12267",
                    "SOKALINGAM, S.; G. RAGHUNATHAN; N. SOUNDRARAJAN; G. LEE: \"A study on the effect of surface lysine to arginine mutagenesis on protein stability and structure using green fluorescent protein\", PLOS ONE, vol. 7, no. 7, 2012, pages e40410, XP055215573, DOI: doi:10.1371/journal.pone.0040410",
                    "SPILLIAERT, R.; A. GUDMUNDSDOTTIR: \"Atlantic Cod Trypsin Y-Member of a Novel Trypsin Group\", MAR BIOTECHNOL (NY), vol. 1, no. 6, 1999, pages 598 - 607, XP009187291, DOI: doi:10.1007/PL00011815",
                    "STEFANSSON, B.; L. HELGADOTTIR; S. OLAFSDOTTIR; A. GUDMUNDSDOTTIR; J. B. BJARNASON: \"Characterization of cold-adapted Atlantic cod (Gadus morhua) trypsin I--kinetic parameters, autolysis and thermal stability\", COMP BIOCHEM PHYSIOL B BIOCHEM MOL BIOL, vol. 155, no. 2, 2010, pages 186 - 194, XP026805399",
                    "STEFANSSON, B.; G. B. SANDHOLT; A. GUDMUNDSDOTTIR: \"Elucidation of different cold-adapted Atlantic cod (Gadus morhua) trypsin X isoenzymes\", BIOCHIM BIOPHVS ACTA, vol. 1865, no. 1, 2017, pages 11 - 19, XP029823711, DOI: doi:10.1016/j.bbapap.2016.10.005",
                    "SUZUKI, T.; Y. ORBA; Y. OKADA; Y. SUNDEN; T. KIMURA; S. TANAKA; K. NAGASHIMA; W. W. HALL; H. SAWA: \"The human polyoma JC virus agnoprotein acts as a viroporin\", PLOS PATHOQ, vol. 6, no. 3, 2010, pages e1000801, XP055030303, DOI: doi:10.1371/journal.ppat.1000801",
                    "THOMPSON ET AL.: \"CLUSTAL W.- improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice\", NUC. ACID RES., vol. 22, 1994, pages 4673 - 4680, XP002956304",
                    "THORSETT ET AL.: \"Dipeptide mimics. Conformationally restricted inhibitors of angiotensin-converting enzyme\", BIOCHEM. BIOPHYS. RES. COMM., vol. 111, 1983, pages 166",
                    "VAN DEN WORM, S. H.; K. K. ERIKSSON; J. C. ZEVENHOVEN; F. WEBER; R. ZUST; T. KURI; R. DIJKMAN; G. CHANG; S. G. SIDDELL; E. J. SNIJ: \"Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination\", PLOS ONE, vol. 7, no. 3, 2012, pages e32857",
                    "VEBER ET AL.: \"Conformationally restricted bicyclic analogs of somatostatin\", PROC. NATL. ACAD. SCI. USA, vol. 75, 1978, pages 2636",
                    "WENTWORTH, D. E.; K. V. HOLMES: \"Molecular Determinants of Species Specificity in the Coronavirus Receptor Aminopeptidase N (CD13): Influence of N-Linked Glycosylation\", J VIROL, vol. 75, no. 20, 2001, pages 9741 - 9752",
                    "\"Emergencies preparedness, response\", 2 February 2017, WHO",
                    "\"Handbook of Pharmaceutical Excipients\", 2000, PHARMACEUTICAL PRESS"
                ],
                "nplResolvedCount": 39,
                "nplResolvedLensIDs": [
                    "057-617-477-665-56X",
                    "032-633-432-127-883",
                    "143-637-150-196-867",
                    "067-532-215-506-788",
                    "161-942-130-898-961",
                    "017-851-353-982-04X",
                    "048-846-919-926-759",
                    "031-351-858-715-648",
                    "026-138-206-058-685",
                    "021-198-619-647-595",
                    "015-612-844-356-616",
                    "074-662-924-798-380",
                    "033-934-211-822-909",
                    "057-513-762-851-111",
                    "113-776-925-274-042",
                    "034-833-383-609-032",
                    "075-063-539-295-009",
                    "045-663-293-601-301",
                    "108-122-357-047-04X",
                    "029-666-470-349-041",
                    "058-162-564-855-431",
                    "039-999-294-190-112",
                    "024-131-624-258-052",
                    "050-493-438-089-604",
                    "084-421-794-573-313",
                    "039-676-361-532-623",
                    "058-574-297-802-044",
                    "133-941-163-537-695",
                    "048-900-900-160-102",
                    "090-394-117-460-967",
                    "082-697-398-764-817",
                    "072-136-312-024-533",
                    "043-583-211-795-307",
                    "043-145-118-781-736",
                    "111-490-138-888-022",
                    "000-665-541-106-905",
                    "147-663-448-487-24X",
                    "059-057-550-173-191",
                    "037-018-560-207-842"
                ],
                "nplResolvedExternalIDs": [
                    "10.1073/pnas.75.6.2636",
                    "28933406",
                    "10.1016/s0006-291x(83)80131-4",
                    "11559807",
                    "10.1128/jvi.02503-16",
                    "10.1093/nar/22.22.4673",
                    "10.1073/pnas.1608147113",
                    "10.1177/1040638713501172",
                    "17608134",
                    "26047443",
                    "10.1016/j.foodchem.2008.04.005",
                    "pmc4306839",
                    "10.1007/3-7643-7339-3_1",
                    "10.1007/bf01863914",
                    "21994442",
                    "pmc4687373",
                    "22816037",
                    "10.1016/j.febslet.2006.07.043",
                    "10.1128/jcm.12.4.493-497.1980",
                    "pmc2640010",
                    "24029404",
                    "26695637",
                    "10.1016/j.febslet.2012.11.016",
                    "10.1007/s40121-013-0002-x",
                    "pmc1843247",
                    "pmc114546",
                    "10.1016/0305-0491(91)90050-n",
                    "pmc3392243",
                    "pmc5456285",
                    "pmc3233180",
                    "10.1128/jvi.75.20.9741-9752.2001",
                    "10.3390/diseases4030026",
                    "10.1128/jvi.05300-11",
                    "20300659",
                    "19913635",
                    "pmc2838128",
                    "22792305",
                    "25270030",
                    "10.1111/j.1432-1033.1993.tb18341.x",
                    "10.1136/bmj.3.5568.767",
                    "10.1371/journal.ppat.1000801",
                    "pmc3416335",
                    "10.1371/journal.pone.0032857",
                    "10.1002/path.4454",
                    "23178926",
                    "10.3390/v4061011",
                    "12517470",
                    "10.1016/j.bbapap.2016.10.005",
                    "pmc2837404",
                    "26852031",
                    "27742554",
                    "10.1155/2013/749078",
                    "pmc4744394",
                    "1764912",
                    "10.1186/s12985-016-0479-5",
                    "pmc392617",
                    "10.1007/978-1-4939-2438-7_1",
                    "25609303",
                    "7984417",
                    "10.1186/s12985-015-0439-5",
                    "23555095",
                    "10.3390/v7010285",
                    "pmc3296753",
                    "pmc308517",
                    "pmc4108096",
                    "28331093",
                    "6252244",
                    "10.1007/pl00011815",
                    "22412934",
                    "pmc4369385",
                    "16879823",
                    "10.1016/j.cbpb.2009.11.004",
                    "pmc273622",
                    "9317121",
                    "208068",
                    "pmc3397359",
                    "pmc4267971",
                    "25135820",
                    "10.1016/s0140-6736(03)12162-9",
                    "10.1111/j.1432-1033.1989.tb14618.x",
                    "10.1371/journal.pone.0040410",
                    "10612685",
                    "27791014",
                    "10.1128/jvi.07222-11",
                    "6043624",
                    "22532692",
                    "25720466",
                    "6299286",
                    "2707266",
                    "10.1128/jvi.01394-09",
                    "pmc3600245",
                    "8223632",
                    "19906932"
                ]
            },
            {
                "index": "148",
                "publicationKey": "CN_106414496_A",
                "lensId": "031-011-072-333-241",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 106414496 A",
                "publicationDate": "2017-02-15",
                "filingNumber": "CN 201580026696 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462051717 P 20140917",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome-coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/031-011-072-333-241",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61K45/06",
                    "A61P31/14",
                    "C12N15/13"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "XIAN-CHUN TANG: \"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution\", \u300aPNAS\u300b",
                    "LIWEI JIANG: \"Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein\", \u300aSCIENCE TRANSLATIONAL MEDICINE\u300b",
                    "\u9a6c\u4ea6\u6797: \"\u4e2d\u4e1c\u547c\u5438\u7efc\u5408\u5f81\u51a0\u72b6\u75c5\u6bd2\u4e0e\u4eba\u7c7b\u611f\u67d3\", \u300a\u4f1a\u8bae\u8bba\u6587\u300b"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "043-148-481-331-661",
                    "079-080-784-051-77X"
                ],
                "nplResolvedExternalIDs": [
                    "24778221",
                    "10.1073/pnas.1402074111",
                    "pmc4024880",
                    "10.1126/scitranslmed.3008140",
                    "24778414"
                ]
            },
            {
                "index": "149",
                "publicationKey": "CN_106892920_A",
                "lensId": "060-652-868-377-866",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 106892920 A",
                "publicationDate": "2017-06-27",
                "filingNumber": "CN 201510956338 A",
                "filingDate": "2015-12-18",
                "priorityFilingKeysActive": [
                    "CN 201510956338 A 20151218"
                ],
                "earliestPriorityDate": "2015-12-18",
                "title": "Aloperin Derivative, Preparation Method And Application Thereof",
                "applicants": [
                    "INST OF MEDICINAL BIOTECHNOLOGY CHINESE ACAD OF MEDICAL SCIENCES"
                ],
                "inventors": [
                    "SONG DANQING",
                    "JIANG JIANDONG",
                    "PENG ZONGGEN",
                    "ZHANG XIN",
                    "TANG SHENG",
                    "LI YINGHONG",
                    "LI YUHUAN"
                ],
                "owners": [],
                "url": "https://lens.org/060-652-868-377-866",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07D471/18",
                    "A61K31/4748",
                    "A61K31/496",
                    "A61P31/12",
                    "A61P31/14",
                    "A61P31/16",
                    "A61P31/20"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "150",
                "publicationKey": "WO_2018_160977_A1",
                "lensId": "125-530-271-842-025",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/160977 A1",
                "publicationDate": "2018-09-07",
                "filingNumber": "US 2018/0020678 W",
                "filingDate": "2018-03-02",
                "priorityFilingKeysActive": [
                    "US 201762466779 P 20170303"
                ],
                "earliestPriorityDate": "2017-03-03",
                "title": "Coronaviruses, Vaccines Comprising The Same, And Methods For Preventing Disease",
                "applicants": [
                    "LOYOLA UNIV CHICAGO"
                ],
                "inventors": [
                    "BAKER SUSAN",
                    "DENG XUFANG",
                    "HACKBART MATTHEW",
                    "METTELMAN ROBERT",
                    "MIELECH ANNA",
                    "O'BRIEN AMORNRAT",
                    "FAABERG KAY",
                    "LAGER KELLY MILTON"
                ],
                "owners": [],
                "url": "https://lens.org/125-530-271-842-025",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N7/00",
                    "A61K39/00",
                    "A61K39/215",
                    "C12N9/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "KANG, H. ET AL.: \"Biochemical and genetic analyses of murine hepatitis virus Nsp15 endoribonuclease\", JOURNAL OF VIROLOGY, vol. 81, no. 24, December 2007 (2007-12-01), pages 13587 - 13597, XP055569173",
                    "ATHMER, J. ET AL.: \"4 and\", MBIO, vol. 8, no. 1, 31 January 2017 (2017-01-31), pages 1 - 14, XP055569198",
                    "DENG, X. ET AL.: \"Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 114, no. 21, pages E4251 - E4260, XP055569217"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "016-304-870-832-876",
                    "033-307-697-300-525"
                ],
                "nplResolvedExternalIDs": [
                    "17898055",
                    "pmc2168834",
                    "28484023",
                    "10.1128/jvi.00547-07",
                    "10.1073/pnas.1618310114"
                ]
            },
            {
                "index": "151",
                "publicationKey": "US_2016_0266118_A1",
                "lensId": "051-648-653-513-05X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0266118 A1",
                "publicationDate": "2016-09-15",
                "filingNumber": "US 201615068371 A",
                "filingDate": "2016-03-11",
                "priorityFilingKeysActive": [
                    "US 201562132568 P 20150313"
                ],
                "earliestPriorityDate": "2015-03-13",
                "title": "Methods And Compositions Of Non-enzymatic Amplification And Direct Detection Of Nucleic Acids",
                "applicants": [
                    "CROSSLIFE TECH INC"
                ],
                "inventors": [
                    "CHO HYUNDAE",
                    "KIM CHANG HEE"
                ],
                "owners": [
                    {
                        "name": "CROSSLIFE TECHNOLOGIES INC",
                        "executionDate": "2016-03-11"
                    }
                ],
                "url": "https://lens.org/051-648-653-513-05X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "152",
                "publicationKey": "US_2018_0333482_A1",
                "lensId": "052-906-398-451-415",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2018/0333482 A1",
                "publicationDate": "2018-11-22",
                "filingNumber": "US 201815910617 A",
                "filingDate": "2018-03-02",
                "priorityFilingKeysActive": [
                    "US 201762466779 P 20170303"
                ],
                "earliestPriorityDate": "2017-03-03",
                "title": "Coronaviruses, Vaccines Comprising The Same, And Methods For Preventing Disease",
                "applicants": [
                    "LOYOLA UNIV CHICAGO"
                ],
                "inventors": [
                    "BAKER SUSAN",
                    "DENG XUFANG",
                    "HACKBART MATTHEW",
                    "METTELMAN ROBERT",
                    "MIELECH ANNA",
                    "O'BRIEN AMORNRAT",
                    "FAABERG KAY",
                    "LAGER KELLY MILTON"
                ],
                "owners": [
                    {
                        "name": "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE",
                        "executionDate": "2018-07-09"
                    },
                    {
                        "name": "LOYOLA UNIVERSITY CHICAGO",
                        "executionDate": "2018-04-06"
                    }
                ],
                "url": "https://lens.org/052-906-398-451-415",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 15,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "153",
                "publicationKey": "BR_112019007931_A2",
                "lensId": "093-847-779-223-31X",
                "jurisdiction": "BR",
                "kindCode": "A2",
                "displayKey": "BR 112019007931 A2",
                "publicationDate": "2019-07-02",
                "filingNumber": "BR 112019007931 A",
                "filingDate": "2017-10-20",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "Composi\u00e7\u00f5es Antivirais Para O Tratamento De Infec\u00e7\u00f5es Ligadas Ao Coronav\u00edrus",
                "applicants": [
                    "CENTRE NAT RECH SCIENT",
                    "INST NAT SANTE RECH MED",
                    "UNIV CLAUDE BERNARD LYON"
                ],
                "inventors": [
                    "ANA\u00cfS PROUST",
                    "MANUEL ROSA-CALATRAVA",
                    "OLIVIER TERRIER",
                    "VINCENT MOULES"
                ],
                "owners": [],
                "url": "https://lens.org/093-847-779-223-31X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/21",
                    "A61K31/351",
                    "A61K31/352",
                    "A61K31/4375",
                    "A61K31/7056",
                    "A61K45/06",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "154",
                "publicationKey": "CA_3041165_A1",
                "lensId": "197-921-240-414-415",
                "jurisdiction": "CA",
                "kindCode": "A1",
                "displayKey": "CA 3041165 A1",
                "publicationDate": "2018-04-26",
                "filingNumber": "CA 3041165 A",
                "filingDate": "2017-10-20",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "Antiviral Compositions For The Treatment Of Infections Linked To Coronaviruses",
                "applicants": [
                    "UNIV CLAUDE BERNARD LYON",
                    "INST NAT SANTE RECH MED",
                    "CENTRE NAT RECH SCIENT"
                ],
                "inventors": [
                    "ROSA-CALATRAVA MANUEL",
                    "TERRIER OLIVIER",
                    "PROUST ANAIS",
                    "MOULES VINCENT"
                ],
                "owners": [],
                "url": "https://lens.org/197-921-240-414-415",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/21",
                    "A61K31/351",
                    "A61K31/352",
                    "A61K31/4375",
                    "A61K31/7056",
                    "A61K45/06",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "155",
                "publicationKey": "FR_3057773_A1",
                "lensId": "199-288-608-108-62X",
                "jurisdiction": "FR",
                "kindCode": "A1",
                "displayKey": "FR 3057773 A1",
                "publicationDate": "2018-04-27",
                "filingNumber": "FR 1660223 A",
                "filingDate": "2016-10-21",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "Nouvelles Compositions Antivirales Pour Le Traitement Des Infections Liees Aux Coronavirus",
                "applicants": [
                    "UNIV CLAUDE BERNARD LYON",
                    "INST NAT SANTE RECH MED",
                    "CENTRE NAT RECH SCIENT"
                ],
                "inventors": [
                    "ROSA-CALATRAVA MANUEL",
                    "TERRIER OLIVIER",
                    "PROUST ANAIS",
                    "MOULES VINCENT"
                ],
                "owners": [],
                "url": "https://lens.org/199-288-608-108-62X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/4375",
                    "A61K31/352",
                    "A61P31/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "DARRYL FALZARANO ET AL: \"Treatment with interferon-[alpha]2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques\", NATURE MEDICINE, vol. 19, no. 10, 8 September 2013 (2013-09-08), pages 1313 - 1317, XP055369198, ISSN: 1078-8956, DOI: 10.1038/nm.3362"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "018-702-914-707-986"
                ],
                "nplResolvedExternalIDs": [
                    "24013700",
                    "pmc4093902",
                    "10.1038/nm.3362"
                ]
            },
            {
                "index": "156",
                "publicationKey": "IL_266119_D0",
                "lensId": "124-559-563-139-30X",
                "jurisdiction": "IL",
                "kindCode": "D0",
                "displayKey": "IL 266119 D0",
                "publicationDate": "2019-06-30",
                "filingNumber": "IL 26611919 A",
                "filingDate": "2019-04-18",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "Antiviral Compositions For The Treatment Of Infections Linked To Coronaviruses",
                "applicants": [
                    "CENTRE NAT RECH SCIENT",
                    "UNIV CLAUDE BERNARD LYON",
                    "INST NAT SANTE RECH MED"
                ],
                "inventors": [],
                "owners": [],
                "url": "https://lens.org/124-559-563-139-30X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "157",
                "publicationKey": "KR_20190071765_A",
                "lensId": "036-768-279-368-691",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20190071765 A",
                "publicationDate": "2019-06-24",
                "filingNumber": "KR 20197014234 A",
                "filingDate": "2017-10-20",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "\ucf54\ub85c\ub098 \ubc14\uc774\ub7ec\uc2a4\uc5d0 \uc5f0\uad00\ub41c \uac10\uc5fc\uc758 \uce58\ub8cc\ub97c \uc704\ud55c \ud56d\ubc14\uc774\ub7ec\uc2a4 \uc870\uc131\ubb3c",
                "applicants": [
                    "UNIV CLAUDE BERNARD LYON",
                    "CENTRE NAT RECH SCIENT",
                    "INST NAT SANTE RECH MED"
                ],
                "inventors": [
                    "ROSA CALATRAVA MANUEL",
                    "TERRIER OLIVIER",
                    "PROUST ANAIS",
                    "MOULES VINCENT"
                ],
                "owners": [],
                "url": "https://lens.org/036-768-279-368-691",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/352",
                    "A61K9/00",
                    "A61K31/4375",
                    "A61K31/7056",
                    "A61K38/21",
                    "A61K45/06",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "158",
                "publicationKey": "EP_3528835_A1",
                "lensId": "101-661-334-775-042",
                "jurisdiction": "EP",
                "kindCode": "A1",
                "displayKey": "EP 3528835 A1",
                "publicationDate": "2019-08-28",
                "filingNumber": "EP 17797395 A",
                "filingDate": "2017-10-20",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "Antiviral Compositions For The Treatment Of Infections Linked To Coronaviruses",
                "applicants": [
                    "UNIV CLAUDE BERNARD LYON",
                    "INST NAT SANTE RECH MED",
                    "CENTRE NAT RECH SCIENT"
                ],
                "inventors": [
                    "ROSA-CALATRAVA MANUEL",
                    "TERRIER OLIVIER",
                    "PROUST ANA\u00cfS",
                    "MOULES VINCENT"
                ],
                "owners": [],
                "url": "https://lens.org/101-661-334-775-042",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/21",
                    "A61K31/351",
                    "A61K31/352",
                    "A61K31/4375",
                    "A61K31/7056",
                    "A61K45/06",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "159",
                "publicationKey": "TW_201817430_A",
                "lensId": "046-579-712-883-53X",
                "jurisdiction": "TW",
                "kindCode": "A",
                "displayKey": "TW 201817430 A",
                "publicationDate": "2018-05-16",
                "filingNumber": "TW 106136358 A",
                "filingDate": "2017-10-23",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "New Antiviral Compositions For The Treatment Of Coronavirus-related Infections",
                "applicants": [
                    "UNIV CLAUDE BERNARD LYON",
                    "INST NAT SANTE RECH MED",
                    "CENTRE NAT RECH SCIENT"
                ],
                "inventors": [
                    "ROSA-CALATRAVA MANUEL",
                    "TERRIER OLIVIER",
                    "PROUST ANAIS",
                    "MOULES VINCENT"
                ],
                "owners": [],
                "url": "https://lens.org/046-579-712-883-53X",
                "docType": "unknown",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K35/42",
                    "A61K38/21",
                    "A61P11/00",
                    "A61P31/16"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "160",
                "publicationKey": "WO_2018_073549_A1",
                "lensId": "098-031-456-469-18X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/073549 A1",
                "publicationDate": "2018-04-26",
                "filingNumber": "FR 2017052889 W",
                "filingDate": "2017-10-20",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "Antiviral Compositions For The Treatment Of Infections Linked To Coronaviruses",
                "applicants": [
                    "UNIV CLAUDE BERNARD LYON",
                    "INST NAT SANTE RECH MED",
                    "CENTRE NAT RECH SCIENT"
                ],
                "inventors": [
                    "ROSA-CALATRAVA MANUEL",
                    "TERRIER OLIVIER",
                    "PROUST ANA\u00cfS",
                    "MOULES VINCENT"
                ],
                "owners": [],
                "url": "https://lens.org/098-031-456-469-18X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/21",
                    "A61K31/351",
                    "A61K31/352",
                    "A61K31/4375",
                    "A61K31/7056",
                    "A61K45/06",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 13,
                "nplCitations": [
                    "DARRYL FALZARANO ET AL: \"Treatment with interferon-[alpha]2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques\", NATURE MEDICINE, vol. 19, no. 10, 8 September 2013 (2013-09-08), pages 1313 - 1317, XP055369198, ISSN: 1078-8956, DOI: 10.1038/nm.3362",
                    "JOSSET ET AL., PLOS ONE, 2010",
                    "EMMIE DE WIT; NEELTJE VAN DOREMALEN; DARRYL FALZARANO; VINCENT J. MUNSTER: \"SARS and MERS: recent insights into emerging coronaviruses\", NATURE REVIEWS MICROBIOLOGY, vol. 14, 2016, pages 523 - 534, XP055369190, DOI: doi:10.1038/nrmicro.2016.81",
                    "R. DIJKMAN; L. VAN DER HOEK: \"Human coronaviruses 229E and NL63: close yet still so far\", J FORMOS MED ASSOC, vol. 108, 2009, pages 270 - 279, XP026117419, DOI: doi:10.1016/S0929-6646(09)60066-8",
                    "DYALL J; COLEMAN CM; HART BJ; VENKATARAMAN T; HOLBROOK MR; KINDRACHUK J; JOHNSON RF; OLINGER GG JR; JAHRLING PB; LAIDLAW M: \"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection\", ANTIMICROB AGENTS CHEMOTHER, vol. 58, no. 8, August 2014 (2014-08-01), pages 4885 - 93, XP055321806, DOI: doi:10.1128/AAC.03036-14",
                    "JAFFAR A; AL-TAWFIQ ET AL.: \"Ribavirin and Interferon Therapy in Patients Infected with the Middle East Respiratory Syndrome Coronavirus: An Observational Study\", INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES: IJID: OFFICIAI PUBLICATION OF THE INTERNATIONAL SOCIETY FOR INFECTIOUS DISEASES, vol. 20, March 2014 (2014-03-01), pages 42 - 46, XP055369194, DOI: doi:10.1016/j.ijid.2013.12.003",
                    "JOSSET L; MENACHERY VD; GRALINSKI LE; AGNIHOTHRAM S; SOVA P; CARTER VS; YOUNT BL; GRAHAM RL; BARIC RS; KATZE MG: \"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important diff\u00e9rences with SARS coronavirus\", MBIO., vol. 4, 30 April 2013 (2013-04-30)",
                    "ADEDEJI AO; SARAFIANOS SG: \"Antiviral drugs sp\u00e9cifi\u00e9 for coronaviruses in preclinical development\", CURR OPIN VIROL., vol. 8, October 2014 (2014-10-01), pages 45 - 53",
                    "KILIANSKI A; BAKER SC: \"Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors\", ANTIVIRAL RES., vol. 101, January 2014 (2014-01-01), pages 105 - 12",
                    "SHIBATA C; OHNO M; OTSUKA M; KISHIKAWA T; GOTO K; MUROYAMA R; KATO N; YOSHIKAWA T; TAKATA A; KOIKE K: \"The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels\", VIROLOGY, no. 462-463, August 2014 (2014-08-01), pages 42 - 8",
                    "LV X; QIU M; CHEN D; ZHENG N; JIN Y; WU Z: \"Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway\", ANTIVIRAL RES., vol. 109C, 24 June 2014 (2014-06-24), pages 30 - 41, XP029045729, DOI: doi:10.1016/j.antiviral.2014.06.004",
                    "SONG S; QIU M; CHU Y; CHEN D; WANG X; SU A; WU Z: \"Berberine down-regulates cellular JNK and NF- B activation and this may result in an inhibition of HSV replication\", ANTIMICROB AGENTS CHEMOTHER, 9 June 2014 (2014-06-09)",
                    "WU Y; LI JQ; KIM YJ; WU J; WANG Q; HAO Y: \"In vivo and in vitro antiviral effects of berberine on influenza virus\", CHIN J INTEGR MED, vol. 17, no. 6, June 2011 (2011-06-01), pages 444 - 52"
                ],
                "nplResolvedCount": 12,
                "nplResolvedLensIDs": [
                    "010-834-584-745-392",
                    "033-574-651-021-21X",
                    "003-121-189-390-233",
                    "018-702-914-707-986",
                    "073-663-856-907-01X",
                    "023-532-394-629-76X",
                    "096-162-228-552-43X",
                    "013-562-912-523-434",
                    "082-751-236-094-130",
                    "119-087-697-694-823",
                    "026-518-238-956-425",
                    "051-768-949-935-987"
                ],
                "nplResolvedExternalIDs": [
                    "25092460",
                    "10.1016/s0929-6646(09)60066-8",
                    "pmc3931262",
                    "10.1016/j.virol.2014.05.024",
                    "10.1038/nrmicro.2016.81",
                    "10.1128/mbio.00165-13",
                    "19369173",
                    "10.1007/s11655-011-0640-3",
                    "10.1016/j.antiviral.2014.06.004",
                    "pmc4195804",
                    "10.1038/nm.3362",
                    "pmc4135844",
                    "10.1128/aac.02427-14",
                    "24013700",
                    "10.1016/j.coviro.2014.06.002",
                    "24997250",
                    "24406736",
                    "24913175",
                    "pmc4093902",
                    "27344959",
                    "24269477",
                    "21660679",
                    "10.1016/j.antiviral.2013.11.004",
                    "pmc4136000",
                    "10.1128/aac.03036-14",
                    "23631916",
                    "10.1016/j.ijid.2013.12.003",
                    "24841273",
                    "24971492"
                ]
            },
            {
                "index": "161",
                "publicationKey": "JP_2019535667_A",
                "lensId": "006-817-791-268-294",
                "jurisdiction": "JP",
                "kindCode": "A",
                "displayKey": "JP 2019535667 A",
                "publicationDate": "2019-12-12",
                "filingNumber": "JP 2019521029 A",
                "filingDate": "2017-10-20",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u306b\u95a2\u9023\u3057\u305f\u611f\u67d3\u75c7\u306e\u6cbb\u7642\u306e\u305f\u3081\u306e\u6297\u30a6\u30a4\u30eb\u30b9\u7d44\u6210\u7269",
                "applicants": [
                    "\u30a6\u30cb\u30d9\u30eb\u30b7\u30c6 \u30af\u30ed\u30fc\u30c9 \u30d9\u30eb\u30ca\u30fc\u30eb \u30ea\u30e8\u30f3 \uff11",
                    "\u30a2\u30f3\u30b9\u30c6\u30a3\u30c8\u30a5\u30fc\u30c8\u30fb\u30ca\u30b7\u30aa\u30ca\u30eb\u30fb\u30c9\u30a5\u30fb\u30e9\u30fb\u30b5\u30f3\u30c6\u30fb\u30a8\u30fb\u30c9\u30a5\u30fb\u30e9\u30fb\u30eb\u30b7\u30e3\u30eb\u30b7\u30e5\u30fb\u30e1\u30c7\u30a3\u30ab\u30eb\u30fb\uff08\u30a4\u30f3\u30bb\u30eb\u30e0\uff09",
                    "\u30b5\u30f3\u30c8\u30eb \u30ca\u30b7\u30e7\u30ca\u30eb \u30c9\u30a5 \u30e9 \u30eb\u30b7\u30a7\u30eb\u30b7\u30e5 \u30b7\u30a2\u30f3\u30c6\u30a3\u30d5\u30a3\u30c3\u30af"
                ],
                "inventors": [
                    "\u30de\u30cb\u30e5\u30a8\u30eb\u30fb\u30ed\u30fc\u30b6\u2212\u30ab\u30e9\u30c8\u30e9\u30f4\u30a1",
                    "\u30aa\u30ea\u30f4\u30a3\u30a8\u30fb\u30c6\u30ea\u30a8",
                    "\u30a2\u30ca\u30a4\u30b9\u30fb\u30d7\u30eb\u30fc\u30b9\u30c8",
                    "\u30f4\u30a1\u30f3\u30b5\u30f3\u30fb\u30e0\u30fc\u30eb"
                ],
                "owners": [],
                "url": "https://lens.org/006-817-791-268-294",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/352",
                    "A61K9/12",
                    "A61K31/35",
                    "A61K31/4745",
                    "A61K31/7056",
                    "A61K38/21",
                    "A61P31/14",
                    "A61P43/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "162",
                "publicationKey": "US_2019_0307722_A1",
                "lensId": "052-547-072-220-471",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0307722 A1",
                "publicationDate": "2019-10-10",
                "filingNumber": "US 201716340346 A",
                "filingDate": "2017-10-20",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "Antiviral Compositions For The Treatment Of Infections Linked To Coronaviruses",
                "applicants": [
                    "UNIV CLAUDE BERNARD LYON",
                    "INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE INSERM",
                    "CENTRE NAT RECH SCIENT"
                ],
                "inventors": [
                    "ROSA-CALATRAVA MANUEL",
                    "TERRIER OLIVIER",
                    "PROUST ANA\u00cfS",
                    "MOULES VINCENT"
                ],
                "owners": [
                    {
                        "name": "CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)",
                        "executionDate": "2019-07-19"
                    },
                    {
                        "name": "INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM}",
                        "executionDate": "2019-07-19"
                    },
                    {
                        "name": "UNIVERSITE CLAUDE BERNARD LYON 1",
                        "executionDate": "2019-07-19"
                    }
                ],
                "url": "https://lens.org/052-547-072-220-471",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/353",
                    "A61K9/00",
                    "A61K31/35",
                    "A61K31/4375",
                    "A61K31/7056",
                    "A61K38/21",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "163",
                "publicationKey": "CN_106928326_A",
                "lensId": "067-240-368-988-584",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 106928326 A",
                "publicationDate": "2017-07-07",
                "filingNumber": "CN 201511021535 A",
                "filingDate": "2016-12-31",
                "priorityFilingKeysActive": [
                    "CN 201511021535 A 20151231"
                ],
                "earliestPriorityDate": "2016-12-31",
                "title": "Subunit Coronavirus Vaccine For Dimerization-based Receptor Binding Domains",
                "applicants": [
                    "INST OF ZOOLOGY CHINESE ACAD OF SCIENCES",
                    "INST MICROBIOLOGY CAS"
                ],
                "inventors": [
                    "GAO FU",
                    "DAI LIANPAN",
                    "YAN JINGHUA",
                    "LI SHIHUA",
                    "YUAN YUAN"
                ],
                "owners": [],
                "url": "https://lens.org/067-240-368-988-584",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K39/215",
                    "A61P31/14",
                    "C07K1/16",
                    "C07K1/18",
                    "C07K1/20",
                    "C07K1/34",
                    "C07K1/36",
                    "C12N1/21",
                    "C12N5/10",
                    "C12N7/01",
                    "C12N15/50",
                    "C12N15/866"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "164",
                "publicationKey": "WO_2017_085692_A1",
                "lensId": "112-852-812-241-32X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/085692 A1",
                "publicationDate": "2017-05-26",
                "filingNumber": "IB 2016056981 W",
                "filingDate": "2016-11-18",
                "priorityFilingKeysActive": [
                    "US 201562256868 P 20151118"
                ],
                "earliestPriorityDate": "2015-11-18",
                "title": "Pharmaceutical Compositions Of Ribavirin",
                "applicants": [
                    "GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD",
                    "LIQUIDIA TECH INC"
                ],
                "inventors": [
                    "DELL'ORCO PHILIP CHARLES",
                    "FARRER BRIAN T",
                    "HONG ZHI",
                    "ROBERTS CHRISTOPHER D",
                    "SAVAGE JOHN ROBERT",
                    "SPRAGUE JACOB J",
                    "WANG YONGCAI"
                ],
                "owners": [],
                "url": "https://lens.org/112-852-812-241-32X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 10,
                "familySize": 10,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K9/14",
                    "A61K9/50",
                    "A61K31/7056"
                ],
                "usClassifications": [],
                "nplCitationCount": 7,
                "nplCitations": [
                    "KURAI ET AL.: \"Virus-Induced exacerbations in asthma and COPD\", FRONT. MICROBIOL., vol. 4, 2013, pages 293",
                    "VENTURA, F. ET AL.: \"Is the use of ribavirin aerosols in respiratory syncytial virus infections justified? Clinical and economic evaluation\", ARCH PEDIATR., vol. 5, no. 2, February 1998 (1998-02-01), pages 123 - 31",
                    "WALSH, B. ET AL.: \"Characterization of Ribavirin Aerosol With Small Particle Aerosol Generator and Vibrating Mesh Micropump Aerosol Technologies\", RESPIR CARE, vol. 61, 2016, pages 577 - 585",
                    "WITKOWSKI J.T ET AL.: \"Design, synthesis, and broad spectrum antiviral activity of 1 -?-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides\", J. MED. CHEM., vol. 15, no. 11, November 1972 (1972-11-01), pages 1150 - 1154",
                    "ROLLAND J. ET AL.: \"Direct Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials\", J. AM. CHEM. SOC., vol. 127, 2005, pages 10096 - 10100",
                    "PRUSINER, P. ET AL.: \"The crystal and molecular structures of two polymorphic crystalline forms of virazole (1-?-D-ribofuranosyl-1,2,4-triazole-3-carboxamide). A new synthetic broad spectrum antiviral agent\", ACTA CRYST., vol. B32, 1976, pages 419 - 426",
                    "\"British Pharmacopaeia\", APPENDIX XVII C, 1988, pages A204 - 207"
                ],
                "nplResolvedCount": 6,
                "nplResolvedLensIDs": [
                    "014-554-401-161-757",
                    "063-034-014-553-003",
                    "096-151-652-277-998",
                    "099-378-176-297-386",
                    "086-255-221-244-215",
                    "005-607-300-043-831"
                ],
                "nplResolvedExternalIDs": [
                    "24098299",
                    "10.1021/jm00281a014",
                    "10.1107/s0567740876003154",
                    "10223131",
                    "10.4187/respcare.04383",
                    "10.3389/fmicb.2013.00293",
                    "10.1021/ja051977c",
                    "16011375",
                    "10.1016/s0929-693x(97)86824-8",
                    "pmc3787546",
                    "4347550",
                    "26932383"
                ]
            },
            {
                "index": "165",
                "publicationKey": "CN_103554235_B",
                "lensId": "060-997-962-422-815",
                "jurisdiction": "CN",
                "kindCode": "B",
                "displayKey": "CN 103554235 B",
                "publicationDate": "2015-06-24",
                "filingNumber": "CN 201310461299 A",
                "filingDate": "2013-09-30",
                "priorityFilingKeysActive": [
                    "CN 201310238961 A 20130617"
                ],
                "earliestPriorityDate": "2013-06-17",
                "title": "Rbd (receptor Binding Domain) Segment In Mers-cov (middle East Respiratory Syndrome Coronavirus) Membrane Protein And Coding Gene And Application Thereof",
                "applicants": [
                    "UNIV TSINGHUA"
                ],
                "inventors": [
                    "WANG XINQUAN",
                    "ZHANG LINQI",
                    "WANG NIANSHUANG",
                    "SHI XUANLING"
                ],
                "owners": [],
                "url": "https://lens.org/060-997-962-422-815",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K39/215",
                    "A61K39/42",
                    "A61P31/14",
                    "C07K16/10",
                    "C12N15/50",
                    "C12R1/93"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "166",
                "publicationKey": "CN_103554235_A",
                "lensId": "171-135-878-764-586",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 103554235 A",
                "publicationDate": "2014-02-05",
                "filingNumber": "CN 201310461299 A",
                "filingDate": "2013-09-30",
                "priorityFilingKeysActive": [
                    "CN 201310238961 A 20130617"
                ],
                "earliestPriorityDate": "2013-06-17",
                "title": "Rbd (receptor Binding Domain) Segment In Mers-cov (middle East Respiratory Syndrome Coronavirus) Membrane Protein And Coding Gene And Application Thereof",
                "applicants": [
                    "UNIV TSINGHUA"
                ],
                "inventors": [
                    "WANG XINQUAN",
                    "ZHANG LINQI",
                    "WANG NIANSHUANG",
                    "SHI XUANLING"
                ],
                "owners": [],
                "url": "https://lens.org/171-135-878-764-586",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 4,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K39/215",
                    "A61K39/42",
                    "A61P31/14",
                    "C07K16/10",
                    "C12N15/50",
                    "C12R1/93"
                ],
                "usClassifications": [],
                "nplCitationCount": 7,
                "nplCitations": [
                    "KALLIES R ET AL: \"AGN52936\", \u300aGENBANK\u300b, 10 June 2013 (2013-06-10), pages 1",
                    "ELASSAL E.M ET AL: \"AGH58717\", \u300aGENBANK\u300b, 25 March 2013 (2013-03-25), pages 1",
                    "A BERMINGHAM ET AL: \"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012\", \u300aEURO SURVEILL\u300b, vol. 17, no. 40, 4 October 2012 (2012-10-04), pages 1 - 5",
                    "MATTHEW COTTEN ET AL: \"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study\", \u300aLANCET\u300b, vol. 382, 20 September 2013 (2013-09-20), pages 1993 - 2002",
                    "GUANGWEN LU ET AL: \"Molecular basis of binding between novel human coronavirus MERS-CoVand its receptor CD26\", \u300aNATURE\u300b, vol. 500, 8 August 2013 (2013-08-08), pages 227 - 231, XP055162686, DOI: doi:10.1038/nature12328",
                    "COTTEN M ET AL: \"AGN70929\", \u300aGENBANK\u300b, 10 June 2013 (2013-06-10), pages 1",
                    "V. STALIN RAJ ET AL: \"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC\", \u300aNATURE\u300b, vol. 495, 14 March 2013 (2013-03-14), pages 251 - 254"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "045-797-239-878-426",
                    "020-009-029-407-493",
                    "145-146-407-738-040",
                    "016-772-377-304-76X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1038/nature12005",
                    "10.1016/s0140-6736(13)61887-5",
                    "10.1038/nature12328",
                    "pmc3898949",
                    "23831647",
                    "24055451",
                    "23078800",
                    "23486063"
                ]
            },
            {
                "index": "167",
                "publicationKey": "EP_3045181_A1",
                "lensId": "085-281-537-144-90X",
                "jurisdiction": "EP",
                "kindCode": "A1",
                "displayKey": "EP 3045181 A1",
                "publicationDate": "2016-07-20",
                "filingNumber": "EP 15151594 A",
                "filingDate": "2015-01-19",
                "priorityFilingKeysActive": [
                    "EP 15151594 A 20150119"
                ],
                "earliestPriorityDate": "2015-01-19",
                "title": "A Novel Vaccine Against The Middle East Respiratory Syndrome Coronavirus (mers-cov)",
                "applicants": [
                    "LUDWIG MAXIMILIANS UNIVERSIT\u00c4T M\u00dcNCHEN",
                    "PHILIPPS UNIVERSIT\u00c4T MARBURG"
                ],
                "inventors": [
                    "SUTTER GERD",
                    "FUX ROBERT",
                    "VOLZ ASISA",
                    "SONG FEI",
                    "BECKER STEPHAN",
                    "EICKMANN MARKUS"
                ],
                "owners": [],
                "url": "https://lens.org/085-281-537-144-90X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 1,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 14,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C07K14/005"
                ],
                "usClassifications": [],
                "nplCitationCount": 39,
                "nplCitations": [
                    "ARWEN ALTENBURG ET AL: \"Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases\", VIRUSES, vol. 6, no. 7, 17 July 2014 (2014-07-17), pages 2735 - 2761, XP055200206, DOI: 10.3390/v6072735",
                    "F. SONG ET AL: \"Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies\", JOURNAL OF VIROLOGY, vol. 87, no. 21, 1 November 2013 (2013-11-01), pages 11950 - 11954, XP055157123, ISSN: 0022-538X, DOI: 10.1128/JVI.01672-13",
                    "RACHEL L. GRAHAM ET AL: \"A decade after SARS: strategies for controlling emerging coronaviruses\", NATURE REVIEWS MICROBIOLOGY, vol. 11, no. 12, 11 November 2013 (2013-11-11), pages 836 - 848, XP055200225, ISSN: 1740-1526, DOI: 10.1038/nrmicro3143",
                    "S. VAN BOHEEMEN ET AL: \"Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans\", MBIO, vol. 3, no. 6, 20 November 2012 (2012-11-20), pages e00473 - 12, XP055128733, ISSN: 2150-7511, DOI: 10.1128/mBio.00473-12",
                    "RUTH MCBRIDE ET AL: \"The Coronavirus Nucleocapsid Is a Multifunctional Protein\", VIRUSES, vol. 6, no. 8, 7 August 2014 (2014-08-07), pages 2991 - 3018, XP055200197, DOI: 10.3390/v6082991",
                    "MA ET AL., VACCINE, vol. 32, 2014, pages 2100 - 2108",
                    "COLEMAN ET AL., VACCINE, vol. 32, 2014, pages 3169 - 3174",
                    "KIM ET AL., VACCINE, vol. 32, 2014, pages 5975 - 5982",
                    "MASTERS; PERLMAN: \"Fields Virology\", 2013, LIPPINCOTT WILLIAMS & WILKINS, article \"Coronaviridae\", pages: 825 - 858",
                    "STEWART ET AL.: \"Solid Phase Peptide Synthesis\", 1969, FREEMAN CO",
                    "MERRIFIELD, J. AM. CHEM. SOC., vol. 85, 1963, pages 2149 - 2154",
                    "HOUGHTON, PROC. NATL. ACAD. SCI. USA, 1985, pages 5131 - 5135",
                    "BRAASCH; COREY, CHEM BIOL., vol. 8, 2001, pages 1",
                    "CHAKRABARTI ET AL., BIOTECHNIQUES, vol. 23, 1997, pages 1094",
                    "WYATT ET AL., VACCINE, vol. 14, 1996, pages 1451",
                    "WYATT ET AL., AIDS RES HUM RETROVIRUSES, vol. 20, no. 6, June 2004 (2004-06-01), pages 645 - 53",
                    "ARIMILLI D; JOHNSON JB; CLARK KM; GRAFF AH; ALEXANDER-MILLER MA; MIZEL SB; PARKS GD: \"Engineered Expression of the TLR5 Ligand Flagellin Enhances Paramyxovirus Activation of Human Dendritic Cell Function\", J. VIROL., vol. 82, no. 22, 2008, pages 10975, XP055072978, DOI: doi:10.1128/JVI.01288-08",
                    "BERCHTOLD C; PANTHEL K; JELLBAUER S; KOHN B; ROIDER E; PARTILLA M; HEESEMANN J; ENDRES S; BOURQUIN C; RUSSMANN H: \"Superior Protective Immunity against Murine Listeriosis by Combined Vaccination with CpG DNA and Recombinant Salmonella enterica Serovar Typhimurium\", INFECT. IMMUN., vol. 77, no. 12, 2009, pages 5501",
                    "BERMINGHAM A; BROWN MA; AARONS E; TONG C; LANGRISH C; HOSCHLER K; BROWN K; GALIANO M; MYERS R; PEBODY RG: \"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to United Kingdom from the Middle East\", EURO SURVEILL., vol. 17, 2012, pages 20290",
                    "COLEMAN CM; LIU YV; MU H; TAYLOR JK; MASSARE M; FLYER DC; GLENN GM; SMITH GE; FRIEMAN MB: \"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice\", VACCINE, vol. 32, 2014, pages 3169 - 3174, XP028654166, DOI: doi:10.1016/j.vaccine.2014.04.016",
                    "DE GROOT RJ; BAKER SC; BARIC RS; BROWN CS; DROSTEN C; ENJUANES L; FOUCHIER RA; GALIANO M; GORBALENYA AE; MEMISH ZA: \"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group\", J VIROL., vol. 87, no. 14, 15 May 2013 (2013-05-15), pages 7790 - 2",
                    "DREXLER I; HELLER K; OHLMANN M; ERFLE V; SUTTER G.: \"Recombinant Vaccinia Virus MVA for Generation and Analysis of T Cell Responses Against Tumor Associated Antigens\", METHODS MOL MED., vol. 35, 2000, pages 57 - 73",
                    "GILBERT SC.: \"Clinical development of modified vaccinia virus Ankara vaccines\", VACCINE, vol. 31, 2013, pages 4241 - 4246, XP028697925, DOI: doi:10.1016/j.vaccine.2013.03.020",
                    "KIM E; OKADA K; KENNISTON T; RAJ VS; AIHAJRI MM; FARAG EA; AIHAJRI F; OSTERHAUS AD; HAAGMANS BL; GAMBOTTO A: \"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice\", VACCINE, vol. 32, 2014, pages 5975 - 5982, XP029069689, DOI: doi:10.1016/j.vaccine.2014.08.058",
                    "KREMER M; VOLZ A; KREIJTZ JCM; FUX R; LEHMANN M; SUTTER G: \"Easy and efficient protocols for working with recombinant vaccinia virus MVA.\", METHODS MOL. BIOL., vol. 890, 2012, pages 59 - 92",
                    "MA C; LI Y; WANG L; ZHAO G; TAO X; TSENG CT; ZHOU Y; DU L; JIANG S: \"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines\", VACCINE, vol. 32, 2014, pages 2100 - 2108, XP028838491, DOI: doi:10.1016/j.vaccine.2014.02.004",
                    "MAYR A; MUNZ E: \"Veranderung von Vaccinevirus durch Dauerpassagen in HOhnerembryofibroblastenkulturen\", ZENTRALBL. BAKTERIOL. B., vol. 195, 1964, pages 24 - 35",
                    "MCBRIDE R; VAN ZYL M; FIELDING BC: \"The coronavirus nucleocapsid is a multifunctional protein\", VIRUSES, vol. 6, no. 8, 7 August 2014 (2014-08-07), pages 2991 - 3018, XP055200197, DOI: doi:10.3390/v6082991",
                    "MEYER H; SUTTER G; MAYR A: \"Mapping of deletions in the genome of the highly attenuated vaccinia virusMVAand their influence on virulence\", J. GEN. VIROL., vol. 72, 1991, pages 1031 - 1038",
                    "M\u00dc!LER MA; RAJ VS; MUTH D; MEYER B; KALLIES S; SMITS SL; WOLLNY R; BESTEBROER TM; SPECHT S; SULIMAN T: \"Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines\", MBIO, vol. 3, no. 6, 11 December 2012 (2012-12-11), pages E00515 - 12",
                    "SONG F; FUX R; PROVACIA LB; VOLZ A; EICKMANN M; BECKER S; OSTERHAUS ADME; HAAGMANS BL; SUTTER G.: \"Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies J Virol.\", J. VIROL., vol. 87, no. 21, 2013, pages 11950 - 11954, XP055157123, DOI: doi:10.1128/JVI.01672-13",
                    "STITTELAAR KJ; WYATT LS; DE SWART RL; VOS HW; GROEN J; VAN AMERONGEN G; VAN BINNENDIJK RS; ROZENBLATT S; MOSS B; OSTERHAUS AD: \"Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies\", J VIROL., vol. 74, no. 9, May 2000 (2000-05-01), pages 4236 - 43, XP002503633, DOI: doi:10.1128/JVI.74.9.4236-4243.2000",
                    "SCALLANA CD; TINGLEYA DW; LINDBLOOMA JD; TOOMEYB JS; TUCKERA SN: \"An Adenovirus-Based Vaccine with a Double-Stranded RNA Adjuvant Protects Mice and Ferrets against H5N1 Avian Influenza in Oral Delivery Models\", CLIN VACCINE IMMUNOL., vol. 20, no. 1, January 2013 (2013-01-01), pages 85 - 94, XP055361762, DOI: doi:10.1128/CVI.00552-12",
                    "STAIB C; DREXLER I; SUTTER G.; CONSTRUCTION AND ISOLATION OF RECOMBINANT MVA, METHODS MOL BIOL., vol. 269, 2004, pages 77 - 100",
                    "SUTTER G; MOSS B: \"Nonreplicating vaccinia vector efficiently expresses recombinant genes\", PROC. NATL. ACAD. SCI. U. S. A., vol. 89, 1992, pages 10847 - 10851, XP001036843, DOI: doi:10.1073/pnas.89.22.10847",
                    "VAN BOHEEMEN S; DE GRAAF M; LAUBER C; BESTEBROER TM; RAJ VS; ZAKI AM; OSTERHAUS AD; HAAGMANS BL; GORBALENYA AE; SNIJDER EJ: \"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans\", MBIO, vol. 3, no. 6, 2012, pages E00473 - 12, XP055128733, DOI: doi:10.1128/mBio.00473-12",
                    "VOLZ A; SUTTER G: \"Protective efficacy of modified vaccinia virus Ankara in preclinical studies\", VACCINE, vol. 31, 2013, pages 4235 - 4240, XP028697923, DOI: doi:10.1016/j.vaccine.2013.03.016",
                    "WYATT LS; SHORS ST; MURPHY BR; MOSS B.: \"Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model\", VACCINE, vol. 14, no. 15, October 1996 (1996-10-01), pages 1451 - 8, XP004070958, DOI: doi:10.1016/S0264-410X(96)00072-2",
                    "ZAKI AM; VAN BOHEEMEN S; BESTEBROER TM; OSTERHAUS AD; FOUCHIER RAM: \"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia\", N. ENGL. J. MED., vol. 367, 2012, pages 1814 - 1820, XP055274765, DOI: doi:10.1056/NEJMoa1211721"
                ],
                "nplResolvedCount": 30,
                "nplResolvedLensIDs": [
                    "028-649-402-860-197",
                    "045-797-239-878-426",
                    "005-732-516-262-69X",
                    "078-081-741-547-36X",
                    "084-941-141-319-771",
                    "168-768-264-462-518",
                    "022-899-518-024-071",
                    "051-986-060-584-276",
                    "049-261-268-948-323",
                    "029-124-221-419-735",
                    "095-031-646-921-756",
                    "025-804-338-184-099",
                    "027-043-089-978-283",
                    "007-348-479-567-414",
                    "034-904-040-112-484",
                    "114-114-185-080-165",
                    "083-152-458-546-878",
                    "023-939-052-489-028",
                    "016-741-112-113-368",
                    "063-119-380-364-205",
                    "026-908-715-293-497",
                    "171-736-096-630-261",
                    "097-527-847-167-915",
                    "027-040-929-448-995",
                    "023-671-383-084-282",
                    "024-311-781-677-427",
                    "145-034-883-356-717",
                    "026-944-353-804-488",
                    "022-510-164-534-753",
                    "080-379-055-502-376"
                ],
                "nplResolvedExternalIDs": [
                    "21390799",
                    "pmc4058772",
                    "19797070",
                    "8994321",
                    "10.1128/mbio.00473-12",
                    "9421642",
                    "10.1016/j.vaccine.2013.03.016",
                    "10.1073/pnas.89.22.10847",
                    "pmc4113791",
                    "10.1128/cvi.00552-12",
                    "10.1128/mbio.00515-12",
                    "10.1089/0889222041217428",
                    "18787007",
                    "10.1021/ja00897a025",
                    "10.1016/s0264-410x(96)00072-2",
                    "10.1385/1-59259-086-1:57",
                    "24217413",
                    "pmc4147684",
                    "11182314",
                    "10.1128/jvi.74.9.4236-4243.2000",
                    "10.1385/1-59259-789-0:077",
                    "25105276",
                    "pmc4194189",
                    "pmc3535765",
                    "pmc3807317",
                    "23678167",
                    "pmc50439",
                    "10.1016/j.vaccine.2013.03.020",
                    "10.3390/v6082991",
                    "10.1099/0022-1317-72-5-1031",
                    "pmc2573257",
                    "24560617",
                    "10.1016/j.vaccine.2014.02.004",
                    "10.1016/j.vaccine.2014.08.058",
                    "23170002",
                    "22688761",
                    "10.1128/jvi.01672-13",
                    "10.1007/978-1-61779-876-4_4",
                    "10.1038/nrmicro3143",
                    "10.1128/jvi.01288-08",
                    "23075143",
                    "5890664",
                    "pmc2786444",
                    "2033387",
                    "10.1056/nejmoa1211721",
                    "10.1016/s1074-5521(00)00058-2",
                    "23986586",
                    "24736006",
                    "1438287",
                    "23523402",
                    "15114009",
                    "pmc3700179",
                    "23078800",
                    "25192975",
                    "15242542",
                    "10.1128/iai.00700-09",
                    "pmc111939",
                    "25036462",
                    "10756037",
                    "23155123",
                    "10.3390/v6072735",
                    "10.1128/jvi.01244-13",
                    "23232719",
                    "10.2144/97236st07",
                    "10.1016/j.vaccine.2014.04.016",
                    "23523410"
                ]
            },
            {
                "index": "168",
                "publicationKey": "KR_101775984_B1",
                "lensId": "137-732-182-958-190",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101775984 B1",
                "publicationDate": "2017-09-07",
                "filingNumber": "KR 20150153524 A",
                "filingDate": "2015-11-03",
                "priorityFilingKeysActive": [
                    "KR 20150153524 A 20151103"
                ],
                "earliestPriorityDate": "2015-11-03",
                "title": "Molecular Beacon For Detection Of Mers-cov And Uses Thereof",
                "applicants": [
                    "\uc11c\uc6b8\ub300\ud559\uad50\ubcd1\uc6d0"
                ],
                "inventors": [
                    "\ud55c\ud638\uc131",
                    "\uae40\uc0c1\ud0dc"
                ],
                "owners": [],
                "url": "https://lens.org/137-732-182-958-190",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 64,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12Q1/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "169",
                "publicationKey": "KR_101944909_B1",
                "lensId": "196-005-279-512-522",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101944909 B1",
                "publicationDate": "2019-02-07",
                "filingNumber": "KR 20170095963 A",
                "filingDate": "2017-07-28",
                "priorityFilingKeysActive": [
                    "KR 20170095963 A 20170728"
                ],
                "earliestPriorityDate": "2017-07-28",
                "title": "A Pharmaceutical Composition For Treating Or Preventing Mers",
                "applicants": [
                    "UNIV ULSAN FOUND IND COOP",
                    "ASAN FOUND"
                ],
                "inventors": [
                    "KIM SUNG HAN",
                    "KIM JI YEUN",
                    "KIM IN KI"
                ],
                "owners": [],
                "url": "https://lens.org/196-005-279-512-522",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/336",
                    "A23L33/10",
                    "A61K8/49",
                    "A61K9/00",
                    "A61K31/343",
                    "A61Q19/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "170",
                "publicationKey": "CN_108060266_A",
                "lensId": "175-308-700-311-393",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 108060266 A",
                "publicationDate": "2018-05-22",
                "filingNumber": "CN 201711395098 A",
                "filingDate": "2017-12-21",
                "priorityFilingKeysActive": [
                    "CN 201711395098 A 20171221"
                ],
                "earliestPriorityDate": "2017-12-21",
                "title": "Primer Probe Set, Kit And Detection Method For Detecting Sars-cov (severe Acute Respiratory Syndrome Coronavirus) And Mers-cov (middle East Respiratory Syndrome Coronavirus)",
                "applicants": [
                    "BEIJING APPLIED BIOLOGICAL TECH CO LTD"
                ],
                "inventors": [
                    "WANG LEI",
                    "WANG YUE",
                    "ZHANG ZHIQIANG"
                ],
                "owners": [],
                "url": "https://lens.org/175-308-700-311-393",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12N15/11",
                    "C12Q1/6844"
                ],
                "usClassifications": [],
                "nplCitationCount": 3,
                "nplCitations": [
                    "ABD EL WAHED AHMED\u7b49: \"Reverse transcription recombinase polymerase amplification assay for the detection of middle east respiratory syndrome coronavirus\", \u300aPLOS CURRENTS\u300b",
                    "BHADRA SANCHITA\u7b49: \"Real-time sequence-validated loop-mediated isothermal amplification assays for detection of middle east respiratory syndrome coronavirus (MERS-CoV)\", \u300aPLOS ONE\u300b",
                    "\u8d3e\u4f73: \"\u4e09\u79cd\u75c5\u6bd2RPA\u68c0\u6d4b\u65b9\u6cd5\u7684\u5efa\u7acb\u53ca\u9633\u6027\u5bf9\u7167\u54c1\u7684\u5236\u5907\", \u300a\u4e2d\u56fd\u4f18\u79c0\u7855\u58eb\u5b66\u4f4d\u8bba\u6587\u5168\u6587\u6570\u636e\u5e93 \u533b\u836f\u536b\u751f\u79d1\u6280\u8f91\u300b"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "171",
                "publicationKey": "US_9460268_B2",
                "lensId": "102-288-835-385-29X",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9460268 B2",
                "publicationDate": "2016-10-04",
                "filingNumber": "US 201414479245 A",
                "filingDate": "2014-09-05",
                "priorityFilingKeysActive": [
                    "US 201361874976 P 20130906",
                    "US 201361885462 P 20131001",
                    "US 201462001039 P 20140520",
                    "US 201462001053 P 20140521",
                    "US 201462010382 P 20140610"
                ],
                "earliestPriorityDate": "2013-09-06",
                "title": "Systems And Methods For Detecting Infectious Diseases",
                "applicants": [
                    "THERANOS INC"
                ],
                "inventors": [
                    "HOLMES ELIZABETH A",
                    "BELHOCINE KAMILA",
                    "LEE JOSEPHINE",
                    "PATEL PRANAV",
                    "RICHARDSON AARON",
                    "TABAKMAN SCOTT"
                ],
                "owners": [
                    {
                        "name": "THERANOS IP COMPANY LLC",
                        "executionDate": "2017-12-11"
                    },
                    {
                        "name": "THERANOS INC",
                        "executionDate": "2015-09-28"
                    }
                ],
                "url": "https://lens.org/102-288-835-385-29X",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 26,
                "familySize": 47,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "G06F19/00",
                    "C12Q1/68",
                    "C12Q1/70",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 36,
                "nplCitations": [
                    "Hung IF, To KK, Lee CK, Lin CK, Chan JF, Tse H, Cheng VC, Chen H, Ho PL, Tse CW, Ng TK, Que TL, Chan KH, Yuen KY. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin Infect Dis. Aug. 1, 2010;51(3):274-9.",
                    "Zimmerman O, Rogowski O, Aviram G, Mizrahi M, Zeltser D, Justo D, Dahan E, Arad R, Touvia O, Tau L, Tarabeia J, Berliner S, Paran Y. C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection. BMC Infect Dis. Oct. 4, 2010;10:288.",
                    "AppliedBiosystems StepOne(TM) Real-Time PCR System Manual, Rev. 2010.",
                    "Li P. (2012) Microfluidics for IVD: In Pursuit of the Holy Grail. J Bioengineer & Biomedical Sci S8:e001.",
                    "Dapat IC, Dapat C, Baranovich T, Suzuki Y, Kondo H, Shobugawa Y, Saito R, Suzuki H; Japanese Influenza Collaborative Study Group. Genetic characterization of human influenza viruses in the pandemic (2009-2010) and post-pandemic (2010-2011) periods in Japan. PLoS One. 2012;7(6):e36455.Epub Jun. 27, 2012.",
                    "Luk FO, Chan CK, Lai TY. A case of dengue maculopathy with spontaneous recovery. Case Rep Ophthalmol. Jun. 8, 2013;4(2):28-33. Print May 2013.",
                    "Sahni AK, Grover N, Sharma A, Khan ID, Kishore J. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) for diagnosis of dengue. Med J Armed Forces India. Jul. 2013;69(3):246-53. doi: 10.1016/j.mjafi.2012.07.017. Epub Dec. 1, 2012.",
                    "Rodriguez-Sanchez B, et. al. Improved diagnosis for nine viral diseases considered as notifiable by the world organization for animal health. Transbound Emerg Dis. Aug. 2008;55(5-6):215-25.",
                    "Gill P, Ghaemi A. Nucleic acid isothermal amplification technologies: a review. Nucleosides Nucleotides Nucleic Acids. Mar. 2008;27(3):224-43.",
                    "Roskos K, Hickerson AI, Lu HW, Ferguson TM, Shinde DN, Klaue Y, Niemz A. Simple system for isothermal DNA amplification coupled to lateral flow detection. PLoS One. Jul. 26, 2013;8(7):e69355. Print 2013.",
                    "Kimura Y, Oguchi-Katayama A, Kawai Y, Naito K, Mitani Y, Morlighem JE, Hayashizaki Y, Lezhava A. Tail variation of the folding primer affects the SmartAmp2 process differently. Biochem Biophys Res Commun. Jun. 12, 2009;383(4):455-9.",
                    "Diamandis EP. Theranos phenomenon: promises and fallacies. Clin Chem Lab Med. Jun. 2015;53(7):989-93.",
                    "Plebani M. Evaluating and using innovative technologies: a lesson from Theranos? Clin Chem Lab Med. Jun. 2015;53(7):961-2.",
                    "Rappleye E. \"Theranos gets extension to fix issues following CMS investigation.\" Becker's Hospital Review. Feb. 8, 2016. http://www.beckershospitalreview.com/hospital-management-administration/theranos-gets-extension-to-fix-issues-following-cms-investigation.html.",
                    "Ramsey L. \"Theranos has a week to respond to the searing report about its business.\" Business Insider. Feb. 5, 2016. http://www.businessinsider.com/theranos-response-to-cms-2016-2.",
                    "Loria K. \"'More skeptical than ever': Experts respond to the government's warning letter to Theranos.\" Jan. 28, 2016. Tech Insider. http://www.techinsider.io/how-bad-the-cms-letter-to-theranos-really-is-2016-1.",
                    "Fuller K. Centers for Medicare and Medicaid Services (CMS). Condition Level Deficiencies Notic-Immediate Jeopardy. Notice to Theranos, Inc. director Dr. Sunil Dhawan. Jan. 25, 2016. https://cdn2.vox-cdn.com/uploads/chorus-asset/file/5969923/Theranos-Inc-Cover-Letter-01-25-2016.0.pdf.",
                    "Havl\u00edckov\u00e1 M, Pljusnin AZ, Tmov\u00e1 B. Influenza virus detection in clinical specimens. Acta Virol. Sep. 1990;34(5):449-56.",
                    "Metzgar D, et. al. Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants. PLoS One. Feb. 3, 2010;5(2):e8995.",
                    "Jannetto PJ, Buchan BW, Vaughan KA, Ledford JS, Anderson DK, Henley DC, Quigley NB, Ledeboer NA. Real-time detection of influenza a, influenza B, and respiratory syncytial virus a and B in respiratory specimens by use of nanoparticle probes. J Clin Microbiol. Nov. 2010;48(11):3997-4002. Epub Sep. 8, 2010.",
                    "Mahony JB, Petrich A, Smieja M. Molecular diagnosis of respiratory virus infections. Crit Rev Clin Lab Sci. Sep.-Dec. 2011;48(5-6):217-49.",
                    "Chin CD, Chin SY, Laksanasopin T, Sia SK. \"Chapter 1: Low-Cost Microdevices for Point-of-Care Testing.\" Biological and Medical Physics, Biomedical Engineering pp. 3-21. Oct. 12, 2012.",
                    "U.S. Appl. No. 14/479,190, filed Sep. 5, 2014.",
                    "U.S. Appl. No. 14/479,241, filed Sep. 5, 2014.",
                    "Written Opinion and International Search Report dated Dec. 18, 2014 for PCT/US2014/054424.",
                    "Anders et al., Am Journal Med Hyg 87(1), 2012, pp. 165-170.",
                    "Kautner et al., Journal of Pediatrics, 1997, 131, pp. 516-524.",
                    "Lounsbury et al., Lab Chip, 2013, 13, pp. 1384-1393.",
                    "Office Action dated Jan. 29, 2015 for U.S. Appl. No. 14/479,241.",
                    "Office Action dated Feb. 12, 2015 for U.S. Appl. No. 14/479,190.",
                    "U.S. Appl. 14/604,194, filed Jan. 23, 2015.",
                    "Voudoukis et al., 2011, Med Sci Monit, 17(4), pp, 185-188.",
                    "World Health Organization (WHO) Guide to Field Operations, Oct. 2006, pp. 1-80.",
                    "Office Action dated Jul. 8, 2015 for U.S. Appl. No. 14/479,241.",
                    "Advisory Action dated Sep. 25, 2015 for U.S. Appl. No. 14/479,241.",
                    "Office Action dated Nov. 19, 2015 for U.S. Appl. No. 14/604,194."
                ],
                "nplResolvedCount": 20,
                "nplResolvedLensIDs": [
                    "041-164-594-381-566",
                    "033-684-769-494-634",
                    "017-357-555-017-666",
                    "006-717-818-600-296",
                    "055-691-444-317-721",
                    "035-576-903-166-928",
                    "024-381-743-890-001",
                    "007-463-586-614-953",
                    "041-851-513-374-802",
                    "058-125-883-994-620",
                    "055-617-498-113-550",
                    "074-132-963-233-333",
                    "009-877-806-763-516",
                    "042-708-210-232-211",
                    "033-640-893-712-104",
                    "122-810-893-296-361",
                    "103-852-169-195-558",
                    "025-353-957-592-93X",
                    "015-173-776-212-116",
                    "105-763-401-360-684"
                ],
                "nplResolvedExternalIDs": [
                    "10.12659/msm.881713",
                    "9386651",
                    "pmc2959060",
                    "25996487",
                    "18666965",
                    "10.1007/978-3-642-29268-2_1",
                    "10.1186/1471-2334-10-288",
                    "20140251",
                    "20575664",
                    "10.1128/jcm.01118-10",
                    "pmc3391044",
                    "10.1111/j.1865-1682.2008.01037.x",
                    "10.1371/journal.pone.0008995",
                    "22185616",
                    "23922706",
                    "1981455",
                    "23389252",
                    "10.1159/000353224",
                    "21455103",
                    "23898289",
                    "20920320",
                    "10.1016/j.mjafi.2012.07.017",
                    "pmc3862550",
                    "10.1016/j.bbrc.2009.04.033",
                    "10.1515/cclm-2015-0411",
                    "10.1515/cclm-2015-0356",
                    "10.1086/653940",
                    "10.1371/journal.pone.0069355",
                    "pmc3020893",
                    "10.1016/s0022-3476(97)70054-4",
                    "pmc2815781",
                    "18260008",
                    "10.3109/10408363.2011.640976",
                    "19371726",
                    "20826644",
                    "22764309",
                    "pmc3724848",
                    "24600118",
                    "22761651",
                    "10.1039/c3lc41326h",
                    "pmc3539528",
                    "10.1371/journal.pone.0036455",
                    "26030792",
                    "pmc3384667",
                    "10.1080/15257770701845204",
                    "10.4269/ajtmh.2012.11-0713"
                ]
            },
            {
                "index": "172",
                "publicationKey": "WO_2016_116398_A1",
                "lensId": "109-746-392-442-207",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2016/116398 A1",
                "publicationDate": "2016-07-28",
                "filingNumber": "EP 2016050888 W",
                "filingDate": "2016-01-18",
                "priorityFilingKeysActive": [
                    "EP 15151594 A 20150119"
                ],
                "earliestPriorityDate": "2015-01-19",
                "title": "A Novel Vaccine Against The Middle East Respiratory Syndrome Coronavirus (mers-cov)",
                "applicants": [
                    "LUDWIG MAXIMILIANS UNIVERSIT\u00c4T M\u00dcNCHEN",
                    "PHILIPPS UNIVERSIT\u00c4T MARBURG"
                ],
                "inventors": [
                    "SUTTER GERD",
                    "SONG FEI",
                    "FUX ROBERT",
                    "VOLZ ASISA",
                    "BECKER STEPHAN",
                    "EICKMANN MARKUS"
                ],
                "owners": [],
                "url": "https://lens.org/109-746-392-442-207",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 14,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C07K14/005"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "ARWEN ALTENBURG ET AL: \"Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases\", VIRUSES, vol. 6, no. 7, 17 July 2014 (2014-07-17), pages 2735 - 2761, XP055200206, DOI: 10.3390/v6072735",
                    "F. SONG ET AL: \"Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies\", JOURNAL OF VIROLOGY, vol. 87, no. 21, 1 November 2013 (2013-11-01), pages 11950 - 11954, XP055157123, ISSN: 0022-538X, DOI: 10.1128/JVI.01672-13",
                    "RACHEL L. GRAHAM ET AL: \"A decade after SARS: strategies for controlling emerging coronaviruses\", NATURE REVIEWS MICROBIOLOGY, vol. 11, no. 12, 11 November 2013 (2013-11-11), pages 836 - 848, XP055200225, ISSN: 1740-1526, DOI: 10.1038/nrmicro3143",
                    "S. VAN BOHEEMEN ET AL: \"Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans\", MBIO, vol. 3, no. 6, 20 November 2012 (2012-11-20), pages e00473 - 12, XP055128733, ISSN: 2150-7511, DOI: 10.1128/mBio.00473-12",
                    "RUTH MCBRIDE ET AL: \"The Coronavirus Nucleocapsid Is a Multifunctional Protein\", VIRUSES, vol. 6, no. 8, 7 August 2014 (2014-08-07), pages 2991 - 3018, XP055200197, DOI: 10.3390/v6082991",
                    "ASISA VOLZ ET AL: \"Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein\", JOURNAL OF VIROLOGY., vol. 89, no. 16, 27 May 2015 (2015-05-27), US, pages 8651 - 8656, XP055257600, ISSN: 0022-538X, DOI: 10.1128/JVI.00614-15"
                ],
                "nplResolvedCount": 6,
                "nplResolvedLensIDs": [
                    "032-514-877-351-077",
                    "168-768-264-462-518",
                    "027-043-089-978-283",
                    "007-348-479-567-414",
                    "114-114-185-080-165",
                    "023-939-052-489-028"
                ],
                "nplResolvedExternalIDs": [
                    "25105276",
                    "pmc3807317",
                    "10.3390/v6082991",
                    "10.1128/mbio.00473-12",
                    "pmc4524222",
                    "pmc4113791",
                    "10.1128/jvi.00614-15",
                    "25036462",
                    "23986586",
                    "26018172",
                    "23170002",
                    "10.1128/jvi.01672-13",
                    "10.3390/v6072735",
                    "24217413",
                    "pmc4147684",
                    "10.1038/nrmicro3143"
                ]
            },
            {
                "index": "173",
                "publicationKey": "WO_2017_078421_A1",
                "lensId": "184-236-016-578-207",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2017/078421 A1",
                "publicationDate": "2017-05-11",
                "filingNumber": "KR 2016012574 W",
                "filingDate": "2016-11-03",
                "priorityFilingKeysActive": [
                    "KR 20150153524 A 20151103"
                ],
                "earliestPriorityDate": "2015-11-03",
                "title": "Molecular Beacons For Detecting Middle East Respiratory Syndrome Coronavirus And Uses Thereof",
                "applicants": [
                    "SEOUL NAT UNIV BUNDANG HOSPITAL"
                ],
                "inventors": [
                    "HAN HO-SEONG",
                    "KIM SANG TAE"
                ],
                "owners": [],
                "url": "https://lens.org/184-236-016-578-207",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 32,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12Q1/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "DATABASE NCBI [O] 10 September 2015 (2015-09-10), XP055381957, Database accession no. KT225476.2",
                    "BAEZ-SANTOS ET AL.: \"Catalytic Function and Substrate Specificity of the Papain-like Protease Domain of Nsp3 from the Middle East Respiratory Syndrome Coronavirus\", JOURNAL OF VIROLOGY, vol. 88, no. 21, November 2014 (2014-11-01), pages 12511 - 12527, XP055381960"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "072-486-785-940-734"
                ],
                "nplResolvedExternalIDs": [
                    "10.1128/jvi.01294-14",
                    "25142582",
                    "pmc4248884"
                ]
            },
            {
                "index": "174",
                "publicationKey": "WO_2018_222983_A1",
                "lensId": "028-351-109-227-884",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/222983 A1",
                "publicationDate": "2018-12-06",
                "filingNumber": "US 2018/0035587 W",
                "filingDate": "2018-06-01",
                "priorityFilingKeysActive": [
                    "US 201762514091 P 20170602"
                ],
                "earliestPriorityDate": "2017-06-02",
                "title": "Phenotypically Wild-type And Genetically Attenuated Viruses",
                "applicants": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "inventors": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "owners": [],
                "url": "https://lens.org/028-351-109-227-884",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/21",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "WANG ET AL.: \"Construction of a live-attenuated HIV-1 vaccine through genetic code expansion\", ANGEW CHEM INT ED ENGL., vol. 53, no. 19, 5 May 2014 (2014-05-05), pages 4867 - 4871, XP055563251",
                    "THE GENETIC CODES, 15 March 2017 (2017-03-15), Retrieved from the Internet <URL:hftps://web.archive.org/web/20170315234037/https://www.ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi> [retrieved on 20180730]"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "008-764-941-717-89X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1002/anie.201402092",
                    "pmc4984542",
                    "24715496"
                ]
            },
            {
                "index": "175",
                "publicationKey": "WO_2018_222986_A1",
                "lensId": "192-721-416-364-258",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/222986 A1",
                "publicationDate": "2018-12-06",
                "filingNumber": "US 2018/0035591 W",
                "filingDate": "2018-06-01",
                "priorityFilingKeysActive": [
                    "US 201762514096 P 20170602"
                ],
                "earliestPriorityDate": "2017-06-02",
                "title": "Genetically Attenuated Nucleic Acid Vaccine",
                "applicants": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "inventors": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "owners": [],
                "url": "https://lens.org/192-721-416-364-258",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N15/66",
                    "C12N15/10",
                    "C12N15/11",
                    "C12N15/33"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "WANG ET AL.: \"Expanding the Genetic Code\", ANGEW. CHEM. INT. ED., vol. 44, no. 1, 17 December 2004 (2004-12-17), pages 34 - 66, XP055562040"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "176",
                "publicationKey": "WO_2019_022357_A1",
                "lensId": "056-402-580-082-261",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/022357 A1",
                "publicationDate": "2019-01-31",
                "filingNumber": "KR 2018005761 W",
                "filingDate": "2018-05-21",
                "priorityFilingKeysActive": [
                    "KR 20170095963 A 20170728"
                ],
                "earliestPriorityDate": "2017-07-28",
                "title": "Pharmaceutical Composition For Preventing Or Treating Middle East Respiratory Syndrome",
                "applicants": [
                    "UNIV ULSAN FOUND IND COOP",
                    "ASAN FOUND"
                ],
                "inventors": [
                    "KIM SUNG-HAN",
                    "KIM JI YEUN",
                    "KIM IN KI"
                ],
                "owners": [],
                "url": "https://lens.org/056-402-580-082-261",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/336",
                    "A23L33/10",
                    "A61K8/49",
                    "A61K9/00",
                    "A61K31/343",
                    "A61Q19/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "HU , XIN ET AL.: \"Kinetic, Mutational, and Structural Studies of the Venezuelan Equine Encephalitis Virus Nonstructural Protein 2 Cysteine Protease\", BIOCHEMISTRY, vol. 55, no. 21, 2016, pages 3007 - 3019, XP055567283",
                    "PARK. JI-YOUNG ET AL.: \"Tanshinones as Selective and Slow-binding Inhibitors for SARS-CoV Cysteine Proteases\", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 20, no. 19, 2012, pages 5928 - 5935, XP055567436"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "094-687-316-022-091",
                    "053-731-301-797-909"
                ],
                "nplResolvedExternalIDs": [
                    "22884354",
                    "10.1016/j.bmc.2012.07.038",
                    "27030368",
                    "10.1021/acs.biochem.5b00992"
                ]
            },
            {
                "index": "177",
                "publicationKey": "US_2019_0290749_A1",
                "lensId": "120-926-310-472-207",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0290749 A1",
                "publicationDate": "2019-09-26",
                "filingNumber": "US 201716345699 A",
                "filingDate": "2017-10-30",
                "priorityFilingKeysActive": [
                    "KR 20160142703 A 20161031",
                    "KR 20170079762 A 20170623"
                ],
                "earliestPriorityDate": "2016-10-31",
                "title": "Immune Modulator And Vaccine Composition Containing The Same",
                "applicants": [
                    "EYEGENE INC"
                ],
                "inventors": [
                    "CHO YANG JE",
                    "KIM KWANGSUNG",
                    "LEE NA GYONG",
                    "PARK SHIN AE"
                ],
                "owners": [
                    {
                        "name": "EYEGENE INC",
                        "executionDate": "2019-05-08"
                    }
                ],
                "url": "https://lens.org/120-926-310-472-207",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 19,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/002",
                    "A61K39/39",
                    "A61P31/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "178",
                "publicationKey": "KR_20170051884_A",
                "lensId": "187-276-308-689-035",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20170051884 A",
                "publicationDate": "2017-05-12",
                "filingNumber": "KR 20150153524 A",
                "filingDate": "2015-11-03",
                "priorityFilingKeysActive": [
                    "KR 20150153524 A 20151103"
                ],
                "earliestPriorityDate": "2015-11-03",
                "title": "Molecular Beacon For Detection Of Mers-cov And Uses Thereof",
                "applicants": [
                    "SEOUL NAT UNIV HOSPITAL"
                ],
                "inventors": [
                    "HAN HO SEONG",
                    "KIM SANG TAE"
                ],
                "owners": [],
                "url": "https://lens.org/187-276-308-689-035",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 64,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12Q1/68"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "179",
                "publicationKey": "EP_2950817_B1",
                "lensId": "091-218-378-511-199",
                "jurisdiction": "EP",
                "kindCode": "B1",
                "displayKey": "EP 2950817 B1",
                "publicationDate": "2019-08-07",
                "filingNumber": "EP 14745410 A",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "PORTLAND STATE UNIV",
                    "PROVIDENCE HEALTH & SERVICES OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [],
                "url": "https://lens.org/091-218-378-511-199",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "ANONYMOUS: \"Dr. Kenneth Stedman - Publications\", 1 January 2017 (2017-01-01), XP055400262, Retrieved from the Internet <URL:http://web.pdx.edu/~kstedman/Publications/allpubs.html> [retrieved on 20170822]",
                    "J E KYLE ET AL: \"PRESERVATION POTENTIAL OF LIPID-CONTAINING VIRUSES UNDER SILICIFYING CONDITIONS\", 43RD LUNAR AND PLANETARY SCIENCE CONFERENCE, 2012, pages 356 - 361, XP055400235, Retrieved from the Internet <URL:http://www.lpi.usra.edu/meetings/lpsc2012/pdf/2228.pdf>"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "180",
                "publicationKey": "KR_101934199_B1",
                "lensId": "080-230-007-991-034",
                "jurisdiction": "KR",
                "kindCode": "B1",
                "displayKey": "KR 101934199 B1",
                "publicationDate": "2019-12-31",
                "filingNumber": "KR 20170074097 A",
                "filingDate": "2017-06-13",
                "priorityFilingKeysActive": [
                    "KR 20160081542 A 20160629"
                ],
                "earliestPriorityDate": "2016-06-29",
                "title": "Composition For Preventing Or Treating Middle East Respiratory Syndrome-coronavirus Mers-cov Infection",
                "applicants": [
                    "\uc544\uc8fc\ub300\ud559\uad50\uc0b0\ud559\ud611\ub825\ub2e8"
                ],
                "inventors": [
                    "\ucd5c\uc0c1\ub3c8",
                    "\ud504\ub77c\uc0b0\ub098\ubca4\uce74\ud14c\uc26c",
                    "\uc2e0\ud604\uc900",
                    "\uc0ac \ub9c8\uc0ac\uc6b0\ub4dc"
                ],
                "owners": [],
                "url": "https://lens.org/080-230-007-991-034",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/35",
                    "A23L33/10",
                    "A61K9/14",
                    "A61K9/20",
                    "A61K9/48",
                    "A61K31/195",
                    "A61K31/4245"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "181",
                "publicationKey": "US_9993543_B2",
                "lensId": "006-662-478-152-128",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9993543 B2",
                "publicationDate": "2018-06-12",
                "filingNumber": "US 201414763947 A",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "PORTLAND STATE UNIV",
                    "PROVIDENCE HEALTH & SERVICES\u2014OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [
                    {
                        "name": "PORTLAND STATE UNIVERSITY",
                        "executionDate": "2015-04-29"
                    },
                    {
                        "name": "PROVIDENCE HEALTH & SERVICES - OREGON",
                        "executionDate": "2014-02-28"
                    },
                    {
                        "name": "OREGON STATE BOARD OF HIGHER EDUCATION ACTING BY AND THROUGH PORTLAND STATE UNIVERSITY",
                        "executionDate": "2014-02-22"
                    }
                ],
                "url": "https://lens.org/006-662-478-152-128",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/00",
                    "A61K39/125",
                    "A61K39/13",
                    "A61K39/145",
                    "A61K39/15",
                    "A61K39/21",
                    "A61K39/215",
                    "A61K39/235",
                    "A61K39/285",
                    "A61K39/29",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 8,
                "nplCitations": [
                    "Wang et al., \u201cHydrated Silica Exterior Produced by Biomimetic Silicification Confers Viral Vaccine Heat-Resistance,\u201d ACS Nano 9(1):799-808, 2015.",
                    "Alcock et al., \u201cLong-Term Thermo stabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass,\u201d Vaccines, vol. 2, 8 pages, 2010.",
                    "Kyle et al., \u201cPreservation Potential of Lipid-Containing Viruses under Silicifying Conditions,\u201d 43rd Lunar and Planetary Science Conference, 2012.",
                    "Laidler et al., \u201cDifferential Activation, Reactivation and Des sication Tolerance of Silicified Viruses,\u201d abstract presented at the Astrobiology Science Conference, Apr. 17, 2012, Atlanta, Georgia.",
                    "Laidler et al., \u201cVirus Silicification under Simulated Hot Spring Conditions,\u201d Astrobiology, vol. 10:569-576, 2010.",
                    "Laidler et al., \u201cReversible Inactivation and Desiccation Tolerance of Silicified Viruses,\u201d J. Virol., vol. 87:13927-13929, 2013.",
                    "Orange et al., \u201cExperimental fossilisation of Viruses from extremophilic Archaea,\u201d Biogeosciences, vol. 8:1465-1475, 2011.",
                    "Royston et al., \u201cCharacterization of Silica-Coated Tobacco Mosaic Virus,\u201d J. Colloid Interface Sci., vol. 298:706-712, 2006."
                ],
                "nplResolvedCount": 6,
                "nplResolvedLensIDs": [
                    "109-976-226-332-33X",
                    "045-732-946-166-420",
                    "095-022-123-251-744",
                    "041-843-275-763-991",
                    "092-852-588-703-636",
                    "052-341-743-573-427"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/j.jcis.2005.12.068",
                    "16426631",
                    "24109222",
                    "10.1089/ast.2010.0463",
                    "pmc3838281",
                    "25574563",
                    "10.1021/nn5063276",
                    "10.1126/scitranslmed.3000490",
                    "20371486",
                    "10.1128/jvi.02825-13",
                    "20735248",
                    "10.5194/bg-8-1465-2011"
                ]
            },
            {
                "index": "182",
                "publicationKey": "WO_2014_121132_A1",
                "lensId": "096-017-478-969-915",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2014/121132 A1",
                "publicationDate": "2014-08-07",
                "filingNumber": "US 2014/0014284 W",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "OREGON STATE",
                    "PROVIDENCE HEALTH & SERVICES OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [],
                "url": "https://lens.org/096-017-478-969-915",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 8,
                "nplCitations": [
                    "LAIDLER ET AL.: \"Virus Silicification under Simulated Hot Spring Conditions\", ASTROBIOLOGY, vol. 10, no. 6, 24 August 2008 (2008-08-24), pages 569 - 576, XP055269930, DOI: 10.1089/AST.2010.0463",
                    "See also references of EP 2950817A4",
                    "SMITH ET AL., AEROBIOLOGIA, vol. 26, 2010, pages 35",
                    "DING ET AL., GYNECOL ONCOL, vol. 121, 2011, pages 148",
                    "FOGARTY ET AL., VIRUS RES, vol. 132, 2008, pages 140",
                    "NAKANO ET AL., FISH PATHOL, vol. 33, 1998, pages 65",
                    "LAIDLER; STEDMAN, ASTROBIOLOGY, vol. 10, 2010, pages 569",
                    "ORANGE ET AL., BIOGEOSCIENCES, vol. 8, 2011, pages 1465"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "109-976-226-332-33X",
                    "124-513-861-219-056",
                    "045-732-946-166-420",
                    "022-833-502-043-217"
                ],
                "nplResolvedExternalIDs": [
                    "18166242",
                    "pmc3610175",
                    "10.1016/j.ygyno.2010.11.040",
                    "10.1089/ast.2010.0463",
                    "10.1016/j.virusres.2007.11.010",
                    "20735248",
                    "21208649",
                    "10.5194/bg-8-1465-2011"
                ]
            },
            {
                "index": "183",
                "publicationKey": "KR_20180002504_A",
                "lensId": "015-273-783-444-52X",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20180002504 A",
                "publicationDate": "2018-01-08",
                "filingNumber": "KR 20170074097 A",
                "filingDate": "2017-06-13",
                "priorityFilingKeysActive": [
                    "KR 20160081542 A 20160629"
                ],
                "earliestPriorityDate": "2016-06-29",
                "title": "Composition For Preventing Or Treating Middle East Respiratory Syndrome-coronavirus Mers-cov Infection",
                "applicants": [
                    "UNIV AJOU IND ACADEMIC COOP FOUND"
                ],
                "inventors": [
                    "CHOI SANG DUN",
                    "PRASANNAVENKATESH",
                    "SHIN HYEON JUN",
                    "SHAH MASAUD"
                ],
                "owners": [],
                "url": "https://lens.org/015-273-783-444-52X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/35",
                    "A23L33/10",
                    "A61K9/14",
                    "A61K9/20",
                    "A61K9/48",
                    "A61K31/195",
                    "A61K31/4245"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "184",
                "publicationKey": "US_2015_0359871_A1",
                "lensId": "128-748-858-313-991",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0359871 A1",
                "publicationDate": "2015-12-17",
                "filingNumber": "US 201414763947 A",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "UNIV PORTLAND STATE",
                    "PROVIDENCE HEALTH & SERVICES OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [
                    {
                        "name": "PORTLAND STATE UNIVERSITY",
                        "executionDate": "2015-04-29"
                    },
                    {
                        "name": "PROVIDENCE HEALTH & SERVICES - OREGON",
                        "executionDate": "2014-02-28"
                    },
                    {
                        "name": "OREGON STATE BOARD OF HIGHER EDUCATION ACTING BY AND THROUGH PORTLAND STATE UNIVERSITY",
                        "executionDate": "2014-02-22"
                    }
                ],
                "url": "https://lens.org/128-748-858-313-991",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K39/125",
                    "A61K39/13",
                    "A61K39/145",
                    "A61K39/15",
                    "A61K39/21",
                    "A61K39/215",
                    "A61K39/235",
                    "A61K39/285",
                    "A61K39/29",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "185",
                "publicationKey": "CN_106380517_A",
                "lensId": "013-236-223-981-137",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 106380517 A",
                "publicationDate": "2017-02-08",
                "filingNumber": "CN 201610962225 A",
                "filingDate": "2016-10-28",
                "priorityFilingKeysActive": [
                    "CN 201610962225 A 20161028"
                ],
                "earliestPriorityDate": "2016-10-28",
                "title": "Micromolecular Antibody Having Neutralization Activity For Middle-east Respiratory Syndrome (mers) Coronavirus And Application Of Micromolecular Antibody",
                "applicants": [
                    "INST OF MICROBIOLOGY AND EPIDEMIOLOGY THE ACAD OF MILITARY MEDICAL SCIENCES"
                ],
                "inventors": [
                    "ZHAO GUANGYU",
                    "ZHOU YUSEN",
                    "QIU HONGJIE",
                    "SUN SHIHUI",
                    "GUO YAN",
                    "KOU ZHIHUA",
                    "LI JUNFENG"
                ],
                "owners": [],
                "url": "https://lens.org/013-236-223-981-137",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61P31/14",
                    "C12N1/21",
                    "C12N15/11",
                    "C12N15/13",
                    "C12N15/70"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "186",
                "publicationKey": "CN_106380517_B",
                "lensId": "122-284-255-039-793",
                "jurisdiction": "CN",
                "kindCode": "B",
                "displayKey": "CN 106380517 B",
                "publicationDate": "2019-07-16",
                "filingNumber": "CN 201610962225 A",
                "filingDate": "2016-10-28",
                "priorityFilingKeysActive": [
                    "CN 201610962225 A 20161028"
                ],
                "earliestPriorityDate": "2016-10-28",
                "title": "\u4e00\u79cd\u5bf9\u4e2d\u4e1c\u547c\u5438\u7efc\u5408\u5f81\u51a0\u72b6\u75c5\u6bd2\u5177\u6709\u4e2d\u548c\u6d3b\u6027\u7684\u5c0f\u5206\u5b50\u6297\u4f53\u53ca\u5176\u5e94\u7528",
                "applicants": [
                    "\u4e2d\u56fd\u4eba\u6c11\u89e3\u653e\u519b\u519b\u4e8b\u533b\u5b66\u79d1\u5b66\u9662\u5fae\u751f\u7269\u6d41\u884c\u75c5\u7814\u7a76\u6240"
                ],
                "inventors": [
                    "\u8d75\u5149\u5b87",
                    "\u5468\u80b2\u68ee",
                    "\u90b1\u6d2a\u6770",
                    "\u5b59\u4e16\u60e0",
                    "\u90ed\u5f66",
                    "\u5bc7\u5fd7\u534e",
                    "\u674e\u519b\u950b"
                ],
                "owners": [],
                "url": "https://lens.org/122-284-255-039-793",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A61K39/42",
                    "A61P31/14",
                    "C12N1/21",
                    "C12N15/11",
                    "C12N15/13",
                    "C12N15/70"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "187",
                "publicationKey": "WO_2016_059161_A1",
                "lensId": "057-743-123-300-202",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2016/059161 A1",
                "publicationDate": "2016-04-21",
                "filingNumber": "EP 2015073892 W",
                "filingDate": "2015-10-15",
                "priorityFilingKeysActive": [
                    "EP 14306633 A 20141015"
                ],
                "earliestPriorityDate": "2014-10-15",
                "title": "Composition With Reduced Immunogenicity",
                "applicants": [
                    "XENOTHERA"
                ],
                "inventors": [
                    "DUVAUX ODILE",
                    "SOULILLOU JEAN-PAUL"
                ],
                "owners": [],
                "url": "https://lens.org/057-743-123-300-202",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 9,
                "familySize": 9,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/08",
                    "A01K67/027",
                    "C07K16/10",
                    "C07K16/12",
                    "C07K16/14",
                    "C12N9/02",
                    "C12N9/10",
                    "C12N9/22",
                    "C12N9/40"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "ANDREW J. LUTZ ET AL: \"Double knockout pigs deficient in N-glycolylneuraminic acid and Galactose [alpha]-1,3-Galactose reduce the humoral barrier to xenotransplantation\", XENOTRANSPLANTATION, vol. 20, no. 1, 5 January 2013 (2013-01-05), pages 27 - 35, XP055069928, ISSN: 0908-665X, DOI: 10.1111/xen.12019",
                    "VERED PADLER-KARAVANI ET AL: \"Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk\", XENOTRANSPLANTATION, vol. 18, no. 1, 1 January 2011 (2011-01-01), pages 1 - 5, XP055176955, ISSN: 0908-665X, DOI: 10.1111/j.1399-3089.2011.00622.x",
                    "RAJU T S ET AL: \"Species-specific variation in glycosylation of IgG: evidence for species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics\", GLYCOBIOLOGY, OXFORD UNIVERSITY PRESS, US, vol. 10, no. 5, 1 January 2000 (2000-01-01), pages 477 - 486, XP002964086, ISSN: 0959-6658, DOI: 10.1093/GLYCOB/10.5.477",
                    "TANGVORANUNTAKUL PAM ET AL: \"Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 100, no. 21, 14 October 2003 (2003-10-14), pages 12045 - 12050, XP002443576, ISSN: 0027-8424, DOI: 10.1073/PNAS.2131556100"
                ],
                "nplResolvedCount": 4,
                "nplResolvedLensIDs": [
                    "040-154-701-721-55X",
                    "128-605-834-274-686",
                    "043-516-092-302-134",
                    "017-055-848-106-562"
                ],
                "nplResolvedExternalIDs": [
                    "10764836",
                    "14523234",
                    "10.1111/j.1399-3089.2011.00622.x",
                    "10.1073/pnas.2131556100",
                    "10.1093/glycob/10.5.477",
                    "pmc218710",
                    "23384142",
                    "21342282",
                    "10.1111/xen.12019"
                ]
            },
            {
                "index": "188",
                "publicationKey": "WO_2018_170347_A1",
                "lensId": "022-222-952-841-90X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2018/170347 A1",
                "publicationDate": "2018-09-20",
                "filingNumber": "US 2018/0022777 W",
                "filingDate": "2018-03-16",
                "priorityFilingKeysActive": [
                    "US 201762473202 P 20170317",
                    "US 201762473174 P 20170317",
                    "US 201762473219 P 20170317"
                ],
                "earliestPriorityDate": "2017-03-17",
                "title": "Zoonotic Disease Rna Vaccines",
                "applicants": [
                    "MODERNATX INC"
                ],
                "inventors": [
                    "CIARAMELLA GIUSEPPE",
                    "HIMANSU SUNNY",
                    "PRESNYAK VLADIMIR",
                    "BENENATO KERRY",
                    "KUMARASINGHE ELLALAHEWAGE"
                ],
                "owners": [],
                "url": "https://lens.org/022-222-952-841-90X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 10,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 30,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K31/7105",
                    "A61K31/7115",
                    "A61K39/12",
                    "A61P37/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "GREER, C.E ET AL.: \"Long-term Protection in Hamsters against Human Parainfluenza Virus Type 3 Following Mucosal or Combinations of Mucosal and Systemic Immunizations with Chimeric Alphavirus-based Replicon Particles\", SCAND J IMMUNOL, vol. 66, no. 6, 2007, pages 645 - 653, XP002537662",
                    "\"Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential\", INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol. 47, 2016, pages 5 - 9, XP029667941",
                    "ANONYMOUS: \"Prevention and Treatment\", 9 November 2017 (2017-11-09), pages 1 - 1, XP055636630, Retrieved from the Internet <URL:https://www.cdc.gov/coronavirus/about/prevention.html>",
                    "ANONYMOUS: \"Lassa Fever\", 25 March 2014 (2014-03-25), XP055636631, Retrieved from the Internet <URL:https://www.cdc.gov/vhf/lassa/prevention/index.html>",
                    "ANONYMOUS: \"Nipah Virus (NiV)\", 20 March 2014 (2014-03-20), XP055636632, Retrieved from the Internet <URL:https://www.cdc.gov/vhf/nipah/prevention/index.html>",
                    "CHAHAL, J.S ET AL.: \"Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose\", PNAS, 2016, pages E4133 - E4142, XP055329399"
                ],
                "nplResolvedCount": 3,
                "nplResolvedLensIDs": [
                    "015-770-990-151-890",
                    "016-819-513-559-042",
                    "066-375-759-866-375"
                ],
                "nplResolvedExternalIDs": [
                    "10.1111/j.1365-3083.2007.02019.x",
                    "17944814",
                    "27321961",
                    "10.1073/pnas.1600299113",
                    "10.1016/j.ijid.2016.06.012",
                    "27382155"
                ]
            },
            {
                "index": "189",
                "publicationKey": "US_2017_0240616_A1",
                "lensId": "101-625-965-925-678",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0240616 A1",
                "publicationDate": "2017-08-24",
                "filingNumber": "US 201515516742 A",
                "filingDate": "2015-10-15",
                "priorityFilingKeysActive": [
                    "EP 14306633 A 20141015"
                ],
                "earliestPriorityDate": "2014-10-15",
                "title": "Composition With Reduced Immunogenicity",
                "applicants": [
                    "XENOTHERA"
                ],
                "inventors": [
                    "DUVAUX ODILE",
                    "SOULILLOU JEAN-PAUL"
                ],
                "owners": [
                    {
                        "name": "XENOTHERA",
                        "executionDate": "2017-04-12"
                    }
                ],
                "url": "https://lens.org/101-625-965-925-678",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 9,
                "familySize": 9,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "A01K67/027",
                    "C07K16/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "190",
                "publicationKey": "US_2019_0255171_A1",
                "lensId": "052-714-468-165-099",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0255171 A1",
                "publicationDate": "2019-08-22",
                "filingNumber": "US 201716346401 A",
                "filingDate": "2017-10-30",
                "priorityFilingKeysActive": [
                    "KR 20160142703 A 20161031",
                    "KR 20170107420 A 20170824",
                    "KR 20170107421 A 20170824"
                ],
                "earliestPriorityDate": "2016-10-31",
                "title": "Composition For Enhancing Immunity Comprising Immune Modulator And Cationic Liposome, And Use Of Same",
                "applicants": [
                    "EYEGENE INC"
                ],
                "inventors": [
                    "CHO YANG JE",
                    "KIM KWANGSUNG",
                    "LEE NA GYONG",
                    "PARK SHIN AE"
                ],
                "owners": [
                    {
                        "name": "EYEGENE INC",
                        "executionDate": "2019-05-08"
                    }
                ],
                "url": "https://lens.org/052-714-468-165-099",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 6,
                "familySize": 19,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/25",
                    "A61K9/127",
                    "A61K9/19",
                    "A61K31/739"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "191",
                "publicationKey": "US_2020_0030432_A1",
                "lensId": "113-299-974-915-089",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2020/0030432 A1",
                "publicationDate": "2020-01-30",
                "filingNumber": "US 201816494988 A",
                "filingDate": "2018-03-16",
                "priorityFilingKeysActive": [
                    "US 201762473174 P 20170317",
                    "US 201762473202 P 20170317",
                    "US 201762473219 P 20170317"
                ],
                "earliestPriorityDate": "2017-03-17",
                "title": "Zoonotic Disease Rna Vaccines",
                "applicants": [
                    "MODERNATX INC"
                ],
                "inventors": [
                    "CIARAMELLA GIUSEPPE",
                    "HIMANSU SUNNY",
                    "PRESNYAK VLADIMIR",
                    "BENENATO KERRY",
                    "KUMARASINGHE ELLALAHEWAGE SATHYAJITH"
                ],
                "owners": [],
                "url": "https://lens.org/113-299-974-915-089",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 30,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K31/7115",
                    "A61P31/14",
                    "C12N15/86"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "192",
                "publicationKey": "CN_107557496_A",
                "lensId": "184-432-698-826-391",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 107557496 A",
                "publicationDate": "2018-01-09",
                "filingNumber": "CN 201710955224 A",
                "filingDate": "2017-10-13",
                "priorityFilingKeysActive": [
                    "CN 201710955224 A 20171013"
                ],
                "earliestPriorityDate": "2017-10-13",
                "title": "Fluorescent Rt-raa (reverse Transcription Recombinase Aid Amplification) Primer For Detecting Mers-cov (middle East Respiratory Syndrome Coronavirus), Probe And Detecting Method",
                "applicants": [
                    "NINGBO INT TRAVEL HEALTH CARE CENTER"
                ],
                "inventors": [
                    "ZHOU DONGGEN",
                    "LUO JIE",
                    "YING QINGJIE",
                    "YU XUEJUN"
                ],
                "owners": [],
                "url": "https://lens.org/184-432-698-826-391",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12N15/11",
                    "C12Q1/68",
                    "C12R1/93"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "ABD EL WAHED ET AL: \"Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirus\", \u300aPLOS CURRENTS\u300b"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "035-287-608-243-715"
                ],
                "nplResolvedExternalIDs": [
                    "24459611",
                    "10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364"
                ]
            },
            {
                "index": "193",
                "publicationKey": "CA_2932055_A1",
                "lensId": "030-580-212-220-630",
                "jurisdiction": "CA",
                "kindCode": "A1",
                "displayKey": "CA 2932055 A1",
                "publicationDate": "2015-06-04",
                "filingNumber": "CA 2932055 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/030-580-212-220-630",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K39/215",
                    "A61P31/14",
                    "A61P37/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "194",
                "publicationKey": "CN_105939730_A",
                "lensId": "051-628-594-437-975",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 105939730 A",
                "publicationDate": "2016-09-14",
                "filingNumber": "CN 201480074433 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/051-628-594-437-975",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 1,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "FEI SONG: \"Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies\", \u300aJ VIROL.\u300b"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "114-114-185-080-165"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3807317",
                    "23986586",
                    "10.1128/jvi.01672-13"
                ]
            },
            {
                "index": "195",
                "publicationKey": "GB_2573649_A",
                "lensId": "056-058-384-229-65X",
                "jurisdiction": "GB",
                "kindCode": "A",
                "displayKey": "GB 2573649 A",
                "publicationDate": "2019-11-13",
                "filingNumber": "GB 201905509 A",
                "filingDate": "2019-04-18",
                "priorityFilingKeysActive": [
                    "GB 201806460 A 20180420"
                ],
                "earliestPriorityDate": "2018-04-20",
                "title": "Pharmaceutical Compositions And Associated Kits And Uses",
                "applicants": [
                    "SECR DEFENCE",
                    "PROXIMA CONCEPTS LTD",
                    "THE UNIV OF STRATHCLYDE"
                ],
                "inventors": [
                    "BARRY DOUGLAS MOORE",
                    "ETHEL DIANE WILLIAMSON",
                    "ROGER RANDAL CHARLES NEW"
                ],
                "owners": [],
                "url": "https://lens.org/056-058-384-229-65X",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/02",
                    "A61K9/107",
                    "A61K9/16",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 5,
                "nplCitations": [
                    "International Journal of Pharmaceutics (2005) 296 117-121 Murdan 'Immobilisation of vaccines onto micro-crystals for enhanced thermal stability'",
                    "Advanced Drug Delivery Reviews (1997) 25 59-69 New 'Solubilisation of hydrophilic drugs in oily formulations'",
                    "Vaccine (2005) 23 1957-1965 Glynn 'Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens'",
                    "Vaccine (2016) 34 2982-2987 Modjarrad 'MERS-CoV vaccine candidates in development: The current landscape'",
                    "Vaccine (2019) 37 4094 - 4102 New 'Antibody-mediated protection against MERS-CoV in the murine model'"
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "005-125-761-114-32X",
                    "182-729-334-400-060",
                    "001-440-549-015-791",
                    "021-690-559-871-214",
                    "093-100-816-721-33X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/s0169-409x(96)00491-7",
                    "15885463",
                    "27083424",
                    "10.1016/j.vaccine.2019.05.074",
                    "10.1016/j.vaccine.2016.03.104",
                    "15734068",
                    "10.1016/j.ijpharm.2005.02.022",
                    "31178378",
                    "10.1016/j.vaccine.2004.10.025"
                ]
            },
            {
                "index": "196",
                "publicationKey": "IL_245903_D0",
                "lensId": "160-447-896-154-355",
                "jurisdiction": "IL",
                "kindCode": "D0",
                "displayKey": "IL 245903 D0",
                "publicationDate": "2016-07-31",
                "filingNumber": "IL 24590316 A",
                "filingDate": "2016-05-29",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [],
                "owners": [],
                "url": "https://lens.org/160-447-896-154-355",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "197",
                "publicationKey": "GB_201806460_D0",
                "lensId": "092-425-363-110-913",
                "jurisdiction": "GB",
                "kindCode": "D0",
                "displayKey": "GB 201806460 D0",
                "publicationDate": "2018-06-06",
                "filingNumber": "GB 201806460 A",
                "filingDate": "2018-04-20",
                "priorityFilingKeysActive": [
                    "GB 201806460 A 20180420"
                ],
                "earliestPriorityDate": "2018-04-20",
                "title": "Pharmaceutical Compositions And Associated Kits",
                "applicants": [
                    "SECR DEFENCE",
                    "PROXIMA CONCEPTS LTD",
                    "UNIV STRATHCLYDE"
                ],
                "inventors": [],
                "owners": [],
                "url": "https://lens.org/092-425-363-110-913",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "198",
                "publicationKey": "GB_201905509_D0",
                "lensId": "073-094-416-775-482",
                "jurisdiction": "GB",
                "kindCode": "D0",
                "displayKey": "GB 201905509 D0",
                "publicationDate": "2019-06-05",
                "filingNumber": "GB 201905509 A",
                "filingDate": "2019-04-18",
                "priorityFilingKeysActive": [
                    "GB 201806460 A 20180420"
                ],
                "earliestPriorityDate": "2018-04-20",
                "title": "Pharmaceutical Compositions And Associated Lits And Uses",
                "applicants": [
                    "SECR DEFENCE",
                    "PROXIMA CONCEPTS LTD",
                    "UNIV STRATHCLYDE"
                ],
                "inventors": [],
                "owners": [],
                "url": "https://lens.org/073-094-416-775-482",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "199",
                "publicationKey": "EP_3074051_A4",
                "lensId": "150-774-913-396-440",
                "jurisdiction": "EP",
                "kindCode": "A4",
                "displayKey": "EP 3074051 A4",
                "publicationDate": "2017-04-12",
                "filingNumber": "EP 14866748 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/150-774-913-396-440",
                "docType": "Search report",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 5,
                "nplCitations": [
                    "F. SONG ET AL: \"Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies\", JOURNAL OF VIROLOGY, vol. 87, no. 21, 1 November 2013 (2013-11-01), pages 11950 - 11954, XP055157123, ISSN: 0022-538X, DOI: 10.1128/JVI.01672-13",
                    "DATABASE GenBank [online] 25 March 2013 (2013-03-25), \"Human betacoronavirus 2c Jordan-N3/2012, complete genome\", XP002764824, Database accession no. KC776174",
                    "DATABASE GenBank [online] 30 April 2013 (2013-04-30), \"Human betacoronavirus 2c England-Qatar/2012, complete genome\", XP002764825, Database accession no. KC667074",
                    "MATTHEW COTTEN ET AL: \"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study\", THE LANCET, vol. 382, no. 9909, 1 December 2013 (2013-12-01), GB, pages 1993 - 2002, XP055324122, ISSN: 0140-6736, DOI: 10.1016/S0140-6736(13)61887-5",
                    "See also references of WO 2015081155A1"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "114-114-185-080-165",
                    "016-772-377-304-76X"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3807317",
                    "10.1016/s0140-6736(13)61887-5",
                    "23986586",
                    "pmc3898949",
                    "24055451",
                    "10.1128/jvi.01672-13"
                ]
            },
            {
                "index": "200",
                "publicationKey": "EP_3074051_A1",
                "lensId": "031-403-084-232-854",
                "jurisdiction": "EP",
                "kindCode": "A1",
                "displayKey": "EP 3074051 A1",
                "publicationDate": "2016-10-05",
                "filingNumber": "EP 14866748 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/031-403-084-232-854",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/00",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "201",
                "publicationKey": "CN_108395471_A",
                "lensId": "132-412-825-799-054",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 108395471 A",
                "publicationDate": "2018-08-14",
                "filingNumber": "CN 201810224816 A",
                "filingDate": "2018-03-19",
                "priorityFilingKeysActive": [
                    "CN 201810035685 A 20180115"
                ],
                "earliestPriorityDate": "2018-01-15",
                "title": "Mers-cov Infection Inhibition Polypeptide",
                "applicants": [
                    "ACAD OF MILITARY SCIENCES PLA CHINA ACAD OF MILITARY MEDICAL SCIENCES"
                ],
                "inventors": [
                    "WANG CHAO",
                    "LIU KELIANG",
                    "ZHANG PEIYU",
                    "MENG GUANGPENG",
                    "LIANG GUODONG"
                ],
                "owners": [],
                "url": "https://lens.org/132-412-825-799-054",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/00",
                    "A61K38/16",
                    "A61K47/60",
                    "A61P11/00",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "\u5218\u5947: \"\u4e2d\u4e1c\u547c\u5438\u7efc\u5408\u5f81\u51a0\u72b6\u75c5\u6bd2(MERS-CoV)\u878d\u5408\u6291\u5236\u5242\u7684\u7814\u7a76\", \u300a\u4e2d\u56fd\u535a\u58eb\u5b66\u4f4d\u8bba\u6587\u5168\u6587\u6570\u636e\u5e93\u533b\u836f\u536b\u751f\u79d1\u6280\u8f91\u300b"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "202",
                "publicationKey": "JP_6412131_B2",
                "lensId": "199-000-779-603-144",
                "jurisdiction": "JP",
                "kindCode": "B2",
                "displayKey": "JP 6412131 B2",
                "publicationDate": "2018-10-24",
                "filingNumber": "JP 2016534936 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "\uff2d\uff45\uff52\uff53\u2010\uff43\uff4f\uff56\u30ef\u30af\u30c1\u30f3",
                "applicants": [
                    "\u30b6 \u30c8\u30e9\u30b9\u30c6\u30a3\u30fc\u30ba \u30aa\u30d6 \u30b6 \u30e6\u30cb\u30d0\u30fc\u30b7\u30c6\u30a3 \u30aa\u30d6 \u30da\u30f3\u30b7\u30eb\u30d0\u30cb\u30a2",
                    "\u30a4\u30ce\u30d3\u30aa \u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\uff0c\u30a4\u30f3\u30b3\u30fc\u30dd\u30ec\u30a4\u30c6\u30a3\u30c9"
                ],
                "inventors": [
                    "\u30c7\u30a4\u30d3\u30c3\u30c9 \u30d3\u30fc\uff0e\u30a6\u30a7\u30a4\u30ca\u30fc",
                    "\u30ab\u30eb\u30c3\u30d4\u30a2\u30fc \u30e0\u30b9\u30de\u30cb",
                    "\u30cb\u30e9\u30f3\u30b8\u30e3\u30f3 \u30ef\u30a4\uff0e\u30b5\u30fc\u30c7\u30b5\u30a4"
                ],
                "owners": [],
                "url": "https://lens.org/199-000-779-603-144",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K48/00",
                    "A61P31/14",
                    "C07K14/165",
                    "C12N15/50"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "203",
                "publicationKey": "CN_110128510_A",
                "lensId": "069-512-487-253-483",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 110128510 A",
                "publicationDate": "2019-08-16",
                "filingNumber": "CN 201910427530 A",
                "filingDate": "2019-05-22",
                "priorityFilingKeysActive": [
                    "CN 201910427530 A 20190522"
                ],
                "earliestPriorityDate": "2019-05-22",
                "title": "Mers-cov Fusion Inhibitor",
                "applicants": [
                    "INST OF MILITARY MEDICINE ACADEMY OF MILITARY SCIENCES OF PLA"
                ],
                "inventors": [
                    "WANG CHAO",
                    "LI YUE"
                ],
                "owners": [],
                "url": "https://lens.org/069-512-487-253-483",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/16",
                    "A61K38/16",
                    "A61P31/14",
                    "C07K1/06"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "204",
                "publicationKey": "KR_20160091350_A",
                "lensId": "195-627-994-715-652",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20160091350 A",
                "publicationDate": "2016-08-02",
                "filingNumber": "KR 20167015308 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/195-627-994-715-652",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 1,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 14,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K9/00",
                    "A61K39/00",
                    "A61K39/215",
                    "A61K39/39"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "205",
                "publicationKey": "JP_2016539946_A",
                "lensId": "196-683-890-384-476",
                "jurisdiction": "JP",
                "kindCode": "A",
                "displayKey": "JP 2016539946 A",
                "publicationDate": "2016-12-22",
                "filingNumber": "JP 2016534936 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "\uff2d\uff45\uff52\uff53\u2010\uff43\uff4f\uff56\u30ef\u30af\u30c1\u30f3",
                "applicants": [
                    "\u30b6 \u30c8\u30e9\u30b9\u30c6\u30a3\u30fc\u30ba \u30aa\u30d6 \u30b6 \u30e6\u30cb\u30d0\u30fc\u30b7\u30c6\u30a3 \u30aa\u30d6 \u30da\u30f3\u30b7\u30eb\u30d0\u30cb\u30a2",
                    "\u30a4\u30ce\u30d3\u30aa \u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\uff0c\u30a4\u30f3\u30b3\u30fc\u30dd\u30ec\u30a4\u30c6\u30a3\u30c9"
                ],
                "inventors": [
                    "\u30c7\u30a4\u30d3\u30c3\u30c9 \u30d3\u30fc\uff0e\u30a6\u30a7\u30a4\u30ca\u30fc",
                    "\u30ab\u30eb\u30c3\u30d4\u30a2\u30fc \u30e0\u30b9\u30de\u30cb",
                    "\u30cb\u30e9\u30f3\u30b8\u30e3\u30f3 \u30ef\u30a4\uff0e\u30b5\u30fc\u30c7\u30b5\u30a4"
                ],
                "owners": [],
                "url": "https://lens.org/196-683-890-384-476",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K35/76",
                    "A61K48/00",
                    "A61P31/14",
                    "A61P37/04",
                    "C07K14/165",
                    "C12N15/09"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "J VIROL, vol. 87, no. 21, JPN6018032977, August 2013 (2013-08-01), pages 11950 - 11954",
                    "LANCET, vol. 382, no. 9909, JPN6018032978, September 2013 (2013-09-01), pages 1993 - 2002",
                    "PNAS, vol. 110, no. 40, JPN6018032979, October 2013 (2013-10-01), pages 16157 - 16162",
                    "PNAS, vol. 105, no. 5, JPN6018032980, 2008, pages 19944 - 19949"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "055-728-448-888-253",
                    "114-114-185-080-165"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3807317",
                    "19036930",
                    "23986586",
                    "10.1073/pnas.0808116105",
                    "10.1128/jvi.01672-13",
                    "pmc2588415"
                ]
            },
            {
                "index": "206",
                "publicationKey": "CN_110257357_A",
                "lensId": "118-427-845-509-872",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 110257357 A",
                "publicationDate": "2019-09-20",
                "filingNumber": "CN 201910599247 A",
                "filingDate": "2019-07-04",
                "priorityFilingKeysActive": [
                    "CN 201910599247 A 20190704"
                ],
                "earliestPriorityDate": "2019-07-04",
                "title": "Application Of Mers-cov 3clpro (middle East Respiratory Syndrome Coronavirus 3c-like Protease) As Deubiquitinating Enzyme And Interferon Inhibitor",
                "applicants": [
                    "INST OF MILITARY MEDICINE ACADEMY OF MILITARY SCIENCES OF PLA"
                ],
                "inventors": [
                    "XING YALING",
                    "CHEN ZHONGBIN",
                    "XIE QING",
                    "CHEN XIAOJUAN"
                ],
                "owners": [],
                "url": "https://lens.org/118-427-845-509-872",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N9/48",
                    "G01N33/573"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "207",
                "publicationKey": "WO_2015_081155_A1",
                "lensId": "156-468-487-892-558",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/081155 A1",
                "publicationDate": "2015-06-04",
                "filingNumber": "US 2014/0067537 W",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/156-468-487-892-558",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 4,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "SONG ET AL.: \"Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies.\", JOURNAL OF VIROLOGY, vol. 87, no. 21, 28 August 2013 (2013-08-28), pages 11950 - 11954, XP055157123",
                    "DATABASE GENBANK [online] 4 December 2012 (2012-12-04), VAN BOHEEMEN: \"Human betacoronavirus 2c EMC/2012, complete genome.\", XP055295836, accession no. NCBI Database accession no. JX869059.2",
                    "DATABASE GENBANK [online] 10 June 2013 (2013-06-10), COTTEN M: \"Middle East respiratory syndrome coronavirus isolate Al-Hasa_4_2013, complete genome.\", XP055295837, accession no. NCBI Database accession no. KF186564.1",
                    "See also references of EP 3074051A4"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "114-114-185-080-165"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3807317",
                    "23986586",
                    "10.1128/jvi.01672-13"
                ]
            },
            {
                "index": "208",
                "publicationKey": "US_10016497_B2",
                "lensId": "131-281-667-701-571",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10016497 B2",
                "publicationDate": "2018-07-10",
                "filingNumber": "US 201415039672 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC",
                    "THE TRUSTEES OF THE UNIVERSTIY OF PENNSYLVANIA"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [
                    {
                        "name": "THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA",
                        "executionDate": "2015-01-12"
                    },
                    {
                        "name": "INOVIO PHARMACEUTICALS INC",
                        "executionDate": "2014-12-16"
                    }
                ],
                "url": "https://lens.org/131-281-667-701-571",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 13,
                "nplCitations": [
                    "Van Boheemen et al. Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans. MBio. Nov. 20, 2012;3(6). pii: e00473-12.",
                    "GenBank: JX869059.2 Human betacoronavirus 2c EMC/2012, complete genome. Dated Dec. 4, 2012.",
                    "Zhou et al. Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins. Biochemical and Biophysical Research Communications 387 (2009) 326-329.",
                    "Lokugamage et al. Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. Vaccine (2008) 26, 797-808.",
                    "Song F, et al., \u2018Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies,\u2019 Journal of Virology, (2013) vol. 87, No. 21, pp. 11950-11954.",
                    "GenBank: JX869059.2 Human betacoronavirus 2c EMC/2012, complete genome. Dec. 4, 2012. [online] Retrieved from internet Nov. 2, 2016. URL:https://www.ncbi.nlm.nih.gov/nuccore/JX869059.",
                    "GenBank: KF186564.1 Middle East respiratory syndrome coronavirus isolate Al-Hasa_4_2013 complete genome. Jun. 10, 2013. [online]. Retrieved from internet Nov. 2, 2016. URL:https://www.ncbi.nlm.nih.gov/nuccore/KF186564.",
                    "Falzarano et al., \u201cInterferon-\u03b12b and ribavirin treatment improves outcome in MERS-CoV-infected rhesus macaques\u201d, Nat Med, vol. 19(10): pp. 1313-1317 (2013).",
                    "Cotten et al., \u201cTransmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study\u201d, Lancet, 2013, 382:1993-2002.",
                    "Cotten et al., \u201cSpread, Circulation, and Evolution of the Middle East Respiratory Syndrome Coronavirus,\u201d mBio, 2014, 5(1):e01062-13.",
                    "[online] 25 March 2013 (2013-03-25), \"Human betacoronavirus 2c Jordan-N3/2012, complete genome\", XP002764824",
                    "DATABASE GenBank [online] 30 April 2013 (2013-04-30), \"Human betacoronavirus 2c England-Qatar/2012, complete genome\", XP002764825",
                    "Van Boheemen et al., \u201cGenomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans,\u201d mBio, 2012, 3(6):e00473-12, Accession No. JX869059."
                ],
                "nplResolvedCount": 6,
                "nplResolvedLensIDs": [
                    "109-155-880-448-590",
                    "105-955-717-757-57X",
                    "015-077-926-384-053",
                    "114-114-185-080-165",
                    "023-939-052-489-028",
                    "016-772-377-304-76X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/j.vaccine.2007.11.092",
                    "pmc3807317",
                    "10.1016/s0140-6736(13)61887-5",
                    "24549846",
                    "24055451",
                    "10.1016/j.bbrc.2009.07.025",
                    "10.1128/mbio.00473-12",
                    "19595990",
                    "23986586",
                    "pmc3898949",
                    "23170002",
                    "10.1128/jvi.01672-13",
                    "18191004",
                    "10.1128/mbio.01062-13",
                    "pmc2267761"
                ]
            },
            {
                "index": "209",
                "publicationKey": "WO_2019_202285_A1",
                "lensId": "119-630-893-222-702",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2019/202285 A1",
                "publicationDate": "2019-10-24",
                "filingNumber": "GB 2019000061 W",
                "filingDate": "2019-04-23",
                "priorityFilingKeysActive": [
                    "GB 201806460 A 20180420"
                ],
                "earliestPriorityDate": "2018-04-20",
                "title": "Pharmaceutical Compositions And Associated Kits And Uses",
                "applicants": [
                    "SECR DEFENCE",
                    "PROXIMA CONCEPTS LTD",
                    "THE UNIV OF STRATHCLYDE"
                ],
                "inventors": [
                    "WILLIAMSON ETHEL",
                    "MOORE BARRY",
                    "NEW ROGER"
                ],
                "owners": [],
                "url": "https://lens.org/119-630-893-222-702",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 4,
                "familySize": 4,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K9/00",
                    "A61K39/00",
                    "A61K39/02",
                    "A61K39/12",
                    "A61P31/04",
                    "A61P31/14",
                    "C07K16/10"
                ],
                "usClassifications": [],
                "nplCitationCount": 20,
                "nplCitations": [
                    "JONES SARAH ET AL: \"Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity\", VACCINE, vol. 32, no. 33, 10 October 2013 (2013-10-10), pages 4234 - 4242, XP028859762, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2013.09.061",
                    "M. DOMINGOS ET AL: \"A New Oil-Based Antigen Delivery Formulation for both Oral and Parenteral Vaccination\", THE OPEN DRUG DELIVERY JOURNAL, 24 July 2008 (2008-07-24), pages 52 - 60, XP055606363, Retrieved from the Internet <URL:https://benthamopen.com/contents/pdf/TODDJ/TODDJ-2-52.pdf> DOI: 10.2174/1874126600802010052",
                    "B.D. MOORE ET AL: \"Dual route vaccination for plague with emergency use applications\", VACCINE, vol. 36, no. 34, 1 August 2018 (2018-08-01), AMSTERDAM, NL, pages 5210 - 5217, XP055606086, ISSN: 0264-410X, DOI: 10.1016/j.vaccine.2018.06.039",
                    "NEW R R C ET AL: \"Antibody-mediated protection against MERS-CoV in the murine model\", VACCINE, vol. 37, no. 30, 6 June 2019 (2019-06-06), pages 4094 - 4102, XP085722628, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2019.05.074",
                    "MURDAN S ET AL.: \"Immobilisation of vaccines onto micro-crystals for enhanced thermal stability\", INT J PHARM., vol. 296, 2005, pages 117 - 21, XP004882228, DOI: doi:10.1016/j.ijpharm.2005.02.022",
                    "NEW R.R.C., KIRBY C.J. SOLUBILISATION OF HYDROPHILIC DRUGS IN OILY FORMULATIONS. ADVANCED DRUG DELIVERY REVIEWS, vol. 25, 1997, pages 59 - 69",
                    "NEW R.R.C.KIRBY C.J.: \"Solubilisation of hydrophilic drugs in oily formulations\", ADVANCED DRUG DELIVERY REVIEWS, vol. 25, 1997, pages 59 - 69",
                    "M. DE O. DOMINGOS ET AL.: \"A new Oil-Based Antigen Delivery Formulation for both Oral and Parenteral Vaccination\", THE OPEN DRUG DELIVERY JOURNAL, vol. 2, 2008, pages 52 - 60",
                    "OKBA NMA ET AL.: \"Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches\", CURRENT OPINION IN VIROLOGY, vol. 23, 2017, pages 49 - 58, XP055499799, DOI: doi:10.1016/j.coviro.2017.03.007",
                    "DU ET AL.: \"A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implications for Developing Therapeutics and Vaccines\", PLOS ONE, vol. 8, 2013, pages e81587, XP009182022, DOI: doi:10.1371/journal.pone.0081587",
                    "JONES S. M. ET AL.: \"Protection conferred by a fully recombinant subunit vaccine against Yersinia pestis in male and female mice of four inbred strains\", VACCINE, vol. 19, 2001, pages 358 - 366",
                    "\"GenBank\", Database accession no. CAA43966.1",
                    "\"UniProtKB\", Database accession no. P23994.1",
                    "\"GenBank\", Database accession no. AFS88936.1",
                    "JONES ET AL.: \"Protein coated microcrystals formulated with model antigens and nodified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity\", VACCINE, vol. 32, 2014, pages 4234 - 4242, XP028859762, DOI: doi:10.1016/j.vaccine.2013.09.061",
                    "DOMINGOS M ET AL.: \"A New Oil-Based antigen Delivery Formulation for both Oral and Parenteral Vaccination\", THE OPEN DRUG DELIVERY JOURNAL, vol. 2, 2008, pages 52 - 60",
                    "PRABAKARAN M ET AL.: \"Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice\", ANTIVIRAL RESEARCH, vol. 86, no. 2, 2010, pages 180 - 187",
                    "\"GenBank\", Database accession no. KC164505.2",
                    "\"GenBank\", Database accession no. JX869059",
                    "LU ET AL.: \"Real-time Reverse Transcription-PCR Assay Panel for Middle East Respiratory Syndrome Coronavirus\", J. CLIN. MICRO., vol. 52, no. 1, 2014, pages 67 - 75, XP055334610, DOI: doi:10.1128/JCM.02533-13"
                ],
                "nplResolvedCount": 11,
                "nplResolvedLensIDs": [
                    "005-125-761-114-32X",
                    "040-763-407-420-581",
                    "073-767-167-739-23X",
                    "182-729-334-400-060",
                    "063-216-973-208-325",
                    "029-976-274-417-370",
                    "154-382-202-363-485",
                    "003-376-346-248-551",
                    "048-402-430-106-694",
                    "022-561-232-465-826",
                    "093-100-816-721-33X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/s0169-409x(96)00491-7",
                    "15885463",
                    "10.1016/s0264-410x(00)00108-0",
                    "20153776",
                    "pmc3911421",
                    "pmc3852489",
                    "pmc4101235",
                    "10.1128/jcm.02533-13",
                    "30017148",
                    "10.1016/j.vaccine.2019.05.074",
                    "10.1016/j.antiviral.2010.02.315",
                    "10.1016/j.ijpharm.2005.02.022",
                    "31178378",
                    "24120484",
                    "10.1016/j.coviro.2017.03.007",
                    "10.1371/journal.pone.0081587",
                    "24324708",
                    "24153118",
                    "10930691",
                    "10.2174/1874126600802010052",
                    "28412285",
                    "10.1016/j.vaccine.2013.09.061",
                    "10.1016/j.vaccine.2018.06.039"
                ]
            },
            {
                "index": "210",
                "publicationKey": "US_2017_0258893_A1",
                "lensId": "113-283-191-957-868",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2017/0258893 A1",
                "publicationDate": "2017-09-14",
                "filingNumber": "US 201415039672 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [
                    {
                        "name": "THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA",
                        "executionDate": "2015-01-12"
                    },
                    {
                        "name": "INOVIO PHARMACEUTICALS INC",
                        "executionDate": "2014-12-16"
                    }
                ],
                "url": "https://lens.org/113-283-191-957-868",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "211",
                "publicationKey": "US_2019_0022213_A1",
                "lensId": "095-044-150-527-23X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0022213 A1",
                "publicationDate": "2019-01-24",
                "filingNumber": "US 201816022839 A",
                "filingDate": "2018-06-29",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/095-044-150-527-23X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/12",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "212",
                "publicationKey": "CA_2922258_A1",
                "lensId": "016-122-566-691-776",
                "jurisdiction": "CA",
                "kindCode": "A1",
                "displayKey": "CA 2922258 A1",
                "publicationDate": "2015-03-26",
                "filingNumber": "CA 2922258 A",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [],
                "url": "https://lens.org/016-122-566-691-776",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "213",
                "publicationKey": "HK_1225631_A1",
                "lensId": "174-605-970-885-869",
                "jurisdiction": "HK",
                "kindCode": "A1",
                "displayKey": "HK 1225631 A1",
                "publicationDate": "2017-09-15",
                "filingNumber": "HK 16113985 A",
                "filingDate": "2016-12-08",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [],
                "url": "https://lens.org/174-605-970-885-869",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "214",
                "publicationKey": "CN_105555306_A",
                "lensId": "126-412-184-215-217",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 105555306 A",
                "publicationDate": "2016-05-04",
                "filingNumber": "CN 201480051512 A",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [],
                "url": "https://lens.org/126-412-184-215-217",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 4,
                "nplCitations": [
                    "WANG N ET AL.: \"R9UQ53\", \u300aEMBL\u300b",
                    "JIANG SB ET AL.: \"A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC\", \u300aJOURNAL OF INFECTION\u300b",
                    "YE V.LIU ET AL.: \"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV\", \u300aVACCINE\u300b",
                    "\u6bb5\u662d\u541b\u7b49: \"\u4e2d\u4e1c\u547c\u5438\u7efc\u5408\u5f81\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\", \u300a\u4e2d\u56fd\u75c5\u6bd2\u75c5\u6742\u5fd7\u300b"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "043-608-737-967-60X",
                    "103-824-584-590-506"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3165014",
                    "21762752",
                    "10.1016/j.jinf.2012.12.003",
                    "10.1016/j.vaccine.2011.06.111",
                    "23266463"
                ]
            },
            {
                "index": "215",
                "publicationKey": "IL_244298_D0",
                "lensId": "034-945-597-003-315",
                "jurisdiction": "IL",
                "kindCode": "D0",
                "displayKey": "IL 244298 D0",
                "publicationDate": "2016-04-21",
                "filingNumber": "IL 24429816 A",
                "filingDate": "2016-02-25",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [],
                "owners": [],
                "url": "https://lens.org/034-945-597-003-315",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "216",
                "publicationKey": "EP_2993977_B1",
                "lensId": "070-475-842-509-97X",
                "jurisdiction": "EP",
                "kindCode": "B1",
                "displayKey": "EP 2993977 B1",
                "publicationDate": "2018-07-18",
                "filingNumber": "EP 15727832 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/070-475-842-509-97X",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "LU ET AL.: \"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26\", NATURE, vol. 500, no. 7461, 2013, pages 227 - 31, XP055162686"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "145-146-407-738-040"
                ],
                "nplResolvedExternalIDs": [
                    "10.1038/nature12328",
                    "23831647"
                ]
            },
            {
                "index": "217",
                "publicationKey": "EP_3046579_A1",
                "lensId": "169-037-897-064-031",
                "jurisdiction": "EP",
                "kindCode": "A1",
                "displayKey": "EP 3046579 A1",
                "publicationDate": "2016-07-27",
                "filingNumber": "EP 14780994 A",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [],
                "url": "https://lens.org/169-037-897-064-031",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "218",
                "publicationKey": "CN_106892920_B",
                "lensId": "057-218-254-779-780",
                "jurisdiction": "CN",
                "kindCode": "B",
                "displayKey": "CN 106892920 B",
                "publicationDate": "2019-12-13",
                "filingNumber": "CN 201510956338 A",
                "filingDate": "2015-12-18",
                "priorityFilingKeysActive": [
                    "CN 201510956338 A 20151218"
                ],
                "earliestPriorityDate": "2015-12-18",
                "title": "\u82e6\u8c46\u78b1\u884d\u751f\u7269\u3001\u5176\u5236\u5907\u65b9\u6cd5\u53ca\u7528\u9014",
                "applicants": [
                    "\u4e2d\u56fd\u533b\u5b66\u79d1\u5b66\u9662\u533b\u836f\u751f\u7269\u6280\u672f\u7814\u7a76\u6240"
                ],
                "inventors": [
                    "\u5b8b\u4e39\u9752",
                    "\u848b\u5efa\u4e1c",
                    "\u5f6d\u5b97\u6839",
                    "\u5f20\u6b23",
                    "\u5510\u80dc",
                    "\u674e\u8fce\u7ea2",
                    "\u674e\u7389\u73af"
                ],
                "owners": [],
                "url": "https://lens.org/057-218-254-779-780",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07D471/18"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "219",
                "publicationKey": "CN_106928326_B",
                "lensId": "012-869-440-535-882",
                "jurisdiction": "CN",
                "kindCode": "B",
                "displayKey": "CN 106928326 B",
                "publicationDate": "2019-12-24",
                "filingNumber": "CN 201511021535 A",
                "filingDate": "2016-12-31",
                "priorityFilingKeysActive": [
                    "CN 201511021535 A 20151231"
                ],
                "earliestPriorityDate": "2016-12-31",
                "title": "\u4e00\u79cd\u57fa\u4e8e\u4e8c\u805a\u5316\u7684\u53d7\u4f53\u7ed3\u5408\u533a\u4e9a\u5355\u4f4d\u7684\u51a0\u72b6\u75c5\u6bd2\u75ab\u82d7",
                "applicants": [
                    "\u4e2d\u56fd\u79d1\u5b66\u9662\u5fae\u751f\u7269\u7814\u7a76\u6240"
                ],
                "inventors": [
                    "\u9ad8\u798f",
                    "\u6234\u8fde\u6500",
                    "\u4e25\u666f\u534e",
                    "\u674e\u4e16\u534e",
                    "\u8881\u56ed"
                ],
                "owners": [],
                "url": "https://lens.org/012-869-440-535-882",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/165",
                    "A61K39/215",
                    "A61P31/14",
                    "C07K1/16",
                    "C07K1/18",
                    "C07K1/20",
                    "C07K1/34",
                    "C07K1/36",
                    "C12N1/21",
                    "C12N5/10",
                    "C12N7/01",
                    "C12N15/50",
                    "C12N15/866"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "220",
                "publicationKey": "MX_2016003419_A",
                "lensId": "139-012-820-894-214",
                "jurisdiction": "MX",
                "kindCode": "A",
                "displayKey": "MX 2016003419 A",
                "publicationDate": "2016-10-10",
                "filingNumber": "MX 2016003419 A",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods.",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "GALE SMITH",
                    "MICHAEL MASSARE",
                    "YE LIU"
                ],
                "owners": [],
                "url": "https://lens.org/139-012-820-894-214",
                "docType": "ambiguous",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "221",
                "publicationKey": "RU_2685185_C2",
                "lensId": "175-811-266-589-680",
                "jurisdiction": "RU",
                "kindCode": "C2",
                "displayKey": "RU 2685185 C2",
                "publicationDate": "2019-04-16",
                "filingNumber": "RU 2016111934 A",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [],
                "url": "https://lens.org/175-811-266-589-680",
                "docType": "Granted Patent",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "YE V LIU ET AL: \"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV\", VACCINE, ELSEVIER LTD, GB, vol. 29, no. 38, pages 6606-6613, 29.06.2011. \"Novavax creates MERS-CoV vaccine candidate\", 7 June 2013 (2013-06-07), \u041d\u0430\u0439\u0434\u0435\u043d\u043e \u0432 \u0418\u043d\u0442\u0435\u0440\u043d\u0435\u0442 \u043f\u043e \u0430\u0434\u0440\u0435\u0441\u0443: URL:http://vaccinenewsdaily.com/vaccine_development/325407-novavax-creates-mers-cov-vaccine-candidate/."
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "222",
                "publicationKey": "KR_20160055164_A",
                "lensId": "098-965-663-104-190",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20160055164 A",
                "publicationDate": "2016-05-17",
                "filingNumber": "KR 20167007733 A",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [],
                "url": "https://lens.org/098-965-663-104-190",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 2,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12",
                    "A61K9/16",
                    "A61K39/00",
                    "A61K39/215",
                    "C07K14/005"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "223",
                "publicationKey": "SG_10201802194W_A",
                "lensId": "043-242-779-311-963",
                "jurisdiction": "SG",
                "kindCode": "A",
                "displayKey": "SG 10201802194W A",
                "publicationDate": "2018-05-30",
                "filingNumber": "SG 10201802194W A",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [],
                "url": "https://lens.org/043-242-779-311-963",
                "docType": "unknown",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "224",
                "publicationKey": "SG_11201601423S_A",
                "lensId": "073-739-981-322-473",
                "jurisdiction": "SG",
                "kindCode": "A",
                "displayKey": "SG 11201601423S A",
                "publicationDate": "2016-04-28",
                "filingNumber": "SG 11201601423S A",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [],
                "url": "https://lens.org/073-739-981-322-473",
                "docType": "unknown",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "225",
                "publicationKey": "WO_2015_042373_A1",
                "lensId": "131-556-173-893-964",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/042373 A1",
                "publicationDate": "2015-03-26",
                "filingNumber": "US 2014/0056517 W",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [],
                "url": "https://lens.org/131-556-173-893-964",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 4,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 2,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 48,
                "nplCitations": [
                    "YE V LIU ET AL: \"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV\", VACCINE, vol. 29, no. 38, 29 June 2011 (2011-06-29), ELSEVIER LTD, GB, pages 6606 - 6613, XP028265259, ISSN: 0264-410X, [retrieved on 20110704], DOI: 10.1016/J.VACCINE.2011.06.111",
                    "ANONYMOUS: \"Stifel 2013 Healthcare Conference\", 12 September 2013 (2013-09-12), pages 1 - 35, XP002733662, Retrieved from the Internet <URL:http://www.novavax.com/download/file/2013_09_12%20Novavax_Stifel_presentation.pdf> [retrieved on 20141211]",
                    "ANONYMOUS: \"Novavax to Present at the 2013 Stifel Nicolaus Healthcare Conference\", 5 September 2013 (2013-09-05), pages 1, XP002733729, Retrieved from the Internet <URL:http://in.reuters.com/article/2013/09/05/idUSnGNX7PTmrq+1d8+GNW20130905> [retrieved on 20141211]",
                    "RYAN PARRISH: \"Novavax creates MERS-CoV vaccine candidate\", 7 June 2013 (2013-06-07), XP002733661, Retrieved from the Internet <URL:http://vaccinenewsdaily.com/vaccine_development/325407-novavax-creates-mers-cov-vaccine-candidate/> [retrieved on 20141211]",
                    "L. DU ET AL: \"Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development\", JOURNAL OF VIROLOGY, vol. 87, no. 17, 3 July 2013 (2013-07-03), pages 9939 - 9942, XP055157122, ISSN: 0022-538X, DOI: 10.1128/JVI.01048-13",
                    "F. SONG ET AL: \"Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies\", JOURNAL OF VIROLOGY, vol. 87, no. 21, 28 August 2013 (2013-08-28), pages 11950 - 11954, XP055157123, ISSN: 0022-538X, DOI: 10.1128/JVI.01672-13",
                    "DATABASE UniProt [online] 18 September 2013 (2013-09-18), \"SubName: Full=S protein {ECO:0000313|EMBL:AGN70973.1};\", XP002733659, retrieved from EBI accession no. UNIPROT:R9UQ53 Database accession no. R9UQ53",
                    "POULSEN TINE RUGH ET AL: \"Limits for Antibody Affinity Maturation and Repertoire Diversification in Hypervaccinated Humans\", JOURNAL OF IMMUNOLOGY, vol. 187, no. 8, October 2011 (2011-10-01), pages 4229 - 4235, XP002733660, ISSN: 0022-1767",
                    "CHENG Y ET AL: \"Use of convalescent plasma therapy in SARS patients in Hong Kong\", EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, vol. 24, no. 1, 1 January 2005 (2005-01-01), SPRINGER, BERLIN, DE, pages 44 - 46, XP019355271, ISSN: 1435-4373, DOI: 10.1007/S10096-004-1271-9",
                    "YOSHIMI KUROIWA ET AL: \"Antigen-specific human polyclonal antibodies from hyperimmunized cattle\", NATURE BIOTECHNOLOGY, vol. 27, no. 2, 1 February 2009 (2009-02-01), pages 173 - 181, XP055012629, ISSN: 1087-0156, DOI: 10.1038/nbt.1521",
                    "K.-M. YEH: \"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital\", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 56, no. 5, 15 September 2005 (2005-09-15), pages 919 - 922, XP055158091, ISSN: 0305-7453, DOI: 10.1093/jac/dki346",
                    "HILGENFELD ROLF ET AL: \"From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses\", ANTIVIRAL RESEARCH, vol. 100, no. 1, 6 September 2013 (2013-09-06), pages 286 - 295, XP028778684, ISSN: 0166-3542, DOI: 10.1016/J.ANTIVIRAL.2013.08.015",
                    "L. GILLIM-ROSS ET AL: \"Emerging Respiratory Viruses: Challenges and Vaccine Strategies\", CLINICAL MICROBIOLOGY REVIEWS, vol. 19, no. 4, 1 October 2006 (2006-10-01), pages 614 - 636, XP055157641, ISSN: 0893-8512, DOI: 10.1128/CMR.00005-06",
                    "COLEMAN CHRISTOPHER M ET AL: \"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice\", VACCINE, vol. 32, no. 26, 13 April 2014 (2014-04-13), pages 3169 - 3174, XP028654166, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2014.04.016",
                    "MATSUSHITA HIROAKI ET AL: \"Triple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production.\", PLOS ONE, vol. 9, no. 3, E90383, 6 March 2014 (2014-03-06), pages 1 - 14, XP002733663, ISSN: 1932-6203",
                    "BERGER; KIMMEL: \"Guide to Molecular Cloning Techniques\", vol. 152, ACADEMIC PRESS, INC., article \"Methods in Enzymology\"",
                    "SAMBROOK ET AL.: \"Molecular Cloning--A Laboratory Manual(3rd Ed.),\", vol. 1-3, 2000, COLD SPRING HARBOR LABORATORY",
                    "F. M. AUSUBEL ET AL.: \"Current Protocols in Molecular Biology\", CURRENT PROTOCOLS",
                    "VOGEL ET AL.: \"A Compendium of Vaccine Adjuvants and Excipients (2nd Edition)\", UNKNOWN",
                    "MATSUSHITA ET AL., PLOS ONE, vol. 9, no. 3, 2014, pages E90383",
                    "SANO ET AL., PLOS ONE, vol. 8, no. 10, 2013, pages E78119",
                    "KUROIWA ET AL., NAT BIOTECHNOL, vol. 27, no. 2, 2009, pages 173 - 81",
                    "ZHAO ET AL., PROC NATL ACAD SCI USA, vol. 111, no. 13, 2014, pages 4970 - 5",
                    "YING ET AL., J. VIROL., 2014",
                    "BERGLUND, P.; FLEETON, M. N.; SMERDOU, C.; LILJESTROM, P.: \"Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice\", VACCINE, vol. 17, 1999, pages 497 - 507, XP004153834, DOI: doi:10.1016/S0264-410X(98)00224-2",
                    "COX, J. C.; COULTER, A. R.: \"Adjuvants--a classification and review of their modes of action\", VACCINE, vol. 15, 1997, pages 248 - 256, XP004094403, DOI: doi:10.1016/S0264-410X(96)00183-1",
                    "CRAWFORD, J.; WILKINSON, B.; VOSNESENSKY, A.; SMITH, G.; GARCIA, M.; STONE, H.; PERDUE, M. L.: \"Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes\", VACCINE, vol. 17, 1999, pages 2265 - 2274, XP004165019, DOI: doi:10.1016/S0264-410X(98)00494-0",
                    "CROWTHER R A; KISELEV N A; BOTTCHER B; BERRIMAN J A; BORISOVA G P; OSE V; PUMPENS P: \"Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy\", CELL, vol. 17, 1994, pages 943 - 50, XP024244786, DOI: doi:10.1016/0092-8674(94)90142-2",
                    "GOMEZ-PUERTAS, P.; MENA, I.; CASTILLO, M.; VIVO, A.; PEREZ-PASTRANA, E.; PORTELA, A.: \"Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins\", J. GEN. VIROL., vol. 80, 1999, pages 1635 - 1645, XP002196046",
                    "JOHANSSON, B. E.: \"Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine\", VACCINE, vol. 17, 1999, pages 2073 - 2080",
                    "LAKEY, D. L.; TREANOR, J. J.; BETTS, B. F.; SMITH, G. E.; THOMPSON, J.; SANNELLA, E.; REED, G.; WILKINSON, B. E.; WRIGHT, P. E.: \"Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults\", J. INFECT. DIS., vol. 174, 1996, pages 838 - 841",
                    "LATHAM, T.; GALARZA, J. M.: \"Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins\", J. VIROL., vol. 75, 2001, pages 6154 - 6165, XP002323947, DOI: doi:10.1128/JVI.75.13.6154-6165.2001",
                    "MENA, I.; VIVO, A.; PEREZ, E.; PORTELA, A: \"Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza-like particles obtained from recombinant plasmids\", J. VIROL., vol. 70, 1996, pages 5016 - 5024, XP002150091",
                    "MURPHY, B. R.; WEBSTER, R. G.: \"Virology\", vol. 1, 1996, LIPPINCOTT-RAVEN, article \"Orthomyxoviruses\", pages: 1397 - 1445",
                    "NEUMANN, G.; WATANABE, T.; KAWAOKA, Y.: \"Plasmid-driven formation of influenza virus-like particles\", J. VIROL., vol. 74, 2000, pages 547 - 551",
                    "OLSEN, C. W.; MCGREGOR, M. W.; DYBDAHL-SISSOKO, N.; SCHRAM, B. R.; NELSON, K. M.; LUNN, D. P.; MACKLIN, M. D.; SWAIN, W. F.: \"Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice\", VACCINE, vol. 15, 1997, pages 1149 - 1156, XP004085977, DOI: doi:10.1016/S0264-410X(96)00309-X",
                    "PEIRIS, J. S.; GUAN, Y.; MARKWELL, D.; GHOSE, P.; WEBSTER, R. G.; SHORTRIDGE, K. F.: \"Cocirculation of avian H9N2 and contemporary ''human'' H3N2 influenza A viruses in pigs in southwestern China: potential for genetic reassortment?\", J. VIROL., vol. 75, 2001, pages 9679 - 9686",
                    "PUMPENS, P.; GRENS, E.: \"Artificial DNA\", 2003, CRC PRESS, article \"Artificial genes for chimeric virus-like particles\", pages: 249 - 327",
                    "PUSHKO, P.; PARKER, M.; LUDWIG, G. V.; DAVIS, N. L.; JOHNSTON, R. E.; SMITH, J. F.: \"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo\", VIROLOGY, vol. 239, 1997, pages 389 - 401",
                    "SLEPUSHKIN, V. A.; KATZ, J. M.; BLACK, R. A.; GAMBLE, W. C.; ROTA, P. A.; COX, N. J.: \"Protection of mice against influenza A virus challenged by vaccination with baculovirus-expressed M2 protein.\", VACCINE, vol. 13, 1995, pages 1399 - 1402, XP004057448, DOI: doi:10.1016/0264-410X(95)92777-Y",
                    "TREANOR, J. J.; BETTS, R. F.; SMITH, G. E.; ANDERSON, E. L.; HACKETT, C. S.; WILKINSON, B. E.; BELSHE, R. B.; POWERS, D. C.: \"Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults\", J. INFECT. DIS., vol. 173, 1996, pages 1467 - 1470, XP009045389",
                    "TSUJI, M. ET AL.: \"Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice\", J. VIROL., vol. 72, 1998, pages 6907 - 6910",
                    "ULMER, J. B. ET AL.: \"Heterologous protection against influenza by injection of DNA encoding a viral protein\", SCIENCE, vol. 259, 1993, pages 1745 - 1749, XP002009751, DOI: doi:10.1126/science.8456302",
                    "ULMER, J. B. ET AL.: \"Protective CD4+ and CD8+T cells against influenza virus induced by vaccination with nucleoprotein DNA\", J. VIROL., vol. 72, 1998, pages 5648 - 5653",
                    "WATANABE, T.; WATANABE, S.; NEUMANN, G.; KAWAOKA, Y.: \"Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles\", J. VIROL., vol. 76, 2002, pages 767 - 773, XP009096900, DOI: doi:10.1128/JVI.76.2.767-773.2002",
                    "ZHOU, X. ET AL.: \"Generation of cytotoxic and humoral immune responses by non-replicative recombinant Semliki Forest virus\", PROC. NATL. ACAD. SCI. USA, vol. 92, 1995, pages 3009 - 3013",
                    "ZABEL ET AL.: \"Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies\", J. IMMUNOL., vol. 192, 2014, pages 5499 - 5508",
                    "ZHANG ET AL.: \"HPV6b virus like particles are potent immunogens without adjuvant in man\", VACCINE, vol. 18, 2000, pages 1051 - 8, XP002947364, DOI: doi:10.1016/S0264-410X(99)00351-5"
                ],
                "nplResolvedCount": 39,
                "nplResolvedLensIDs": [
                    "165-446-500-090-218",
                    "115-754-820-400-589",
                    "048-975-130-135-408",
                    "039-573-828-270-021",
                    "044-564-257-976-51X",
                    "017-878-134-661-342",
                    "063-254-466-122-620",
                    "077-658-963-728-382",
                    "085-864-316-354-254",
                    "031-238-478-268-52X",
                    "067-884-443-627-767",
                    "079-932-522-833-904",
                    "022-899-518-024-071",
                    "080-327-178-288-985",
                    "087-000-625-015-736",
                    "033-374-490-595-442",
                    "005-715-223-280-195",
                    "007-992-761-284-968",
                    "103-824-584-590-506",
                    "054-391-011-603-49X",
                    "068-725-851-076-878",
                    "114-114-185-080-165",
                    "060-321-923-835-940",
                    "001-539-454-339-996",
                    "015-360-627-674-02X",
                    "088-189-357-944-78X",
                    "157-036-087-252-284",
                    "020-629-766-582-539",
                    "043-121-908-783-81X",
                    "115-454-046-845-153",
                    "003-305-607-141-245",
                    "032-017-583-020-953",
                    "034-646-499-971-734",
                    "071-395-498-391-349",
                    "107-689-388-675-875",
                    "004-450-245-414-409",
                    "044-916-135-201-317",
                    "025-452-114-362-62X",
                    "083-533-810-485-576"
                ],
                "nplResolvedExternalIDs": [
                    "10.1371/journal.pone.0090383",
                    "10.1016/j.antiviral.2013.08.015",
                    "pmc114331",
                    "24821969",
                    "10.1007/978-1-4615-1823-5_7",
                    "pmc4058772",
                    "10.1371/journal.pone.0099279",
                    "pmc114539",
                    "10.1128/jvi.70.8.5016-5024.1996",
                    "pmc3946162",
                    "10.1128/jvi.74.1.547-551.2000",
                    "8578816",
                    "21930965",
                    "24205120",
                    "9621023",
                    "24012996",
                    "10.1016/s0264-410x(98)00224-2",
                    "10.1099/0022-1317-80-7-1635",
                    "16183666",
                    "9658144",
                    "pmc3813428",
                    "pmc42348",
                    "10.1016/s0264-410x(98)00494-0",
                    "10.1128/jvi.72.7.5648-5653.1998",
                    "pmc3807317",
                    "10.1128/jvi.72.8.6907-6910.1998",
                    "8456302",
                    "10217609",
                    "10.1201/9781420040166.ch8",
                    "10.1016/s0264-410x(96)00309-x",
                    "10.1016/s0264-410x(96)00183-1",
                    "pmc1592697",
                    "10590147",
                    "19151699",
                    "pmc110229",
                    "8004680",
                    "15616839",
                    "10.1128/jvi.76.2.767-773.2002",
                    "pmc3165014",
                    "pmc3807362",
                    "9139482",
                    "11752166",
                    "10.1128/jvi.01672-13",
                    "11559800",
                    "10423131",
                    "23824801",
                    "7708765",
                    "17041137",
                    "10.1006/viro.1997.8878",
                    "24603704",
                    "10.1128/jvi.01048-13",
                    "10.4049/jimmunol.1400065",
                    "10.1128/jvi.75.20.9679-9686.2001",
                    "pmc111569",
                    "10.1128/jvi.75.13.6154-6165.2001",
                    "8764008",
                    "pmc136812",
                    "10.1093/infdis/174.4.838",
                    "10.1126/science.8456302",
                    "23986586",
                    "8648221",
                    "10.1093/infdis/173.6.1467",
                    "10.1016/j.vaccine.2011.06.111",
                    "11390617",
                    "10.1093/jac/dki346",
                    "10073729",
                    "10.1038/nbt.1521",
                    "24736006",
                    "10.4049/jimmunol.1000928",
                    "pmc190455",
                    "9434729",
                    "10.1016/s0264-410x(99)00351-5",
                    "10403594",
                    "10.1128/cmr.00005-06",
                    "10.1016/s0264-410x(98)00413-7",
                    "10590325",
                    "9269061",
                    "10.1016/0264-410x(95)92777-y",
                    "10.1007/s10096-004-1271-9",
                    "24599590",
                    "10.1073/pnas.92.7.3009",
                    "7551218",
                    "21762752",
                    "8843225",
                    "10.1016/0092-8674(94)90142-2",
                    "10.1371/journal.pone.0078119",
                    "10.1073/pnas.1323279111",
                    "pmc3883224",
                    "pmc3754113",
                    "pmc3977243",
                    "10.1016/j.vaccine.2014.04.016",
                    "pmc109904"
                ]
            },
            {
                "index": "226",
                "publicationKey": "WO_2015_184164_A1",
                "lensId": "184-629-420-435-520",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/184164 A1",
                "publicationDate": "2015-12-03",
                "filingNumber": "US 2015/0033024 W",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/184-629-420-435-520",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 3,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027"
                ],
                "usClassifications": [],
                "nplCitationCount": 16,
                "nplCitations": [
                    "LUCA SIMEONI ET AL: \"Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution\", HUMAN IMMUNOLOGY, vol. 63, no. 9, September 2002 (2002-09-01), pages 719 - 730, XP055211847, ISSN: 0198-8859, DOI: 10.1016/S0198-8859(02)00433-0",
                    "SARA REARDON: \"Biologists make first mouse model for MERS : Nature News & Comment\", NATURE NEWS, 30 January 2014 (2014-01-30), XP055212045, Retrieved from the Internet <URL:http://www.nature.com/news/biologists-make-first-mouse-model-for-mers-1.14634> [retrieved on 20150908], DOI: 10.1038/nature.2014.14634",
                    "ABBOTT C A ET AL: \"GENOMIC ORGANIZATION, EXACT LOCALIZATION, AND TISSUE EXPRESSION OF THE HUMAN CD26 (DIPEPTIDYL PEPTIDASE IV) GENE\", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, vol. 40, no. 5, 1994, pages 331 - 338, XP001026517, ISSN: 0093-7711, DOI: 10.1007/BF01246674",
                    "ANNE-MARIE BERNARD ET AL: \"Structure of the mouse dipeptidyl peptidase IV (CD26) gene\", BIOCHEMISTRY, vol. 33, no. 50, December 1994 (1994-12-01), US, pages 15204 - 15214, XP055212119, ISSN: 0006-2960, DOI: 10.1021/bi00254a032",
                    "GERICH: \"Pathogenesis and Management of Postpandrial Hyperglycemia: Role of Incretin-Based Therapies\", INTL. J. GEN. MED., vol. 6, 2013, pages 877 - 895",
                    "RAJ ET AL.: \"Dipeptidyl Peptidase 4 is a Functional Receptor for the Emerging Human Coronovirus-EMC\", NATURE, vol. 495, no. 7440, 2013, pages 251 - 254, XP055302115, DOI: doi:10.1038/nature12005",
                    "FESTING ET AL.: \"Revised nomenclature for strain 129 mice\", MAMMALIAN GENOME, vol. 10, 1999, pages 836, XP055344303, DOI: doi:10.1007/s003359901099",
                    "VALENZUELA ET AL., NATURE BIOTECH, vol. 21.6, 2003, pages 652 - 659",
                    "PAGE ET AL.: \"Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection\", J VIROL, vol. 86, 2012, pages 13334 - 13349",
                    "VALENZUELA ET AL.: \"High-throughput engineering of the mouse genome coupled with high-resolution expression analysis\", NATURE BIOTECH, vol. 21, no. 6, 2003, pages 652 - 659",
                    "POUEYMIROU ET AL.: \"FO generation mice that are essentially fully derived from the donor gene-targeted ES cells allowing immediate phenotypic analyses\", NATURE BIOTECH., vol. 25, no. 1, 2007, pages 91 - 99",
                    "RAJ ET AL.: \"Dipeptidyl Peptidase 4 is a Functional Receptor for the Emerging Human Coronavirus-EMC\", NATUERE, vol. 495, no. 7440, 2013, pages 251 - 254, XP055302115, DOI: doi:10.1038/nature12005",
                    "COCKRELL ET AL.: \"Mouse Dipeptidyl Peptidase is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection\", J. VIROL., vol. 88, no. 9, 2014, pages 5195 - 5199",
                    "COLEMAN ET AL.: \"Wild-Type and Innate Immune-Deficient Mice are Not Susceptible to the Middle East Respiratory Syndrome Coronavirus\", J. GEN. VIROL., vol. 95, no. 2, 2014, pages 408 - 412",
                    "LU ET AL.: \"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26\", NATURE, vol. 500, no. 7461, 2013, pages 227 - 31, XP055162686, DOI: doi:10.1038/nature12328",
                    "ZHAO ET AL.: \"Rapid Generation of a Mouse Model for Middle East Respiratory Syndrome\", PROC. NATL. ACAD. SCI. USA, vol. 111, no. 13, 2014, pages 4970 - 4975, XP055212024, DOI: doi:10.1073/pnas.1323279111"
                ],
                "nplResolvedCount": 15,
                "nplResolvedLensIDs": [
                    "118-660-215-665-839",
                    "113-247-817-446-456",
                    "015-091-157-711-697",
                    "085-122-255-782-470",
                    "077-654-442-397-567",
                    "144-694-712-972-15X",
                    "046-419-902-381-810",
                    "054-391-011-603-49X",
                    "037-334-759-900-091",
                    "122-156-759-782-023",
                    "020-009-029-407-493",
                    "145-146-407-738-040",
                    "000-667-406-763-514",
                    "068-538-867-072-00X",
                    "172-177-240-760-035"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3884108",
                    "pmc3993820",
                    "7927537",
                    "10.1021/bi00254a032",
                    "24574399",
                    "10.1128/jvi.03764-13",
                    "23015710",
                    "12730667",
                    "24403842",
                    "17187059",
                    "7999781",
                    "10.1038/nbt1263",
                    "10430671",
                    "pmc3917065",
                    "10.1038/nbt822",
                    "10.1038/nature12005",
                    "10.1128/jvi.01689-12",
                    "pmc3503056",
                    "10.1007/bf01246674",
                    "12175726",
                    "10.1038/nature12328",
                    "10.2147/ijgm.s51665",
                    "23831647",
                    "10.1099/vir.0.060640-0",
                    "24197535",
                    "24599590",
                    "10.1007/s003359901099",
                    "10.1073/pnas.1323279111",
                    "pmc3977243",
                    "10.1016/s0198-8859(02)00433-0",
                    "23486063",
                    "10.1038/nature.2014.14634"
                ]
            },
            {
                "index": "227",
                "publicationKey": "US_9497945_B2",
                "lensId": "051-073-552-319-915",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9497945 B2",
                "publicationDate": "2016-11-22",
                "filingNumber": "US 201514723855 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2015-09-14"
                    }
                ],
                "url": "https://lens.org/051-073-552-319-915",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 1,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/00",
                    "A01K67/027",
                    "C12Q1/68",
                    "C12Q1/70",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 35,
                "nplCitations": [
                    "Mullins et al. Journal of Clinical Investigation, 1996.",
                    "Moreadith et al., J. Mol. Med., 1997;75:208-16.",
                    "Pera et al. Journal of Cell Science 2000; 113: 5-10.",
                    "Kuroiwa et al. Nature Genetics 2004;36:775-80.",
                    "Simenoi et al. Hum Immunol 2002;63:719-30.",
                    "Lu et al. Nature 2013;500:227-32.",
                    "Auerbach, W. et al. (Nov. 2000). \"Establishment and Chimera Analysis of 129/SvEv- and C57BL/6-Derived Mouse Embryonic Stem Cells,\" BioTechniques 29(5): 1024-1032.",
                    "Cockrell, A.S. et al. (May 2014, e-published Feb. 26, 2014). \"Mouse Dipeptidyl Peptidase is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection,\" J. Virol. 88(9):5195-5199.",
                    "Coleman, C.M. et al. (Feb. 2014, e-published Nov. 6, 2013). \"Wild-Type and Innate Immune-Deficient Mice are Not Susceptible to the Middle East Respiratory Syndrome Coronavirus,\" J. Gen. Virol. 95(Pt 2):408-412.",
                    "Festing, M.F. et al. (Aug. 1999). \"Revised Nomenclature for Strain 129 Mice,\" Mamm Genome 10(8):836.",
                    "GenBank Accession No. KC776174.1, located at , last visited Aug. 10, 2015, 12 pages.",
                    "GenBank Accession No. JX869059.2 located at , last visited Aug. 10, 2015, 13 pages.",
                    "Gerich, J. (Dec. 4, 2013). \"Pathogenesis and Management of Postpandrial Hyperglycemia: Role of Incretin-Based Therapies,\" Intl. J. Gen. Med. 6:877-895.",
                    "Lu, G. et al. (Aug. 8, 2013, e-published Jul. 7, 2013). \"Molecular Basis of Binding Between Novel Human Coronavirus MERS-CoV and Its Receptor CD26,\" Nature 500(7461):227-231.",
                    "Page, C. et al. (Dec. 2012). \"Induction of Alternatively Activated Macrophages Enhances Pathogenesis During Severe Acute Respiratory Syndrome Coronavirus Infection,\" J Virol 86(24):13334-13349.",
                    "Pascal, K.E. et al. (Jul. 14, 2015, e-published Jun. 29, 2015). \"Pre- and Postexposure Efficacy of Fully Human Antibodies Against Spike Protein in a Novel Humanized Mouse Model of MERS-CoV Infection,\" Proc. Natl. Acad. Sci. USA 112(28):8738-8743.",
                    "Pascal, K.E. et al. (2015). \"Supporting Information,\" Proc. Natl. Acad. Sci. USA, 10 pages.",
                    "Poueymirou, W.T. et al. (Jan. 2007, e-published Dec. 24, 2006). F0 Generation Mice Fully Derived From Gene-Targeted Embryonic Stem Cells Allowing Immediate Phenotypic Analyses, Nat Biotechnol 25(1):91-99.",
                    "Raj, V.S. et al. (Mar. 14, 2013). \"Dipeptidyl Peptidase 4 is a Functional Receptor for the Emerging Human Coronavirus-EMC,\" Nature 495(7440):251-254.",
                    "Valenzuela, D.M. et al. (Jun. 2003, e-published May 5, 2003). High-Throughput Engineering of the Mouse Genome Coupled with High-Resolution Expression Analysis, Nature Biotechnology 21(6):652-659.",
                    "Zhao, J. et al. (Apr. 1, 2014). Rapid Generation of a Mouse Model for Middle East Respiratory Syndrome, Proc. Natl. Acad. Sci. USA 111(13):4970-4975.",
                    "Abbott, C.A. et al. (1994). \"Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene,\" Immunogenetics 40(5):331-338.",
                    "Bernard, A.M. et al. (Dec. 20, 1994). \"Structure of the mouse dipeptidyl peptidase IV (CD26) gene,\" Biochemistry 33(50):15204-15214.",
                    "International Search Report mailed on Sep. 18, 2015, for PCT Application No. PCT/US2015/033024, filed May 28, 2015, 7 pages.",
                    "Reardon, S. (Jan. 30, 2014). \"Biologists Make First Mouse Model for MERS,\" Nature News located at http://www.nature.com/news/biologists-make-first-mouse-model-for-mers-1.14634, last visited Sep. 8, 2015.",
                    "Simeoni, L. et al. (Sep. 2002). \"Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution,\" Human Immunology 63(9):719-730.",
                    "Written Opinion mailed on Sep. 18, 2015, for PCT Application No. PCT/US2015/033024, filed May 28, 2015, 7 pages.",
                    "Center for Disease Control and Prevention (Oct. 4, 2012). \"Severe Respiratory Illness Associated with a Novel Coronavirus-Saudi Arabia and Qatar, 2012,\" Morbidity and Mortality Weekly Report (MMWR), MMWR Early Release, located at , last visited on Apr. 23, 2016, 3 pages.",
                    "Gama Sosa, M.A. et al. (Mar. 2010, e-published Nov. 25, 2009). \"Animal transgenesis: an overview,\" Brain Struct Funct 214(2-3):91-109.",
                    "Mulvihill, E.E. et al. (Dec. 2014, e-published Sep. 12, 2014). \"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors,\" Endocr Rev 35(6):992-1019.",
                    "Ristevski, S. (Feb. 2005). \"Making better transgenic models: conditional, temporal, and spatial approaches,\" Mol Biotechnol 29(2):153-163.",
                    "Sigmund, C.D. (Jun. 2000). \"Viewpoint: are studies in genetically altered mice out of control?\" Arteroscler Throm Vasc Biol 20(6):1425-1429.",
                    "Smith, K.R. (Oct. 9, 2002). \"Gene transfer in higher animals: theoretical considerations and key concepts,\" J Biotechnol 99(1):1-22.",
                    "Tong, C. et al. (Sep. 9, 2010). \"Production of p53 gene knockout rats by homologous recombination in embryonic stem cells,\" Nature 467(7312):211-213.",
                    "Van Der Weyden L. et al. (Dec. 3, 2002, e-published Dec. 3, 2002). \"Tools for targeted manipulation of the mouse genome,\" Physiol Genomics 11(3):133-164."
                ],
                "nplResolvedCount": 27,
                "nplResolvedLensIDs": [
                    "044-217-677-312-406",
                    "104-556-161-839-355",
                    "035-760-912-363-624",
                    "024-385-617-574-946",
                    "051-508-475-126-991",
                    "118-660-215-665-839",
                    "113-247-817-446-456",
                    "015-091-157-711-697",
                    "085-122-255-782-470",
                    "077-654-442-397-567",
                    "144-694-712-972-15X",
                    "046-419-902-381-810",
                    "080-586-043-504-747",
                    "134-958-999-769-59X",
                    "054-391-011-603-49X",
                    "037-334-759-900-091",
                    "122-156-759-782-023",
                    "020-379-126-711-305",
                    "023-154-204-899-879",
                    "020-009-029-407-493",
                    "145-146-407-738-040",
                    "000-667-406-763-514",
                    "079-521-739-746-928",
                    "002-305-399-176-585",
                    "068-538-867-072-00X",
                    "006-727-147-254-300",
                    "172-177-240-760-035"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3884108",
                    "10.3410/f.725599658.793535757",
                    "pmc2937076",
                    "pmc3993820",
                    "24574399",
                    "10.2144/00295st04",
                    "10.1038/ng1373",
                    "10845854",
                    "19937345",
                    "10.1038/nbt1263",
                    "10.1210/er.2014-1035",
                    "10.1152/physiolgenomics.00074.2002",
                    "10.1007/s001090050105",
                    "12175726",
                    "pmc4507189",
                    "10.2147/ijgm.s51665",
                    "23831647",
                    "11084865",
                    "9106077",
                    "10.1016/s0168-1656(02)00105-0",
                    "24197535",
                    "10.1007/s00429-009-0230-8",
                    "12464689",
                    "10.1007/s003359901099",
                    "23486063",
                    "10.1073/pnas.1510830112",
                    "25216328",
                    "7927537",
                    "20703227",
                    "10591620",
                    "10.1038/nature09368",
                    "10.1021/bi00254a032",
                    "10.1128/jvi.03764-13",
                    "23015710",
                    "12730667",
                    "24403842",
                    "17187059",
                    "7999781",
                    "10430671",
                    "pmc3917065",
                    "12204554",
                    "10.1038/nbt822",
                    "10.1038/nature12005",
                    "10.1128/jvi.01689-12",
                    "pmc3503056",
                    "15184897",
                    "10.1007/bf01246674",
                    "10.1038/nature12328",
                    "10.1161/01.atv.20.6.1425",
                    "10.1385/mb:29:2:153",
                    "10.1099/vir.0.060640-0",
                    "24599590",
                    "26124093",
                    "10.1073/pnas.1323279111",
                    "15699570",
                    "pmc3977243",
                    "10.1016/s0198-8859(02)00433-0",
                    "10.1038/nature.2014.14634"
                ]
            },
            {
                "index": "228",
                "publicationKey": "US_9532555_B2",
                "lensId": "069-071-708-626-765",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 9532555 B2",
                "publicationDate": "2017-01-03",
                "filingNumber": "US 201514824475 A",
                "filingDate": "2015-08-12",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/069-071-708-626-765",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027",
                    "C12Q1/68",
                    "C12Q1/70",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 36,
                "nplCitations": [
                    "Abbott et al Immunogenetics, 1994, 331-338.",
                    "Bernard et al Biochemistry, 33(50), 1994, 15204-15214.",
                    "Reardon et al (Nature News, Jan. 30, 2014, 1-4.",
                    "Gama Sosa et al Brain Struct Funct (2010) 214:91-109.",
                    "Smith, et al Journal of Biotechnology 99 (2002) 1-22.",
                    "Ristevski, Molecular Biotechnology, 2005, 153-163.",
                    "Sigmund Arteroscler Throm Vasc Biol 20: 2000, 1425-1429.",
                    "Mulvihill et al Endocr Rev. Dec. 2014;35(6):992-1019.",
                    "Auerbach, W. et al. (Nov. 2000). \"Establishment and Chimera Analysis of 129/SvEv-and C57BL/6-Derived Mouse Embryonic Stem Cell Lines,\" BioTechniques 29(5): 1024-1032.",
                    "Cockrell, A.S. et al. (May 2014, e-published Feb. 26, 2014). \"Mouse Dipeptidyl Peptidase is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection,\" J. Virol. 88(9):5195-5199.",
                    "Coleman, C.M. et al. (Feb. 2014, e-published Nov. 6, 2013). \"Wild-Type and Innate Immune-Deficient Mice are Not Susceptible to the Middle East Respiratory Syndrome Coronavirus,\" J. Gen.Virol. 95(Pt 2):408-412.",
                    "Festing, M.F. et al. (Aug. 1999). \"Revised Nomenclature for Strain 129 Mice,\" Mamm Genome 10(8):836.",
                    "GenBank Accession No. KC776174.1, located at , last visited Aug. 10, 2015, 12 pages.",
                    "GenBank Accession No. JX869059.2 located at , last visited Aug. 10, 2015, 13 pages.",
                    "Gerich, J. (Dec. 4, 2013). \"Pathogenesis and Management of Postpandrial Hyperglycemia: Role of Incretin-Based Therapies,\" Intl. J. Gen. Med. 6:877-895.",
                    "Lu, G. et al. (Aug. 8, 2013, e-published Jul. 7, 2013). \"Molecular Basis of Binding Between Novel Human Coronavirus MERS-CoV and its Receptor CD26,\" Nature 500(7461):227-231.",
                    "Page, C. et al. (Dec. 2012). \"Induction of Alternatively Activated Macrophages Enhances Pathogenesis During Severe Acute Respiratory Syndrome Coronavirus Infection,\" J Virol 86(24):13334-13349.",
                    "Pascal, K.E. et al. (Jul. 14, 2015, e-published Jun. 29, 2015). \"Pre- and Postexposure Efficacy of Fully Human Antibodies Against Spike Protein in a Novel Humanized Mouse Model of MERS-CoV Infection,\" Proc. Natl. Acad. Sci. USA 112(28):8738-8743.",
                    "Pascal, K.E. et al. (2015). \"Supporting Information,\" Proc. Natl. Acad. Sci. USA, 10 pages.",
                    "Poueymirou, W.T. et al. (Jan. 2007, e-published Dec. 24, 2006). F0 Generation Mice Fully Derived From Gene-Targeted Embryonic Stem Cells Allowing Immediate Phenotypic Analyses, Nat Biotechnol 25(1):91-99.",
                    "Raj, V.S. et al. (Mar. 14, 2013). \"Dipeptidyl Peptidase 4 is a Functional Receptor for the Emerging Human Coronavirus-EMC,\" Nature 495(7440):251-254.",
                    "Valenzuela, D.M. et al. (Jun. 2003, e-published May 5, 2003). High-Throughput Engineering of the Mouse Genome Coupled with High-Resolution Expression Analysis, Nature Biotechnology 21(6):652-659.",
                    "Zhao, J. et al. (Apr. 1, 2014). Rapid Generation of a Mouse Model for Middle East Respiratory Syndrome, Proc. Natl. Acad. Sci. USA 111(13):4970-4975.",
                    "Abbott, C.A. et al. (1994). \"Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene,\" Immunogenetics 40(5):331-338.",
                    "Bernard, A.M. et al. (Dec. 20, 1994). \"Structure of the mouse dipeptidyl peptidase IV (CD26) gene,\" Biochemistry 33(50):15204-15214.",
                    "International Search Report mailed on Sep. 18, 2015, for PCT Application No. PCT/US2015/033024, filed May 28, 2015, 7 pages.",
                    "Reardon, S. (Jan. 30, 2014). \"Biologists Make First Mouse Model for MERS,\" Nature News located at http://www.nature.com/news/biologists-make-first-mouse-model-for-mers-1.14634, last visited Sep. 8, 2015.",
                    "Simeoni, L. et al. (Sep. 2002). \"Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution,\" Human Immunology 63(9):719-730.",
                    "Written Opinion mailed on Sep. 18, 2015, for PCT Application No. PCT/US2015/033024, filed May 28, 2015, 7 pages.",
                    "Center for Disease Control and Prevention (Oct. 4, 2012). \"Severe Respiratory Illness Associated with a Novel Coronavirus-Saudi Arabia and Qatar, 2012,\" Morbidity and Mortality Weekly Report (MMWR), MMWR Early Release, located at , last visited on Apr. 23, 2016, 3 pages.",
                    "Kuroiwa, Y. et al. (Jul. 2004, e-published Jun. 6, 2004). \"Sequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle,\" Nat Genet 36(7):775-780.",
                    "Moreadith, R.W. et al. (Mar. 1997). \"Gene targeting in embryonic stem cells: the new physiology and metabolism,\" J Mol Med (Berl) 75(3):208-216.",
                    "Mullins, L.J. et al. (Apr. 1, 1996). \"Transgenesis in the rat and larger mammals,\" J Clin Invest 97(7):1557-1560.",
                    "Pera, M.F. et al. (Jan. 2000). \"Human embryonic stem cells,\" J Cell Sci 13(Pt1):5-10.",
                    "Tong, C. et al. (Sep. 9, 2010). \"Production of p53 gene knockout rats by homologous recombination in embryonic stem cells,\" Nature 467(7312):211-213.",
                    "Van Der Weyden L. et al. (Dec. 3, 2002, e-published Dec. 3, 2002). \"Tools for targeted manipulation of the mouse genome,\" Physiol Genomics 11(3):133-164."
                ],
                "nplResolvedCount": 28,
                "nplResolvedLensIDs": [
                    "044-217-677-312-406",
                    "104-556-161-839-355",
                    "035-760-912-363-624",
                    "024-385-617-574-946",
                    "051-508-475-126-991",
                    "028-926-245-995-882",
                    "118-660-215-665-839",
                    "113-247-817-446-456",
                    "015-091-157-711-697",
                    "085-122-255-782-470",
                    "077-654-442-397-567",
                    "144-694-712-972-15X",
                    "046-419-902-381-810",
                    "080-586-043-504-747",
                    "134-958-999-769-59X",
                    "054-391-011-603-49X",
                    "037-334-759-900-091",
                    "122-156-759-782-023",
                    "020-379-126-711-305",
                    "023-154-204-899-879",
                    "020-009-029-407-493",
                    "145-146-407-738-040",
                    "000-667-406-763-514",
                    "079-521-739-746-928",
                    "002-305-399-176-585",
                    "068-538-867-072-00X",
                    "006-727-147-254-300",
                    "172-177-240-760-035"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3884108",
                    "10.3410/f.725599658.793535757",
                    "pmc2937076",
                    "pmc3993820",
                    "24574399",
                    "10.2144/00295st04",
                    "10.1038/ng1373",
                    "10845854",
                    "19937345",
                    "10.1038/nbt1263",
                    "10.1210/er.2014-1035",
                    "10.1152/physiolgenomics.00074.2002",
                    "10.1007/s001090050105",
                    "12175726",
                    "pmc4507189",
                    "10.2147/ijgm.s51665",
                    "23831647",
                    "11084865",
                    "9106077",
                    "10.1016/s0168-1656(02)00105-0",
                    "24197535",
                    "10.1007/s00429-009-0230-8",
                    "12464689",
                    "10.1007/s003359901099",
                    "23486063",
                    "10.1073/pnas.1510830112",
                    "8601618",
                    "25216328",
                    "7927537",
                    "20703227",
                    "10591620",
                    "10.1172/jci118579",
                    "10.1038/nature09368",
                    "10.1021/bi00254a032",
                    "10.1128/jvi.03764-13",
                    "23015710",
                    "12730667",
                    "24403842",
                    "17187059",
                    "7999781",
                    "10430671",
                    "pmc3917065",
                    "12204554",
                    "10.1038/nbt822",
                    "10.1038/nature12005",
                    "10.1128/jvi.01689-12",
                    "pmc3503056",
                    "15184897",
                    "10.1007/bf01246674",
                    "10.1038/nature12328",
                    "10.1161/01.atv.20.6.1425",
                    "10.1385/mb:29:2:153",
                    "pmc507217",
                    "10.1099/vir.0.060640-0",
                    "24599590",
                    "26124093",
                    "10.1073/pnas.1323279111",
                    "15699570",
                    "pmc3977243",
                    "10.1016/s0198-8859(02)00433-0",
                    "10.1038/nature.2014.14634"
                ]
            },
            {
                "index": "229",
                "publicationKey": "WO_2020_006494_A1",
                "lensId": "171-554-584-429-551",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2020/006494 A1",
                "publicationDate": "2020-01-02",
                "filingNumber": "US 2019/0039952 W",
                "filingDate": "2019-06-28",
                "priorityFilingKeysActive": [
                    "US 201862692398 P 20180629"
                ],
                "earliestPriorityDate": "2018-06-29",
                "title": "Cell-stored Barcoded Deep Mutational Scanning Libraries And Uses Of The Same",
                "applicants": [
                    "HUTCHINSON FRED CANCER RES",
                    "UNIV WASHINGTON"
                ],
                "inventors": [
                    "BLOOM JESSE",
                    "DINGENS ADAM S",
                    "DUSENBURY KATHARINE",
                    "RADFORD CAELAN"
                ],
                "owners": [],
                "url": "https://lens.org/171-554-584-429-551",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 56,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/005",
                    "C07K14/155",
                    "C12N15/10",
                    "C40B20/04",
                    "C40B40/02",
                    "C40B40/08",
                    "C40B50/10",
                    "C40B70/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 5,
                "nplCitations": [
                    "DINGENS, AS ET AL.: \"Comprehensive Mapping of HIV-1 Escape from a Broadly Neutralizing Antibody\", CELL HOST AND MICROBE, vol. 21, no. 6, 1 June 2017 (2017-06-01), pages 777 - 791, XP085072737, DOI: 10.1016/j.chom.2017.05.003",
                    "DOUD, MB ET AL.: \"Complete mapping of viral escape from neutralizing antibodies\", PLOS PATHOGENS, vol. 13, no. 3, 13 March 2017 (2017-03-13), pages e1006271, XP055666997",
                    "BEHERA, V ET AL.: \"Exploiting genetic variation to uncover rules of transcription factor binding and chromatin accessibility\", NATURE COMMUNICATIONS, vol. 9, no. 1, 22 February 2018 (2018-02-22), pages 1 - 15, XP055666998",
                    "DOUD, MB ET AL.: \"Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin\", VIRUSES, vol. 8, no. 6, 3 June 2016 (2016-06-03), pages 155, XP055667000",
                    "THYAGARAJAN, B ET AL.: \"The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin\", ELIFE, vol. 3, 8 July 2014 (2014-07-08), pages 1 - 26, XP055667006"
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "051-273-441-645-917",
                    "008-619-103-971-468",
                    "025-200-772-459-094",
                    "008-420-266-376-77X",
                    "038-824-069-847-148"
                ],
                "nplResolvedExternalIDs": [
                    "29472540",
                    "10.1016/j.chom.2017.05.003",
                    "10.1371/journal.ppat.1006271",
                    "10.7554/elife.03300",
                    "pmc4109307",
                    "10.1038/s41467-018-03082-6",
                    "28579254",
                    "25006036",
                    "10.3390/v8060155",
                    "pmc4926175",
                    "27271655",
                    "28288189"
                ]
            },
            {
                "index": "230",
                "publicationKey": "WO_2020_010474_A1",
                "lensId": "179-919-524-812-76X",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2020/010474 A1",
                "publicationDate": "2020-01-16",
                "filingNumber": "CA 2019050975 W",
                "filingDate": "2019-07-15",
                "priorityFilingKeysActive": [
                    "US 201862697695 P 20180713"
                ],
                "earliestPriorityDate": "2018-07-13",
                "title": "The Ebola Virus Glycoprotein As A Tool To Stimulate An Immune Response",
                "applicants": [
                    "UNIV LAVAL",
                    "THE UNIV OF MANITOBA"
                ],
                "inventors": [
                    "KOBINGER GARY",
                    "DE LA VEGA MARC-ANTOINE",
                    "AZIZI HIVA",
                    "YAO XIAOJIAN"
                ],
                "owners": [],
                "url": "https://lens.org/179-919-524-812-76X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 35,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N15/86",
                    "A61K39/39",
                    "A61P37/04",
                    "C07K14/08",
                    "C07K14/115",
                    "C07K14/145",
                    "C07K14/16",
                    "C07K14/165",
                    "C07K14/175",
                    "C12N7/01",
                    "C12N15/45",
                    "C12N15/47",
                    "C12N15/49",
                    "C12N15/50",
                    "C40B40/02"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "231",
                "publicationKey": "US_10212923_B2",
                "lensId": "046-549-305-281-649",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10212923 B2",
                "publicationDate": "2019-02-26",
                "filingNumber": "US 201615295955 A",
                "filingDate": "2016-10-17",
                "priorityFilingKeysActive": [
                    "US 201462072692 P 20141030",
                    "US 201462051626 P 20140917",
                    "US 201462005476 P 20140530"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl-peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2015-09-14"
                    }
                ],
                "url": "https://lens.org/046-549-305-281-649",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027",
                    "C12Q1/68",
                    "C12Q1/6883",
                    "C12Q1/70",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 46,
                "nplCitations": [
                    "Abbott, C.A. et al. (1994). \u201cGenomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene,\u201d Immunogenetics 40(5):331-338.",
                    "Auerbach, W. et al. (Nov. 2000). \u201cEstablishment and Chimera Analysis of 129/SvEv- and C57BL/6-Derived Mouse Embryonic Stem Cell Lines,\u201d BioTechniques 29(5): 1024-1032.",
                    "Bernard, A.M. et al. (Dec. 20, 1994). \u201cStructure of the mouse dipeptidyl peptidase IV (CD26) gene,\u201d Biochemistry 33(50):15204-15214.",
                    "Center for Disease Control and Prevention (Oct. 4, 2012). \u201cSevere Respiratory Illness Associated with a Novel Coronavirus\u2014Saudi Arabia and Qatar, 2012,\u201d Morbidity and Mortality Weekly Report (MMWR), MMWR Early Release, located at <http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6140a5.htm?s_cid=mm6140a5_w>, last visited on Apr. 23, 2016, 3 pages.",
                    "Cockrell, A.S. et al. (May 2014, e-published Feb. 26, 2014). \u201cMouse Dipeptidyl Peptidase is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection,\u201d J. Virol. 88(9):5195-5199.",
                    "Coleman, C.M. et al. (Feb. 2014, e-published Nov. 6, 2013). \u201cWild-Type and Innate Immune-Deficient Mice are Not Susceptible to the Middle East Respiratory Syndrome Coronavirus,\u201d J. Gen. Virol. 95(Pt 2):408-412.",
                    "Festing, M.F. et al. (Aug. 1999). \u201cRevised Nomenclature for Strain 129 Mice,\u201d Mamm Genome 10(8):836.",
                    "Gama Sosa, M.A. et al. (Mar. 2010, e-published Nov. 25, 2009). \u201cAnimal transgenesis: an overview,\u201d Brain Struct Funct 214(2-3):91-109.",
                    "GenBank Accession No. KC776174.1, located at <http:www.ncbi.nlm.nih.gov/nuccore/KC776174.1>, last visited Aug. 10, 2015, 12 pages.",
                    "GenBank Accession No. JX869059.2 located at <http:www.ncbi.nlm.nih.gov/nuccore/JX869059.2>, last visited Aug. 10, 2015, 13 pages.",
                    "Gerich, J. (Dec. 4, 2013). \u201cPathogenesis and Management of Postpandrial Hyperglycemia: Role of Incretin-Based Therapies,\u201d Intl. J. Gen. Med. 6:877-895.",
                    "International Search Report dated Sep. 18, 2015, for PCT Application No. PCT/US2015/033024, filed May 28, 2015, 7 pages.",
                    "Kuroiwa, Y. et al. (Jul. 2004, e-published Jun. 6, 2004). \u201cSequential targeting of the genes encoding immunoglobulin-mu and prion protein in cattle,\u201d Nat Genet 36(7):775-780.",
                    "Lu, G. et al. (Aug. 8, 2013, e-published Jul. 7, 2013). \u201cMolecular Basis of Binding Between Novel Human Coronavirus MERS-CoV and Its Receptor CD26,\u201d Nature 500(7461):227-231.",
                    "Moreadith, R.W. et al. (Mar. 1997). \u201cGene targeting in embryonic stem cells: the new physiology and metabolism,\u201d J Mol Med (Berl) 75(3):208-216.",
                    "Mullins, L.J. et al. (Apr. 1, 1996). \u201cTransgenesis in the rat and larger mammals,\u201d J Clin Invest 97(7):1557-1560.",
                    "Mulvihill, E.E. et al. (Dec. 2014, e-published Sep. 12, 2014). \u201cPharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors,\u201d Endocr Rev 35(6):992-1019.",
                    "Page, C. et al. (Dec. 2012). \u201cInduction of Alternatively Activated Macrophages Enhances Pathogenesis During Severe Acute Respiratory Syndrome Coronavirus Infection,\u201d J Virol 86(24):13334-13349.",
                    "Pascal, K.E. et al. (Jul. 14, 2015, e-published Jun. 29, 2015). \u201cPre- and Postexposure Efficacy of Fully Human Antibodies Against Spike Protein in a Novel Humanized Mouse Model of MERS-CoV Infection,\u201d Proc. Natl. Acad. Sci. USA 112(28):8738-8743.",
                    "Pascal, K.E. et al. (2015). \u201cSupporting Information,\u201d Proc. Natl. Acad. Sci. USA, 10 pages.",
                    "Pera, M.F. et al. (Jan. 2000). \u201cHuman embryonic stem cells,\u201d J Cell Sci 113(Pt1):5-10.",
                    "Poueymirou, W.T. et al. (Jan. 2007, e-published Dec. 24, 2006). F0 Generation Mice Fully Derived From Gene-Targeted Embryonic Stem Cells Allowing Immediate Phenotypic Analyses, Nat Biotechnol 25(1):91-99.",
                    "Raj, V.S. et al. (Mar. 14, 2013). \u201cDipeptidyl Peptidase 4 is a Functional Receptor for the Emerging Human Coronavirus-EMC,\u201d Nature 495(7440):251-254.",
                    "Reardon, S. (Jan. 30, 2014). \u201cBiologists Make First Mouse Model for MERS,\u201d Nature News located at http://www.nature.com/news/biologists-make-first-mouse-model-for-mers-1.14634, last visited Sep. 8, 2015.",
                    "Ristevski, S. (Feb. 2005). \u201cMaking better transgenic models: conditional, temporal, and spatial approaches,\u201d Mol Biotechnol 29(2):153-163.",
                    "Sigmund, C.D. (Jun. 2000). \u201cViewpoint: are studies in genetically altered mice out of control?\u201d Arteroscler Throm Vasc Biol 20(6):1425-1429.",
                    "Simeoni, L. et al. (Sep. 2002). \u201cHuman CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution,\u201d Human Immunology 63(9):719-730.",
                    "Smith, K.R. (Oct. 9, 2002). \u201cGene transfer in higher animals: theoretical considerations and key concepts,\u201d J Biotechnol 99(1):1-22.",
                    "Tong, C. et al. (Sep. 9, 2010). \u201cProduction of p53 gene knockout rats by homologous recombination in embryonic stem cells,\u201d Nature 467(7312):211-213.",
                    "Valenzuela, D.M. et al. (Jun. 2003, e-published May 5, 2003). High-Throughput Engineering of the Mouse Genome Coupled with High-Resolution Expression Analysis, Nature Biotechnology 21 (6):652-659.",
                    "Van Der Weyden L. et al. (Dec. 3, 2002, e-published Dec. 3, 2002). \u201cTools for targeted manipulation of the mouse genome,\u201d Physiol Genomics 11(3):133-164.",
                    "Written Opinion dated Sep. 18, 2015, for PCT Application No. PCT/US2015/033024, filed May 28, 2015, 7 pages.",
                    "Zhao, J. et al. (Apr. 1, 2014). Rapid Generation of a Mouse Model for Middle East Respiratory Syndrome, Proc. Natl. Acad. Sci. USA 111(13):4970-4975.",
                    "Raj V.S. et al., \u201cAdenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus\u201d, Journal of Virology 88(3):1834-1838 (Feb. 1, 2014).",
                    "Tang X-C et al, \u201cIdentification of Human Neutralizing Antibodies Against MERS-CoV and Their Role in Virus Adaptive Evolution\u201d, PNAS 111(19):E2018-E2026 (May 13, 2014).",
                    "European Extended Search Report dated Jul. 3, 2018 received European Patent Application No. 18 17 3004.5.",
                    "Abbott C.A. et al.,\u201cGenomic Organization, Exact Localization, and Tissue Expression of the Human CD26 (Dipeptidyl Peptidase IV) Gene\u201d, Immunogenetics 40:331-338 (1994).",
                    "Coleman C.M. et al., \u201cWild-Type and Innate Immune-Deficient Mice are Not Susceptible to the Middle East Respiratory Syndrome Coronavirus\u201d, Journal of General Virology 95:408-412 (2014).",
                    "Dennis, Jr. M.B., \u201cWelfare Issues of Genetically Modified Animals\u201d, ILAR Journal 43(2)100-109 (2002).",
                    "Reardon S., \u201cBiologists Make First Mouse Model for MERS\u201d, Nature NEWS, 4 pages (Jan. 30, 2014).",
                    "Rybchin V.N., \u201cBasics of Genetic Engineering\u201d, Textbook for High Schools, Saint-Petersburg, Publishing House SPbSTU 522:410-417 (2002).",
                    "Simeoni L. et al., \u201cHuman CD26 Expression in Transgenic Mice Affects Murine T-Cell Populations and Modifies Their Subset Distribution\u201d, Human Immunology 63:719-730 (2002).",
                    "Zhou H. et al., \u201cDeveloping tTA Transgenic Rats for Inducible and Reversible Gene Expression\u201d, International Journal of Biological Sciences 5(2):171-181 (2009).",
                    "Canadian Examination Report dated May 4, 2017 received in Canadian Patent Application No. 2,947,899.",
                    "Russian Search Report dated Aug. 15, 2017 received in Russian Patent Application No. 2016150679, together with an English-language translation.",
                    "Russian Office Action dated Aug. 22, 2017 received in Russian Patent Application No. 2016150679, together with an English-language translation."
                ],
                "nplResolvedCount": 32,
                "nplResolvedLensIDs": [
                    "044-217-677-312-406",
                    "104-556-161-839-355",
                    "035-760-912-363-624",
                    "024-385-617-574-946",
                    "058-612-104-204-676",
                    "051-508-475-126-991",
                    "028-926-245-995-882",
                    "118-660-215-665-839",
                    "113-247-817-446-456",
                    "015-091-157-711-697",
                    "085-122-255-782-470",
                    "077-654-442-397-567",
                    "144-694-712-972-15X",
                    "046-419-902-381-810",
                    "080-586-043-504-747",
                    "134-958-999-769-59X",
                    "054-391-011-603-49X",
                    "037-334-759-900-091",
                    "122-156-759-782-023",
                    "113-843-389-492-042",
                    "020-379-126-711-305",
                    "023-154-204-899-879",
                    "020-009-029-407-493",
                    "145-146-407-738-040",
                    "000-667-406-763-514",
                    "079-521-739-746-928",
                    "002-305-399-176-585",
                    "018-489-609-653-07X",
                    "068-538-867-072-00X",
                    "006-727-147-254-300",
                    "079-080-784-051-77X",
                    "172-177-240-760-035"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3884108",
                    "10.3410/f.725599658.793535757",
                    "pmc2937076",
                    "pmc3993820",
                    "10.1093/ilar.43.2.100",
                    "24574399",
                    "10.2144/00295st04",
                    "10.1038/ng1373",
                    "10845854",
                    "19937345",
                    "10.1038/nbt1263",
                    "10.1210/er.2014-1035",
                    "10.1152/physiolgenomics.00074.2002",
                    "10.1007/s001090050105",
                    "19214245",
                    "pmc2640494",
                    "12175726",
                    "pmc4507189",
                    "10.2147/ijgm.s51665",
                    "23831647",
                    "11084865",
                    "9106077",
                    "10.1016/s0168-1656(02)00105-0",
                    "pmc4024880",
                    "24197535",
                    "10.1007/s00429-009-0230-8",
                    "12464689",
                    "10.1007/s003359901099",
                    "23486063",
                    "10.1128/jvi.02935-13",
                    "10.1073/pnas.1510830112",
                    "pmc3911594",
                    "8601618",
                    "25216328",
                    "7927537",
                    "20703227",
                    "10591620",
                    "10.1172/jci118579",
                    "10.1038/nature09368",
                    "10.1021/bi00254a032",
                    "10.1128/jvi.03764-13",
                    "23015710",
                    "10.1073/pnas.1402074111",
                    "24257613",
                    "12730667",
                    "24403842",
                    "17187059",
                    "7999781",
                    "10430671",
                    "pmc3917065",
                    "12204554",
                    "10.1038/nbt822",
                    "10.1038/nature12005",
                    "10.1128/jvi.01689-12",
                    "24778221",
                    "pmc3503056",
                    "15184897",
                    "10.1007/bf01246674",
                    "10.1038/nature12328",
                    "10.1161/01.atv.20.6.1425",
                    "10.1385/mb:29:2:153",
                    "pmc507217",
                    "10.1099/vir.0.060640-0",
                    "10.7150/ijbs.5.171",
                    "24599590",
                    "11917161",
                    "26124093",
                    "10.1073/pnas.1323279111",
                    "15699570",
                    "pmc3977243",
                    "10.1016/s0198-8859(02)00433-0",
                    "10.1038/nature.2014.14634"
                ]
            },
            {
                "index": "232",
                "publicationKey": "US_10548971_B2",
                "lensId": "048-312-099-134-978",
                "jurisdiction": "US",
                "kindCode": "B2",
                "displayKey": "US 10548971 B2",
                "publicationDate": "2020-02-04",
                "filingNumber": "US 201816022839 A",
                "filingDate": "2018-06-29",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "UNIV PENNSYLVANIA",
                    "INOVIO PHARMACEUTICALS INC"
                ],
                "inventors": [
                    "WEINER DAVID",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/048-312-099-134-978",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 7,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/00",
                    "A61K39/12",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 15,
                "nplCitations": [
                    "Van Boheemen S, et al. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3(6): e00473-12. doi:10.1128/mBio.00473-12.",
                    "Lokugamage et al. Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. Vaccine (2008) 26, 797-808.",
                    "Zhou et al. Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins. Biochemical and Biophysical Research Communications 387 (2009) 326-329.",
                    "Gen Bank: JX869059.2. Human betacoronavirus 2c EMC/2012, complete genome. Date Dec. 4, 2012.",
                    "[online] 25 March 2013 (2013-03-25), \"Human betacoronavirus 2c Jordan-N3/2012, complete genome\", XP002764824",
                    "Corrected Notice of Allowability dated Mar. 15, 2018 for U.S. Appl. No. 15/039,672 (pp. 1-2).",
                    "Corrected Notice of Allowability dated Mar. 26, 2018 for U.S. Appl. No. 15/039,672 (pp. 1-3).",
                    "DATABASE GenBank [online] 30 April 2013 (2013-04-30), \"Human betacoronavirus 2c England-Qatar/2012, complete genome\", XP002764825",
                    "Cotten et al., \u201cSpread, Circulation, and Evolution of the Middle East Respiratory Syndrome Coronavirus,\u201d mBio, 2014, 5(1):e01062-13.",
                    "Cotten et al., \u201cTransmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study\u201d, Lancet, 2013, 382:1993-2002.",
                    "Cotten M, \u201cMiddle East respiratory syndrome coronavirus isolate Al-HASA_4_2013, complete genome.\u201d, Database Genbank, (Jun. 10, 2013), Database accession No. KF186564.1, XP055295837, 17 pages.",
                    "Falzarano et al., \u201cInterferon-a2b and ribavirin treatment improves outcome in MERS-CoV-infected rhesus macaques\u201d, Mat Med, vol. 19(10): pp. 1313-1317 (2013).",
                    "Gen Bank: AFS88936. S protein, Human betacoronavirus 2c EMC/2012. Date Dec. 4, 2012, 2 pages.",
                    "Notice of Allowance dated Mar. 5, 2018 for U.S. Appl. No. 15/039,672 (pp. 1-8).",
                    "Song F, et al., \u2018Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies,\u2019 Journal of Virology, (2013) vol. 87, No. 21, pp. 11950-11954."
                ],
                "nplResolvedCount": 7,
                "nplResolvedLensIDs": [
                    "109-155-880-448-590",
                    "105-955-717-757-57X",
                    "018-702-914-707-986",
                    "015-077-926-384-053",
                    "114-114-185-080-165",
                    "023-939-052-489-028",
                    "016-772-377-304-76X"
                ],
                "nplResolvedExternalIDs": [
                    "10.1016/j.vaccine.2007.11.092",
                    "pmc3807317",
                    "10.1016/s0140-6736(13)61887-5",
                    "24549846",
                    "24055451",
                    "10.1016/j.bbrc.2009.07.025",
                    "10.1128/mbio.00473-12",
                    "10.1038/nm.3362",
                    "19595990",
                    "24013700",
                    "23986586",
                    "pmc3898949",
                    "23170002",
                    "10.1128/jvi.01672-13",
                    "18191004",
                    "10.1128/mbio.01062-13",
                    "pmc2267761",
                    "pmc4093902"
                ]
            },
            {
                "index": "233",
                "publicationKey": "US_2015_0351372_A1",
                "lensId": "191-443-415-367-584",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2015/0351372 A1",
                "publicationDate": "2015-12-10",
                "filingNumber": "US 201514824475 A",
                "filingDate": "2015-08-12",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2015-09-14"
                    }
                ],
                "url": "https://lens.org/191-443-415-367-584",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 5,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027",
                    "C12Q1/68",
                    "C12Q1/70"
                ],
                "usClassifications": [],
                "nplCitationCount": 8,
                "nplCitations": [
                    "Abbott et al Immunogenetics, 1994, 331-338",
                    "Bernard et al Biochemistry, 33(50), 1994, 15204-15214",
                    "Reardon et al (Nature NEWS, 30 January 2014, 1-4",
                    "Gama Sosa et al Brain Struct Funct (2010) 214:91\u2013109",
                    "Smith, et al Journal of Biotechnology 99 (2002) 1-22",
                    "Ristevski, Molecular Biotechnology, 2005, 153-163",
                    "Sigmund Arteroscler Throm Vasc Biol 20: 2000, 1425-1429",
                    "Mulvihill et al Endocr Rev. 2014 Dec;35(6):992-1019"
                ],
                "nplResolvedCount": 7,
                "nplResolvedLensIDs": [
                    "051-508-475-126-991",
                    "015-091-157-711-697",
                    "134-958-999-769-59X",
                    "122-156-759-782-023",
                    "023-154-204-899-879",
                    "079-521-739-746-928",
                    "002-305-399-176-585"
                ],
                "nplResolvedExternalIDs": [
                    "10.1007/bf01246674",
                    "25216328",
                    "7927537",
                    "10.1161/01.atv.20.6.1425",
                    "10.1385/mb:29:2:153",
                    "10.1021/bi00254a032",
                    "10.1016/s0168-1656(02)00105-0",
                    "10845854",
                    "10.1007/s00429-009-0230-8",
                    "7999781",
                    "19937345",
                    "10.1210/er.2014-1035",
                    "15699570",
                    "12204554"
                ]
            },
            {
                "index": "234",
                "publicationKey": "US_2016_0007579_A1",
                "lensId": "161-746-608-598-59X",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0007579 A1",
                "publicationDate": "2016-01-14",
                "filingNumber": "US 201514723855 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462005476 P 20140530",
                    "US 201462051626 P 20140917",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [
                    {
                        "name": "REGENERON PHARMACEUTICALS INC",
                        "executionDate": "2015-09-14"
                    }
                ],
                "url": "https://lens.org/161-746-608-598-59X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 4,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 26,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027",
                    "C12Q1/70",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "Mullins et al. Journal of Clinical Investigation, 1996.",
                    "Moreadith et al., J. Mol. Med., 1997;75:208-16.",
                    "Pera et al. Journal of Cell Science 2000; 113: 5-10.",
                    "Kuroiwa et al. Nature Genetics 2004;36:775-80.",
                    "Simenoi et al. Hum Immunol 2002;63:719-30.",
                    "Lu et al. Nature 2013;500:227-32."
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "104-556-161-839-355",
                    "024-385-617-574-946",
                    "037-334-759-900-091",
                    "020-379-126-711-305",
                    "145-146-407-738-040"
                ],
                "nplResolvedExternalIDs": [
                    "15184897",
                    "12175726",
                    "10.1038/nature12328",
                    "10591620",
                    "23831647",
                    "10.1007/s001090050105",
                    "9106077",
                    "10.1016/s0198-8859(02)00433-0",
                    "10.1038/ng1373"
                ]
            },
            {
                "index": "235",
                "publicationKey": "US_2016_0206729_A1",
                "lensId": "124-751-515-975-629",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2016/0206729 A1",
                "publicationDate": "2016-07-21",
                "filingNumber": "US 201415023629 A",
                "filingDate": "2014-09-19",
                "priorityFilingKeysActive": [
                    "US 201361880111 P 20130919"
                ],
                "earliestPriorityDate": "2013-09-19",
                "title": "Immunogenic Middle East Respiratory Syndrome Coronavirus (mers-cov) Compositions And Methods",
                "applicants": [
                    "NOVAVAX INC"
                ],
                "inventors": [
                    "SMITH GALE",
                    "LIU YE",
                    "MASSARE MICHAEL"
                ],
                "owners": [
                    {
                        "name": "NOVAVAX INC",
                        "executionDate": "2015-02-04"
                    }
                ],
                "url": "https://lens.org/124-751-515-975-629",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 2,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 2,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/215",
                    "A61K39/42",
                    "C07K14/005",
                    "C07K16/10",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 6,
                "nplCitations": [
                    "Liu et al. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV. Vaccine, 2011; 29: 6606\u00e2\u0080\u0093 6613",
                    "van Boheemen S, et al. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3(6): e00473-12. doi:10.1128/mBio.00473-12: pages 1-9",
                    "S. Shimizu. Chapter 32: Routes of Adminitration. The Laboratory Mouse. Copyright 2004 ElsevierISBN 0-1233-6425-6: 527-541.",
                    "Lu et al. Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice. Immunol. 2007; 122: 496\u2013502",
                    "Du et al. The spike protein of SARS-CoV \u2014 a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009; 7(3): 226\u2013236",
                    "L\u00f6vgren Bengtsson et al. ISCOM technology-based Matrix M\u2122 adjuvant: success in future vaccines relies on formulation, Expert Review of Vaccines, 2011; 10:4: 401-403"
                ],
                "nplResolvedCount": 5,
                "nplResolvedLensIDs": [
                    "042-950-360-609-42X",
                    "001-172-069-168-870",
                    "103-824-584-590-506",
                    "118-835-531-241-79X",
                    "023-939-052-489-028"
                ],
                "nplResolvedExternalIDs": [
                    "19198616",
                    "10.1038/nrmicro2090",
                    "21506635",
                    "10.1128/mbio.00473-12",
                    "17680799",
                    "10.1586/erv.11.25",
                    "pmc3165014",
                    "21762752",
                    "pmc2266036",
                    "10.1016/j.vaccine.2011.06.111",
                    "10.1111/j.1365-2567.2007.02676.x",
                    "23170002",
                    "pmc2750777"
                ]
            },
            {
                "index": "236",
                "publicationKey": "EP_3045181_B1",
                "lensId": "100-419-349-516-121",
                "jurisdiction": "EP",
                "kindCode": "B1",
                "displayKey": "EP 3045181 B1",
                "publicationDate": "2018-11-14",
                "filingNumber": "EP 15151594 A",
                "filingDate": "2015-01-19",
                "priorityFilingKeysActive": [
                    "EP 15151594 A 20150119"
                ],
                "earliestPriorityDate": "2015-01-19",
                "title": "A Novel Vaccine Against The Middle East Respiratory Syndrome Coronavirus (mers-cov)",
                "applicants": [
                    "UNIV MUENCHEN LUDWIG MAXIMILIANS",
                    "PHILIPPS UNIV MARBURG"
                ],
                "inventors": [
                    "SUTTER GERD",
                    "FUX ROBERT",
                    "VOLZ ASISA",
                    "SONG FEI",
                    "BECKER STEPHAN",
                    "EICKMANN MARKUS"
                ],
                "owners": [],
                "url": "https://lens.org/100-419-349-516-121",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K14/005",
                    "A61K39/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "ZHAO JINCUN ET AL: \"Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.\", IMMUNITY 21 JUN 2016, vol. 44, no. 6, 21 June 2016 (2016-06-21), pages 1379 - 1391, XP029619108, ISSN: 1097-4180, DOI: doi:10.1016/j.immuni.2016.05.006",
                    "ZHAO JINCUN ET AL: \"Rapid generation of a mouse model for Middle East respiratory syndrome.\", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 01 APR 2014, vol. 111, no. 13, 1 April 2014 (2014-04-01), pages 4970 - 4975, XP055212024, ISSN: 1091-6490, DOI: doi:10.1073/pnas.1323279111"
                ],
                "nplResolvedCount": 2,
                "nplResolvedLensIDs": [
                    "054-391-011-603-49X",
                    "028-241-381-303-519"
                ],
                "nplResolvedExternalIDs": [
                    "27287409",
                    "24599590",
                    "10.1016/j.immuni.2016.05.006",
                    "10.1073/pnas.1323279111",
                    "pmc3977243"
                ]
            },
            {
                "index": "237",
                "publicationKey": "CN_110035767_A",
                "lensId": "174-390-480-432-079",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 110035767 A",
                "publicationDate": "2019-07-19",
                "filingNumber": "CN 201780064143 A",
                "filingDate": "2017-10-20",
                "priorityFilingKeysActive": [
                    "FR 1660223 A 20161021"
                ],
                "earliestPriorityDate": "2016-10-21",
                "title": "Antiviral Compositions For The Treatment Of Infections Linked To Coronaviruses",
                "applicants": [
                    "UNIV CLAUDE BERNARD LYON",
                    "INST NAT SANTE RECH MED",
                    "CENTRE NAT RECH SCIENT"
                ],
                "inventors": [
                    "ROSA-CALATRAVA MANUEL",
                    "TERRIER OLIVIER",
                    "PROUST ANAIS",
                    "MOULES VINCENT"
                ],
                "owners": [],
                "url": "https://lens.org/174-390-480-432-079",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 11,
                "familySize": 11,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K38/21",
                    "A61K31/351",
                    "A61K31/352",
                    "A61K31/4375",
                    "A61K31/7056",
                    "A61K45/06",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 2,
                "nplCitations": [
                    "LIANG\uff0cR.Y. \u7b49: \"Development of Small-Molecule MERS-CoV Inhibitors\", \u300aVIRUS\u300b",
                    "\u65b9\u6ce2 \u7b49: \"\u5c0f\u6a97\u78b1\u7c7b\u6297\u5fae\u751f\u7269\u5316\u5408\u7269\u7814\u7a76\u8fdb\u5c55\", \u300a\u56fd\u9645\u836f\u5b66\u7814\u7a76\u6742\u5fd7\u300b"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "238",
                "publicationKey": "KR_20190119391_A",
                "lensId": "187-870-672-562-737",
                "jurisdiction": "KR",
                "kindCode": "A",
                "displayKey": "KR 20190119391 A",
                "publicationDate": "2019-10-22",
                "filingNumber": "KR 20180042778 A",
                "filingDate": "2018-04-12",
                "priorityFilingKeysActive": [
                    "KR 20180042778 A 20180412"
                ],
                "earliestPriorityDate": "2018-04-12",
                "title": "Whole Protein Gene Of Mers-cov Nucleoprotein And Vaccine Composition For Preventing Infection Of Mers-cov Comprising The Same",
                "applicants": [
                    "KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY"
                ],
                "inventors": [
                    "JEONG DAE GWIN",
                    "KIM HYE KWON",
                    "YOON SUN WOO",
                    "KIM DOO JIN",
                    "KIM JI HYUNG",
                    "PARK SUNG KYUN",
                    "SONG DAESUB"
                ],
                "owners": [],
                "url": "https://lens.org/187-870-672-562-737",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 2,
                "familySize": 2,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N15/63",
                    "A61K39/215",
                    "A61P31/12",
                    "C07K14/005",
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 10,
                "nplCitations": [
                    "Scientific Reports (2017) 7:44875",
                    "Human Vaccines & Immunotherapeutics (2016) 12(9):2351-2356",
                    "Viruses (2019) 11:74",
                    "International Journal of Virology & Infectious Diseases (2017) 2(1):001-007",
                    "Annals of Translational Medicine (2016) 4(24):499",
                    "NCBI, GenBank: JX869059.2 (2012.12.04.)",
                    "Journal of Virology (2015) 89(17):9029-9043",
                    "Vaccine (2017) 35(16):2069-2075",
                    "Human Vaccines & Immunotherapeutics (2017.11.29.) 14(2):304-313",
                    "Azhar EI, Hashem AM, El-Kafrawy SA, Sohrab SS, Aburizaiza AS, Farraj SA, Hassan AM, Al-Saeed MS, Jamjoom GA, Madani TA. 2014. Detection of the middle east respiratory syndrome coronavirus genome in an air sample originating from a camel barn owned by an infected patient. mBio 5(4):e01450-14. doi:10.1128/mBio.01450-14."
                ],
                "nplResolvedCount": 7,
                "nplResolvedLensIDs": [
                    "061-746-565-451-540",
                    "008-876-457-044-44X",
                    "059-315-587-039-286",
                    "058-043-399-214-566",
                    "064-032-852-064-070",
                    "074-664-396-227-136",
                    "079-602-442-821-274"
                ],
                "nplResolvedExternalIDs": [
                    "pmc4524063",
                    "10.21037/atm.2016.11.40",
                    "pmc5233508",
                    "28314561",
                    "26085159",
                    "28332568",
                    "28149861",
                    "10.1080/21645515.2016.1177688",
                    "10.1038/srep44875",
                    "10.1128/jvi.01331-15",
                    "27269431",
                    "pmc5027702",
                    "10.1016/j.vaccine.2017.02.063",
                    "29048984",
                    "25053787",
                    "pmc5806638",
                    "10.1080/21645515.2017.1389362",
                    "10.1128/mbio.01450-14"
                ]
            },
            {
                "index": "239",
                "publicationKey": "WO_2015_026958_A1",
                "lensId": "061-716-056-821-059",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2015/026958 A1",
                "publicationDate": "2015-02-26",
                "filingNumber": "US 2014/0051914 W",
                "filingDate": "2014-08-20",
                "priorityFilingKeysActive": [
                    "US 201361867971 P 20130820"
                ],
                "earliestPriorityDate": "2013-08-20",
                "title": "Methods For Improving Respiratory System Health And Increasing The Concentration Of Hypothiocyanate Ion In Vertebrate Lungs",
                "applicants": [
                    "LEE JAMES D"
                ],
                "inventors": [
                    "LEE JAMES D"
                ],
                "owners": [],
                "url": "https://lens.org/061-716-056-821-059",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 8,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61L2/20"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "BLOCK SEYMOUR: \"Disinfection, sterilization, and preservation\", 1 January 2001, DISINFECTION, STERILIZATION AND PRESERVATION, XX, XX, PAGE(S) 187-191,344, XP002503889"
                ],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "240",
                "publicationKey": "WO_2020_036403_A1",
                "lensId": "156-443-339-876-918",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2020/036403 A1",
                "publicationDate": "2020-02-20",
                "filingNumber": "KR 2019010272 W",
                "filingDate": "2019-08-13",
                "priorityFilingKeysActive": [
                    "KR 20180096102 A 20180817"
                ],
                "earliestPriorityDate": "2018-08-17",
                "title": "Monoclonal Antibody Against S Protein Of Mers-coronavirus, And Use Of Same",
                "applicants": [
                    "INDUSTRY ACADEMIC COOPERATION FOUNDATION HALLYM UNIV"
                ],
                "inventors": [
                    "KWON HYUNG JOO",
                    "PARK BYOUNG KWON",
                    "KIM DONG BUM"
                ],
                "owners": [],
                "url": "https://lens.org/156-443-339-876-918",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/10",
                    "G01N33/569"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "241",
                "publicationKey": "CN_110468237_A",
                "lensId": "162-987-576-101-174",
                "jurisdiction": "CN",
                "kindCode": "A",
                "displayKey": "CN 110468237 A",
                "publicationDate": "2019-11-19",
                "filingNumber": "CN 201910821266 A",
                "filingDate": "2016-03-10",
                "priorityFilingKeysActive": [
                    "CN 201610147784 A 20160310"
                ],
                "earliestPriorityDate": "2016-03-10",
                "title": "Primer Probe Mixed Liquid And Kit For Detecting Middle East Respiratory Syndrome Corona Virus (mers-cov)",
                "applicants": [
                    "DA AN GENE CO LTD OF SUN YAT SEN UNIV"
                ],
                "inventors": [
                    "LI MING",
                    "HE WANPING",
                    "JIANG XIWEN",
                    "ZHOU QIWEI",
                    "GAO XIUJIE",
                    "XIA QIAO",
                    "YOU HUAN",
                    "YE AIHUA",
                    "WU JIE"
                ],
                "owners": [],
                "url": "https://lens.org/162-987-576-101-174",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12Q1/70",
                    "C12N15/11",
                    "C12Q1/686"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "242",
                "publicationKey": "US_2019_0336526_A1",
                "lensId": "003-192-299-100-485",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0336526 A1",
                "publicationDate": "2019-11-07",
                "filingNumber": "US 201916431032 A",
                "filingDate": "2019-06-04",
                "priorityFilingKeysActive": [
                    "US 201361867971 P 20130820"
                ],
                "earliestPriorityDate": "2013-08-20",
                "title": "Methods For Improving Respiratory System Health And Increasing The Concentration Of Hypothiocyanate Ion In Vertebrate Lungs",
                "applicants": [
                    "LEE JAMES D"
                ],
                "inventors": [
                    "LEE JAMES D"
                ],
                "owners": [],
                "url": "https://lens.org/003-192-299-100-485",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K33/40",
                    "A61L2/20",
                    "A61L9/04"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "243",
                "publicationKey": "WO_2020_040343_A1",
                "lensId": "075-934-481-205-613",
                "jurisdiction": "WO",
                "kindCode": "A1",
                "displayKey": "WO 2020/040343 A1",
                "publicationDate": "2020-02-27",
                "filingNumber": "KR 2018010557 W",
                "filingDate": "2018-09-10",
                "priorityFilingKeysActive": [
                    "KR 20180099378 A 20180824"
                ],
                "earliestPriorityDate": "2018-08-24",
                "title": "Isoxazole Derivatives And Preparation Process Thereof",
                "applicants": [
                    "IL YANG PHARM CO LTD"
                ],
                "inventors": [
                    "KIM DONG YEON",
                    "SHIN JAE SOO",
                    "CHO DAE JIN",
                    "LEE GONG YEAL",
                    "KIM HONG YOUB",
                    "LEE HEA UN",
                    "AHN CHOONG AM",
                    "SONG SONG EI",
                    "PARK JONG SEONG",
                    "KANG SOUNG YOUNG",
                    "PARK MAN SEONG"
                ],
                "owners": [],
                "url": "https://lens.org/075-934-481-205-613",
                "docType": "Patent Application",
                "hasFullText": false,
                "citedByPatentCount": 0,
                "simpleFamilySize": 1,
                "familySize": 1,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07D261/08",
                    "A61K31/496",
                    "A61P31/14"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "244",
                "publicationKey": "US_2019_0256585_A1",
                "lensId": "174-156-700-336-404",
                "jurisdiction": "US",
                "kindCode": "A1",
                "displayKey": "US 2019/0256585 A1",
                "publicationDate": "2019-08-22",
                "filingNumber": "US 201615570734 A",
                "filingDate": "2016-06-10",
                "priorityFilingKeysActive": [
                    "KR 20150082132 A 20150610"
                ],
                "earliestPriorityDate": "2015-06-10",
                "title": "Antibody Specifically Binding To An Isolated Peptide Derived From Vimentin Or A Fragment Binding To The Peptide",
                "applicants": [
                    "IMMUNEMED INC"
                ],
                "inventors": [
                    "KIM YOON WON",
                    "KIM YOUNG JIN",
                    "HONG HYO JEONG",
                    "PARK SANG JIN",
                    "KIM MIN WOO",
                    "PARK SUNG MAN"
                ],
                "owners": [
                    {
                        "name": "IMMUNEMED INC",
                        "executionDate": "2017-11-14"
                    }
                ],
                "url": "https://lens.org/174-156-700-336-404",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 15,
                "familySize": 16,
                "seqCount": 162,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/18",
                    "A61P29/00",
                    "A61P31/12",
                    "A61P31/16",
                    "A61P31/20"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "245",
                "publicationKey": "AU_2017_269336_A1",
                "lensId": "052-189-838-573-469",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2017/269336 A1",
                "publicationDate": "2018-09-27",
                "filingNumber": "AU 2017/269336 A",
                "filingDate": "2017-05-24",
                "priorityFilingKeysActive": [
                    "US 201662340624 P 20160524"
                ],
                "earliestPriorityDate": "2016-05-24",
                "title": "Metabalomics And Viral Diagnostics Suite",
                "applicants": [
                    "EXCISION BIOTHERAPEUTICS INC"
                ],
                "inventors": [
                    "MALCOLM THOMAS"
                ],
                "owners": [],
                "url": "https://lens.org/052-189-838-573-469",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 7,
                "familySize": 7,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "G01N33/573",
                    "G01N33/574"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "246",
                "publicationKey": "AU_2016_357651_A1",
                "lensId": "040-428-257-126-193",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2016/357651 A1",
                "publicationDate": "2018-05-17",
                "filingNumber": "AU 2016/357651 A",
                "filingDate": "2016-11-18",
                "priorityFilingKeysActive": [
                    "US 201562256868 P 20151118"
                ],
                "earliestPriorityDate": "2015-11-18",
                "title": "Pharmaceutical Compositions Of Ribavirin",
                "applicants": [
                    "GLAXOSMITHKLINE IP NO 2 LTD",
                    "LIQUIDIA TECHNOLOGIES INC"
                ],
                "inventors": [
                    "DELL'ORCO PHILIP CHARLES",
                    "FARRER BRIAN T",
                    "HONG ZHI",
                    "ROBERTS CHRISTOPHER D",
                    "SAVAGE JOHN ROBERT",
                    "SPRAGUE JACOB J",
                    "WANG YONGCAI"
                ],
                "owners": [],
                "url": "https://lens.org/040-428-257-126-193",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 10,
                "familySize": 10,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K9/14",
                    "A61K9/50",
                    "A61K31/7056"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "247",
                "publicationKey": "AU_2015_264189_A1",
                "lensId": "132-408-086-125-619",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2015/264189 A1",
                "publicationDate": "2016-11-17",
                "filingNumber": "AU 2015/264189 A",
                "filingDate": "2015-05-20",
                "priorityFilingKeysActive": [
                    "US 201462051717 P 20140917",
                    "US 201462002233 P 20140523",
                    "US 201462004971 P 20140530",
                    "US 201462072716 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-23",
                "title": "Human Antibodies To Middle East Respiratory Syndrome -coronavirus Spike Protein",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "STAHL NEIL",
                    "SIVAPALASINGAM SUMATHI"
                ],
                "owners": [],
                "url": "https://lens.org/132-408-086-125-619",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 20,
                "familySize": 21,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/08",
                    "A61K39/00",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "248",
                "publicationKey": "AU_2018_275267_A1",
                "lensId": "077-879-273-568-536",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2018/275267 A1",
                "publicationDate": "2019-12-19",
                "filingNumber": "AU 2018/275267 A",
                "filingDate": "2018-06-01",
                "priorityFilingKeysActive": [
                    "US 201762514091 P 20170602"
                ],
                "earliestPriorityDate": "2017-06-02",
                "title": "Phenotypically Wild-type And Genetically Attenuated Viruses",
                "applicants": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "inventors": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "owners": [],
                "url": "https://lens.org/077-879-273-568-536",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/21",
                    "C12N7/00"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "249",
                "publicationKey": "AU_2018_275790_A1",
                "lensId": "146-235-512-758-263",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2018/275790 A1",
                "publicationDate": "2019-12-19",
                "filingNumber": "AU 2018/275790 A",
                "filingDate": "2018-06-01",
                "priorityFilingKeysActive": [
                    "US 201762514096 P 20170602"
                ],
                "earliestPriorityDate": "2017-06-02",
                "title": "Genetically Attenuated Nucleic Acid Vaccine",
                "applicants": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "inventors": [
                    "SHACKELTON LAURA",
                    "KERNER MATTHEW"
                ],
                "owners": [],
                "url": "https://lens.org/146-235-512-758-263",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 3,
                "familySize": 3,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C12N15/66",
                    "C12N15/10",
                    "C12N15/11",
                    "C12N15/33"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "250",
                "publicationKey": "AU_2014_212104_B2",
                "lensId": "098-617-620-673-245",
                "jurisdiction": "AU",
                "kindCode": "B2",
                "displayKey": "AU 2014/212104 B2",
                "publicationDate": "2018-02-15",
                "filingNumber": "AU 2014/212104 A",
                "filingDate": "2014-01-31",
                "priorityFilingKeysActive": [
                    "US 201361759131 P 20130131"
                ],
                "earliestPriorityDate": "2013-01-31",
                "title": "Immunogenic Compositions Comprising Silicified Virus And Methods Of Use",
                "applicants": [
                    "PORTLAND STATE UNIV",
                    "PROVIDENCE HEALTH & SERVICES OREGON"
                ],
                "inventors": [
                    "STEDMAN KENNETH M",
                    "LAIDLER JAMES R",
                    "BAHJAT KEITH"
                ],
                "owners": [],
                "url": "https://lens.org/098-617-620-673-245",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 18,
                "familySize": 18,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K39/12"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "LAIDLER et al., \"Virus Silicification under Simulated Hot Spring Conditions\", Astrobiology, 2010, Vol. 10, No. 6, pages 569-576"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "045-732-946-166-420"
                ],
                "nplResolvedExternalIDs": [
                    "10.1089/ast.2010.0463",
                    "20735248"
                ]
            },
            {
                "index": "251",
                "publicationKey": "AU_2015_332634_A1",
                "lensId": "167-220-684-585-24X",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2015/332634 A1",
                "publicationDate": "2017-04-27",
                "filingNumber": "AU 2015/332634 A",
                "filingDate": "2015-10-15",
                "priorityFilingKeysActive": [
                    "EP 14306633 A 20141015"
                ],
                "earliestPriorityDate": "2014-10-15",
                "title": "Composition With Reduced Immunogenicity",
                "applicants": [
                    "XENOTHERA"
                ],
                "inventors": [
                    "SOULILLOU JEAN-PAUL",
                    "DUVAUX ODILE"
                ],
                "owners": [],
                "url": "https://lens.org/167-220-684-585-24X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 9,
                "familySize": 9,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/08",
                    "A01K67/027",
                    "C07K16/10",
                    "C07K16/12",
                    "C07K16/14",
                    "C12N9/02",
                    "C12N9/10",
                    "C12N9/22",
                    "C12N9/40"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "252",
                "publicationKey": "AU_2014_354797_B2",
                "lensId": "038-520-559-056-952",
                "jurisdiction": "AU",
                "kindCode": "B2",
                "displayKey": "AU 2014/354797 B2",
                "publicationDate": "2017-10-26",
                "filingNumber": "AU 2014/354797 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "INOVIO PHARMACEUTICALS INC",
                    "UNIV PENNSYLVANIA"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/038-520-559-056-952",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "SONG F, et al., 'Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies,' Journal of Virology, (2013) vol 87 No 21, pp 11950-11954"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "114-114-185-080-165"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3807317",
                    "23986586",
                    "10.1128/jvi.01672-13"
                ]
            },
            {
                "index": "253",
                "publicationKey": "AU_2014_354797_C1",
                "lensId": "049-291-082-842-755",
                "jurisdiction": "AU",
                "kindCode": "C1",
                "displayKey": "AU 2014/354797 C1",
                "publicationDate": "2018-02-01",
                "filingNumber": "AU 2014/354797 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "INOVIO PHARMACEUTICALS INC",
                    "UNIV PENNSYLVANIA"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/049-291-082-842-755",
                "docType": "Amended Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "SONG F, et al., 'Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies,' Journal of Virology, (2013) vol 87 No 21, pp 11950-11954"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "114-114-185-080-165"
                ],
                "nplResolvedExternalIDs": [
                    "pmc3807317",
                    "23986586",
                    "10.1128/jvi.01672-13"
                ]
            },
            {
                "index": "254",
                "publicationKey": "AU_2014_354797_A1",
                "lensId": "117-582-520-419-776",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2014/354797 A1",
                "publicationDate": "2016-07-07",
                "filingNumber": "AU 2014/354797 A",
                "filingDate": "2014-11-26",
                "priorityFilingKeysActive": [
                    "US 201361910153 P 20131129"
                ],
                "earliestPriorityDate": "2013-11-29",
                "title": "Mers-cov Vaccine",
                "applicants": [
                    "INOVIO PHARMACEUTICALS INC",
                    "UNIV PENNSYLVANIA"
                ],
                "inventors": [
                    "WEINER DAVID B",
                    "MUTHUMANI KARUPPIAH",
                    "SARDESAI NIRANJAN Y"
                ],
                "owners": [],
                "url": "https://lens.org/117-582-520-419-776",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61K48/00",
                    "A61K38/16",
                    "A61K39/12",
                    "A61K39/215"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "255",
                "publicationKey": "AU_2015_266841_C1",
                "lensId": "086-878-343-453-999",
                "jurisdiction": "AU",
                "kindCode": "C1",
                "displayKey": "AU 2015/266841 C1",
                "publicationDate": "2018-06-07",
                "filingNumber": "AU 2015/266841 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462051626 P 20140917",
                    "US 201462005476 P 20140530",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/086-878-343-453-999",
                "docType": "Amended Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "SIMEONI L. et al., Human Immunology, 2002, Vol. 63, pages 719-730"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "037-334-759-900-091"
                ],
                "nplResolvedExternalIDs": [
                    "12175726",
                    "10.1016/s0198-8859(02)00433-0"
                ]
            },
            {
                "index": "256",
                "publicationKey": "AU_2015_266841_B2",
                "lensId": "039-850-836-515-474",
                "jurisdiction": "AU",
                "kindCode": "B2",
                "displayKey": "AU 2015/266841 B2",
                "publicationDate": "2017-04-13",
                "filingNumber": "AU 2015/266841 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462051626 P 20140917",
                    "US 201462005476 P 20140530",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/039-850-836-515-474",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "257",
                "publicationKey": "AU_2015_266841_A1",
                "lensId": "022-640-834-554-75X",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2015/266841 A1",
                "publicationDate": "2016-12-08",
                "filingNumber": "AU 2015/266841 A",
                "filingDate": "2015-05-28",
                "priorityFilingKeysActive": [
                    "US 201462051626 P 20140917",
                    "US 201462005476 P 20140530",
                    "US 201462072692 P 20141030"
                ],
                "earliestPriorityDate": "2014-05-30",
                "title": "Humanized Dipeptidyl Peptidase Iv (dpp4) Animals",
                "applicants": [
                    "REGENERON PHARMA"
                ],
                "inventors": [
                    "KYRATSOUS CHRISTOS",
                    "MUJICA ALEXANDER"
                ],
                "owners": [],
                "url": "https://lens.org/022-640-834-554-75X",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 33,
                "familySize": 33,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A01K67/027"
                ],
                "usClassifications": [],
                "nplCitationCount": 1,
                "nplCitations": [
                    "SIMEONI L. et al., Human Immunology, 2002, Vol. 63, pages 719-730"
                ],
                "nplResolvedCount": 1,
                "nplResolvedLensIDs": [
                    "037-334-759-900-091"
                ],
                "nplResolvedExternalIDs": [
                    "12175726",
                    "10.1016/s0198-8859(02)00433-0"
                ]
            },
            {
                "index": "258",
                "publicationKey": "AU_2014_308878_B2",
                "lensId": "166-694-962-816-115",
                "jurisdiction": "AU",
                "kindCode": "B2",
                "displayKey": "AU 2014/308878 B2",
                "publicationDate": "2018-07-26",
                "filingNumber": "AU 2014/308878 A",
                "filingDate": "2014-08-20",
                "priorityFilingKeysActive": [
                    "US 201361867971 P 20130820"
                ],
                "earliestPriorityDate": "2013-08-20",
                "title": "Methods For Improving Respiratory System Health And Increasing The Concentration Of Hypothiocyanate Ion In Vertebrate Lungs",
                "applicants": [
                    "LEE JAMES D"
                ],
                "inventors": [
                    "LEE JAMES D"
                ],
                "owners": [],
                "url": "https://lens.org/166-694-962-816-115",
                "docType": "Granted Patent",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 16,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "A61L2/20"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            },
            {
                "index": "259",
                "publicationKey": "AU_2019_204638_A1",
                "lensId": "066-616-123-539-541",
                "jurisdiction": "AU",
                "kindCode": "A1",
                "displayKey": "AU 2019/204638 A1",
                "publicationDate": "2019-07-18",
                "filingNumber": "AU 2019/204638 A",
                "filingDate": "2019-06-28",
                "priorityFilingKeysActive": [
                    "KR 20150082132 A 20150610"
                ],
                "earliestPriorityDate": "2015-06-10",
                "title": "Antibody Binding Specifically Isolated Vimentin-derived Peptide, Or Binding Fragment Of The Peptide",
                "applicants": [
                    "IMMUNEMED INC"
                ],
                "inventors": [
                    "KIM YOON",
                    "KIM YOUNG",
                    "HONG HYO JEONG",
                    "PARK SANG",
                    "KIM MIN",
                    "PARK SUNG"
                ],
                "owners": [],
                "url": "https://lens.org/066-616-123-539-541",
                "docType": "Patent Application",
                "hasFullText": true,
                "citedByPatentCount": 0,
                "simpleFamilySize": 15,
                "familySize": 16,
                "seqCount": 0,
                "cpcClassifications": [],
                "ipcrClassifications": [
                    "C07K16/18",
                    "A61K39/00",
                    "A61K39/395"
                ],
                "usClassifications": [],
                "nplCitationCount": 0,
                "nplCitations": [],
                "nplResolvedCount": 0,
                "nplResolvedLensIDs": [],
                "nplResolvedExternalIDs": []
            }
        ]
    }
}
